Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
Celiac Disease,34/312,2.056982588033606E-56,2.021602487519428E-52,0,0,54.48717948717949,6986.538224519504,IL21;CD80;HMGB1;FUT2;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;IL12A;TNFRSF14;CD14;CCR4;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;THEMIS;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Autoimmune Diseases,36/1060,4.9734704277960355E-42,2.443963368218972E-38,0,0,16.9811320754717,1614.9813288811408,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;TNF;INS;DPP4;ZMIZ1;TNFRSF14;CD14;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Multiple Sclerosis,34/1106,3.0576998089502292E-37,1.001702457412095E-33,0,0,15.370705244122965,1292.3379327001257,IL21;CD80;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;IL12A;CD14;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Asthma,35/1313,1.2441668191611691E-36,3.0569178746789925E-33,0,0,13.328255902513328,1101.908188964556,IL21;CD80;AHR;HMGB1;ETS1;HIF1A;TNF;ZMIZ1;IL12A;TNFRSF14;CD14;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Infection,28/492,1.745210782711024E-36,3.4303863144967885E-33,0,0,28.455284552845526,2342.899658736954,IL21;CD80;HMGB1;FUT2;HIF1A;TNF;DPP4;TNFRSF14;CD14;HLA-DQA1;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Inflammatory Bowel Diseases,32/911,3.7685901023776895E-36,6.172950587694655E-33,0,0,17.56311745334797,1432.5596029755811,IL21;AHR;HMGB1;FUT2;ETS1;HIF1A;TNF;DPP4;ZMIZ1;IL12A;TNFRSF14;CD14;IL6R;HLA-DQA1;IL10;TGFB1;IL15;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Psoriasis,31/818,1.0159523491426662E-35,1.4263970981963033E-32,0,0,18.94865525672372,1526.781299524905,IL21;AHR;PRL;FUT2;ETS1;TNF;ZMIZ1;TNFRSF14;CD14;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;VDR;TNFRSF9;MTHFR;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Ulcerative Colitis,31/915,3.336769023725563E-34,4.0992207456468545E-31,0,0,16.93989071038251,1305.7757353093998,IL21;CD80;AHR;HMGB1;FUT2;ETS1;TNF;ZMIZ1;TNFRSF14;CD14;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Diabetes Mellitus,31/956,1.3033368611173034E-33,1.4232438523400952E-30,0,0,16.213389121338913,1227.6839898425158,IL21;CD80;HMGB1;FUT2;TNF;INS;ZMIZ1;IL12A;CD14;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;THEMIS;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Eczema,26/454,1.5293097129827876E-33,1.5030055859194837E-30,0,0,28.634361233480178,2163.6264115451218,IL21;CD80;AHR;HMGB1;TNF;DPP4;IL12A;CD14;CCR4;IL6R;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Rheumatoid Arthritis,36/1833,1.9986030276776542E-33,1.785660959637817E-30,0,0,9.819967266775777,739.3734168752194,IL21;CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;IL12A;TNFRSF14;CD14;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Lupus Erythematosus, Systemic,32/1113,2.3318495175161505E-33,1.9097847548457273E-30,0,0,14.375561545372866,1080.160234778284,IL21;CD80;HMGB1;PRL;FUT2;ETS1;TNF;ZMIZ1;IL12A;TNFRSF14;CD14;CCR4;IL6R;HLA-DQA1;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Juvenile arthritis,24/326,2.6133084684519735E-33,1.975661202149692E-30,0,0,36.809815950920246,2761.6450688752466,IL21;IL10;STAT1;VDR;MTHFR;HMGB1;FUT2;HIF1A;TNF;IL2;DPP4;CXCL10;IL6;IFNG;ZMIZ1;IL1B;IL2RA;IRF1;CD14;CCR4;IL6R;TLR4;HLA-DRB1;IL17A
Periodontal Diseases,19/137,2.3955998635320254E-31,1.681711104199482E-28,0,0,69.34306569343066,4889.137153828809,IL21;IL10;IL15;STAT1;VDR;CD80;HIF1A;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;TLR4;HLA-DRB1;IL17A
Hepatitis B, Chronic,21/238,1.6887286217677326E-30,1.1064549929822183E-27,0,0,44.11764705882353,3024.4225075947406,IL21;IL10;TGFB1;STAT1;VDR;CD80;TNFRSF9;HMGB1;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Arthritis,26/630,8.33699139807042E-30,5.120996966264756E-27,0,0,20.634920634920633,1381.6492936003538,IL21;CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;DPP4;IL12A;TNFRSF14;HLA-DQA1;IL10;IL15;VDR;MTHFR;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Juvenile rheumatoid arthritis,18/131,1.4672071591521325E-29,8.482183505968917E-27,0,0,68.70229007633588,4561.255442394511,IL10;IL15;VDR;MTHFR;HMGB1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;CCR4;TLR4;HLA-DQA1;HLA-DRB1
Graves Disease,22/335,3.654653145535456E-29,1.9954406174623592E-26,0,0,32.83582089552239,2150.055616639587,IL21;IL10;TGFB1;IL15;VDR;FUT2;ETS1;HIF1A;TNF;IL2;INS;CXCL10;IL6;IFNG;IL1B;IL2RA;IL12A;CD14;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Dermatitis, Atopic,24/484,4.054003754819946E-29,2.0969867843352858E-26,0,0,24.793388429752067,1620.87428237843,IL21;IL10;TGFB1;IL15;VDR;MTHFR;AHR;HMGB1;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;IL12A;TNFRSF14;CD14;CCR4;IL6R;S100A9;TLR4;IL17A
Allergic asthma,19/197,3.3844038775451627E-28,1.663096065425693E-25,0,0,48.223350253807105,3050.2814507132866,IL21;IL10;TGFB1;VDR;TNFRSF9;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;CCR4;TLR4;HLA-DRB1;IL17A
Behcet Syndrome,20/258,8.456346541720731E-28,3.957570181525302E-25,0,0,38.75968992248062,2416.180828463179,IL10;IL15;VDR;MTHFR;AHR;FUT2;ETS1;TNF;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;IL12A;CCR4;TLR4;HLA-DRB1;IL17A
Hepatitis C, Chronic,22/386,8.683352191855558E-28,3.8790902427980196E-25,0,0,28.497409326424872,1775.7013587499314,IL21;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;PRL;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;S100A9;TLR4;HLA-DQA1;HLA-DRB1
Lymphoma,30/1307,9.358120258644803E-28,3.99876547399831E-25,0,0,11.476664116296863,714.2632535644235,IL21;CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;DPP4;IL12A;TNFRSF14;CD14;CCR4;HLA-DQA1;IL10;TGFB1;IL15;STAT1;TNFRSF9;MTHFR;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1
Virus Diseases,27/875,9.585390270408734E-28,3.9252173157323763E-25,0,0,15.428571428571429,959.8444844612454,IL21;CD80;HMGB1;FUT2;TNF;INS;DPP4;CD14;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Graft-vs-Host Disease,19/226,5.028870044185625E-27,1.9769493917702527E-24,0,0,42.0353982300885,2545.4368179426283,IL21;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;FUT2;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Gingival Diseases,16/114,2.3257415265094906E-26,8.791302970205874E-24,0,0,70.17543859649122,4141.977087264706,IL10;STAT1;VDR;CD80;HIF1A;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;TLR4;HLA-DRB1
Leishmaniasis, Visceral,15/86,3.2286218748334817E-26,1.1752183624393873E-23,0,0,87.20930232558139,5118.763694982201,IL10;TGFB1;IL15;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Malignant neoplasm of stomach,34/2398,7.162584067565817E-26,2.5140670077156017E-23,0,0,7.089241034195163,410.45529907329075,IL21;CD80;AHR;HMGB1;FUT2;ETS1;HIF1A;TNF;INS;DPP4;IL12A;CD14;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Eosinophilic disorder,17/161,7.953639451168274E-26,2.695460983657993E-23,0,0,52.79503105590062,3051.2139988282047,IL10;TGFB1;IL15;VDR;CD80;TNFRSF9;AHR;HMGB1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;IL17A
leukemia,32/1941,1.0724006833944514E-25,3.5131846388002226E-23,0,0,8.243173621844411,473.93902161949217,CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;CD14;CCR4;IL6R;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1
Crohn Disease,26/912,1.2118666319565213E-25,3.842008148022158E-23,0,0,14.254385964912279,817.8092667518449,IL21;HMGB1;FUT2;ETS1;TNF;ZMIZ1;TNFRSF14;CD14;IL6R;IL10;TGFB1;IL15;VDR;TNFRSF9;MTHFR;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Liver Cirrhosis,24/683,1.5990094144984409E-25,4.9109576642783364E-23,0,0,17.569546120058565,1003.1375051819963,IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;HIF1A;TNF;IL2;INS;SOD1;DPP4;CXCL10;IL6;IFNG;IL1B;IL12A;CD14;S100A9;TLR4;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Pseudohyperkalemia Cardiff,16/131,2.4489536889048986E-25,7.293429349865862E-23,0,0,61.06870229007633,3460.7002416651085,IL21;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;TNF;DPP4;CXCL10;IL6;IFNG;IRF1;TLR4;HLA-DQA1;HLA-DRB1
Tuberculosis,23/602,3.691024328665033E-25,1.0669231500623512E-22,0,0,19.102990033222593,1074.709830662769,IL21;IL10;TGFB1;IL15;STAT1;VDR;CD80;THEMIS;PRL;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;IL12A;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Colitis,23/608,4.63315891850112E-25,1.3009910243151145E-22,0,0,18.914473684210527,1059.8042217140974,IL21;IL10;TGFB1;IL15;STAT1;VDR;AHR;HMGB1;HIF1A;TNF;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Diabetes,28/1268,5.763732887884178E-25,1.5734990783923806E-22,0,0,11.041009463722398,616.2323248023048,IL21;CD80;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Sarcoidosis,18/236,9.184000133870711E-25,2.439469008531928E-22,0,0,38.13559322033898,2110.696950153715,TGFB1;IL15;STAT1;VDR;CD80;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Atherosclerosis,27/1134,9.740277146761476E-25,2.519143257851889E-22,0,0,11.904761904761903,658.1947351560542,AHR;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;TNFRSF14;CD14;IL6R;IL10;TGFB1;IL15;STAT1;TNFRSF9;MTHFR;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;IL17A
Liver carcinoma,37/3593,1.2401584160986928E-24,3.125199208568706E-22,0,0,5.1489006401335935,283.4305197471232,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;INS;ZMIZ1;IL12A;TNFRSF14;CD14;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Multiple Myeloma,28/1312,1.4727870792222719E-24,3.618637853649122E-22,0,0,10.670731707317074,585.5551822823971,IL21;CD80;AHR;HMGB1;HIF1A;TNF;DPP4;CD14;IL6R;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Vitiligo,18/243,1.5734960680452315E-24,3.7717852089630575E-22,0,0,37.03703703703703,2029.9534182665543,IL10;TGFB1;VDR;CD80;MTHFR;AHR;TNF;IL2;SOD1;IL6;IFNG;ZMIZ1;IL1B;IL2RA;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Colorectal Carcinoma,35/2931,1.665285678305296E-24,3.896768487234393E-22,0,0,5.970658478335039,326.90576493693794,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;IL12A;CD14;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Diabetes Mellitus,29/1507,2.1641329204850994E-24,4.946301940122688E-22,0,0,9.62176509621765,524.2901960942602,IL21;CD80;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Cerebrovascular accident,24/768,2.6120569779179874E-24,5.834385449767723E-22,0,0,15.625,848.4672532308836,IL21;IL10;TGFB1;STAT1;VDR;MTHFR;AHR;HMGB1;PRL;HIF1A;TNF;INS;SOD1;CXCL10;IL6;IL1B;IRF1;IL12A;CD14;IL6R;TLR4;HLA-DRB1;TGM2;IL17A
Dermatomyositis,15/114,2.989526428281486E-24,6.529125719366765E-22,0,0,65.78947368421052,3563.613634354532,IL10;TGFB1;IL15;STAT1;HMGB1;TNF;IL2;SOD1;IL6;IL1B;IL2RA;TLR4;HLA-DRB1;TGM2;IL17A
Acute Coronary Syndrome,18/255,3.816854885377399E-24,8.154793437715016E-22,0,0,35.29411764705882,1903.1511344751123,IL10;TGFB1;IL15;CD80;TNFRSF9;MTHFR;TNF;IL2;IL6;IL1B;IL2RA;IRF1;CD14;S100A9;TLR4;HLA-DRB1;TGM2;IL17A
Acute lymphocytic leukemia,25/907,3.9563841968151014E-24,8.273051890701876E-22,0,0,13.781697905181918,742.6503818262954,CD80;AHR;HMGB1;HIF1A;TNF;DPP4;CD14;HLA-DQA1;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DRB1
Sjogren's Syndrome,18/260,5.45092769479689E-24,1.1160774455096632E-21,0,0,34.61538461538461,1854.2165683305739,IL21;IL10;TGFB1;STAT1;HMGB1;PRL;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;IL12A;CD14;HLA-DRB1;IL17A
Glioma,32/2211,6.362380171234223E-24,1.2761116800589787E-21,0,0,7.236544549977386,386.51571005883727,IL21;CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;DPP4;IL12A;CCR4;IL6R;TGM2;IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Hodgkin Disease,22/592,1.0953273305437744E-23,2.152975400916843E-21,0,0,18.58108108108108,982.3520992751461,IL21;IL10;TGFB1;STAT1;VDR;CD80;TNFRSF9;MTHFR;HMGB1;ETS1;HIF1A;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;CCR4;IL6R;IL17A
Encephalitis, St. Louis,15/124,1.1308779135929532E-23,2.1792682617238322E-21,0,0,60.483870967741936,3195.7538040179497,IL10;STAT1;HMGB1;PRL;ETS1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;HLA-DRB1;IL17A
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),16/166,1.2808045262250264E-23,2.4207205545653E-21,0,0,48.19277108433735,2540.3358420368345,IL10;TGFB1;VDR;MTHFR;AHR;TNF;IL2;SOD1;IL6;IFNG;ZMIZ1;IL1B;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Acute GVH disease,16/166,1.2808045262250264E-23,2.375046581837653E-21,0,0,48.19277108433735,2540.3358420368345,IL10;TGFB1;VDR;MTHFR;HMGB1;FUT2;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DRB1;IL17A
Pneumonitis,19/339,1.29588005963066E-23,2.358501708527801E-21,0,0,28.023598820058996,1476.851142690475,IL10;TGFB1;IL15;VDR;MTHFR;AHR;HMGB1;HIF1A;TNF;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Complete atrioventricular block,16/170,1.9003888156818668E-23,3.3958220510038884E-21,0,0,47.05882352941176,2461.9952298255985,IL21;IL10;TGFB1;STAT1;VDR;TNF;IL2;CXCL10;IL6;IFNG;IL2RA;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Hepatitis, Autoimmune,15/129,2.1078322818282796E-23,3.6992456546086305E-21,0,0,58.13953488372093,3035.6858763982136,IL10;TGFB1;VDR;TNF;IL2;INS;CXCL10;IL6;IFNG;IL1B;IL2RA;TNFRSF14;HLA-DQA1;HLA-DRB1;IL17A
Hepatitis B,24/839,2.1256949157505338E-23,3.6651455494730256E-21,0,0,14.302741358760429,746.6797383185086,IL21;IL10;TGFB1;STAT1;VDR;CD80;TNFRSF9;MTHFR;HMGB1;HIF1A;TNF;IL2;INS;CXCL10;IL6;IFNG;IL1B;IL2RA;IL12A;CD14;IL6R;TLR4;HLA-DRB1;IL17A
Ankylosing spondylitis,19/348,2.14142184094268E-23,3.628602388411148E-21,0,0,27.298850574712645,1424.9450506568296,IL10;TGFB1;VDR;FUT2;ETS1;TNF;RUNX3;IL2;IL6;IFNG;ZMIZ1;IL1B;IL2RA;TNFRSF14;CD14;IL6R;TLR4;HLA-DRB1;IL17A
Encephalomyelitis,19/348,2.14142184094268E-23,3.567100653014349E-21,0,0,27.298850574712645,1424.9450506568296,IL10;TGFB1;IL15;STAT1;VDR;CD80;TNFRSF9;AHR;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Chronic Lymphocytic Leukemia,26/1120,2.3368328782483863E-23,3.8277322545708565E-21,0,0,11.607142857142858,604.8558819305835,IL21;CD80;ETS1;HIF1A;TNF;DPP4;TNFRSF14;CD14;IL6R;HLA-DQA1;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Uveitis,15/130,2.3799732852309818E-23,3.834488106106572E-21,0,0,57.69230769230769,3005.3289159193578,IL10;IL15;STAT1;ETS1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Autoimmune thyroid disease,15/132,3.0252017859615926E-23,4.795432766521053E-21,0,0,56.81818181818181,2946.163599062613,IL21;IL10;IL15;VDR;FUT2;TNF;INS;CXCL10;IL6;IFNG;ZMIZ1;IL2RA;HLA-DQA1;HLA-DRB1;IL17A
Myasthenia Gravis,16/179,4.459314340559598E-23,6.956530371272973E-21,0,0,44.6927374301676,2300.0876925117363,IL10;TGFB1;HMGB1;TNF;IL2;INS;CXCL10;IL6;IFNG;IL1B;IL2RA;CCR4;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Stomach Carcinoma,32/2378,6.178475497161965E-23,9.487821435329343E-21,0,0,6.72834314550042,344.0766060967664,IL21;CD80;AHR;HMGB1;FUT2;ETS1;HIF1A;TNF;INS;DPP4;IL12A;CD14;CCR4;HLA-DQA1;TGM2;IL10;TGFB1;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Hepatitis, Chronic,16/183,6.421230466621308E-23,9.708900465531418E-21,0,0,43.71584699453552,2233.873109423318,IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;TNF;RUNX3;SOD1;CXCL10;IL6;IFNG;IL1B;S100A9;HLA-DRB1;IL17A
Periodontitis,17/237,6.983570929174855E-23,1.039917198362583E-20,0,0,35.86497890295359,1829.6840609578182,IL10;TGFB1;VDR;AHR;HMGB1;TNF;IL2;IL6;IFNG;IL1B;IL2RA;IL12A;CD14;IL6R;TLR4;HLA-DRB1;IL17A
Eosinophilia,16/186,8.394545570408232E-23,1.2313670726264495E-20,0,0,43.01075268817205,2186.317203474427,IL10;TGFB1;IL15;VDR;CD80;AHR;HMGB1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;TLR4;IL17A
Hashimoto Disease,16/186,8.394545570408232E-23,1.2132587333231193E-20,0,0,43.01075268817205,2186.317203474427,IL21;IL10;TGFB1;IL15;VDR;HIF1A;TNF;INS;CXCL10;IL6;IFNG;IL1B;IL2RA;IL6R;HLA-DRB1;IL17A
Allergic disposition,17/240,8.685346741122638E-23,1.2370954749529463E-20,0,0,35.416666666666664,1799.0894518106725,IL10;VDR;CD80;TNFRSF9;MTHFR;TNF;IL2;IL6;IFNG;IL2RA;IRF1;CD14;CCR4;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Spondylarthritis,13/74,8.890065862477577E-23,1.2481652470918518E-20,0,0,87.83783783783784,4459.924289526394,IL10;STAT1;VDR;TNF;RUNX3;IL2;IL6;IFNG;IL1B;IRF1;IL6R;HLA-DRB1;IL17A
Colorectal Cancer,35/3298,9.52904090196791E-23,1.3190339997822622E-20,0,0,5.306246209824136,269.05381402590393,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;IL12A;CD14;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Lupus Erythematosus, Discoid,18/309,1.2766705979248346E-22,1.7426553661673993E-20,0,0,29.12621359223301,1468.328634525286,IL21;IL10;IL15;STAT1;CD80;MTHFR;HMGB1;PRL;ETS1;TNF;IL2;IL6;IFNG;IL1B;CD14;TLR4;HLA-DRB1;IL17A
Diabetic Nephropathy,21/561,1.4079118548463248E-22,1.8954736588259836E-20,0,0,18.71657754010695,941.7201891772576,IL10;TGFB1;IL15;STAT1;VDR;MTHFR;HMGB1;ETS1;HIF1A;TNF;INS;SOD1;DPP4;CXCL10;IL6;IL1B;IL6R;S100A9;TLR4;HLA-DRB1;IL17A
Hepatitis C,23/783,1.479209929254832E-22,1.964550700637363E-20,0,0,14.687100893997446,738.252471545962,IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;TNF;IL2;SOD1;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;TLR4;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Malaria,20/469,1.5118624215988513E-22,1.9811445172631347E-20,0,0,21.321961620469082,1071.2906132890755,IL10;TGFB1;IL15;VDR;MTHFR;AHR;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;IL12A;CD14;TLR4;HLA-DRB1;IL17A
Chronic Obstructive Airway Disease,22/669,1.5783101682178672E-22,2.0410042543743685E-20,0,0,16.442451420029897,825.4195667182319,IL21;IL10;TGFB1;STAT1;VDR;CD80;AHR;HMGB1;HIF1A;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL12A;CD14;IL6R;S100A9;TLR4;IL17A
Immune System Diseases,17/250,1.7608787254387044E-22,2.24752157319631E-20,0,0,34.0,1703.0960089103387,IL10;STAT1;VDR;ETS1;TNF;IL2;SOD1;DPP4;IL6;IFNG;ZMIZ1;IL1B;IL2RA;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Hepatitis,18/317,2.0317327378459816E-22,2.5599832496859368E-20,0,0,28.391167192429023,1418.081537738435,IL21;IL10;TGFB1;STAT1;TNFRSF9;MTHFR;AHR;HMGB1;HIF1A;TNF;IL2;INS;CXCL10;IL6;IFNG;IL1B;HLA-DRB1;IL17A
HIV Infections,23/806,2.8500831847050293E-22,3.545647789782408E-20,0,0,14.267990074441686,707.8281940950171,IL21;IL10;TGFB1;IL15;STAT1;VDR;CD80;HMGB1;FUT2;HIF1A;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;TLR4;HLA-DRB1;IL17A
Arteriosclerosis,25/1087,3.3725990646048426E-22,4.143237950867049E-20,0,0,11.499540018399264,568.5509241371486,AHR;HMGB1;ETS1;HIF1A;TNF;INS;DPP4;CD14;IL6R;IL10;TGFB1;IL15;STAT1;TNFRSF9;MTHFR;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;IL17A
Mucocutaneous Lymph Node Syndrome,15/156,4.1096933985420266E-22,4.986427990230992E-20,0,0,48.07692307692308,2367.4770970691534,IL10;TGFB1;STAT1;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;HLA-DRB1;IL17A
Coronary Artery Disease,24/981,8.48988430028267E-22,1.0175436939411961E-19,0,0,12.232415902140673,593.4923140477397,IL10;TGFB1;IL15;STAT1;VDR;CD80;MTHFR;ETS1;HIF1A;TNF;IL2;INS;SOD1;DPP4;IL6;IFNG;IL1B;IRF1;CD14;IL6R;S100A9;TLR4;HLA-DRB1;IL17A
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,16/216,9.75660485708179E-22,1.1552760546433712E-19,0,0,37.03703703703703,1791.8121321839365,IL10;TGFB1;IL15;STAT1;VDR;HIF1A;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;CD14;TLR4
Spinal Cord Diseases,11/40,1.003846889654725E-21,1.1745008608960281E-19,0,0,137.5,6648.186523492069,IL10;IL6;IFNG;IL15;VDR;MTHFR;HIF1A;TNF;IL2;HLA-DRB1;IL17A
Inflammation,19/429,1.1570900932789274E-21,1.3378684043229763E-19,0,0,22.144522144522142,1067.5515083381777,IL10;TGFB1;IL15;TNFRSF9;AHR;HMGB1;HIF1A;TNF;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;IL12A;S100A9;TLR4;TGM2;IL17A
Periodontitis, Juvenile,13/90,1.368323634339943E-21,1.5637075207317395E-19,0,0,72.22222222222221,3469.6061534942964,IL10;STAT1;VDR;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DRB1;IL17A
Tuberculosis, Pulmonary,15/169,1.4207621297283716E-21,1.6049712886172916E-19,0,0,44.378698224852066,2130.3148009244087,IL10;TGFB1;VDR;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Lupus Vulgaris,17/284,1.5866422163309364E-21,1.7719908752386867E-19,0,0,29.92957746478873,1433.4072864718253,IL21;IL10;STAT1;CD80;MTHFR;HMGB1;PRL;ETS1;TNF;IL2;IL6;IFNG;IL1B;CD14;TLR4;HLA-DRB1;IL17A
Epithelial ovarian cancer,26/1329,1.8023251204238483E-21,1.9902529532051214E-19,0,0,9.781790820165538,467.22928671456975,CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;DPP4;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1
Myeloid Leukemia, Chronic,23/876,1.871077962732068E-21,2.0432171353034183E-19,0,0,13.127853881278538,626.563220011969,IL10;TGFB1;IL15;STAT1;VDR;CD80;MTHFR;AHR;HMGB1;ETS1;HIF1A;TNF;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;HLA-DRB1;TGM2;IL17A
Aortic Aneurysm, Abdominal,17/288,2.0176085956505197E-21,2.179017283302561E-19,0,0,29.513888888888886,1406.4068717143407,IL10;TGFB1;STAT1;MTHFR;HIF1A;TNF;DPP4;IL6;IFNG;IL1B;IL2RA;CD14;IL6R;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Coronary Arteriosclerosis,22/760,2.5112892271338652E-21,2.6827120135077857E-19,0,0,14.473684210526315,686.5373653265502,IL10;TGFB1;IL15;VDR;MTHFR;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;INS;SOD1;IL6;IFNG;IL1B;CD14;IL6R;S100A9;TLR4;HLA-DRB1;IL17A
Gastritis,15/181,4.094561755763284E-21,4.3270271973808125E-19,0,0,41.436464088397784,1945.2193616289996,IL10;TGFB1;IL15;VDR;HIF1A;TNF;RUNX3;CXCL10;IL6;IFNG;IL1B;S100A9;TLR4;HLA-DQA1;IL17A
Carcinogenesis,36/4065,4.1310105654277754E-21,4.3191033869174655E-19,0,0,4.428044280442804,207.83364525550365,CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;TNFRSF14;CD14;CCR4;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
melanoma,31/2454,4.260417959686747E-21,4.407514495558036E-19,0,0,6.316218418907905,296.26171765055426,IL21;CD80;AHR;HMGB1;ETS1;HIF1A;TNF;DPP4;IL12A;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Immune thrombocytopenic purpura,15/183,4.849321003320658E-21,4.964492377149525E-19,0,0,40.983606557377044,1917.0265679115455,IL21;IL10;TGFB1;STAT1;VDR;TNF;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Lupus Erythematosus,17/304,5.100293571825135E-21,5.167596414834786E-19,0,0,27.960526315789473,1306.455280392883,IL21;IL10;STAT1;CD80;MTHFR;HMGB1;PRL;ETS1;TNF;IL2;IL6;IFNG;IL1B;CD14;TLR4;HLA-DRB1;IL17A
Psoriasis vulgaris,14/138,5.613453749198985E-21,5.629492188482411E-19,0,0,50.72463768115942,2365.245257017464,IL10;TGFB1;IL15;VDR;MTHFR;ETS1;TNF;RUNX3;IL6;IFNG;ZMIZ1;CCR4;HLA-DRB1;IL17A
Hypersensitivity,15/185,5.732070258218212E-21,5.690382474522079E-19,0,0,40.54054054054054,1889.522034559186,TGFB1;MTHFR;TNF;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;CD14;IL6R;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Polymyositis,13/100,5.846708549557848E-21,5.746145162505454E-19,0,0,65.0,3028.24652591983,TGFB1;IL15;HMGB1;TNF;IL2;SOD1;CXCL10;IL6;IL1B;IL2RA;TLR4;HLA-DRB1;TGM2
Acquired Immunodeficiency Syndrome,15/188,7.340370138275023E-21,7.142688883066032E-19,0,0,39.8936170212766,1849.5038969665716,IL21;IL10;IL15;VDR;TNF;IL2;CXCL10;IL6;IFNG;IL1B;CD14;TLR4;HLA-DRB1;TGM2;IL17A
Hyperglycemia,19/488,1.3246518045216052E-20,1.2763409740037584E-18,0,0,19.4672131147541,891.0250945249429,IL21;IL10;TGFB1;VDR;MTHFR;AHR;HMGB1;HIF1A;TNF;IL2;INS;SOD1;DPP4;CXCL10;IL6;IFNG;IL1B;TLR4;HLA-DRB1
Leishmaniasis, Cutaneous,11/50,1.600730150625136E-20,1.5273763029460035E-18,0,0,110.0,5013.936618964657,IL10;CXCL10;IL6;TGFB1;IFNG;IL1B;IL2RA;TNF;TLR4;IL2;IL17A
Pneumonia,19/497,1.8695634487190074E-20,1.766737459039462E-18,0,0,19.114688128772634,868.3037637996664,IL10;TGFB1;IL15;VDR;AHR;HMGB1;HIF1A;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Stable angina,12/76,1.8698759429539832E-20,1.7502038826049284E-18,0,0,78.94736842105263,3586.24971883274,CXCL10;IL6;TGFB1;IFNG;STAT1;CD80;IL1B;CD14;TNF;TLR4;IL2;IL17A
Lymphoma, T-Cell, Cutaneous,16/260,1.988668828940862E-20,1.8438337029085652E-18,0,0,30.76923076923077,1395.8226576971879,IL21;IL10;TGFB1;IL15;STAT1;CD80;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL2RA;CCR4;HLA-DRB1;IL17A
Arthritis, Psoriatic,15/201,2.0471495823604192E-20,1.8803164575175888E-18,0,0,37.31343283582089,1691.613935892872,IL10;TGFB1;IL15;CD80;TNFRSF9;MTHFR;TNF;RUNX3;IL2;DPP4;IL1B;IL12A;S100A9;HLA-DRB1;IL17A
Adult T-Cell Lymphoma/Leukemia,19/500,2.0940650402869933E-20,1.905599186661164E-18,0,0,19.0,860.9392990645132,IL21;IL10;TGFB1;IL15;STAT1;CD80;MTHFR;AHR;ETS1;TNF;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;CCR4;IL6R;HLA-DRB1
Degenerative polyarthritis,23/976,2.1279816721616696E-20,1.9186976031197147E-18,0,0,11.782786885245901,533.7193349007815,IL21;IL10;TGFB1;VDR;AHR;HMGB1;HIF1A;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;CD14;CCR4;IL6R;S100A9;TLR4;HLA-DRB1;TGM2;IL17A
Liver diseases,20/606,2.4449622441254096E-20,2.1844626304785933E-18,0,0,16.5016501650165,745.1761085668119,IL21;IL10;TGFB1;VDR;MTHFR;AHR;FUT2;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;CD14;S100A9;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Diabetes Mellitus, Non-Insulin-Dependent,27/1672,2.682170020668653E-20,2.3748078345163533E-18,0,0,8.074162679425838,363.86275223156673,AHR;HMGB1;HIF1A;TNF;INS;DPP4;ZMIZ1;CD14;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;VDR;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Thymoma,15/205,2.767686885320174E-20,2.4286452418684528E-18,0,0,36.58536585365854,1647.5740224874112,TGFB1;STAT1;HMGB1;ETS1;TNF;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;S100A9;HLA-DQA1;HLA-DRB1;IL17A
Liver neoplasms,25/1321,3.878817943589936E-20,3.373541836247955E-18,0,0,9.462528387585163,422.9387907492055,IL21;AHR;HMGB1;PRL;HIF1A;TNF;INS;IL12A;CCR4;IL6R;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4
Respiratory Syncytial Virus Infections,13/116,4.4345215838824286E-20,3.823024397052325E-18,0,0,56.03448275862069,2497.0244292945104,IL10;STAT1;VDR;CD80;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IRF1;TLR4;IL17A
Carcinoma of bladder,24/1162,4.462752094265024E-20,3.81390674629884E-18,0,0,10.327022375215147,460.13015032005546,IL10;TGFB1;IL15;STAT1;VDR;CD80;MTHFR;AHR;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;CD14;IL6R;S100A9;TLR4;TGM2;IL17A
Glioblastoma,28/1937,5.973132618475635E-20,5.060685118480909E-18,0,0,7.227671657201858,319.928768615066,IL21;AHR;HMGB1;ETS1;HIF1A;TNF;CD14;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Lymphoma, Non-Hodgkin,19/539,8.599484603092319E-20,7.223567066597548E-18,0,0,17.625231910946194,773.7476736340591,IL10;TGFB1;VDR;MTHFR;AHR;HMGB1;PRL;HIF1A;TNF;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;IL12A;TNFRSF14;CD14;HLA-DRB1
Ovarian Carcinoma,29/2203,9.519300425626987E-20,7.928447846022204E-18,0,0,6.581933726736269,288.27803777937896,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;DPP4;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Adult type dermatomyositis,12/87,1.0540159139632016E-19,8.704931430613736E-18,0,0,68.9655172413793,3013.5523598789564,IL10;IL6;TGFB1;IL15;STAT1;IL1B;IL2RA;TNF;TLR4;IL2;HLA-DRB1;SOD1
Fibrosis, Liver,19/545,1.0585458683956108E-19,8.669490662160053E-18,0,0,17.431192660550458,761.6075154440135,IL10;TGFB1;STAT1;VDR;MTHFR;AHR;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IL12A;CD14;TLR4;HLA-DRB1;TGM2;IL17A
Bladder Neoplasm,24/1217,1.309000592525722E-19,1.0632113903589087E-17,0,0,9.860312243221035,428.72492516651397,IL10;TGFB1;IL15;STAT1;VDR;CD80;MTHFR;AHR;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IRF1;CD14;IL6R;S100A9;TLR4;IL17A
Myocarditis,13/126,1.3588336084214182E-19,1.0946407134070244E-17,0,0,51.58730158730158,2241.0808372534443,IL10;TNFRSF9;TNF;INS;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;IL17A
Malignant tumor of colon,28/2001,1.433743693079554E-19,1.1455961801289314E-17,0,0,6.9965017491254375,303.57000942961906,IL21;CD80;AHR;HMGB1;ETS1;HIF1A;TNF;DPP4;ZMIZ1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Childhood asthma,13/127,1.511887441350476E-19,1.1982927236768127E-17,0,0,51.181102362204726,2217.9718628380874,IL10;TGFB1;VDR;MTHFR;HMGB1;TNF;IL6;IFNG;IRF1;CD14;TLR4;HLA-DRB1;IL17A
Peritonitis,13/128,1.68068318956889E-19,1.321420350966644E-17,0,0,50.78125,2195.2691919680224,IL10;TGFB1;IL15;HMGB1;PRL;HIF1A;TNF;IL6;IFNG;IL1B;CD14;TLR4;IL17A
Systemic Scleroderma,19/562,1.8829357463448116E-19,1.4686898821489532E-17,0,0,16.90391459074733,728.8339930387483,IL21;IL10;TGFB1;TNFRSF9;MTHFR;PRL;HIF1A;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Malignant neoplasm of ovary,28/2026,2.0022886949397245E-19,1.5494876609344576E-17,0,0,6.910167818361303,297.5160723118112,IL21;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;DPP4;IL6R;TGM2;IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Primary sclerosing cholangitis,13/130,2.0714930283539293E-19,1.5905182408330013E-17,0,0,50.0,2151.04235749317,IL10;VDR;CD80;FUT2;HIF1A;TNF;IL2;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1
Infection caused by Helicobacter pylori,16/308,3.0509153184711307E-19,2.3243717635607962E-17,0,0,25.974025974025974,1107.368184853847,IL10;TGFB1;MTHFR;FUT2;TNF;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Mycoses,13/135,3.4429743984601953E-19,2.6028886452359075E-17,0,0,48.148148148148145,2046.911678662812,IL10;STAT1;VDR;AHR;HIF1A;TNF;SOD1;CXCL10;IL6;IFNG;IL1B;TLR4;IL17A
Malignant neoplasm of pancreas,27/1846,3.51883639504284E-19,2.6399331366779414E-17,0,0,7.313109425785482,310.7412331638577,CD80;AHR;HMGB1;FUT2;ETS1;HIF1A;TNF;CD14;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1
IMMUNE SUPPRESSION,12/96,3.6692235249598113E-19,2.731903697220078E-17,0,0,62.5,2653.0710437991047,IL10;IL6;TGFB1;IFNG;STAT1;CD80;IL1B;IL2RA;HMGB1;CD14;TNF;IL2
Vasculitis,13/136,3.8020824348860874E-19,2.809538809778982E-17,0,0,47.79411764705882,2027.1190512279052,IL10;HMGB1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL12A;S100A9;TLR4;HLA-DRB1;IL17A
Oligoarticular Juvenile Idiopathic Arthritis,10/42,4.236927578358607E-19,3.107501808963313E-17,0,0,119.04761904761904,5036.342665245023,IL10;IL6;IFNG;STAT1;IL2RA;CD14;TNF;IL6R;HLA-DQA1;HLA-DRB1
Influenza,19/589,4.531349699245105E-19,3.2988225810504364E-17,0,0,16.129032258064516,681.2596278212266,IL10;TGFB1;IL15;STAT1;CD80;TNFRSF9;HMGB1;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IL6R;TLR4;HLA-DRB1;IL17A
Tumor Progression,28/2090,4.617231494586932E-19,3.336628759470615E-17,0,0,6.698564593301436,282.80885205268066,AHR;HMGB1;PRL;ETS1;HIF1A;TNF;DPP4;TNFRSF14;CCR4;IL6R;TGM2;IL10;TGFB1;STAT1;VDR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Pancreatic carcinoma,27/1869,4.850185801044942E-19,3.479388762968591E-17,0,0,7.223113964686998,304.5994364194199,IL21;CD80;HMGB1;FUT2;ETS1;HIF1A;TNF;CD14;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1
Squamous cell carcinoma,27/1876,5.34331662758355E-19,3.8053707112964584E-17,0,0,7.196162046908316,302.7660703134109,CD80;HMGB1;ETS1;HIF1A;TNF;ZMIZ1;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Leishmaniasis,11/68,6.414871655951943E-19,4.535637311848611E-17,0,0,80.88235294117648,3388.202025990766,DPP4;IL10;CXCL10;IL6;TGFB1;IFNG;VDR;IL1B;TNF;TLR4;IL17A
Malignant neoplasm of urinary bladder,23/1144,7.391166440343591E-19,5.188598841121201E-17,0,0,10.052447552447552,419.6779360543062,IL10;TGFB1;IL15;STAT1;VDR;CD80;MTHFR;AHR;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;CD14;IL6R;S100A9;TLR4;IL17A
Leprosy,13/143,7.456499492719679E-19,5.197338795350993E-17,0,0,45.45454545454545,1897.2741227135514,IL10;IL15;VDR;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DQA1;HLA-DRB1
Neoplasm Metastasis,34/3920,8.403719557574952E-19,5.816320831820185E-17,0,0,4.336734693877551,180.49681633360896,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;DPP4;ZMIZ1;IL12A;CD14;CCR4;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Primary biliary cirrhosis,16/329,8.77980616391492E-19,6.03412132719971E-17,0,0,24.3161094224924,1010.9826732276327,IL10;TGFB1;VDR;CD80;HIF1A;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;IL12A;TLR4;HLA-DRB1;IL17A
Leukemia, Myelocytic, Acute,26/1703,9.15158615581043E-19,6.24595755134062E-17,0,0,7.633587786259541,317.0625156661151,CD80;HMGB1;PRL;ETS1;HIF1A;TNF;INS;CD14;IL6R;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1
Endothelial dysfunction,15/262,1.1524050667402834E-18,7.810922066154141E-17,0,0,28.62595419847328,1182.3858936924282,IL10;TGFB1;STAT1;VDR;MTHFR;HMGB1;HIF1A;TNF;CXCL10;IL6;IL1B;IRF1;S100A9;HLA-DRB1;IL17A
Chronic Periodontitis,13/148,1.1812171220085118E-18,7.95137114732853E-17,0,0,43.91891891891892,1812.972371620847,IL10;TGFB1;VDR;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;TLR4;HLA-DRB1;IL17A
Renal Cell Carcinoma,24/1348,1.398796328176354E-18,9.351952594093338E-17,0,0,8.902077151335313,365.9725777982523,IL10;TGFB1;IL15;STAT1;VDR;CD80;MTHFR;AHR;HIF1A;TNF;RUNX3;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;IL6R;S100A9;HLA-DRB1;TGM2
Guillain-Barre Syndrome,11/73,1.4791570538312417E-18,9.822402381792868E-17,0,0,75.34246575342465,3093.18939981224,IL10;CD80;IL1B;IL2RA;IL12A;CD14;TNF;TLR4;IL2;HLA-DRB1;IL17A
Obesity,27/1961,1.6808661216293486E-18,1.1086947814344455E-16,0,0,6.884242733299336,281.7529338469998,AHR;HMGB1;PRL;HIF1A;TNF;INS;DPP4;CD14;IL6R;IL10;TGFB1;IL15;STAT1;VDR;THEMIS;MTHFR;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Pancreatitis,15/269,1.7158224612438259E-18,1.1242068766069546E-16,0,0,27.881040892193308,1140.5196785964622,IL10;TGFB1;IL15;TNF;INS;SOD1;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;HLA-DQA1;HLA-DRB1
Cirrhosis,17/433,2.0748622402342463E-18,1.350446761392197E-16,0,0,19.630484988452658,799.2873296943014,IL10;TGFB1;STAT1;MTHFR;HIF1A;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Glomerulonephritis,14/210,2.3318665169530023E-18,1.5077357979351386E-16,0,0,33.333333333333336,1353.3287548923797,IL10;TGFB1;STAT1;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;CCR4;TLR4;HLA-DRB1;IL17A
Cerebral Ischemia,15/275,2.392921155352566E-18,1.5370999421441187E-16,0,0,27.27272727272727,1106.564094914843,IL21;IL10;VDR;MTHFR;HMGB1;HIF1A;TNF;SOD1;CXCL10;IL6;IL1B;CD14;CCR4;TLR4;IL17A
Kidney Failure, Chronic,17/437,2.4223585698762094E-18,1.5459051964119083E-16,0,0,19.450800915331808,788.9593019175519,IL10;TGFB1;VDR;MTHFR;HIF1A;TNF;IL2;SOD1;IL6;IFNG;ZMIZ1;IL1B;IL2RA;S100A9;TLR4;HLA-DRB1;IL17A
Carcinoma of lung,29/2476,2.4430184795010255E-18,1.549031330099102E-16,0,0,5.856219709208401,237.48901902342988,CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;DPP4;IL12A;CCR4;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Metabolic Syndrome X,18/548,3.727205387009747E-18,2.3481393938161405E-16,0,0,16.423357664233578,659.0836797873162,IL10;TGFB1;IL15;VDR;MTHFR;AHR;HMGB1;TNF;INS;DPP4;IL6;IFNG;IL1B;IRF1;CD14;IL6R;TLR4;HLA-DRB1
Neoplasms,23/1236,4.112829115608425E-18,2.574578633643287E-16,0,0,9.3042071197411,372.469932142603,IL10;TGFB1;IL15;STAT1;VDR;CD80;TNFRSF9;AHR;HMGB1;HIF1A;TNF;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;CCR4;IL6R;TLR4;IL17A
Inflammatory dermatosis,13/163,4.279881275135492E-18,2.662194504558963E-16,0,0,39.87730061349693,1594.797187895081,IL10;TGFB1;IL15;AHR;TNF;IL2;CXCL10;IL6;IFNG;IL1B;IL2RA;S100A9;IL17A
Breast Carcinoma,36/4963,4.4856987096587266E-18,2.772669617517356E-16,0,0,3.6268386056820474,144.87637985963383,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;DPP4;ZMIZ1;TNFRSF14;CD14;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
ovarian neoplasm,21/938,5.618398585774369E-18,3.451101331311906E-16,0,0,11.194029850746269,444.63229477324717,IL10;TGFB1;IL15;VDR;MTHFR;AHR;ETS1;HIF1A;TNF;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL6R;TLR4;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Prostate carcinoma,31/3145,6.866581852661907E-18,4.191600400494486E-16,0,0,4.9284578696343395,194.7719908410602,AHR;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;IL12A;CD14;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Early Rheumatoid Arthritis,10/55,8.274570781878555E-18,5.019906274339657E-16,0,0,90.9090909090909,3575.7586021122124,IL21;IL10;IL6;IFNG;VDR;TNF;TLR4;IL2;HLA-DRB1;IL17A
Gingivitis,10/55,8.274570781878555E-18,4.989109303331438E-16,0,0,90.9090909090909,3575.7586021122124,IL10;IL6;IFNG;IL1B;IL2RA;IL12A;TNF;S100A9;TLR4;IL17A
Malignant neoplasm of breast,36/5054,8.447969583582318E-18,5.062600308990673E-16,0,0,3.561535417491096,140.0132370107925,IL21;CD80;AHR;HMGB1;PRL;FUT2;ETS1;HIF1A;TNF;DPP4;ZMIZ1;TNFRSF14;CD14;IL6R;HLA-DQA1;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Colon Carcinoma,27/2091,8.78902799283984E-18,5.23506467355333E-16,0,0,6.456241032998565,253.55613195406502,IL21;CD80;AHR;HMGB1;FUT2;ETS1;HIF1A;TNF;DPP4;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IRF1;TLR4;HLA-DRB1;IL17A
Uterine Cervical Neoplasm,12/124,9.021001306661922E-18,5.340867520594781E-16,0,0,48.387096774193544,1899.0472420824988,CXCL10;IL6;TGFB1;CD80;IL1B;MTHFR;AHR;ETS1;HIF1A;TNF;S100A9;IL17A
cervical cancer,21/965,1.000166337239261E-17,5.886008839752969E-16,0,0,10.880829015544041,425.91678000379915,IL10;TGFB1;IL15;CD80;MTHFR;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;IRF1;IL12A;S100A9;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Autoimmune arthritis,10/56,1.0059699223690424E-17,5.884924045858898E-16,0,0,89.28571428571429,3494.463786420509,IL10;IL6;IL1B;IL2RA;TNFRSF14;AHR;TNF;TLR4;HLA-DRB1;IL17A
early pregnancy,12/129,1.4723106503128905E-17,8.562052704896501E-16,0,0,46.51162790697674,1802.6564438717714,IL10;IL6;IFNG;VDR;CD80;MTHFR;AHR;HIF1A;TNF;S100A9;TLR4;IL2
Wheezing,11/89,1.4860780898203092E-17,8.591279686325882E-16,0,0,61.79775280898876,2394.5273423706276,IL10;CXCL10;IL6;TGFB1;IFNG;IL2RA;MTHFR;CD14;TNF;TLR4;IL2
Chagas Disease,11/89,1.4860780898203092E-17,8.541038284651462E-16,0,0,61.79775280898876,2394.5273423706276,IL10;IL6;TGFB1;IFNG;IL15;IL1B;IL2RA;TNF;TLR4;IL2;IL17A
Lung diseases,16/393,1.4905072022950744E-17,8.516688827997669E-16,0,0,20.356234096692113,788.6988318501964,IL10;TGFB1;IL15;VDR;AHR;HMGB1;HIF1A;TNF;DPP4;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4
Cystic Fibrosis,18/594,1.5478367569893907E-17,8.793144305024123E-16,0,0,15.151515151515152,586.4710343247447,IL10;TGFB1;STAT1;HMGB1;HIF1A;TNF;IL2;INS;IL6;IFNG;IL1B;IRF1;CD14;S100A9;TLR4;HLA-DQA1;TGM2;IL17A
Mammary Neoplasms,28/2387,1.608469601031998E-17,9.085080022380735E-16,0,0,5.865102639296188,226.79567983774032,CD80;AHR;PRL;ETS1;HIF1A;TNF;INS;DPP4;CD14;CCR4;TGM2;IL10;TGFB1;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Malignant neoplasm of prostate,31/3239,1.6372254998561003E-17,9.19465840719186E-16,0,0,4.785427601111454,184.96129202579147,AHR;HMGB1;PRL;ETS1;HIF1A;TNF;INS;DPP4;ZMIZ1;IL12A;CD14;TGM2;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;S100A9;TLR4;HLA-DRB1;IL17A
Anemia,17/490,1.6552396927736598E-17,9.243008920783823E-16,0,0,17.346938775510203,670.2857273494516,IL10;IL15;STAT1;VDR;MTHFR;PRL;HIF1A;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;IL12A;TLR4;IL17A
Myeloid Leukemia,17/501,2.3997962140995527E-17,1.3324970165068024E-15,0,0,16.96606786427146,649.2670328193728,IL10;IL15;STAT1;VDR;MTHFR;HMGB1;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;TLR4
Rheumatoid Nodule,8/21,2.421258949051865E-17,1.3368614017574006E-15,0,0,190.47619047619045,7287.55408554673,IL10;IFNG;IL15;IL1B;TNF;IL2;HLA-DRB1;IL17A
Pleurisy,8/21,2.421258949051865E-17,1.329392902306242E-15,0,0,190.47619047619045,7287.55408554673,IL10;IL6;IFNG;IL1B;TNF;CCR4;IL2;HLA-DRB1
B-Cell Lymphomas,19/730,2.4494869638487502E-17,1.3374198822614175E-15,0,0,13.013698630136986,497.74882988687114,IL21;IL10;TGFB1;IL15;VDR;CD80;TNFRSF9;MTHFR;ETS1;TNF;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;IL12A;CD14;TLR4
Malignant neoplasm of lung,28/2449,3.1795492665941697E-17,1.7264425520490331E-15,0,0,5.716619028174765,217.15839113068392,CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;IL12A;CCR4;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;HLA-DRB1;IL17A
Dermatitis,13/190,3.2585314441860925E-17,1.75960697986049E-15,0,0,34.21052631578947,1298.7229198299146,IL10;TGFB1;IL15;AHR;TNF;IL2;IL6;IFNG;IL1B;IL2RA;S100A9;HLA-DQA1;IL17A
Squamous cell carcinoma of esophagus,21/1023,3.265087210764358E-17,1.7535124102400061E-15,0,0,10.263929618768328,389.6255436276902,IL10;TGFB1;STAT1;VDR;MTHFR;AHR;HMGB1;ETS1;HIF1A;TNF;RUNX3;CXCL10;IL6;IFNG;IL1B;IL2RA;TNFRSF14;CD14;TLR4;HLA-DQA1;HLA-DRB1
Prostatic Neoplasms,24/1554,3.683427081404773E-17,1.9674305084807667E-15,0,0,7.722007722007722,292.20156749005343,IL10;TGFB1;STAT1;VDR;MTHFR;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;IL2;INS;SOD1;DPP4;CXCL10;IL6;IFNG;IL2RA;CD14;IL6R;S100A9;TLR4;HLA-DRB1
Inflammatory disorder,13/192,3.7409989222224565E-17,1.9873804004109353E-15,0,0,33.854166666666664,1280.5201064510693,IL21;IL10;TGFB1;HMGB1;HIF1A;TNF;IL2;CXCL10;IL6;IL1B;TLR4;HLA-DRB1;IL17A
Endometriosis,19/749,3.9373884527628995E-17,2.0804652534276225E-15,0,0,12.683578104138851,479.1022357980652,IL10;TGFB1;IL15;VDR;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;TLR4;HLA-DRB1;IL17A
Tropical Spastic Paraparesis,9/39,3.942728023440453E-17,2.0721460435493462E-15,0,0,115.38461538461539,4358.316196782156,IL21;TGFB1;IL15;IL2RA;TNF;IL6R;IL2;HLA-DRB1;IL17A
Alzheimer's Disease,26/1982,3.9532957771545666E-17,2.066648452014632E-15,0,0,6.559031281533803,247.73065624972105,CD80;AHR;HMGB1;PRL;HIF1A;TNF;INS;DPP4;IL12A;CD14;IL6R;TGM2;IL10;TGFB1;STAT1;VDR;MTHFR;IL2;SOD1;IL6;IFNG;IL1B;S100A9;TLR4;HLA-DRB1;IL17A
Bronchiolitis Obliterans,10/64,4.23307698075056E-17,2.201200029990291E-15,0,0,78.125,2945.39198700501,DPP4;IL10;CXCL10;IL6;IFNG;HIF1A;TNF;TLR4;IL2;IL17A
Mycosis Fungoides,12/142,4.815441220891669E-17,2.4908503325749116E-15,0,0,42.25352112676056,1587.5543199374408,DPP4;IL10;IL6;TGFB1;IFNG;IL15;TNF;CCR4;TLR4;IL2;HLA-DRB1;IL17A
Hepatitis A,14/261,5.020572331591533E-17,2.583360464653486E-15,0,0,26.81992337164751,1006.5625230035109,IL10;TGFB1;TNFRSF9;MTHFR;AHR;HMGB1;TNF;IL2;CXCL10;IFNG;IL1B;IL2RA;HLA-DRB1;IL17A
Esophageal Neoplasms,18/637,5.2938956681844153E-17,2.709812845151898E-15,0,0,14.128728414442701,529.5078958612568,TGFB1;VDR;CD80;MTHFR;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;TNFRSF14;S100A9;TLR4;HLA-DRB1;TGM2
Kidney Diseases,18/639,5.593483128694564E-17,2.8483291289538955E-15,0,0,14.084507042253522,527.0752730680645,IL10;TGFB1;VDR;MTHFR;AHR;HMGB1;HIF1A;TNF;INS;SOD1;DPP4;IL6;IFNG;IL1B;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Bronchiolitis,10/66,5.880033041639925E-17,2.9788126151153184E-15,0,0,75.75757575757576,2831.2412272482966,IL10;IFNG;IL15;VDR;IL2RA;CD14;TNF;TLR4;IL2;IL17A
Immunologic Deficiency Syndromes,18/641,5.908952826314003E-17,2.9781122244622578E-15,0,0,14.0405616224649,524.660376860159,IL21;IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;PRL;TNF;RUNX3;IL2;SOD1;DPP4;IL6;IFNG;IL1B;IL2RA;TLR4
Sepsis,17/529,5.950442211024954E-17,2.9837217372425126E-15,0,0,16.068052930056712,600.3101868900552,IL10;TGFB1;VDR;CD80;HMGB1;HIF1A;TNF;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;IL17A
Refractory anemias,14/266,6.552618766237867E-17,3.2689917377962314E-15,0,0,26.31578947368421,980.6337315662005,TGFB1;IL15;STAT1;HMGB1;TNF;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;HLA-DRB1;TGM2;IL17A
Primary malignant neoplasm of lung,27/2268,7.059362808636967E-17,3.504010994105258E-15,0,0,5.952380952380952,221.3666177809576,CD80;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;IL12A;CCR4;IL6R;TGM2;IL10;TGFB1;IL15;STAT1;VDR;MTHFR;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Coronary heart disease,20/913,7.301272420636855E-17,3.605874640704473E-15,0,0,10.952902519167578,406.9649281898883,IL10;TGFB1;IL15;VDR;MTHFR;ETS1;HIF1A;TNF;IL2;INS;SOD1;IL6;IFNG;IL1B;CD14;IL6R;S100A9;TLR4;HLA-DRB1;IL17A
Colonic Neoplasms,19/778,7.932615071582978E-17,3.898087046175875E-15,0,0,12.210796915167094,452.6904323737074,IL10;TGFB1;IL15;STAT1;VDR;TNFRSF9;MTHFR;HMGB1;HIF1A;TNF;RUNX3;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;S100A9;IL17A
Cervical Intraepithelial Neoplasia,13/205,8.859874391228144E-17,4.3320818665169255E-15,0,0,31.70731707317073,1171.9789802799498,IL10;TGFB1;CD80;MTHFR;HMGB1;TNF;IL2;IL6;IFNG;IL1B;S100A9;TLR4;HLA-DRB1
Bacterial Infections,14/276,1.0991148115079216E-16,5.347574439356363E-15,0,0,25.36231884057971,931.9854871090159,IL10;TGFB1;STAT1;VDR;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;IL1B;CD14;TLR4;IL17A
Brain Injuries, Focal,10/70,1.0996075065068008E-16,5.32361703150189E-15,0,0,71.42857142857142,2624.7434417171135,IL10;CXCL10;IL6;IL1B;IRF1;TNFRSF14;CD14;TNF;TLR4;IL2
Injuries, Acute Brain,10/70,1.0996075065068008E-16,5.2975208695827636E-15,0,0,71.42857142857142,2624.7434417171135,IL10;CXCL10;IL6;IL1B;IRF1;TNFRSF14;CD14;TNF;TLR4;IL2
Brain Injuries,10/70,1.0996075065068008E-16,5.271679304365286E-15,0,0,71.42857142857142,2624.7434417171135,IL10;CXCL10;IL6;IL1B;IRF1;TNFRSF14;CD14;TNF;TLR4;IL2
Brain Lacerations,10/70,1.0996075065068008E-16,5.246088628130503E-15,0,0,71.42857142857142,2624.7434417171135,IL10;CXCL10;IL6;IL1B;IRF1;TNFRSF14;CD14;TNF;TLR4;IL2
Common Variable Immunodeficiency,12/152,1.1109123266052575E-16,5.274418524578005E-15,0,0,39.473684210526315,1450.1123642489908,IL21;IL10;IL6;IFNG;ZMIZ1;IL2RA;CD14;FUT2;TNF;IL2;HLA-DRB1;IL17A
Malignant Neoplasms,23/1438,1.155110315894523E-16,5.457896242601622E-15,0,0,7.997218358831711,293.4752467484643,IL10;TGFB1;IL15;STAT1;VDR;MTHFR;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;CCR4;S100A9;TLR4;TGM2;IL17A
Lupus Nephritis,13/210,1.2157266583378945E-16,5.716823731169774E-15,0,0,30.952380952380953,1134.2815564841533,IL10;TGFB1;STAT1;CD80;HMGB1;TNF;IL2;CXCL10;IL6;IFNG;TLR4;HLA-DRB1;IL17A
Infant, Premature,14/278,1.2160253681818792E-16,5.690998723091194E-15,0,0,25.179856115107913,922.735312583118,IL10;TGFB1;PRL;TNF;IL2;SOD1;IFNG;IL1B;IL12A;CD14;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Acquired aplastic anemia,9/44,1.3098489732166033E-16,6.101040620271458E-15,0,0,102.27272727272728,3740.261895507141,IL21;CXCL10;TGFB1;IFNG;VDR;IL2RA;TNF;IL2;IL17A
Cervix carcinoma,21/1105,1.5483689109862867E-16,7.17800455527039E-15,0,0,9.502262443438912,345.92187690376403,IL10;TGFB1;IL15;STAT1;CD80;MTHFR;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IRF1;IL12A;IL6R;S100A9;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Restenosis,13/215,1.6551887765731716E-16,7.637180890216492E-15,0,0,30.232558139534884,1098.5739615707362,IL10;TGFB1;VDR;MTHFR;HMGB1;TNF;IL6;IFNG;IL1B;IRF1;IL12A;CD14;TLR4
Diabetes, Autoimmune,11/111,1.8701596375030284E-16,8.588751830551291E-15,0,0,49.549549549549546,1794.4536694746164,IL10;IFNG;TNFRSF9;IL1B;IL2RA;TNF;HLA-DQA1;IL2;HLA-DRB1;INS;IL17A
Uveomeningoencephalitic Syndrome,10/74,1.9804925683234352E-16,9.053153935573359E-15,0,0,67.56756756756756,2443.109182584889,IL21;IL6;IFNG;IL1B;IL2RA;ETS1;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Steatohepatitis,17/569,2.001679908330062E-16,9.107643582901782E-15,0,0,14.938488576449911,539.9871441104088,IL10;TGFB1;MTHFR;AHR;HMGB1;TNF;INS;SOD1;DPP4;CXCL10;IL6;IFNG;IL1B;CD14;TLR4;TGM2;IL17A
Regional enteritis,9/46,2.0299226891861565E-16,9.193585340701172E-15,0,0,97.82608695652173,3534.7855871466195,IL10;IL6;IFNG;IL2RA;MTHFR;FUT2;TNF;TLR4;HLA-DRB1
Acute periodontitis,9/46,2.0299226891861565E-16,9.151412930881442E-15,0,0,97.82608695652173,3534.7855871466195,IL10;IL6;IFNG;STAT1;VDR;IL1B;CD14;TNF;TLR4
IIeocolitis,9/46,2.0299226891861565E-16,9.10962565722445E-15,0,0,97.82608695652173,3534.7855871466195,IL10;IL6;IFNG;IL2RA;MTHFR;FUT2;TNF;TLR4;HLA-DRB1
Synovitis,11/112,2.0710794852730444E-16,9.25207690057431E-15,0,0,49.107142857142854,1773.4205660131656,IL10;IL6;IFNG;STAT1;IL1B;HMGB1;CD14;TNF;IL2;HLA-DRB1;IL17A
Nasal Polyps,13/219,2.107266852195455E-16,9.371139648586846E-15,0,0,29.68036529680365,1071.3415667587797,IL21;IL10;TGFB1;TNFRSF9;AHR;TNF;IL2;IL6;IFNG;IL1B;S100A9;TLR4;IL17A
Myocardial Infarction,20/966,2.1660050098499378E-16,9.588962719281617E-15,0,0,10.351966873706004,373.3796793620962,IL10;TGFB1;VDR;MTHFR;HMGB1;HIF1A;TNF;INS;SOD1;DPP4;CXCL10;IL6;IFNG;IL1B;TNFRSF14;CD14;IL6R;S100A9;TLR4;IL17A
Septicemia,16/468,2.3512623529818876E-16,1.0362424396908516E-14,0,0,17.094017094017094,615.1522928631105,IL10;TGFB1;VDR;CD80;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CD14;S100A9;TLR4;IL17A
Diffuse Large B-Cell Lymphoma,17/575,2.3825484085187037E-16,1.0453431142375814E-14,0,0,14.782608695652174,531.7776033254767,IL21;IL10;STAT1;TNFRSF9;MTHFR;AHR;ETS1;HIF1A;TNF;IL2;DPP4;IL6;IFNG;IL1B;IRF1;TLR4;HLA-DRB1
Allergic rhinitis (disorder),12/163,2.612082108108452E-16,1.140957464821772E-14,0,0,36.809815950920246,1320.7808776206375,IL10;IFNG;IL1B;IL2RA;AHR;CD14;ETS1;HIF1A;TNF;CCR4;TLR4;IL17A
Acute Promyelocytic Leukemia,16/475,2.96920048761238E-16,1.2912080704537376E-14,0,0,16.842105263157894,602.1569476618106,IL10;TGFB1;STAT1;HIF1A;TNF;SOD1;IL6;IFNG;IL1B;IRF1;CD14;S100A9;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Chronic Kidney Diseases,15/380,3.011604511842017E-16,1.3038788168450814E-14,0,0,19.736842105263158,705.3727991596884,IL10;TGFB1;VDR;MTHFR;HMGB1;HIF1A;TNF;SOD1;DPP4;IL6;IFNG;IL1B;CD14;S100A9;HLA-DRB1
Age related macular degeneration,15/382,3.25540493172302E-16,1.4032508626742912E-14,0,0,19.63350785340314,700.151403475023,TGFB1;IL15;MTHFR;AHR;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1;IL17A
Adenocarcinoma,24/1712,3.3547727651544E-16,1.439768853097705E-14,0,0,7.009345794392523,249.74984193912763,IL10;TGFB1;STAT1;VDR;CD80;MTHFR;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;RUNX3;IL2;SOD1;DPP4;IL6;IFNG;IL1B;IRF1;S100A9;TLR4;HLA-DQA1;TGM2
Cardiomyopathy, Familial Idiopathic,15/388,4.101297118352806E-16,1.7525020903987555E-14,0,0,19.329896907216494,684.8593723047497,IL10;TGFB1;HIF1A;TNF;RUNX3;IL2;IL6;IL1B;IL2RA;IRF1;TLR4;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Active tuberculosis,9/50,4.590664863300312E-16,1.9531192327495876E-14,0,0,90.0,3178.560296153687,IL10;IFNG;IL15;IL1B;IL2RA;TNF;TLR4;IL2;IL17A
Trachoma,8/29,5.049747300087972E-16,2.1391774338476116E-14,0,0,137.9310344827586,4858.2101083387615,IL10;IL6;IFNG;IL15;IL1B;TNF;HLA-DRB1;IL17A
Alveolar Bone Loss,8/29,5.049747300087972E-16,2.1299964148182228E-14,0,0,137.9310344827586,4858.2101083387615,IL10;IL6;IFNG;IL15;IL1B;TNF;TLR4;IL17A
Fever,12/173,5.398837372154942E-16,2.2675116963050755E-14,0,0,34.682080924855484,1219.254723432415,IL10;IL6;IFNG;IL1B;IL12A;HMGB1;PRL;TNF;IL6R;TLR4;IL2;HLA-DRB1
Arthropathy,11/125,7.192373879254935E-16,3.0079425738432984E-14,0,0,44.0,1534.2069690926314,IL10;IL6;TGFB1;IFNG;IL1B;IL2RA;CD14;TNF;TLR4;HLA-DRB1;IL17A
Familial M??ni??re disease,11/125,7.192373879254935E-16,2.995197054462606E-14,0,0,44.0,1534.2069690926314,IL10;CXCL10;IL6;IFNG;CD80;IL1B;IL2RA;MTHFR;TLR4;HLA-DQA1;HLA-DRB1
Malignant Glioma,16/504,7.522338078495955E-16,3.11938981584212E-14,0,0,15.873015873015872,552.7537219614813,IL10;TGFB1;STAT1;CD80;MTHFR;AHR;HMGB1;HIF1A;TNF;SOD1;CXCL10;IL6;IFNG;IL1B;IL12A;CCR4
Precursor Cell Lymphoblastic Leukemia Lymphoma,17/618,7.869577877764936E-16,3.2496727471711675E-14,0,0,13.754045307443365,478.3430987738463,IL10;TGFB1;IL15;CD80;MTHFR;HMGB1;TNF;IL2;DPP4;CXCL10;IFNG;ZMIZ1;IL1B;IL2RA;CD14;HLA-DQA1;HLA-DRB1
Thrombocytopenia due to platelet alloimmunization,9/53,8.086130362138987E-16,3.325125071092132E-14,0,0,84.90566037735849,2950.574535412621,IL21;IL10;STAT1;VDR;TNF;RUNX3;TLR4;IL2;IL17A
Congestive heart failure,19/884,8.266500438873892E-16,3.385131929718859E-14,0,0,10.746606334841628,373.2205058847802,IL10;TGFB1;VDR;HMGB1;PRL;HIF1A;TNF;INS;SOD1;DPP4;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;IL6R;TLR4;IL17A
T-Cell Lymphoma,14/324,1.0285531098402692E-15,4.194448117639073E-14,0,0,21.604938271604937,745.5998867156195,IL10;TGFB1;IL15;VDR;MTHFR;ETS1;HIF1A;TNF;RUNX3;IL2;DPP4;IL6;IL1B;IL2RA
DOSAGE-SENSITIVE SEX REVERSAL,10/87,1.083533680260622E-15,4.400400417190659E-14,0,0,57.47126436781609,1980.3763660178415,IL10;IL6;IFNG;VDR;IL1B;TNF;S100A9;TLR4;HLA-DRB1;IL17A
Ulcer,12/184,1.1420969216334402E-15,4.619147549717469E-14,0,0,32.608695652173914,1121.9318614303145,IL10;IL6;TGFB1;IFNG;VDR;IL1B;MTHFR;HIF1A;TNF;S100A9;TLR4;IL17A
Systemic onset juvenile chronic arthritis,9/55,1.1569569249511495E-15,4.6600707616474985E-14,0,0,81.81818181818181,2813.971350873219,IL10;IL6;IFNG;STAT1;IL1B;IL2RA;IL6R;HLA-DQA1;HLA-DRB1
Crohn's disease of the ileum,9/55,1.1569569249511495E-15,4.641050064661182E-14,0,0,81.81818181818181,2813.971350873219,IL10;IL6;IFNG;IL2RA;MTHFR;FUT2;TNF;TLR4;HLA-DRB1
Osteopenia,14/329,1.2722605334682794E-15,5.08283598492937E-14,0,0,21.27659574468085,729.7442793416355,IL10;IL15;STAT1;VDR;MTHFR;AHR;HIF1A;TNF;RUNX3;IL6;IFNG;IL1B;S100A9;IL17A
Non-alcoholic Fatty Liver Disease,14/334,1.5684201915794345E-15,6.240661393863435E-14,0,0,20.958083832335326,714.4339901404558,IL10;TGFB1;VDR;MTHFR;HMGB1;HIF1A;TNF;DPP4;IL6;IFNG;IL1B;CD14;TLR4;IL17A
Tumor Immunity,11/134,1.5753459265146011E-15,6.242943453945766E-14,0,0,41.04477611940298,1398.9825246997746,IL10;IFNG;IL15;CD80;TNFRSF9;IL2RA;AHR;TNF;CCR4;IL2;IL17A
Necrosis,9/57,1.6324165878438034E-15,6.443128604549759E-14,0,0,78.94736842105263,2688.0564401671118,IL6;IFNG;IL1B;MTHFR;AHR;HMGB1;TNF;SOD1;IL17A
Thyroid associated opthalmopathies,10/92,1.9395983486195685E-15,7.624949028093248E-14,0,0,54.347826086956516,1841.1030152209,IL10;CXCL10;IL6;TGFB1;IFNG;STAT1;CD80;IL1B;TNF;IL2
Cardiovascular Diseases,18/787,2.1229267141787806E-15,8.31239989918289E-14,0,0,11.435832274459974,386.37080888752246,IL10;TGFB1;IL15;VDR;MTHFR;HIF1A;TNF;INS;DPP4;IL6;IFNG;IL1B;CD14;IL6R;S100A9;TLR4;HLA-DRB1;IL17A
Liver Cirrhosis, Alcoholic,10/93,2.170319307978923E-15,8.4642453011178E-14,0,0,53.763440860215056,1815.2635533144755,IL10;IL6;TGFB1;IFNG;VDR;IL1B;MTHFR;CD14;TNF;TLR4
Measles,11/138,2.1929286366534365E-15,8.518617644675879E-14,0,0,39.85507246376811,1345.2497215280118,IL10;CXCL10;IL6;IFNG;STAT1;VDR;IL1B;TNF;TLR4;IL2;HLA-DRB1
Renal Insufficiency,13/263,2.290955129699278E-15,8.86437284042697E-14,0,0,24.714828897338403,833.1321264301367,IL10;TGFB1;MTHFR;HIF1A;TNF;INS;DPP4;IL6;IFNG;IL1B;IL2RA;TLR4;HLA-DRB1
nervous system disorder,15/436,2.2968882382840777E-15,8.852477492492516E-14,0,0,17.201834862385322,579.826051512068,IL10;MTHFR;HMGB1;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL2RA;TNFRSF14;CCR4;HLA-DRB1;TGM2;IL17A
airway disease,10/94,2.4253763052385143E-15,9.311171221829734E-14,0,0,53.191489361702125,1790.0420055926627,IL10;IL6;TGFB1;IFNG;IL1B;AHR;TNF;TLR4;HLA-DRB1;IL17A
Thyroid Diseases,11/140,2.5775586536633756E-15,9.856905232764068E-14,0,0,39.285714285714285,1319.683109730549,CXCL10;IL6;TGFB1;IL15;VDR;IL1B;IL2RA;IL12A;TNF;HLA-DRB1;IL17A
Malignant neoplasm of esophagus,17/673,3.2111068940883205E-15,1.2232076959341092E-13,0,0,12.63001485884101,421.49088539124386,TGFB1;VDR;CD80;MTHFR;ETS1;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;TNFRSF14;S100A9;TLR4;HLA-DRB1;TGM2
Myocardial Ischemia,15/448,3.424954355578367E-15,1.2996313284410884E-13,0,0,16.741071428571427,557.6063881159106,IL10;TGFB1;MTHFR;HMGB1;HIF1A;TNF;IL2;INS;CXCL10;IL6;IL1B;IRF1;CD14;TLR4;HLA-DRB1
Hematologic Neoplasms,16/557,3.585771323004129E-15,1.3554215600955608E-13,0,0,14.362657091561939,477.7278677363142,IL21;IL10;TGFB1;MTHFR;AHR;HMGB1;ETS1;TNF;IL2;DPP4;CXCL10;IL6;IFNG;IL1B;HLA-DRB1;IL17A
Lymphoma, Follicular,14/359,4.2602443983386976E-15,1.6042023734433992E-13,0,0,19.498607242339833,645.1981867978021,IL21;IL10;TGFB1;STAT1;VDR;MTHFR;PRL;ETS1;TNF;IL2;IL2RA;TNFRSF14;S100A9;HLA-DRB1
Esophageal carcinoma,17/685,4.294055888350001E-15,1.610762643919993E-13,0,0,12.408759124087592,410.5009193879409,TGFB1;VDR;CD80;MTHFR;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL1B;TNFRSF14;S100A9;TLR4;HLA-DRB1
Neuroblastoma,23/1698,4.318697745084515E-15,1.6138464425357648E-13,0,0,6.772673733804476,224.01175417488673,IL21;TGFB1;STAT1;VDR;CD80;TNFRSF9;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;IL6R;TGM2
Brucellosis,8/37,4.49110795371492E-15,1.6719170064056905E-13,0,0,108.10810810810811,3571.5326446815116,IL10;IL6;TGFB1;IFNG;IL1B;TNF;TLR4;IL17A
Allergic Reaction,9/64,4.9487460688138235E-15,1.8353311835585759E-13,0,0,70.3125,2316.0685900677486,IL6;TGFB1;IFNG;IL1B;MTHFR;TNF;HLA-DQA1;HLA-DRB1;IL17A
Nonalcoholic Steatohepatitis,12/209,5.3322989355872885E-15,1.9701441330433034E-13,0,0,28.708133971291865,943.492648700298,CXCL10;IL6;TGFB1;IFNG;IL1B;MTHFR;CD14;HIF1A;TNF;TLR4;TGM2;IL17A
Early onset periodontitis,7/20,5.587724158810486E-15,2.0567847577823768E-13,0,0,174.99999999999997,5743.185755626861,IL10;IFNG;VDR;IL1B;TNF;IL2;HLA-DRB1
Experimental Organism Basal Cell Carcinoma,13/282,5.653666345140551E-15,2.073292270150796E-13,0,0,23.04964539007092,756.1775495465835,IL10;TGFB1;STAT1;VDR;MTHFR;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IFNG;IL2RA
Cerebral Infarction,13/283,5.918374042395324E-15,2.1622966575710498E-13,0,0,22.968197879858657,752.454576508166,IL21;IL10;TGFB1;VDR;MTHFR;HMGB1;HIF1A;TNF;SOD1;IL6;IL1B;CD14;TLR4
Lung Diseases, Interstitial,11/151,6.014941709584155E-15,2.189438782288632E-13,0,0,36.423841059602644,1192.68154668909,IL10;CXCL10;IL6;TGFB1;IFNG;IL1B;TNF;S100A9;IL2;HLA-DRB1;IL17A
Severe Sepsis,10/103,6.251183538358724E-15,2.267034384316957E-13,0,0,48.543689320388346,1587.6701739297323,IL10;IL6;TGFB1;IFNG;IL15;HMGB1;CD14;TNF;TLR4;IL17A
Solid Neoplasm,18/840,6.560495305760011E-15,2.370461318566522E-13,0,0,10.714285714285714,349.9040388308371,IL21;IL10;IL15;CD80;TNFRSF9;AHR;ETS1;HIF1A;TNF;RUNX3;IL2;DPP4;IL6;IFNG;IL1B;IL2RA;IRF1;HLA-DRB1
Acute pancreatitis,10/104,6.9067583079943824E-15,2.4864329908779773E-13,0,0,48.07692307692308,1567.609422968439,IL10;IL6;TGFB1;IL1B;MTHFR;CD14;FUT2;TNF;S100A9;TLR4
Lymphoproliferative Disorders,12/215,7.498924813949557E-15,2.6897603310765057E-13,0,0,27.906976744186046,907.6469788684253,IL10;IL6;TGFB1;IFNG;IL1B;IL2RA;MTHFR;IL12A;TNF;IL2;HLA-DRB1;IL17A
Hyperactive behavior,17/709,7.557929981419506E-15,2.701066758450579E-13,0,0,11.988716502115656,389.82725241276466,IL10;TGFB1;STAT1;MTHFR;AHR;PRL;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IRF1;HLA-DRB1;TGM2;IL17A
Parasitemia,9/67,7.651022328555351E-15,2.7244292552551447E-13,0,0,67.16417910447761,2183.100254212924,IL10;CXCL10;IL6;IFNG;VDR;AHR;TNF;TLR4;IL17A
Alopecia,12/216,7.929703587753244E-15,2.813470283770357E-13,0,0,27.777777777777775,901.8933538487795,IL10;TGFB1;IFNG;VDR;IL1B;IL2RA;MTHFR;PRL;TNF;IL2;HLA-DRB1;SOD1
Drug-Induced Liver Disease,14/377,8.368556217670725E-15,2.9584953419880536E-13,0,0,18.567639257294427,601.8569367144069,IL10;MTHFR;AHR;HMGB1;TNF;SOD1;CXCL10;IL6;IFNG;IL1B;S100A9;HLA-DQA1;HLA-DRB1;IL17A
Chronic graft-versus-host disease,10/106,8.405963820788807E-15,2.96106854590367E-13,0,0,47.16981132075472,1528.7658001090429,DPP4;IL10;IL6;IFNG;VDR;IL1B;IL2RA;TNF;IL2;IL17A
Acute otitis media,6/10,9.017681002771205E-15,3.165206031972693E-13,0,0,300.0,9701.876756678159,IL10;IL6;TGFB1;IFNG;IL1B;TNF
Pituitary Adenoma,13/294,9.683890818183057E-15,3.386949429220751E-13,0,0,22.108843537414966,713.4150751608631,TGFB1;AHR;PRL;HIF1A;TNF;IL2;SOD1;IL6;IL1B;CD14;IL6R;TLR4;IL17A
Carcinoma, Lewis Lung,10/108,1.0190840914020703E-14,3.551616471737428E-13,0,0,46.29629629629629,1491.541066093728,IL10;IL6;TGFB1;IFNG;TNFRSF9;IL1B;TNF;TLR4;IL2;IL17A
Gastric Adenocarcinoma,14/383,1.0402201822270341E-14,3.6124678271827887E-13,0,0,18.276762402088774,588.4525124867935,IL10;STAT1;HMGB1;ETS1;HIF1A;TNF;IL6;IL1B;IL2RA;IRF1;IL6R;HLA-DQA1;HLA-DRB1;IL17A
Kidney Failure,13/297,1.1038597110246038E-14,3.8199764929400725E-13,0,0,21.885521885521886,703.3432990930737,TGFB1;VDR;CD80;MTHFR;HIF1A;TNF;IL2;INS;IL6;IFNG;IL1B;IL2RA;TLR4
Non-Small Cell Lung Carcinoma,25/2243,1.1552769553009918E-14,3.9838813742800516E-13,0,0,5.572893446277307,178.84446722329514,CD80;AHR;HMGB1;ETS1;HIF1A;TNF;DPP4;CD14;IL6R;TGM2;IL10;TGFB1;STAT1;VDR;MTHFR;RUNX3;SOD1;CXCL10;IL6;IFNG;IL1B;IL2RA;IRF1;TLR4;IL17A
Angina, Unstable,9/70,1.1588439970563912E-14,3.982209371702871E-13,0,0,64.28571428571428,2062.8493937968137,IL10;IL6;IFNG;IL1B;AHR;CD14;HIF1A;TNF;TLR4
Reperfusion Injury,10/110,1.2308542979546256E-14,4.2149254495812057E-13,0,0,45.45454545454545,1455.84012829267,IL10;IL6;IL1B;IL12A;ETS1;HIF1A;TNF;IL6R;TLR4;SOD1
Chronic kidney disease stage 5,14/388,1.2435732935500522E-14,4.2436938642395534E-13,0,0,18.041237113402058,577.6479810474254,IL10;TGFB1;VDR;MTHFR;HIF1A;TNF;IL2;IL6;IFNG;ZMIZ1;IL1B;IL2RA;HLA-DRB1;IL17A
Malnutrition,12/225,1.2954196993580742E-14,4.4053234620384616E-13,0,0,26.666666666666668,852.729508456087,IL21;IL10;IL6;IFNG;STAT1;IL1B;MTHFR;HMGB1;HIF1A;TNF;IL2;SOD1
Duodenal Ulcer,9/71,1.3252130727838401E-14,4.4911014066619245E-13,0,0,63.38028169014084,2025.2926930410479,IL10;IL6;TGFB1;IL1B;IL2RA;TNF;TLR4;HLA-DQA1;IL2
Pancreatitis, Chronic,13/302,1.3688585852216316E-14,4.623072912562954E-13,0,0,21.52317880794702,687.0675211333662,IL10;TGFB1;VDR;MTHFR;FUT2;TNF;CXCL10;IL6;IFNG;IL1B;IL2RA;CD14;HLA-DRB1
Malignant tumor of cervix,18/884,1.5824684513987363E-14,5.326198609707802E-13,0,0,10.180995475113122,323.52358401248557,IL10;TGFB1;IL15;CD80;MTHFR;HIF1A;TNF;IL2;IL6;IFNG;IL1B;IRF1;IL12A;S100A9;TLR4;HLA-DQA1;HLA-DRB1;IL17A
Irritable Bowel Syndrome,11/167,1.849026262096997E-14,6.202126315320575E-13,0,0,32.93413173652695,1041.4277054139998,IL10;IL6;TGFB1;IFNG;IL1B;IL2RA;HIF1A;TNF;S100A9;TLR4;HLA-DRB1
Kidney Failure, Acute,13/310,1.9166294114255228E-14,6.40701831819389E-13,0,0,20.967741935483872,662.2791955729996,IL10;TGFB1;MTHFR;HMGB1;HIF1A;TNF;INS;SOD1;IL6;IL1B;TLR4;HLA-DRB1;IL17A
Vascular Diseases,14/401,1.9564345656202005E-14,6.517911495225536E-13,0,0,17.456359102244388,551.0111548402103,TGFB1;STAT1;MTHFR;AHR;HIF1A;TNF;IL6;IFNG;IL1B;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Fungal keratitis,6/11,1.981045392159685E-14,6.57760611964371E-13,0,0,272.7272727272727,8605.245442009682,IL6;IFNG;IL1B;S100A9;TLR4;IL17A
Immune reconstitution inflammatory syndrome [IRIS],6/11,1.981045392159685E-14,6.555459297692049E-13,0,0,272.7272727272727,8605.245442009682,IL10;IL6;IFNG;TNF;IL2;IL17A
Arthritis, Adjuvant-Induced,8/44,2.041303587441553E-14,6.732191831334088E-13,0,0,90.9090909090909,2865.6911531537207,IL10;IL6;IFNG;STAT1;IL1B;AHR;TNF;IL17A
Arthritis, Collagen-Induced,8/44,2.041303587441553E-14,6.709676139590496E-13,0,0,90.9090909090909,2865.6911531537207,IL10;IL6;IFNG;STAT1;IL1B;AHR;TNF;IL17A
Arthritis, Experimental,8/44,2.041303587441553E-14,6.687310552458527E-13,0,0,90.9090909090909,2865.6911531537207,IL10;IL6;IFNG;STAT1;IL1B;AHR;TNF;IL17A
Multiple Sclerosis, Acute Fulminating,8/44,2.041303587441553E-14,6.665093573878931E-13,0,0,90.9090909090909,2865.6911531537207,IL10;IFNG;VDR;IL1B;IL2RA;IL12A;HLA-DRB1;IL17A
Acute anterior uveitis,8/44,2.041303587441553E-14,6.643023727607809E-13,0,0,90.9090909090909,2865.6911531537207,IL10;IL1B;IL2RA;TNF;TLR4;IL2;HLA-DRB1;IL17A
Pneumococcal Infections,8/44,2.041303587441553E-14,6.621099556889631E-13,0,0,90.9090909090909,2865.6911531537207,IL10;IL6;IFNG;IL1B;CD14;TNF;TLR4;IL17A
Epstein-Barr Virus Infections,12/234,2.07389346998509E-14,6.704679283886008E-13,0,0,25.64102564102564,807.8657322550952,IL10;CXCL10;IL6;TGFB1;IFNG;IL1B;IL2RA;TNF;CCR4;S100A9;IL2;HLA-DRB1
Mitral Valve Stenosis,9/75,2.2224501315721663E-14,7.161390128882378E-13,0,0,60.0,1886.2548631050138,IL10;IFNG;IL1B;IL2RA;CD14;TNF;HLA-DQA1;HLA-DRB1;IL17A
Coinfection,11/171,2.405406170863028E-14,7.72559864288949E-13,0,0,32.16374269005848,1008.6058414989853,DPP4;IL10;CXCL10;IL6;IFNG;IL1B;CD14;TNF;TLR4;IL2;HLA-DRB1
IGA Glomerulonephritis,12/237,2.4159101913472762E-14,7.734060378032909E-13,0,0,25.31645569620253,793.7750682276096,IL10;IL6;TGFB1;IFNG;STAT1;CD80;IL1B;CD14;TNF;TLR4;IL2;HLA-DRB1
Colonic Diseases,7/24,2.4804817372824477E-14,7.914991725328537E-13,0,0,145.83333333333334,4568.628532956164,IL10;IL6;IFNG;TNF;TLR4;HLA-DRB1;IL17A
Autoimmune thrombocytopenia,9/76,2.517471933393513E-14,8.007027236696261E-13,0,0,59.21052631578947,1854.055427267995,IL21;IL10;STAT1;VDR;TNF;RUNX3;TLR4;IL2;IL17A
Giant Cell Arteritis,10/119,2.7582613675532725E-14,8.744578296875343E-13,0,0,42.016806722689076,1311.8315445367643,IL10;IL6;IFNG;IL2RA;MTHFR;TNF;S100A9;TLR4;HLA-DRB1;IL17A
Sarcoidosis, Pulmonary,8/46,2.996813120444037E-14,9.470314902805144E-13,0,0,86.95652173913044,2707.707988788449,CXCL10;IFNG;CD14;TNF;TLR4;IL2;HLA-DRB1;IL17A
Sicca Syndrome,9/78,3.213508591025204E-14,1.0122552061729394E-12,0,0,57.69230769230769,1792.4323813081219,IL21;TGFB1;IFNG;IL2RA;MTHFR;IL12A;HMGB1;TNF;IL2
Multiple Sclerosis, Relapsing-Remitting,9/78,3.213508591025204E-14,1.0090211639806934E-12,0,0,57.69230769230769,1792.4323813081219,IL10;IL6;IFNG;IL15;IL1B;IL2RA;CD14;TNF;HLA-DRB1
Cerebral arterial aneurysm,9/78,3.213508591025204E-14,1.0058077207833027E-12,0,0,57.69230769230769,1792.4323813081219,IL10;IL6;TGFB1;IFNG;STAT1;IL1B;ETS1;TNF;TLR4
Crohn's disease of large bowel,9/78,3.213508591025204E-14,1.0026146803998637E-12,0,0,57.69230769230769,1792.4323813081219,IL10;IL6;IFNG;IL2RA;MTHFR;FUT2;TNF;TLR4;HLA-DRB1
Kaposi Sarcoma,13/323,3.2495229579762065E-14,1.0106427731325998E-12,0,0,20.123839009287924,624.999814675892,VDR;CD80;ETS1;HIF1A;TNF;CXCL10;IL6;IFNG;IL1B;IRF1;IL12A;TLR4;HLA-DRB1
Dengue Fever,11/177,3.526860116935375E-14,1.0934378936669041E-12,0,0,31.073446327683616,962.524340206051,IL10;CXCL10;IL6;IFNG;STAT1;IL1B;IL2RA;TNF;TLR4;HLA-DRB1;IL17A
Central neuroblastoma,22/1655,3.577803147906256E-14,1.1057436898623487E-12,0,0,6.646525679758308,205.7860215665724,IL21;TGFB1;STAT1;VDR;CD80;TNFRSF9;AHR;HMGB1;PRL;ETS1;HIF1A;TNF;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1;IL6R;TGM2
Acute myocardial infarction,12/247,3.9614869411510915E-14,1.2204856945966433E-12,0,0,24.291497975708502,749.625227294074,IL10;IL6;IFNG;IL1B;MTHFR;HMGB1;CD14;HIF1A;TNF;TLR4;HLA-DRB1;IL17A
Osteosarcoma,19/1103,4.584041624072143E-14,1.4078737837931568E-12,0,0,8.612873980054397,264.5324544890112,IL10;TGFB1;IL15;VDR;MTHFR;HMGB1;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IL12A;CD14;IL6R;S100A9;HLA-DRB1;IL17A
Thromboangiitis Obliterans,8/49,5.157464899443819E-14,1.579051870147472E-12,0,0,81.63265306122449,2497.6119299352854,CXCL10;IL6;IFNG;STAT1;IL1B;CD14;TNF;HLA-DRB1
Gastritis, Atrophic,10/127,5.362421993500118E-14,1.6367044519291666E-12,0,0,39.37007874015748,1203.0226600171243,IL10;IL1B;AHR;TNF;RUNX3;TLR4;HLA-DQA1;IL2;HLA-DRB1;SOD1
Pulmonary Fibrosis,14/432,5.430330787412245E-14,1.652300030299924E-12,0,0,16.203703703703702,494.929024905877,IL10;TGFB1;STAT1;HMGB1;HIF1A;TNF;SOD1;IL6;IFNG;IL1B;IL2RA;CCR4;HLA-DRB1;IL17A
Pancreatic Neoplasm,16/665,5.5859871447473484E-14,1.6944161005733625E-12,0,0,12.030075187969926,367.1089339636748,TGFB1;VDR;MTHFR;AHR;HMGB1;FUT2;ETS1;HIF1A;TNF;RUNX3;IL2;IL6;IFNG;IL1B;IL6R;TGM2
bone destruction,9/83,5.751723595941505E-14,1.739321215412711E-12,0,0,54.21686746987952,1652.892925457129,IL21;CXCL10;IL6;HMGB1;HIF1A;TNF;RUNX3;HLA-DRB1;IL17A
Schizophrenia,23/1923,6.295655382827664E-14,1.8979662914855914E-12,0,0,5.980239209568382,181.77733363192752,IL21;IL10;TGFB1;VDR;MTHFR;PRL;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IL2RA;IL12A;CD14;IL6R;S100A9;TLR4;HLA-DQA1;HLA-DRB1;TGM2;IL17A
Appendicitis,7/27,6.337022071800217E-14,1.904594890570414E-12,0,0,129.62962962962962,3939.4162303710555,IL10;IL6;IFNG;IL2RA;CD14;TNF;TLR4
Adenoma of large intestine,12/258,6.665029540379425E-14,1.997070436672225E-12,0,0,23.25581395348837,705.5655096774613,IL21;IL10;IL6;TGFB1;VDR;IL1B;MTHFR;HMGB1;ETS1;HIF1A;RUNX3;HLA-DRB1
Hypertensive disease,20/1310,7.148336264728433E-14,2.1353753437614295E-12,0,0,7.633587786259541,231.06344780561122,IL10;TGFB1;IL15;VDR;MTHFR;AHR;HMGB1;HIF1A;TNF;INS;SOD1;DPP4;IL6;IFNG;IL1B;IRF1;TLR4;HLA-DRB1;TGM2;IL17A
Alcoholic Liver Diseases,9/85,7.184693535713336E-14,2.13973236572699E-12,0,0,52.94117647058823,1602.2243878221561,IL10;IL6;TGFB1;IL1B;HMGB1;CD14;TNF;TLR4;IL17A
Lesion of brain,9/85,7.184693535713336E-14,2.1332679174921653E-12,0,0,52.94117647058823,1602.2243878221561,IL10;IL6;IFNG;IL15;MTHFR;TNF;HLA-DRB1;INS;SOD1
Osteoporosis,14/441,7.198984248951873E-14,2.1310728071897292E-12,0,0,15.873015873015872,480.35319622827495,TGFB1;IL15;STAT1;VDR;MTHFR;PRL;HIF1A;TNF;RUNX3;IL6;IFNG;IL1B;IL6R;TGM2
Autoimmune Primary Adrenal Insufficiency,8/51,7.261476165041231E-14,2.1431167492500065E-12,0,0,78.4313725490196,2372.832012959239,CXCL10;VDR;IL2RA;HLA-DQA1;IL2;HLA-DRB1;INS;TGM2
Beryllium Disease,6/13,7.3370148416937E-14,2.1589276007235235E-12,0,0,230.76923076923077,6979.21367061483,IL6;TGFB1;IL1B;IL2RA;TNF;HLA-DRB1
Fatty Liver,14/443,7.658129807367997E-14,2.246689544680975E-12,0,0,15.80135440180587,477.2075947836007,IL10;TGFB1;MTHFR;AHR;HMGB1;TNF;INS;SOD1;DPP4;CXCL10;IL6;IL1B;TLR4;IL17A
Precancerous Conditions,14/446,8.397707845675471E-14,2.4563295448600754E-12,0,0,15.695067264573991,472.5507344433553,IL10;TGFB1;STAT1;PRL;ETS1;HIF1A;TNF;RUNX3;IL2;IL6;IL1B;IL2RA;TLR4;TGM2
Extrinsic allergic alveolitis,7/28,8.437223926764916E-14,2.4605648887906705E-12,0,0,125.0,3762.9422457555147,IL10;IFNG;IL1B;IL12A;TNF;HLA-DRB1;IL17A
Allergic sensitization,8/52,8.569560967278012E-14,2.4917646504854526E-12,0,0,76.92307692307692,2314.459599972431,IL10;TGFB1;IL15;MTHFR;CD14;TNF;TLR4;HLA-DRB1
Brain Ischemia,12/264,8.766244384783306E-14,2.5414350977477973E-12,0,0,22.727272727272727,683.30188230903,CXCL10;IL6;TGFB1;IL1B;MTHFR;HMGB1;HIF1A;TNF;CCR4;TLR4;SOD1;IL17A
Eclampsia,11/194,9.725645048654444E-14,2.811283515828702E-12,0,0,28.350515463917525,849.4218452131814,IL10;IL6;TGFB1;IL15;MTHFR;HMGB1;HIF1A;TNF;TLR4;IL2;HLA-DRB1
Experimental Lung Inflammation,8/53,1.0078707647332056E-13,2.9047958580052624E-12,0,0,75.47169811320754,2258.5483967609844,IL6;TGFB1;IFNG;IL1B;AHR;TNF;TLR4;IL17A
Amyloidosis,17/833,1.0481579798646913E-13,3.0120750368743233E-12,0,0,10.204081632653061,304.96501928815104,IL10;TGFB1;VDR;HMGB1;TNF;IL2;INS;SOD1;IL6;IFNG;IL1B;IL12A;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Malaria, Falciparum,9/89,1.1029847413827659E-13,3.1603889324518434E-12,0,0,50.561797752808985,1508.540880462914,IL21;IL10;IFNG;IL1B;CD14;TNF;TLR4;IL2;HLA-DRB1
Cholangiocarcinoma,14/455,1.1030332648830796E-13,3.1513403858345655E-12,0,0,15.384615384615385,459.00834323928905,IL10;TGFB1;STAT1;VDR;MTHFR;HMGB1;FUT2;TNF;IL2;IL6;IFNG;IL1B;CD14;IL6R
Cytomegalovirus Infections,12/270,1.1455504811360922E-13,3.2633246749581205E-12,0,0,22.22222222222222,662.1715759532859,IL10;CXCL10;IL6;TGFB1;IFNG;STAT1;IL1B;CD14;TNF;TLR4;IL2;HLA-DRB1
Lymphopenia,10/137,1.159813116206776E-13,3.2944055797919637E-12,0,0,36.4963503649635,1087.0564716606457,IL10;IL15;STAT1;IL1B;IL2RA;HMGB1;TNF;IL2;INS;SOD1
Hamartoma Syndrome, Multiple,10/138,1.248712687270045E-13,3.5366997955302596E-12,0,0,36.231884057971016,1076.5033709584209,IL10;TGFB1;IFNG;IL15;IL1B;TNF;TLR4;HLA-DQA1;TGM2;IL17A
Mental Depression,15/575,1.3102822262807924E-13,3.700417735599893E-12,0,0,13.043478260869565,386.9134389783179,IL10;TGFB1;VDR;MTHFR;PRL;HIF1A;TNF;SOD1;DPP4;IL6;IFNG;IL1B;IL6R;TLR4;IL17A
Cholangitis, Sclerosing,10/140,1.4450503940059288E-13,4.069328158249361E-12,0,0,35.71428571428571,1055.9093576150613,IL10;ZMIZ1;IL2RA;TNFRSF14;FUT2;ETS1;HIF1A;IL6R;TLR4;HLA-DRB1
Chorioretinitis,5/6,1.4784822486401417E-13,4.151578154181518E-12,0,0,416.6666666666667,12309.412564589551,IL10;IL6;IFNG;TNF;IL2
Leukemia, T-Cell,13/364,1.4996285838721433E-13,4.1989600348420014E-12,0,0,17.857142857142854,527.2926561111952,IL10;TGFB1;IL15;STAT1;HMGB1;TNF;IL2;IL6;IFNG;IL1B;IL2RA;CCR4;TLR4
Dejerine-Sottas Disease (disorder),9/92,1.5012181973265705E-13,4.191469444126572E-12,0,0,48.91304347826087,1444.2715417922495,IL10;IL6;VDR;IL1B;TNF;S100A9;TLR4;HLA-DRB1;IL17A
Glioblastoma Multiforme,17/854,1.5693708833374688E-13,4.3693419380851684E-12,0,0,9.953161592505856,293.4483802570353,IL10;TGFB1;STAT1;VDR;TNFRSF9;MTHFR;HMGB1;HIF1A;TNF;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;HLA-DRB1;TGM2
Adenocarcinoma of lung (disorder),19/1187,1.711306447104752E-13,4.751050780267091E-12,0,0,8.003369839932603,235.26985399880385,IL10;TGFB1;VDR;CD80;AHR;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;S100A9;TLR4;HLA-DQA1;IL17A
Myositis,10/143,1.7916181086905265E-13,4.960006414707182E-12,0,0,34.96503496503497,1026.240805107359,IL6;TGFB1;IFNG;IL1B;HMGB1;TNF;TLR4;HLA-DQA1;HLA-DRB1;TGM2
Bright Disease,7/31,1.8657117585331009E-13,5.150622236759358E-12,0,0,112.9032258064516,3309.189437430336,IL10;IL6;IFNG;IL1B;IL2RA;TNF;IL2
Intervertebral disc disorder,7/31,1.8657117585331009E-13,5.136194723491125E-12,0,0,112.9032258064516,3309.189437430336,IL6;IFNG;VDR;IL1B;HIF1A;TNF;IL17A
Latent autoimmune diabetes mellitus in adult,7/31,1.8657117585331009E-13,5.121847810855675E-12,0,0,112.9032258064516,3309.189437430336,IL10;IFNG;ZMIZ1;VDR;IL2RA;HLA-DRB1;INS
Spondylarthropathies,8/57,1.8683670121354202E-13,5.114849859405824E-12,0,0,70.17543859649122,2056.7397484286594,IL10;IFNG;IL1B;TNF;TLR4;IL2;HLA-DRB1;IL17A
Atrophic,8/57,1.8683670121354202E-13,5.100641943129697E-12,0,0,70.17543859649122,2056.7397484286594,TGFB1;IFNG;MTHFR;AHR;TLR4;IL2;TGM2;SOD1
Lip and Oral Cavity Carcinoma,14/473,1.871482353885424E-13,5.094994064816052E-12,0,0,14.799154334038054,433.7169719371341,IL10;TGFB1;STAT1;MTHFR;HMGB1;FUT2;ETS1;HIF1A;TNF;IL2;INS;IL6;IL1B;S100A9
Severe Dengue,8/58,2.1642268468907464E-13,5.875696533492336E-12,0,0,68.9655172413793,2011.140898334404,IL10;IL6;IL1B;CD14;TNF;TLR4;HLA-DRB1;IL17A
polyps,12/285,2.1778400915567493E-13,5.896367057801579E-12,0,0,21.052631578947366,613.7952127781423,IL21;IL10;IL6;TGFB1;VDR;IL1B;MTHFR;AHR;TNF;RUNX3;INS;IL17A
Pain,14/485,2.6312978344095005E-13,7.104504152905651E-12,0,0,14.43298969072165,418.06784140007994,IL10;TGFB1;VDR;MTHFR;TNF;IL2;SOD1;CXCL10;IL6;IFNG;IL1B;CD14;HLA-DRB1;IL17A
Osteosarcoma of bone,18/1042,2.6402371766250003E-13,7.1091098553069865E-12,0,0,8.637236084452976,250.1580010609609,IL10;TGFB1;IL15;VDR;HMGB1;HIF1A;TNF;IL2;SOD1;IL6;IFNG;IL1B;IL12A;CD14;IL6R;S100A9;HLA-DRB1;IL17A
Mycobacterium Infections,9/98,2.6966015526032017E-13,7.24103826748204E-12,0,0,45.91836734693878,1328.9516592677296,IL10;IL6;TGFB1;IFNG;STAT1;IL12A;TNF;HLA-DRB1;IL17A
Adrenoleukodystrophy,10/149,2.716020586405322E-13,7.273310714766077E-12,0,0,33.557046979865774,970.9543093817758,IL10;IL6;TGFB1;IFNG;IL1B;HMGB1;CD14;TNF;TLR4;IL17A
Autoimmune thyroiditis,8/60,2.88069679785147E-13,7.693339165566373E-12,0,0,66.66666666666667,1925.0382666893315,CXCL10;IL6;IFNG;IL1B;IL2RA;TNF;HLA-DRB1;INS
Dry Eye Syndromes,8/60,2.88069679785147E-13,7.67249000793611E-12,0,0,66.66666666666667,1925.0382666893315,IL6;TGFB1;IFNG;VDR;IL1B;TNF;TGM2;SOD1
Primary Sj??gren's syndrome,10/151,3.1078795694679573E-13,8.25520011046786E-12,0,0,33.11258278145696,953.631308799019,IL21;IL10;IL6;IFNG;STAT1;IL2RA;CD14;TNF;HLA-DRB1;IL17A
Malignant neoplasm of mouth,14/492,3.196786093829548E-13,8.468467312710727E-12,0,0,14.227642276422763,409.3500442000361,IL10;TGFB1;STAT1;MTHFR;HMGB1;FUT2;ETS1;HIF1A;TNF;IL2;INS;IL6;IL1B;S100A9
Epithelial hyperplasia of skin,8/61,3.310807618417169E-13,8.74694012736665E-12,0,0,65.57377049180329,1884.3550200534876,IL21;IL10;IL6;TGFB1;IL1B;HIF1A;TNF;IL17A
Pre-Eclampsia,10/152,3.322189615680581E-13,8.753479770216822E-12,0,0,32.89473684210526,945.1638855456717,IL10;CXCL10;IL6;TGFB1;IFNG;IL15;MTHFR;HIF1A;TNF;TLR4
Severe Combined Immunodeficiency,11/217,3.33654628663593E-13,8.767801311512814E-12,0,0,25.34562211981567,728.1460133900981,IL21;DPP4;IL10;IL6;IFNG;IL15;STAT1;IL2RA;HIF1A;TNF;IL2
Disease caused by Shigella dysenteriae,6/16,3.4091352899218157E-13,8.934661767827094E-12,0,0,187.5,5382.590161959801,IL10;IL6;IFNG;CD80;IL1B;TNF
Sezary Syndrome,10/153,3.549643790114832E-13,9.278164672672492E-12,0,0,32.67973856209151,936.8221879504076,IL21;DPP4;IL10;CXCL10;TGFB1;IFNG;TNF;CCR4;IL2;IL17A
Fibrosarcoma,12/298,3.694970397913304E-13,9.632405589042956E-12,0,0,20.13422818791946,576.3751744821079,IL10;IL6;TGFB1;IFNG;IL15;STAT1;IL1B;HIF1A;TNF;IL2;TGM2;IL17A
prostatitis,7/34,3.8004471537227467E-13,9.881162599679143E-12,0,0,102.94117647058823,2943.9619461700786,IL10;IL6;TGFB1;IL15;HIF1A;HLA-DRB1;IL17A
Carcinoma breast stage IV,13/392,3.8521634318215036E-13,9.989198471752438E-12,0,0,16.581632653061224,473.9854932976327,IL10;TGFB1;VDR;CD80;AHR;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;TLR4;TGM2
Aplastic Anemia,10/155,4.046844742609211E-13,1.046641845535877E-11,0,0,32.25806451612903,920.5054421722725,IL21;IL10;IL6;TGFB1;IFNG;IL15;IL1B;TNF;HLA-DQA1;HLA-DRB1
Herpes Simplex Infections,14/503,4.3154366409890275E-13,1.1131787744787445E-11,0,0,13.916500994035786,396.222373531984,IL10;TGFB1;STAT1;CD80;TNF;IL2;INS;SOD1;CXCL10;IL6;IFNG;TNFRSF14;HLA-DRB1;IL17A
Neutrophilia (disorder),8/63,4.3418462228848546E-13,1.1170592847778104E-11,0,0,63.49206349206349,1807.3210510658948,CXCL10;IL6;IFNG;IL15;IL1B;TNF;TLR4;IL17A
Colorectal Neoplasms,18/1073,4.3446906445281755E-13,1.1148725758334962E-11,0,0,8.387698042870456,238.75290294221307,TGFB1;VDR;TNFRSF9;MTHFR;HMGB1;ETS1;HIF1A;TNF;RUNX3;CXCL10;IL6;IFNG;ZMIZ1;IL1B;CD14;IL6R;S100A9;TLR4
Enterovirus Infections,9/104,4.668687423037284E-13,1.1948921873336049E-11,0,0,43.26923076923077,1228.531510491877,CXCL10;IL6;IFNG;TNF;HLA-DRB1;INS;TGM2;SOD1;IL17A
Exanthema,11/225,4.961756337243044E-13,1.2666010722707698E-11,0,0,24.444444444444446,692.5562460816717,IL10;IL6;TGFB1;IFNG;STAT1;IL1B;HMGB1;TNF;CCR4;HLA-DRB1;SOD1
Entamoeba histolytica Infection,5/7,5.16731753479424E-13,1.315657946423777E-11,0,0,357.14285714285717,10104.018752544043,IL10;IL6;IFNG;IL1B;IL2
Entamoebiasis,5/7,5.16731753479424E-13,1.3122583134872814E-11,0,0,357.14285714285717,10104.018752544043,IL10;IL6;IFNG;IL1B;IL2
Viral respiratory infection,6/17,5.261044943521622E-13,1.3326172604363531E-11,0,0,176.47058823529412,4989.4017429597825,IL10;IL6;IFNG;IL1B;TNF;IL17A
Dermatologic disorders,13/406,6.013426501274981E-13,1.5192790656691647E-11,0,0,16.00985221674877,450.5110213838786,IL10;TGFB1;VDR;MTHFR;AHR;TNF;IL2;CXCL10;IL6;IFNG;IL1B;HLA-DRB1;IL17A
Dermatitis, Allergic Contact,9/107,6.067121274383364E-13,1.5289145611446077E-11,0,0,42.05607476635514,1183.067746442981,IL10;CXCL10;IFNG;CD80;IL1B;IL2RA;TNF;IL2;IL17A
Hairy Cell Leukemia,9/107,6.067121274383364E-13,1.5250042937248006E-11,0,0,42.05607476635514,1183.067746442981,IL10;IL6;TGFB1;IFNG;IL1B;IL2RA;TNF;IL2;HLA-DRB1
Nasopharyngeal carcinoma,16/782,6.697567251923785E-13,1.6791757895894633E-11,0,0,10.230179028132993,286.77096516817437,IL10;TGFB1;STAT1;CD80;MTHFR;HMGB1;ETS1;HIF1A;TNF;IL2;CXCL10;IL6;IFNG;IL1B;TLR4;HLA-DRB1
Brain Neoplasms,15/646,7.040394929787401E-13,1.760636167174315E-11,0,0,11.609907120743035,324.86774700864834,IL10;STAT1;CD80;MTHFR;AHR;HMGB1;ETS1;HIF1A;TNF;IL2;IL6;IFNG;IL1B;IL12A;TGM2
Bone Marrow Diseases,7/37,7.241908249169135E-13,1.8064333571785345E-11,0,0,94.5945945945946,2644.270949574109,IL15;VDR;MTHFR;HIF1A;TNF;IL2;IL17A
Idiopathic Inflammatory Myopathies,8/67,7.270636364370987E-13,1.8090079541528622E-11,0,0,59.70149253731343,1668.6425306437068,CXCL10;IFNG;CD80;IL1B;TNF;HLA-DQA1;HLA-DRB1;IL17A
Post-kala-azar dermal leishmaniasis,6/18,7.880148104701258E-13,1.9557094841667667E-11,0,0,166.66666666666666,4644.876585036096,IL10;DPP4;IL6;IFNG;VDR;TNF
Pulpitis,6/18,7.880148104701258E-13,1.9507832638036264E-11,0,0,166.66666666666666,4644.876585036096,IL10;CXCL10;IFNG;HMGB1;TNF;TLR4
Classical Hodgkin's Lymphoma,10/166,8.072966683255316E-13,1.9934953910309862E-11,0,0,30.12048192771084,838.7073848028023,DPP4;IL10;IL6;IFNG;IL15;STAT1;TNFRSF14;TNF;IL2;HLA-DRB1
Metastatic melanoma,13/417,8.437417848990697E-13,2.0782692385934978E-11,0,0,15.587529976019185,433.3478280089142,IL10;IL15;STAT1;VDR;ETS1;HIF1A;TNF;RUNX3;IL2;IL6;IFNG;IL1B;TGM2
Bacterial Vaginosis,7/38,8.864396114251588E-13,2.1779821252716148E-11,0,0,92.10526315789473,2556.0650492573086,IL10;CXCL10;IL6;IL1B;MTHFR;TNF;TLR4
Infectious Mononucleosis,7/38,8.864396114251588E-13,2.1725507484006133E-11,0,0,92.10526315789473,2556.0650492573086,IL10;IL6;IFNG;IL1B;IL2RA;TNF;HLA-DRB1
Painful Bladder Syndrome,7/38,8.864396114251588E-13,2.1671463933050896E-11,0,0,92.10526315789473,2556.0650492573086,IL10;CXCL10;IL6;IFNG;HIF1A;TNF;IL17A
Barrett Esophagus,12/323,9.569289674478302E-13,2.3336719335179342E-11,0,0,18.575851393188852,514.0875646514846,DPP4;IL10;IL6;VDR;HMGB1;HIF1A;TNF;RUNX3;S100A9;IL2;TGM2;IL17A
Amyotrophic Lateral Sclerosis,15/660,9.582081325242067E-13,2.3310073085267088E-11,0,0,11.363636363636363,314.4739929909616,IL10;TGFB1;VDR;HIF1A;TNF;SOD1;CXCL10;IFNG;IL1B;CD14;S100A9;TLR4;HLA-DRB1;TGM2;IL17A
Intracranial Aneurysm,9/114,1.086127534925061E-12,2.6356694847514813E-11,0,0,39.473684210526315,1087.4369394409555,IL10;IL6;TGFB1;IFNG;STAT1;IL1B;MTHFR;TNF;IL17A
Fatigue,12/330,1.2318722949885133E-12,2.981980520972194E-11,0,0,18.18181818181818,498.590652961002,IL10;IL6;IFNG;IL1B;IL12A;CD14;TNF;IL6R;TLR4;IL2;HLA-DRB1;SOD1
Heart failure,16/815,1.2563162175310725E-12,3.033679554274049E-11,0,0,9.815950920245399,268.98490614988907,IL10;TGFB1;HMGB1;PRL;HIF1A;TNF;INS;SOD1;DPP4;IL6;IFNG;IL1B;IRF1;IL6R;TLR4;IL17A
Diabetic Retinopathy,11/247,1.3747762670874766E-12,3.3115934198371866E-11,0,0,22.267206477732792,608.1782008944226,IL10;CXCL10;IL6;TGFB1;VDR;MTHFR;HIF1A;TNF;TLR4;INS;SOD1
Panuveitis,5/8,1.3759769760400938E-12,3.306381838758445E-11,0,0,312.5,8534.955346589497,IL10;IFNG;TNF;HLA-DRB1;IL17A
Meningioma,13/438,1.5701597679739286E-12,3.763787853572627E-11,0,0,14.840182648401825,403.3538454374047,TGFB1;MTHFR;PRL;ETS1;HIF1A;TNF;RUNX3;IL2;DPP4;IL6;TLR4;HLA-DRB1;TGM2
Optic Neuritis,7/42,1.88404834819855E-12,4.505213422407628E-11,0,0,83.33333333333333,2249.7998564648233,IL10;IL6;IFNG;CD14;TNF;HLA-DQA1;HLA-DRB1
Adenoma,17/1000,1.9923703066228697E-12,4.752673634342127E-11,0,0,8.5,229.00441665572228,IL10;TGFB1;VDR;MTHFR;PRL;ETS1;HIF1A;RUNX3;IL2;INS;IL6;IFNG;IL1B;CD14;TLR4;TGM2;IL17A
Granulomatosis with polyangiitis,8/76,2.075160274582694E-12,4.938178009345936E-11,0,0,52.63157894736842,1415.8411960245292,DPP4;IL10;TGFB1;IFNG;TNF;TLR4;HLA-DRB1;IL17A
Lung Neoplasms,18/1177,2.075485258617779E-12,4.927021526979597E-11,0,0,7.646559048428207,205.69875545463677,IL10;TGFB1;VDR;MTHFR;AHR;HMGB1;PRL;HIF1A;TNF;RUNX3;IL2;SOD1;IL6;IFNG;IL1B;IRF1;TLR4;IL17A
Adult-Onset Still Disease,6/21,2.2934322075373016E-12,5.4312895748618315E-11,0,0,142.85714285714283,3828.7102342612916,IL6;IFNG;IL1B;TNF;HLA-DRB1;IL17A
Cryopyrin-Associated Periodic Syndromes,6/21,2.2934322075373016E-12,5.418233590306875E-11,0,0,142.85714285714283,3828.7102342612916,IL10;IL6;IFNG;IL1B;TNF;IL17A
Latent Tuberculosis,6/21,2.2934322075373016E-12,5.405240224382878E-11,0,0,142.85714285714283,3828.7102342612916,CXCL10;IFNG;IL15;TNF;IL2;IL17A
Papillary thyroid carcinoma,14/571,2.392474573234638E-12,5.6251770587918705E-11,0,0,12.259194395796847,328.04001803040313,TGFB1;VDR;AHR;HMGB1;PRL;HIF1A;TNF;IL2;DPP4;CXCL10;IL2RA;TLR4;HLA-DRB1;IL17A
Respiratory Distress Syndrome, Adult,10/186,2.5252486216380544E-12,5.923184595097566E-11,0,0,26.881720430107528,717.8677847858446,IL10;CXCL10;IL6;TGFB1;IL1B;HMGB1;TNF;S100A9;TLR4;IL17A
Leprosy, Lepromatous,7/44,2.668434061386621E-12,6.244135703644694E-11,0,0,79.54545454545455,2119.848922341331,IL10;IL6;VDR;CD80;TNF;HLA-DRB1;IL17A
Toxic Shock Syndrome,7/44,2.668434061386621E-12,6.229304027389006E-11,0,0,79.54545454545455,2119.848922341331,IL10;IL6;IFNG;IL1B;TNF;IL2;HLA-DRB1
Brittle diabetes,7/44,2.668434061386621E-12,6.214542643437846E-11,0,0,79.54545454545455,2119.848922341331,IL10;IFNG;IL2RA;TNF;HLA-DQA1;HLA-DRB1;INS
Bronchopulmonary Dysplasia,10/188,2.8100785441076646E-12,6.528948447160786E-11,0,0,26.595744680851062,707.3885287588774,IL10;IL6;TGFB1;IFNG;VDR;IL1B;MTHFR;AHR;TNF;TLR4
Acute alcoholic liver disease,5/9,3.0914961873224766E-12,7.165854841746534E-11,0,0,277.77777777777777,7361.768316441768,IL10;IL6;IFNG;TLR4;TNF
Pancolitis,6/22,3.1488972061125194E-12,7.281732174511491E-11,0,0,136.36363636363635,3611.4502933207614,IL21;TNF;TLR4;IL2;HLA-DRB1;IL17A
Intestinal Diseases,8/80,3.172069436390815E-12,7.318098220856555E-11,0,0,50.0,1323.8318460991147,IL10;IL6;TGFB1;IL15;TNF;TLR4;IL2;TGM2
Adenocarcinoma of colon,11/267,3.206141665508456E-12,7.379381800612905E-11,0,0,20.599250936329586,545.1788045432136,DPP4;IL10;TGFB1;IFNG;IL15;VDR;HMGB1;HIF1A;TNF;IL2;TGM2
Chronic liver disease,9/129,3.3625021455697894E-12,7.72118483333175E-11,0,0,34.883720930232556,921.5698511481322,IL10;IL6;TGFB1;IFNG;IL15;IL1B;TNF;IL2;HLA-DRB1
Thyroid carcinoma,15/721,3.3984052646388883E-12,7.785437515354543E-11,0,0,10.402219140083218,274.6988366936766,IL10;TGFB1;STAT1;VDR;MTHFR;AHR;ETS1;HIF1A;TNF;IL2;DPP4;CXCL10;IL6;IL1B;S100A9
Vascular lesions,8/81,3.5146849777395323E-12,8.033098595633517E-11,0,0,49.382716049382715,1302.4232699726888,IL10;IL6;TGFB1;IL1B;IRF1;HMGB1;HIF1A;TNF
Lobar Pneumonia,8/81,3.5146849777395323E-12,8.014460315829264E-11,0,0,49.382716049382715,1302.4232699726888,IL6;TGFB1;IFNG;IL1B;AHR;TNF;TLR4;IL17A
Peptic Ulcer,8/81,3.5146849777395323E-12,7.995908324357436E-11,0,0,49.382716049382715,1302.4232699726888,IL10;TGFB1;IL1B;CD14;TNF;RUNX3;TLR4;IL2
Lyme Disease,9/130,3.6075512199681063E-12,8.188224801350242E-11,0,0,34.61538461538461,912.0458736752571,IL10;IL6;TGFB1;IFNG;IL1B;IL12A;TNF;HLA-DRB1;IL17A
Diabetes Mellitus, Ketosis-Prone,7/46,3.716429137236985E-12,8.415913723678591E-11,0,0,76.08695652173914,2002.4761383258135,IL10;IFNG;IL2RA;TNF;HLA-DQA1;HLA-DRB1;INS
Toxoplasmosis,7/46,3.716429137236985E-12,8.396566795578181E-11,0,0,76.08695652173914,2002.4761383258135,IL21;IL10;IL6;IFNG;IL15;IL1B;TLR4
Acute-On-Chronic Liver Failure,6/23,4.2540937009577485E-12,9.589273599314851E-11,0,0,130.43478260869566,3415.192092109537,IL21;IL6;IFNG;HMGB1;IL2;IL17A
Van der Woude syndrome,8/83,4.29782158671341E-12,9.665672895702378E-11,0,0,48.19277108433735,1261.3451965946583,IL10;IL6;STAT1;IL1B;IL2RA;HMGB1;TNF;TLR4
Hay fever,8/83,4.29782158671341E-12,9.643605149365157E-11,0,0,48.19277108433735,1261.3451965946583,IL10;CXCL10;IL6;IFNG;IL2RA;TNF;TLR4;IL2
Down Syndrome,13/475,4.359261515146577E-12,9.759185004751836E-11,0,0,13.68421052631579,357.9614103707954,IL10;TGFB1;IL15;STAT1;MTHFR;PRL;TNF;SOD1;IL6;IFNG;IL1B;IL2RA;IRF1
Depressive disorder,15/741,5.020468081034044E-12,1.1213900068273314E-10,0,0,10.121457489878543,263.3349994264972,IL10;TGFB1;VDR;MTHFR;PRL;TNF;INS;SOD1;DPP4;IL6;IFNG;IL1B;IL6R;TLR4;IL17A
Severe Acute Respiratory Syndrome,8/85,5.228837625587936E-12,1.1652838137024542E-10,0,0,47.05882352941176,1222.4391582999915,DPP4;IL10;CXCL10;IL6;IFNG;TNF;IL2;HLA-DRB1
Parkinson Disease,17/1064,5.362242627189442E-12,1.1923104194574171E-10,0,0,7.988721804511278,207.32042296609518,IL10;TGFB1;VDR;MTHFR;PRL;HIF1A;TNF;INS;SOD1;IL6;IFNG;IL1B;TNFRSF14;CD14;TLR4;HLA-DRB1;TGM2
Cardiac Arrest,10/201,5.473963003095265E-12,1.214404252695717E-10,0,0,24.875621890547265,645.0502055719622,IL10;IL6;IFNG;STAT1;IL1B;MTHFR;TNF;INS;SOD1;IL17A
Staphylococcal toxic shock syndrome,6/24,5.663895595611363E-12,1.2537109440015423E-10,0,0,125.0,3237.1136490856547,IL10;IL6;IFNG;IL1B;TNF;HLA-DRB1
Neuropathy,11/284,6.258094719265783E-12,1.3821248292346992E-10,0,0,19.36619718309859,499.5926033203581,IL10;IL6;CD80;MTHFR;TNF;S100A9;TLR4;IL2;INS;TGM2;SOD1
Contact Dermatitis,8/87,6.330877498779915E-12,1.3950642165472872E-10,0,0,45.97701149425287,1185.54401213703,IL10;IFNG;IL1B;AHR;TNF;CCR4;TLR4;SOD1
Cervical Squamous Intraepithelial Neoplasia,7/50,6.895458551635597E-12,1.5160753164535715E-10,0,0,70.0,1799.0110671360703,IL10;TGFB1;MTHFR;HMGB1;TNF;S100A9;TLR4
Chronic inflammatory disorder,7/50,6.895458551635597E-12,1.512691219765059E-10,0,0,70.0,1799.0110671360703,IL6;IL1B;HIF1A;TNF;TLR4;HLA-DRB1;IL17A
Retroviridae Infections,8/88,6.954051754515574E-12,1.522147453081939E-10,0,0,45.45454545454545,1167.804392725504,CXCL10;IL6;IFNG;IL1B;IL2RA;AHR;TNF;IL17A
Pyemia,6/25,7.441678710189941E-12,1.6252626303054832E-10,0,0,120.0,3074.870959133378,IL10;TGFB1;IFNG;HMGB1;TNF;TLR4
Acute Kidney Insufficiency,8/89,7.62999401726092E-12,1.662695813783599E-10,0,0,44.9438202247191,1150.513890100667,IL10;IL6;TGFB1;MTHFR;TNF;TLR4;INS;SOD1
Hemophilia A,8/89,7.62999401726092E-12,1.659017283222131E-10,0,0,44.9438202247191,1150.513890100667,DPP4;IL10;TGFB1;IFNG;IL2RA;TNF;IL2;HLA-DRB1
Hypotension,8/89,7.62999401726092E-12,1.6553549934136937E-10,0,0,44.9438202247191,1150.513890100667,IL6;IFNG;IL1B;PRL;TNF;IL2;INS;SOD1
Cockayne Syndrome, Type I,7/51,7.980937937183093E-12,1.7276796926571683E-10,0,0,68.62745098039215,1753.7034924284364,IL10;IL6;IFNG;STAT1;IL2;HLA-DRB1;IL17A
Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,7/51,7.980937937183093E-12,1.7238825944315482E-10,0,0,68.62745098039215,1753.7034924284364,DPP4;IL10;TGFB1;IFNG;TNF;TLR4;HLA-DRB1
Vascular inflammations,9/142,8.046877040050624E-12,1.734313762053016E-10,0,0,31.69014084507042,809.548004950468,IL10;IL6;AHR;HMGB1;ETS1;TNF;S100A9;TLR4;IL17A
Acute Cerebrovascular Accidents,8/91,9.15542779638256E-12,1.968917820193606E-10,0,0,43.956043956043956,1117.2164488230906,IL21;IL6;TGFB1;IL1B;IRF1;MTHFR;TNF;SOD1
Malaria, Vivax,6/26,9.660138901498223E-12,2.0729223826184395E-10,0,0,115.38461538461539,2926.50151024274,IL10;IL6;IFNG;VDR;IL1B;TNF
Melioidosis,6/26,9.660138901498223E-12,2.0684062118502076E-10,0,0,115.38461538461539,2926.50151024274,IL10;IFNG;IL1B;CD14;TNF;TLR4
Lymphoid leukemia,10/213,9.741632260276451E-12,2.0813209098694992E-10,0,0,23.474178403755868,595.1786955193426,IL10;IL6;IFNG;IL15;IL1B;IL2RA;MTHFR;ETS1;TNF;TLR4
Acute kidney injury,8/92,1.001309601060526E-11,2.1346791234756723E-10,0,0,43.47826086956522,1101.1794468979783,IL10;IL6;TGFB1;MTHFR;TNF;TLR4;INS;SOD1
Idiopathic pulmonary arterial hypertension,11/297,1.0149585772901134E-11,2.1590937007807868E-10,0,0,18.518518518518515,468.770152256021,IL21;IL10;IL6;TGFB1;IFNG;IL1B;HMGB1;HIF1A;TNF;HLA-DRB1;SOD1
Tumor Angiogenesis,13/511,1.0888832966900858E-11,2.311348820706299E-10,0,0,12.720156555772993,321.09851619755585,IL10;TGFB1;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;CXCL10;IL6;IL1B;TLR4;IL17A
Depressive Symptoms,9/147,1.1008921358296695E-11,2.3318034290806013E-10,0,0,30.612244897959183,772.417810385723,IL10;IL6;TGFB1;VDR;IL1B;MTHFR;TNF;IL2;INS
Burning Mouth Syndrome,5/11,1.1302800147240742E-11,2.388901502087785E-10,0,0,227.27272727272725,5728.629686424315,IL6;IL1B;CD14;TNF;IL2
Sciatic Neuropathy,8/95,1.3019957532882322E-11,2.7459258075787006E-10,0,0,42.10526315789473,1055.348957508919,IL10;IL6;IL1B;HMGB1;TNF;IL6R;TLR4;SOD1
Osteoporosis, Postmenopausal,7/55,1.3908258631060735E-11,2.926988561585972E-10,0,0,63.636363636363626,1590.8160740250128,IL6;TGFB1;VDR;IL1B;CD14;HIF1A;TNF
Hantavirus Infections,7/55,1.3908258631060735E-11,2.9207343125227543E-10,0,0,63.636363636363626,1590.8160740250128,IL10;CXCL10;IL6;IFNG;TNF;IL2;HLA-DRB1
Idiopathic pulmonary hypertension,8/96,1.4183362589812614E-11,2.972155384492076E-10,0,0,41.666666666666664,1040.7896452851212,IL21;IL6;TGFB1;HMGB1;HIF1A;TNF;HLA-DRB1;SOD1
Aneurysm,9/152,1.489619686389413E-11,3.114889846347904E-10,0,0,29.605263157894736,738.0566993957978,IL10;IL6;TGFB1;IFNG;STAT1;IL1B;TNF;TLR4;IL17A
Polycystic Ovary Syndrome,13/526,1.5628044457851297E-11,3.260985582415341E-10,0,0,12.357414448669202,307.47661903211525,IL10;TGFB1;VDR;MTHFR;PRL;TNF;RUNX3;INS;DPP4;IL6;IL1B;TLR4;HLA-DRB1
Aphthous Stomatitis,6/28,1.5761623759992647E-11,3.2818906422289773E-10,0,0,107.14285714285714,2665.0117506803253,IL10;IL6;IL1B;IL12A;TNF;TLR4
Psoriasiform eczema,6/28,1.5761623759992647E-11,3.27495218421158E-10,0,0,107.14285714285714,2665.0117506803253,IL10;IL6;IFNG;TNF;HLA-DRB1;IL17A
Carotid Stenosis,7/56,1.5872222136785574E-11,3.2909746658297177E-10,0,0,62.5,1554.1531606231727,IL10;IL6;MTHFR;CD14;ETS1;HIF1A;TLR4
Radiation Injuries, Experimental,5/12,1.9348211138620767E-11,4.00324671727084E-10,0,0,208.33333333333334,5139.25440590475,IFNG;IL1B;HIF1A;TNF;SOD1
Berylliosis,5/12,1.9348211138620767E-11,3.9948365350916995E-10,0,0,208.33333333333334,5139.25440590475,IL6;TGFB1;IL2RA;TNF;HLA-DRB1
Ileitis,6/29,1.9844483704813483E-11,4.0887124916332686E-10,0,0,103.44827586206897,2549.2856944570626,IL10;CXCL10;IL15;TNF;TLR4;IL17A
Silicosis,7/58,2.0518533655492236E-11,4.2187478821376085E-10,0,0,60.3448275862069,1485.0676543296831,TGFB1;IFNG;IL1B;AHR;TNF;HLA-DRB1;IL17A
Benign Prostatic Hyperplasia,12/420,2.0660414622384208E-11,4.2390512507054696E-10,0,0,14.285714285714285,351.46859405130255,IL21;IL6;TGFB1;IFNG;IL15;VDR;PRL;ETS1;HIF1A;IL6R;S100A9;IL2
Impaired cognition,14/671,2.0722155940123964E-11,4.2428614287403817E-10,0,0,10.432190760059614,256.62999041654473,IL10;TGFB1;MTHFR;HIF1A;TNF;SOD1;DPP4;IL6;IFNG;IL1B;CD14;IL6R;TLR4;HLA-DRB1
Malignant neoplasm of kidney,12/421,2.12386653204935E-11,4.3395759411602936E-10,0,0,14.251781472684085,350.240348117065,IL10;IL6;TGFB1;IFNG;VDR;TNFRSF9;IL2RA;AHR;HIF1A;TNF;CCR4;IL2
Metabolic Diseases,12/421,2.12386653204935E-11,4.330572671572824E-10,0,0,14.251781472684085,350.240348117065,IL10;IL6;TGFB1;IL1B;IRF1;MTHFR;AHR;PRL;HIF1A;TNF;TLR4;INS
Alopecia Areata,7/59,2.324705176878462E-11,4.730269664257044E-10,0,0,59.32203389830509,1452.4906744326747,CXCL10;TGFB1;IFNG;IL1B;IL2RA;TNF;HLA-DRB1
Libman-Sacks Disease,7/59,2.324705176878462E-11,4.720496379826761E-10,0,0,59.32203389830509,1452.4906744326747,IL21;IL10;IL6;PRL;ETS1;HLA-DQA1;HLA-DRB1
Heart Decompensation,8/102,2.3256645633302797E-11,4.712707490393812E-10,0,0,39.2156862745098,960.1737329822511,IL6;IFNG;IL1B;PRL;HIF1A;TNF;INS;SOD1
Recurrent aphthous ulcer,6/30,2.4769565352259232E-11,5.008956549012423E-10,0,0,100.0,2442.1405419926446,IL10;IL6;IL1B;IL12A;TNF;TLR4
Secondary malignant neoplasm of lung,14/683,2.6227199367760863E-11,5.292831938118147E-10,0,0,10.248901903367496,249.70654275105005,IL10;TGFB1;IL15;TNFRSF9;AHR;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;IL1B;CCR4;TLR4
MYELODYSPLASTIC SYNDROME,14/683,2.6227199367760863E-11,5.28198597103184E-10,0,0,10.248901903367496,249.70654275105005,IL10;TGFB1;TNF;IL2;IL6;IFNG;IL1B;IL2RA;IRF1;CD14;S100A9;TLR4;HLA-DRB1;IL17A
Hepatitis, Toxic,11/325,2.6765906316153516E-11,5.379454545504228E-10,0,0,16.923076923076923,411.9735601497465,CXCL10;IL6;IFNG;IL1B;MTHFR;AHR;HMGB1;TNF;HLA-DRB1;SOD1;IL17A
Chemical and Drug Induced Liver Injury,11/325,2.6765906316153516E-11,5.368476066839934E-10,0,0,16.923076923076923,411.9735601497465,CXCL10;IL6;IFNG;IL1B;MTHFR;AHR;HMGB1;TNF;HLA-DRB1;SOD1;IL17A
Chemically-Induced Liver Toxicity,11/325,2.6765906316153516E-11,5.357542307029669E-10,0,0,16.923076923076923,411.9735601497465,CXCL10;IL6;IFNG;IL1B;MTHFR;AHR;HMGB1;TNF;HLA-DRB1;SOD1;IL17A
Drug-Induced Acute Liver Injury,11/325,2.6765906316153516E-11,5.346652993397495E-10,0,0,16.923076923076923,411.9735601497465,CXCL10;IL6;IFNG;IL1B;MTHFR;AHR;HMGB1;TNF;HLA-DRB1;SOD1;IL17A
Stomach Neoplasms,15/835,2.73076871160306E-11,5.443812352461435E-10,0,0,8.982035928143713,218.47772042543602,IL10;TGFB1;CD80;TNFRSF9;MTHFR;AHR;HIF1A;TNF;RUNX3;IL2;IL6;IL1B;IRF1;IL12A;IL6R
Overweight,10/238,2.921474656119635E-11,5.81219694743801E-10,0,0,21.008403361344538,509.587132666272,IL10;IL6;TGFB1;IL1B;MTHFR;PRL;CD14;TNF;TLR4;HLA-DQA1
Biliary Atresia,8/105,2.944305832101808E-11,5.845785397554862E-10,0,0,38.095238095238095,923.7547788295849,CXCL10;IL6;IFNG;STAT1;HMGB1;CD14;HIF1A;TNF
M5b Acute differentiated monocytic leukemia,8/105,2.944305832101808E-11,5.833999539898501E-10,0,0,38.095238095238095,923.7547788295849,IL6;IFNG;VDR;IL1B;HMGB1;CD14;ETS1;TNF
Hepatitis, Drug-Induced,11/329,3.052077869910177E-11,6.035376520216744E-10,0,0,16.717325227963524,404.77013275069106,CXCL10;IL6;IFNG;IL1B;MTHFR;AHR;HMGB1;TNF;HLA-DRB1;SOD1;IL17A
Oral Ulcer,6/31,3.0669629562693555E-11,6.052632918517114E-10,0,0,96.77419354838709,2342.685311229665,IL21;IL10;IL12A;TNF;TLR4;HLA-DRB1
Heart Failure, Right-Sided,8/106,3.180119983572348E-11,6.26337058087155E-10,0,0,37.73584905660377,912.1327206102291,IL6;IFNG;IL1B;PRL;HIF1A;TNF;INS;SOD1
Tumor Promotion,8/108,3.70149663715858E-11,7.275661789998905E-10,0,0,37.03703703703703,889.6184736496905,IL6;TGFB1;STAT1;IL1B;AHR;PRL;HIF1A;TNF
Myocardial Failure,8/108,3.70149663715858E-11,7.26113951097695E-10,0,0,37.03703703703703,889.6184736496905,IL6;IFNG;IL1B;PRL;HIF1A;TNF;INS;SOD1
Lichen Planus, Oral,7/63,3.748452610911305E-11,7.338604035863806E-10,0,0,55.55555555555555,1333.727383622256,IL10;CXCL10;IL6;IFNG;CD14;TNF;TLR4
Monocytic leukemia,7/63,3.748452610911305E-11,7.324014365812387E-10,0,0,55.55555555555555,1333.727383622256,IL6;IFNG;VDR;IL1B;CD14;ETS1;TNF
Subacute Sclerosing Panencephalitis,6/32,3.769237637343867E-11,7.350013392820541E-10,0,0,93.75,2250.14655563762,IL10;IL6;IFNG;IRF1;TNF;IL2
Cardiovascular morbidity,6/32,3.769237637343867E-11,7.33545891085456E-10,0,0,93.75,2250.14655563762,IL10;VDR;MTHFR;TNF;HLA-DRB1;SOD1
Fibrosis,9/169,3.8711650113616066E-11,7.518934729577445E-10,0,0,26.627218934911244,638.3843926686658,IL10;IL6;TGFB1;IFNG;STAT1;IL1B;CD14;TNF;TLR4
Chronic Fatigue Syndrome,7/64,4.2027139953903854E-11,8.146799437218286E-10,0,0,54.6875,1306.6323329585846,IL10;IL6;CD14;TNF;HLA-DQA1;IL2;HLA-DRB1
Primary malignant neoplasm,16/1032,4.387163360920475E-11,8.487606596678431E-10,0,0,7.751937984496124,184.88180747241785,IL10;TGFB1;IL15;VDR;AHR;HMGB1;ETS1;HIF1A;TNF;IL2;IL6;IFNG;IL2RA;S100A9;TGM2;IL17A
Thrombocytopenia,11/341,4.480578262321679E-11,8.651301210628184E-10,0,0,16.129032258064516,384.33361142622846,CXCL10;IL6;TGFB1;STAT1;IL2RA;MTHFR;ETS1;TNF;TLR4;HLA-DRB1;IL17A
Corneal Ulcer,6/33,4.6001496343717546E-11,8.864758942471687E-10,0,0,90.9090909090909,2163.849744614297,IL10;IL6;IFNG;IL1B;TNF;S100A9
Periapical Periodontitis,6/33,4.6001496343717546E-11,8.847411077613621E-10,0,0,90.9090909090909,2163.849744614297,IL6;IL1B;CD14;TNF;TLR4;IL17A
Pleural Tuberculosis,6/33,4.6001496343717546E-11,8.830130977852657E-10,0,0,90.9090909090909,2163.849744614297,IL10;TGFB1;IFNG;IL2RA;TNF;CCR4
Systemic Inflammatory Response Syndrome,7/65,4.703139444140809E-11,9.01022504035397E-10,0,0,53.84615384615385,1280.4726184045694,IL10;IL6;IL1B;HMGB1;CD14;TNF;TLR4
Addison Disease,7/66,5.253544302993033E-11,1.0045103776228702E-9,0,0,53.03030303030303,1255.202511223185,CXCL10;VDR;MTHFR;PRL;HLA-DQA1;HLA-DRB1;INS
Anastomosis,6/34,5.5777753677646244E-11,1.0644344915415675E-9,0,0,88.23529411764706,2083.204059321812,CXCL10;TGFB1;MTHFR;TNF;RUNX3;TLR4
Urticaria,8/114,5.737431153034123E-11,1.0927804917058017E-9,0,0,35.08771929824561,827.418401652316,TGFB1;IFNG;IL1B;IL2RA;TNF;HLA-DRB1;SOD1;IL17A
Joint swelling,7/67,5.857988780637957E-11,1.1135844049537685E-9,0,0,52.23880597014925,1230.7791628974587,IL10;IL6;IFNG;IL2RA;TNF;IL6R;HLA-DRB1
Skin Neoplasms,10/256,5.98971611623891E-11,1.136427219891815E-9,0,0,19.53125,459.73421884528625,DPP4;IL6;TGFB1;IFNG;ZMIZ1;VDR;IL1B;IRF1;HIF1A;TNF
Neutropenia,9/178,6.165885664602093E-11,1.1675977709385234E-9,0,0,25.280898876404493,594.3388711480391,IL10;IL6;TGFB1;IFNG;IL1B;MTHFR;TNF;TLR4;HLA-DRB1
Ewings sarcoma,11/352,6.292260022611128E-11,1.1892371442735033E-9,0,0,15.625,367.01743301069814,DPP4;IL6;IFNG;IL15;STAT1;ETS1;HIF1A;TNF;IL6R;RUNX3;IL2
Leukemogenesis,14/730,6.33345110844522E-11,1.1947247119731214E-9,0,0,9.589041095890412,225.17552761064584,IL21;IL10;IL15;MTHFR;ETS1;HIF1A;TNF;RUNX3;IL2;IL6;IL1B;IL2RA;IRF1;TNFRSF14
Respiratory Tract Infections,7/70,8.04007411691726E-11,1.5137518854609736E-9,0,0,50.0,1162.1998860632034,IL10;IL6;STAT1;VDR;IL1B;CD14;IL2
Presenile dementia,11/362,8.48581225328393E-11,1.5946187920702575E-9,0,0,15.193370165745856,352.33486796625516,DPP4;CXCL10;IL6;STAT1;IL1B;MTHFR;AHR;TNF;IL6R;INS;SOD1
Liver Failure, Acute,8/120,8.685297469767369E-11,1.6289905254365211E-9,0,0,33.333333333333336,772.226812428243,IL10;IL6;IFNG;IL1B;HMGB1;CD14;TNF;INS
Childhood Glioblastoma,9/187,9.586703690498023E-11,1.7946309308612299E-9,0,0,24.06417112299465,555.1137172478554,TGFB1;STAT1;VDR;IL1B;AHR;ETS1;HIF1A;TNF;TLR4
Escherichia coli Infections,6/37,9.599671979184873E-11,1.793642133297128E-9,0,0,81.08108108108108,1870.273548152383,IL10;IL6;IL1B;HIF1A;TNF;TLR4
Cardiomyopathies,12/480,9.670423402201845E-11,1.8034330397882301E-9,0,0,12.5,288.2420491162298,DPP4;IL10;IL6;IFNG;IL15;IL1B;IL2RA;THEMIS;HMGB1;PRL;HIF1A;TNF
Precursor B-cell lymphoblastic leukemia,11/367,9.822373326890981E-11,1.8283008533462984E-9,0,0,14.986376021798364,345.34265083739183,IL10;IL6;IFNG;IL15;CD80;IL1B;IL2RA;MTHFR;CD14;HIF1A;TNF
Adult Glioblastoma,9/189,1.054252161815755E-10,1.958637097604015E-9,0,0,23.809523809523807,546.9766491839479,TGFB1;STAT1;VDR;IL1B;AHR;ETS1;HIF1A;TNF;TLR4
Auricular swelling,5/16,1.0609113609495016E-10,1.9672899727191894E-9,0,0,156.25,3588.5504088640914,CXCL10;IFNG;IL2RA;TNF;IL2
Arthritis, Reactive,6/38,1.1383030118053039E-10,2.106825235409139E-9,0,0,78.94736842105263,1807.60360758275,IL10;IFNG;TNF;TLR4;HLA-DRB1;IL17A
Salmonella infections,6/38,1.1383030118053039E-10,2.1028650375982195E-9,0,0,78.94736842105263,1807.60360758275,IFNG;IL15;IL1B;TNF;TLR4;IL17A
Septic Shock,6/38,1.1383030118053039E-10,2.0989196998166094E-9,0,0,78.94736842105263,1807.60360758275,IL10;IL6;IL1B;HMGB1;TNF;TLR4
Lichen Planus,6/38,1.1383030118053039E-10,2.0949891385809976E-9,0,0,78.94736842105263,1807.60360758275,IL6;IFNG;TNF;S100A9;HLA-DRB1;TGM2
Necrotizing enterocolitis in fetus OR newborn,7/74,1.2000048946675914E-10,2.204420206503381E-9,0,0,47.2972972972973,1080.4370071611902,IL6;TGFB1;IL1B;HMGB1;TNF;TLR4;IL17A
Peripheral Arterial Diseases,8/125,1.2071009114373043E-10,2.2133186114936245E-9,0,0,32.0,730.8041403568694,DPP4;IL10;IL6;MTHFR;CD14;HIF1A;TNF;TLR4
Acute leukemia,12/492,1.2845368585073035E-10,2.350917736575378E-9,0,0,12.195121951219512,277.7494231458021,DPP4;IL6;STAT1;IRF1;MTHFR;CD14;ETS1;TNF;RUNX3;TLR4;IL2;HLA-DRB1
Left-Sided Heart Failure,8/126,1.28710037335402E-10,2.351230942253403E-9,0,0,31.746031746031743,722.966952831539,IL6;IFNG;IL1B;PRL;HIF1A;TNF;INS;SOD1
Hyperinsulinism,11/377,1.30782741797988E-10,2.3846619413555214E-9,0,0,14.588859416445624,332.0057293362909,DPP4;IL6;IFNG;STAT1;PRL;CD14;HIF1A;TNF;TLR4;HLA-DRB1;INS
Squamous cell carcinoma of the head and neck,15/934,1.3173242460959088E-10,2.3975301278945537E-9,0,0,8.029978586723768,182.6840069883829,TGFB1;STAT1;VDR;MTHFR;AHR;ETS1;HIF1A;TNF;IL2;IL6;IFNG;IL2RA;CCR4;S100A9;TLR4
Arthralgia,8/128,1.4610276372717622E-10,2.6541551976167983E-9,0,0,31.25,707.709715020914,IL10;IL6;VDR;IL2RA;IL12A;TNF;TLR4;HLA-DRB1
Colitis, Collagenous,5/17,1.50077664231609E-10,2.721334472450652E-9,0,0,147.05882352941177,3326.451205041249,IL21;IL6;IFNG;IL1B;TNF
Schistosomiasis mansoni,5/17,1.50077664231609E-10,2.716322806755531E-9,0,0,147.05882352941177,3326.451205041249,IL10;TGFB1;IFNG;TNF;SOD1
Triple Negative Breast Neoplasms,13/632,1.521532878345553E-10,2.748828148599282E-9,0,0,10.284810126582277,232.49978180260595,TGFB1;IL15;STAT1;TNFRSF9;MTHFR;AHR;PRL;ETS1;HIF1A;TNF;IL2;IL6;IL1B
Renal carcinoma,12/500,1.5458722313907223E-10,2.7876756495611045E-9,0,0,12.0,271.08315153393346,IL10;IL6;TGFB1;IFNG;VDR;IL2RA;IRF1;AHR;HIF1A;TNF;CCR4;IL2
X-Linked Lymphoproliferative Disorder,6/40,1.5780660639871213E-10,2.8405189151768184E-9,0,0,75.0,1692.7238132061414,IL10;IFNG;IL1B;CCR4;INS;IL17A
Bronchial Hyperreactivity,7/78,1.7515314264192822E-10,3.1469928443964728E-9,0,0,44.87179487179487,1008.0610446609002,IL10;VDR;IRF1;CD14;TNF;TLR4;HLA-DRB1
Anoxia,10/288,1.8988219683853601E-10,3.4054055301626496E-9,0,0,17.36111111111111,388.6218273037699,IL10;IL6;TGFB1;IFNG;STAT1;IL1B;AHR;HIF1A;TNF;TLR4
Left Ventricular Hypertrophy,9/203,1.9933952275184232E-10,3.56850424336085E-9,0,0,22.167487684729064,495.1332620807932,IL10;IL6;TGFB1;VDR;MTHFR;AHR;TNF;TLR4;IL2
Uveitis, Intermediate,4/6,2.0504843851358923E-10,3.6640291885664635E-9,0,0,333.3333333333333,7435.924959756335,IL10;IL6;IL2RA;IL17A
Major Depressive Disorder,12/513,2.0747878696628393E-10,3.700728708356876E-9,0,0,11.695906432748536,260.7718364090243,IL10;CXCL10;IL6;IFNG;VDR;IL1B;IL2RA;MTHFR;HIF1A;TNF;IL2;SOD1
Diffuse cutaneous leishmaniasis,5/18,2.0749815519107007E-10,3.6943693282931823E-9,0,0,138.88888888888889,3096.652592630939,IL10;IL6;IFNG;IL1B;TNF
Heat Stroke,5/18,2.0749815519107007E-10,3.687688732762815E-9,0,0,138.88888888888889,3096.652592630939,IL10;IL6;IL1B;TNF;IL6R
Hernia,6/42,2.150419064543088E-10,3.814858946990879E-9,0,0,71.42857142857142,1590.0134423609375,IL6;IFNG;VDR;IL1B;TNF;INS
Mixed cryoglobulinemia,6/42,2.150419064543088E-10,3.807985327266571E-9,0,0,71.42857142857142,1590.0134423609375,IL10;CXCL10;IL6;IFNG;TNF;HLA-DRB1
Hormone refractory prostate cancer,8/135,2.2409480880628348E-10,3.9611578794031545E-9,0,0,29.62962962962963,658.3393155561649,IL6;TGFB1;IFNG;AHR;HMGB1;TNF;IL6R;IL2
Middle Cerebral Artery Occlusion,8/135,2.2409480880628348E-10,3.954046285364729E-9,0,0,29.62962962962963,658.3393155561649,IL6;IL1B;AHR;CD14;TNF;IL6R;SOD1;IL17A
Unipolar Depression,12/517,2.2677733674953046E-10,3.994207285975601E-9,0,0,11.60541586073501,257.72207901605054,IL10;CXCL10;IL6;IFNG;VDR;IL1B;IL2RA;MTHFR;HIF1A;TNF;INS;SOD1
Malignant neoplasm of liver,14/805,2.2937444289656147E-10,4.032722763483732E-9,0,0,8.695652173913043,193.00578544270866,TGFB1;MTHFR;AHR;HMGB1;HIF1A;TNF;IL2;IL6;IFNG;IRF1;IL12A;CCR4;TLR4;HLA-DRB1
Neoplasms, Experimental,7/81,2.2953530827513813E-10,4.028344660228674E-9,0,0,43.20987654320987,959.0416651047914,IFNG;IL1B;IL12A;AHR;HIF1A;TNF;IL2
Pituitary Neoplasms,10/296,2.4806442313626994E-10,4.345770321895296E-9,0,0,16.89189189189189,373.60359177005694,IL6;TGFB1;IFNG;AHR;PRL;HIF1A;TNF;IL6R;TLR4;INS
Sarcoma,13/658,2.4975146630980545E-10,4.367539877033395E-9,0,0,9.878419452887538,218.41733492020384,IL10;IL15;STAT1;MTHFR;AHR;ETS1;HIF1A;TNF;IL2;DPP4;IL6;IFNG;S100A9
Prediabetes syndrome,7/82,2.5059604745614037E-10,4.374525673888006E-9,0,0,42.6829268292683,943.5990970816453,IL6;IFNG;IL15;IL2RA;TNF;TLR4;INS
Hemochromatosis,7/84,2.9769494027226584E-10,5.187492682616718E-9,0,0,41.666666666666664,913.9563268380629,IL10;IL6;IFNG;TNF;S100A9;TLR4;SOD1
Delirium,6/45,3.324370390340797E-10,5.782639326773336E-9,0,0,66.66666666666667,1454.9713753367525,IL10;IL6;IL1B;TNF;IL6R;IL17A
Malaria, Cerebral,7/86,3.521366340384843E-10,6.114485581855519E-9,0,0,40.697674418604656,885.8663543915945,IL10;CXCL10;IL6;IFNG;IL1B;TNF;IL17A
Acquired Hypogammaglobulinemia,7/86,3.521366340384843E-10,6.103701656667061E-9,0,0,40.697674418604656,885.8663543915945,IL21;IL10;IL6;IFNG;IL2RA;TNF;IL2
Headache,7/86,3.521366340384843E-10,6.092955703046169E-9,0,0,40.697674418604656,885.8663543915945,IL6;TGFB1;MTHFR;PRL;TNF;IL2;SOD1
Endophthalmitis,5/20,3.743828471352789E-10,6.466493183911285E-9,0,0,125.0,2713.217773331256,IFNG;IL1B;HMGB1;TNF;TLR4
Peptic Esophagitis,6/46,3.817461614111453E-10,6.582107498857432E-9,0,0,65.21739130434783,1414.3216452471484,IL10;IL6;VDR;IL1B;TNF;IL2
Congo hemorrhagic fever,4/7,4.777656903659331E-10,8.223259553268635E-9,0,0,285.71428571428567,6131.97162603921,IL10;IL6;IFNG;TNF
Fetid chronic bronchitis,4/7,4.777656903659331E-10,8.208883225378305E-9,0,0,285.71428571428567,6131.97162603921,CXCL10;IL6;IFNG;IL1B
Pelvic pain female,4/7,4.777656903659331E-10,8.194557076642915E-9,0,0,285.71428571428567,6131.97162603921,IL6;IFNG;IL1B;IL17A
Pulmonary Emphysema,9/225,4.966928526807723E-10,8.50435079468054E-9,0,0,20.0,428.4609856705731,IL10;IL6;TGFB1;IFNG;IL1B;HIF1A;TNF;TLR4;SOD1
Meningitis,7/91,5.266238839952033E-10,9.001147012008449E-9,0,0,38.46153846153846,821.7128659536814,IL10;IL6;TGFB1;IFNG;IL12A;TNF;TLR4
Cachexia,8/153,6.096951704720474E-10,1.040292384617931E-8,0,0,26.143790849673202,554.7205752732219,IL10;IL6;TGFB1;IL15;VDR;IL1B;TNF;TLR4
Dementia,11/436,6.099436030267049E-10,1.0389126049473927E-8,0,0,12.61467889908257,267.653899986226,DPP4;CXCL10;IL6;TGFB1;STAT1;IL1B;MTHFR;AHR;TNF;IL6R;SOD1
Anemia, Sickle Cell,9/231,6.268190126389418E-10,1.0658092138781178E-8,0,0,19.48051948051948,412.7992845397997,IL10;IL6;TGFB1;IFNG;IL1B;MTHFR;HIF1A;TNF;HLA-DRB1
Impaired glucose tolerance,10/326,6.339621666036589E-10,1.0760932941935681E-8,0,0,15.337423312883436,324.831776647218,DPP4;IL6;IFNG;CD14;HIF1A;TNF;S100A9;TLR4;INS;TGM2
Hypoglycemia,9/232,6.512007466062971E-10,1.103448437525291E-8,0,0,19.396551724137932,410.2798025702412,DPP4;IL6;IL1B;MTHFR;PRL;HIF1A;TNF;INS;TGM2
Biliary cirrhosis,8/155,6.76167577874838E-10,1.1437822642605694E-8,0,0,25.806451612903224,544.8923915959285,CXCL10;TGFB1;STAT1;CD80;IL12A;HIF1A;TLR4;HLA-DRB1
Hamman-Rich syndrome,9/233,6.764136744156983E-10,1.142232575972076E-8,0,0,19.313304721030043,407.78529301246266,CXCL10;IL6;TGFB1;IFNG;IL1B;HMGB1;TNF;HLA-DRB1;SOD1
Gastric ulcer,7/95,7.148103879984758E-10,1.2050011137648407E-8,0,0,36.84210526315789,775.8580347373791,IL10;IL1B;HIF1A;TNF;IL2;SOD1;IL17A
Limb ischemia,7/95,7.148103879984758E-10,1.2029377556933254E-8,0,0,36.84210526315789,775.8580347373791,IL10;IL1B;MTHFR;HMGB1;HIF1A;TNF;TLR4
Uveal melanoma,9/236,7.572859877297589E-10,1.2722404593859949E-8,0,0,19.06779661016949,400.4481383182323,IL10;TGFB1;IFNG;CD80;IL1B;HMGB1;HIF1A;TNF;IL2
Dermatitis, Irritant,5/23,8.090012318988089E-10,1.356802748652132E-8,0,0,108.69565217391303,2275.567464796582,CXCL10;CD80;IL1B;TNF;IL2
Smallpox,5/23,8.090012318988089E-10,1.3544913300002545E-8,0,0,108.69565217391303,2275.567464796582,IFNG;IL15;IL1B;IRF1;MTHFR
Job Syndrome,5/23,8.090012318988089E-10,1.3521877733165806E-8,0,0,108.69565217391303,2275.567464796582,IL10;IL6;IFNG;STAT1;IL17A
Endometrial Neoplasms,9/238,8.158191221148256E-10,1.3612683076646019E-8,0,0,18.90756302521008,395.6753278287703,CXCL10;IL6;IL1B;MTHFR;ETS1;HIF1A;TNF;RUNX3;TLR4
Malignant mesothelioma,10/335,8.252487753790428E-10,1.3746686380381749E-8,0,0,14.925373134328357,312.1691974497867,DPP4;CXCL10;IL6;TGFB1;IFNG;IL1B;IL2RA;HMGB1;TNF;IL2
Hypercholesterolemia,9/240,8.782984384952865E-10,1.4605612611728725E-8,0,0,18.75,390.9944001164767,IL10;IL6;IL1B;MTHFR;CD14;TNF;TLR4;INS;SOD1
Hypercalcemia,7/98,8.910483689400322E-10,1.4792607043822021E-8,0,0,35.71428571428571,744.2365144215426,IL6;IFNG;VDR;IL1B;TNF;IL2;HLA-DRB1
Secondary malignant neoplasm of lymph node,16/1271,9.459231465629626E-10,1.56771208843521E-8,0,0,6.294256490952006,130.787473111544,IL10;TGFB1;VDR;CD80;HMGB1;ETS1;HIF1A;TNF;RUNX3;IL2;IL6;IL1B;TNFRSF14;CCR4;S100A9;TLR4
Boutonneuse Fever,4/8,9.541684622414508E-10,1.5787150920722186E-8,0,0,250.0,5192.545218727708,IL10;IFNG;TLR4;TNF
Ischemia of kidney,7/99,9.57459397064917E-10,1.5814976393872275E-8,0,0,35.35353535353535,734.1775990226718,IL10;IL6;TGFB1;IL1B;HMGB1;HIF1A;TLR4
Glossitis, Benign Migratory,5/24,1.0204103063538926E-9,1.682649746786251E-8,0,0,104.16666666666667,2156.5688572296126,IL10;CXCL10;IFNG;IL1B;TNF
Otitis Media,7/101,1.1029969482846932E-9,1.815787940995304E-8,0,0,34.65346534653465,714.7358616036585,IL10;IL6;IL1B;CD14;TNF;IL6R;TLR4
Atherogenesis,6/55,1.1660870910695947E-9,1.916438784453508E-8,0,0,54.54545454545454,1121.9788396166164,IL6;IFNG;AHR;TNF;TLR4;SOD1
Immunoglobulin A deficiency (disorder),6/55,1.1660870910695947E-9,1.9132393874844703E-8,0,0,54.54545454545454,1121.9788396166164,IL10;TGFB1;IL2RA;FUT2;TNF;TGM2
Progressive Neoplastic Disease,8/167,1.2232239909647571E-9,2.0036408972002722E-8,0,0,23.952095808383234,491.5395412748621,IL10;CXCL10;IL6;TGFB1;IFNG;TNF;IL2;SOD1
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse,10/349,1.22569834344334E-9,2.00435329773064E-8,0,0,14.326647564469914,293.97929912752426,IL21;DPP4;IL10;IL6;STAT1;TNFRSF9;IL12A;TNF;TLR4;TGM2
Hepatic Veno-Occlusive Disease,5/25,1.2736577740487806E-9,2.0793203660052186E-8,0,0,100.0,2048.1372939077733,IL6;TGFB1;IL1B;MTHFR;TNF
Lymphomatoid Papulosis,5/25,1.2736577740487806E-9,2.0758720735242814E-8,0,0,100.0,2048.1372939077733,IL10;IL1B;CCR4;IL2;INS
Gonorrhea,6/56,1.3041155313286E-9,2.1219946095856753E-8,0,0,53.57142857142857,1095.9503989136708,IL10;IL6;IL1B;TLR4;IL2;IL17A
Malignant Head and Neck Neoplasm,11/470,1.343001433270515E-9,2.181655882013656E-8,0,0,11.702127659574467,239.0552631639291,IL10;IL6;IFNG;STAT1;VDR;MTHFR;HIF1A;TNF;RUNX3;TLR4;IL2
Progressive cGVHD,8/169,1.3443579256589998E-9,2.1802557249796453E-8,0,0,23.668639053254438,483.48755778855116,IL10;CXCL10;IL6;TGFB1;IFNG;TNF;IL2;SOD1
Alzheimer Disease, Late Onset,9/253,1.3973746786163116E-9,2.262503845377448E-8,0,0,17.786561264822137,362.6443385631658,IL10;IL6;TGFB1;VDR;IL1B;MTHFR;TNF;TLR4;INS
Premature Obstetric Labor,7/105,1.4512030752257958E-9,2.3457933919932764E-8,0,0,33.333333333333336,678.3624305826092,IL10;IL6;IL1B;IRF1;TNF;IL6R;TLR4
Keloid,8/171,1.4757610363420359E-9,2.3815729827864578E-8,0,0,23.391812865497073,475.651275400527,IL6;TGFB1;VDR;IL1B;HIF1A;S100A9;HLA-DQA1;HLA-DRB1
AA amyloidosis,5/26,1.5746157984086002E-9,2.5369383715999548E-8,0,0,96.15384615384616,1948.9667819177655,IL1B;TNF;TLR4;HLA-DRB1;SOD1
Acne Vulgaris,5/26,1.5746157984086002E-9,2.5327862629721317E-8,0,0,96.15384615384616,1948.9667819177655,IL10;IL1B;TNF;TLR4;IL17A
Generalized pustular psoriasis,5/26,1.5746157984086002E-9,2.5286477233267526E-8,0,0,96.15384615384616,1948.9667819177655,IL6;IL1B;TNF;HLA-DRB1;IL17A
Human anaplasmosis due to Anaplasma phagocytophilum,5/26,1.5746157984086002E-9,2.524522686257704E-8,0,0,96.15384615384616,1948.9667819177655,IL10;IL6;IFNG;TNF;IL2
Chlamydia Infections,6/58,1.6209865772765997E-9,2.5946345409567463E-8,0,0,51.724137931034484,1046.90849352142,IL10;IFNG;VDR;TNF;TLR4;HLA-DRB1
Pleural effusion disorder,7/107,1.6577756668726853E-9,2.649206382768252E-8,0,0,32.71028037383177,661.3295497658596,IL10;IL6;IL2RA;IL12A;TNF;IL2;HLA-DRB1
Hypoxia-Ischemia, Brain,4/9,1.7150492788048153E-9,2.7362831675476824E-8,0,0,222.2222222222222,4485.29422727652,IL6;IL1B;HIF1A;TNF
Corneal infection,4/9,1.7150492788048153E-9,2.731848348799631E-8,0,0,222.2222222222222,4485.29422727652,IFNG;IL1B;CD14;IL17A
Gluten sensitivity,4/9,1.7150492788048153E-9,2.727427882215813E-8,0,0,222.2222222222222,4485.29422727652,HLA-DQA1;IL17A;SOD1;TGM2
Infection of ear,4/9,1.7150492788048153E-9,2.7230216982380814E-8,0,0,222.2222222222222,4485.29422727652,IL10;IL6;TLR4;TNF
Acne,6/59,1.8018661537745824E-9,2.8562484773059026E-8,0,0,50.847457627118644,1023.7852351018776,IL10;IL1B;IL12A;TNF;TLR4;IL17A
Anterior uveitis,5/27,1.9296715614303627E-9,3.0539149928724E-8,0,0,92.59259259259258,1857.955187401461,TNF;TLR4;IL2;HLA-DRB1;IL17A
Chronic Lung Injury,5/27,1.9296715614303627E-9,3.0490051616941486E-8,0,0,92.59259259259258,1857.955187401461,IL6;AHR;TNF;TLR4;SOD1
Fatty Liver, Alcoholic,6/60,1.999157252183854E-9,3.153726721422619E-8,0,0,50.0,1001.5270059548735,IL10;IL6;TGFB1;IL1B;TNF;SOD1
Subfertility, Male,6/60,1.999157252183854E-9,3.1486726721895696E-8,0,0,50.0,1001.5270059548735,IL10;IL6;IFNG;MTHFR;AHR;TNF
Scleroderma,8/179,2.1192274113497116E-9,3.332442719799194E-8,0,0,22.3463687150838,446.30646353723705,IL6;TGFB1;IFNG;TNF;TLR4;HLA-DQA1;IL2;HLA-DRB1
Plasmacytoma,7/111,2.1467702663800175E-9,3.370360731307158E-8,0,0,31.531531531531527,629.3473391057979,DPP4;IL10;IL6;STAT1;IL1B;TNF;IL6R
Nephroblastoma,10/370,2.1517223561338784E-9,3.3727475783227687E-8,0,0,13.513513513513514,269.6891516167115,TGFB1;IFNG;IL15;STAT1;VDR;CD14;HIF1A;IL2;HLA-DRB1;INS
Conventional (Clear Cell) Renal Cell Carcinoma,12/631,2.1815889690990658E-9,3.414117259284334E-8,0,0,9.508716323296355,189.634348723409,IL6;TGFB1;STAT1;IL1B;MTHFR;AHR;HMGB1;HIF1A;TNF;IL6R;IL2;TGM2
Cholestasis, Extrahepatic,6/61,2.214017316922493E-9,3.459358058937085E-8,0,0,49.18032786885246,980.08805808864,IL6;TGFB1;IL1B;HMGB1;TNF;TLR4
Hemorrhagic Fever, Ebola,6/61,2.214017316922493E-9,3.453867014399089E-8,0,0,49.18032786885246,980.08805808864,IL10;IL6;IFNG;IRF1;TNF;TLR4
Skin Erosion,7/112,2.2865765559571735E-9,3.561406401259446E-8,0,0,31.25,621.7565653646567,CXCL10;IL6;IL1B;TNF;S100A9;HLA-DRB1;IL17A
Infectious disease of lung,7/112,2.2865765559571735E-9,3.5557712645485925E-8,0,0,31.25,621.7565653646567,DPP4;IL10;IL1B;CD14;TNF;TLR4;IL17A
Osteomyelitis,6/62,2.447662647343658E-9,3.8002572666814335E-8,0,0,48.387096774193544,959.4257559314665,IFNG;STAT1;IL1B;ETS1;TLR4;HLA-DRB1
Pemphigus Vulgaris,6/62,2.447662647343658E-9,3.794263170046289E-8,0,0,48.387096774193544,959.4257559314665,IL10;IL6;TNFRSF9;TNF;HLA-DRB1;INS
Neoplasm Invasiveness,8/183,2.5235147533570637E-9,3.905685511180035E-8,0,0,21.85792349726776,432.73471396237227,IL6;TGFB1;IL1B;AHR;ETS1;HIF1A;TNF;TLR4
Necrotizing Enterocolitis,6/63,2.701370248453145E-9,4.174381572609672E-8,0,0,47.61904761904761,939.5003187258723,IL10;IL1B;CD14;TNF;TLR4;IL17A
Idiopathic Pulmonary Fibrosis,10/379,2.710416108501594E-9,4.181784853116745E-8,0,0,13.192612137203167,260.239626230464,IL10;CXCL10;IL6;TGFB1;IFNG;IL1B;HIF1A;TNF;HLA-DRB1;IL17A
Microvascular Angina,5/29,2.8303198722575432E-9,4.359934749929018E-8,0,0,86.20689655172414,1696.7996640183017,IL10;IL6;IFNG;MTHFR;TNF
Neuropathy, Painful,4/10,2.8543264220570987E-9,4.390034440685002E-8,0,0,200.0,3934.8859901802102,IL10;HMGB1;TNF;IL2
Urban cutaneous leishmaniasis,4/10,2.8543264220570987E-9,4.383175011871432E-8,0,0,200.0,3934.8859901802102,IL10;IFNG;IL1B;TNF
Burn injury,4/10,2.8543264220570987E-9,4.376336985331851E-8,0,0,200.0,3934.8859901802102,IL10;IL6;IL1B;TNF
Chronic idiopathic neutropenia,4/10,2.8543264220570987E-9,4.369520261055633E-8,0,0,200.0,3934.8859901802102,IL10;HMGB1;TLR4;TNF
Infection by Leishmania braziliensis,4/10,2.8543264220570987E-9,4.362724739654303E-8,0,0,200.0,3934.8859901802102,IL6;IFNG;TNF;IL17A
Pelvic Pain,4/10,2.8543264220570987E-9,4.3559503223567026E-8,0,0,200.0,3934.8859901802102,IL6;IFNG;IL1B;IL17A
Rectal Carcinoma,9/276,2.996528122151957E-9,4.565872617753401E-8,0,0,16.304347826086957,319.98605724578033,IL6;TGFB1;IL15;VDR;MTHFR;HIF1A;TNF;RUNX3;TLR4
Infarction, Middle Cerebral Artery,7/119,3.4999814269265584E-9,5.324739545485173E-8,0,0,29.41176470588235,572.6620051487511,IL6;IL1B;HMGB1;HIF1A;TNF;IL6R;SOD1
Premature Birth,7/119,3.4999814269265584E-9,5.3165096543793224E-8,0,0,29.41176470588235,572.6620051487511,IL6;TGFB1;IL1B;MTHFR;TNF;IL6R;TLR4
Congenital arteriovenous malformation,6/66,3.5965868198006815E-9,5.454823343364367E-8,0,0,45.45454545454545,883.7854794014399,IL6;IFNG;IL1B;ETS1;TNF;TLR4
Giant Cell Tumor of Bone,6/66,3.5965868198006815E-9,5.446418376733605E-8,0,0,45.45454545454545,883.7854794014399,IL6;VDR;CD14;HIF1A;RUNX3;HLA-DRB1
Ischemic stroke,10/394,3.931846029568171E-9,5.9449511967070757E-8,0,0,12.690355329949238,245.61112682394972,IL21;IL10;IL6;TGFB1;IL1B;MTHFR;HMGB1;TNF;TLR4;IL17A
Schistosomiasis,6/67,3.944593699946048E-9,5.955064037337906E-8,0,0,44.776119402985074,866.4590990639199,IL21;IL10;IFNG;TNF;HLA-DRB1;SOD1
Meningococcal Infections,6/67,3.944593699946048E-9,5.945930503538308E-8,0,0,44.776119402985074,866.4590990639199,IL10;CXCL10;ZMIZ1;IL1B;TNF;TLR4
Acute colitis,5/31,4.03775535437922E-9,6.077038227081007E-8,0,0,80.64516129032258,1558.6755568331353,IL10;IL6;IL1B;TNF;TLR4
Childhood Ataxia with Central Nervous System Hypomyelinization,5/31,4.03775535437922E-9,6.067746119700149E-8,0,0,80.64516129032258,1558.6755568331353,IL6;MTHFR;HMGB1;TNF;IL17A
Opportunistic Infections,5/31,4.03775535437922E-9,6.058482385166255E-8,0,0,80.64516129032258,1558.6755568331353,IFNG;TNF;TLR4;IL2;HLA-DRB1
Acute Megakaryocytic Leukemias,7/122,4.1670133687745385E-9,6.242897467731122E-8,0,0,28.688524590163933,553.5756718599757,IL6;TGFB1;VDR;IL1B;AHR;IL6R;IL2
Atrial Fibrillation,9/288,4.345510687734022E-9,6.500407768500757E-8,0,0,15.625,300.8456648524907,DPP4;IL10;IL6;TGFB1;IL1B;MTHFR;HIF1A;TNF;IL6R
Hyperplasia,7/123,4.412078797292632E-9,6.589955990849845E-8,0,0,28.455284552845526,547.4489395594816,TGFB1;IL15;VDR;HIF1A;TNF;S100A9;SOD1
Ear Inflammation,4/11,4.4789478444596715E-9,6.679681246638794E-8,0,0,181.8181818181818,3495.2504862272613,IL10;IL6;TLR4;TNF
Eosinophilia-Myalgia Syndrome,4/11,4.4789478444596715E-9,6.66956051747722E-8,0,0,181.8181818181818,3495.2504862272613,TGFB1;IFNG;HLA-DQA1;HLA-DRB1
Hyperoxia,4/11,4.4789478444596715E-9,6.659470410794198E-8,0,0,181.8181818181818,3495.2504862272613,IL1B;AHR;HIF1A;TNF
Bipolar Disorder,13/837,4.64151645625147E-9,6.890758871909281E-8,0,0,7.765830346475507,149.0124976829487,TGFB1;VDR;MTHFR;HIF1A;TNF;INS;SOD1;IL6;IFNG;IL1B;TLR4;HLA-DRB1;TGM2
Hyperthyroidism,7/124,4.669284210307802E-9,6.921527182338624E-8,0,0,28.2258064516129,541.4347595050848,IL10;IL6;VDR;MTHFR;TNF;HLA-DRB1;SOD1
Histiocytosis, Langerhans-Cell,6/69,4.72456136116074E-9,6.992920038778276E-8,0,0,43.47826086956522,833.4996136489907,IFNG;IL1B;CD14;TNF;HLA-DRB1;IL17A
Hepatolenticular Degeneration,6/69,4.72456136116074E-9,6.982404369547031E-8,0,0,43.47826086956522,833.4996136489907,IL10;IL6;IL1B;MTHFR;TNF;IL2
Gastro-esophageal reflux disease with esophagitis,5/32,4.778521753266519E-9,7.051548316982485E-8,0,0,78.125,1496.8073902274646,IL10;IL6;VDR;IL1B;IL2
Autistic Disorder,12/677,4.809688745705486E-9,7.086899699069492E-8,0,0,8.862629246676514,169.74268949561346,DPP4;IL10;IL6;IFNG;IL15;MTHFR;PRL;TNF;IL2;HLA-DRB1;SOD1;IL17A
Burkitt Lymphoma,10/407,5.362652292761433E-9,7.889842325338229E-8,0,0,12.285012285012284,233.9534048343118,IL21;IL10;IL6;TGFB1;IFNG;PRL;ETS1;HIF1A;TNF;IL2
Renal fibrosis,8/202,5.493201260579985E-9,8.06983288325562E-8,0,0,19.801980198019802,376.6288048275716,IL6;TGFB1;IFNG;STAT1;VDR;HIF1A;TNF;TLR4
Stickler syndrome, type 1,5/33,5.623630419665286E-9,8.249110412607527E-8,0,0,75.75757575757576,1439.112757534138,IL10;IL6;TGFB1;IFNG;TNF
CREST Syndrome,5/33,5.623630419665286E-9,8.236816656403939E-8,0,0,75.75757575757576,1439.112757534138,IL10;IL6;HMGB1;IL2;HLA-DRB1
Pemphigus,5/33,5.623630419665286E-9,8.224559488760481E-8,0,0,75.75757575757576,1439.112757534138,IL6;TNF;HLA-DQA1;IL2;HLA-DRB1
Cleft palate, isolated,7/129,6.155094337205614E-9,8.988449798819729E-8,0,0,27.131782945736433,512.9531017578967,IL10;TGFB1;IL1B;MTHFR;AHR;HMGB1;ETS1
Hereditary Diffuse Gastric Cancer,9/300,6.201176715537924E-9,9.042309311618208E-8,0,0,15.0,283.47790155112574,IL6;TNFRSF9;IL1B;IRF1;MTHFR;AHR;TNF;IL6R;RUNX3
Senile Plaques,9/301,6.383310441784085E-9,9.294100003237627E-8,0,0,14.950166112956811,282.1033404738207,IL10;IL6;TGFB1;IFNG;IL1B;TNF;S100A9;TLR4;SOD1
Cutaneous Melanoma,9/301,6.383310441784085E-9,9.280351334593785E-8,0,0,14.950166112956811,282.1033404738207,IL10;IFNG;VDR;TNFRSF9;IL2RA;HIF1A;TNF;RUNX3;HLA-DRB1
Infective endocarditis,5/34,6.583622702046412E-9,9.557436324329711E-8,0,0,73.52941176470588,1385.1971088597163,IL10;IL6;IL1B;TNF;TLR4
Leishmaniasis, New World,4/12,6.708795490402478E-9,9.724784967503769E-8,0,0,166.66666666666666,3136.6410686172753,IL10;IFNG;IL1B;TNF
Coprophilia (disorder),4/12,6.708795490402478E-9,9.710462751056783E-8,0,0,166.66666666666666,3136.6410686172753,IL6;IFNG;IL1B;TNF
Ocular Toxoplasmosis,4/12,6.708795490402478E-9,9.696182658775817E-8,0,0,166.66666666666666,3136.6410686172753,IL10;IL6;IFNG;IL17A
Pancreatic Ductal Adenocarcinoma,12/701,7.100597222654697E-9,1.024738171868581E-7,0,0,8.559201141226819,160.59703515466325,CXCL10;IL6;TGFB1;IFNG;HMGB1;ETS1;HIF1A;TNF;RUNX3;TLR4;IL2;TGM2
Keratitis,6/74,7.247984095856642E-9,1.04447489287506E-7,0,0,40.54054054054054,759.8328025333137,IL10;IL6;IL1B;TNF;TLR4;IL17A
Alcoholic Intoxication, Chronic,10/424,7.921960257903775E-9,1.1399271656614684E-7,0,0,11.79245283018868,219.97201833058813,IL10;IL6;IL1B;THEMIS;MTHFR;HMGB1;PRL;TNF;TLR4;IL17A
Oestrogen deficiency,5/36,8.893790093724028E-9,1.277897208203505E-7,0,0,69.44444444444444,1287.3550379181909,IL6;IFNG;IL1B;HIF1A;TNF
Melanoma, B16,7/136,8.896908470089901E-9,1.276479072175818E-7,0,0,25.735294117647058,477.06960986855967,IL10;IL6;TGFB1;IFNG;IL1B;TNF;IL2
Superficial ulcer,6/77,9.235853683619371E-9,1.3231774052858772E-7,0,0,38.96103896103896,720.7859527614455,IL6;IL1B;IL2RA;TNF;HLA-DRB1;IL17A
Dyslipidemias,8/216,9.288446296018057E-9,1.3287751120417097E-7,0,0,18.518518518518515,342.4906396830559,DPP4;IL10;IL6;MTHFR;IL12A;AHR;TNF;TLR4
Congenital emphysema,4/13,9.676590027007359E-9,1.3822896335091324E-7,0,0,153.84615384615384,2839.008656562586,IL6;HMGB1;TNF;IL17A
Pleural Effusion, Malignant,6/78,9.990924628525738E-9,1.42512056965386E-7,0,0,38.46153846153846,708.5226420446521,IL6;IFNG;IL2RA;TNF;IL2;IL17A
Sudden infant death syndrome,6/78,9.990924628525738E-9,1.4230551775239268E-7,0,0,38.46153846153846,708.5226420446521,IL10;IL6;IL1B;CD14;FUT2;TNF
Acute monocytic leukemia,6/78,9.990924628525738E-9,1.4209957633741092E-7,0,0,38.46153846153846,708.5226420446521,VDR;IL1B;HMGB1;ETS1;TNF;IL2
Peripheral Vascular Diseases,6/78,9.990924628525738E-9,1.4189423012883085E-7,0,0,38.46153846153846,708.5226420446521,IL6;MTHFR;CD14;HIF1A;TNF;TLR4
Pulmonary Edema,6/78,9.990924628525738E-9,1.416894765500014E-7,0,0,38.46153846153846,708.5226420446521,IL6;IFNG;IL2RA;HIF1A;TNF;IL2
Salivary Gland Pleomorphic Adenoma,5/37,1.0268469752540387E-8,1.454157359192607E-7,0,0,67.56756756756756,1242.8505287708015,IFNG;IL2RA;HIF1A;TNF;IL2
Abscess,5/37,1.0268469752540387E-8,1.4520650464455672E-7,0,0,67.56756756756756,1242.8505287708015,IL10;IL6;HIF1A;TNF;IL17A
Bacterial Endocarditis,5/37,1.0268469752540387E-8,1.4499787460914788E-7,0,0,67.56756756756756,1242.8505287708015,IL10;IL6;IL1B;TNF;TLR4
Polyendocrinopathies, Autoimmune,6/79,1.079633688652028E-8,1.522329970168168E-7,0,0,37.9746835443038,696.6098330705269,IL2RA;MTHFR;TNF;TLR4;HLA-DRB1;IL17A
Chronic granulomatous disease,6/79,1.079633688652028E-8,1.5201489816722252E-7,0,0,37.9746835443038,696.6098330705269,IL10;IFNG;IL1B;CD14;S100A9;IL17A
Eczema, Infantile,5/38,1.1807078544011105E-8,1.6600853781193296E-7,0,0,65.78947368421052,1200.9583295209031,IL10;CXCL10;IL6;IFNG;IL1B
Anti-Basement Membrane Glomerulonephritis,5/38,1.1807078544011105E-8,1.6577138275791591E-7,0,0,65.78947368421052,1200.9583295209031,IL10;CD80;IL1B;TNF;IL17A
Arteriovenous hemangioma,5/38,1.1807078544011105E-8,1.6553490432316854E-7,0,0,65.78947368421052,1200.9583295209031,IL6;IFNG;IL1B;ETS1;TNF
End Stage Liver Disease,5/38,1.1807078544011105E-8,1.6529909961615547E-7,0,0,65.78947368421052,1200.9583295209031,IL1B;MTHFR;TNF;TLR4;HLA-DRB1
Childhood Acute Lymphoblastic Leukemia,10/443,1.201688727561028E-8,1.679971097364123E-7,0,0,11.286681715575622,205.83468288342522,IL10;IL6;IFNG;IL15;VDR;MTHFR;HIF1A;TNF;S100A9;HLA-DRB1
Encephalitis,7/144,1.3237831647977893E-8,1.8480313840387319E-7,0,0,24.305555555555557,440.9073246827355,IL10;CXCL10;IL6;IFNG;STAT1;IL1B;TNF
heavy drinking,5/39,1.352368892171296E-8,1.8852597832992196E-7,0,0,64.1025641025641,1161.463009891606,IL10;IL6;MTHFR;CD14;TLR4
Thrombocytopenic purpura,4/14,1.3527795988900864E-8,1.8831611753387775E-7,0,0,142.85714285714283,2588.3599008741026,IL6;TGFB1;IFNG;IL17A
Coronary Occlusion,4/14,1.3527795988900864E-8,1.8804975810313679E-7,0,0,142.85714285714283,2588.3599008741026,IL6;IFNG;CD14;TNF
Mucocutaneous leishmaniasis,4/14,1.3527795988900864E-8,1.8778415110016625E-7,0,0,142.85714285714283,2588.3599008741026,CXCL10;IFNG;TNF;HLA-DRB1
Ki-1+ Anaplastic Large Cell Lymphoma,8/228,1.416980870585371E-8,1.964187305516647E-7,0,0,17.543859649122805,317.0553032153456,DPP4;IL10;IL6;IFNG;ETS1;TNF;IL2;IL17A
Secondary malignant neoplasm of bone,9/330,1.4173304688470916E-8,1.9619047672998895E-7,0,0,13.636363636363635,246.43507627066398,IL6;TGFB1;IFNG;VDR;ETS1;HIF1A;TNF;CCR4;TLR4
Glaucoma, Primary Open Angle,7/147,1.527374972308302E-8,2.1112575566590707E-7,0,0,23.809523809523807,428.50309967685877,TGFB1;IL1B;MTHFR;TNF;TLR4;HLA-DRB1;TGM2
Dermatomyositis, Childhood Type,5/40,1.543313354382775E-8,2.1302926470328526E-7,0,0,62.5,1124.1718193706538,IL1B;TNF;TLR4;HLA-DQA1;HLA-DRB1
Cicatrix, Hypertrophic,6/85,1.683919430705104E-8,2.321116432674581E-7,0,0,35.29411764705882,631.7490590568046,IL10;IL6;TGFB1;IFNG;IL15;TNF
Rheumatic Heart Disease,5/41,1.7551022857229794E-8,2.415846675642219E-7,0,0,60.97560975609756,1088.9118052603449,IL10;IL6;TGFB1;TNF;HLA-DRB1
Nephrotic Syndrome, Minimal Change,5/41,1.7551022857229794E-8,2.412467869102859E-7,0,0,60.97560975609756,1088.9118052603449,IL6;IL1B;TNF;HLA-DRB1;IL17A
Plaque, Amyloid,8/235,1.7934920857678466E-8,2.461793326665698E-7,0,0,17.02127659574468,303.6002747013175,IL6;TGFB1;IFNG;IL1B;TNF;S100A9;TLR4;INS
Chronic gastritis,6/86,1.807574331073348E-8,2.4776625558980283E-7,0,0,34.883720930232556,621.9312190484338,IL10;IL6;IL1B;TNF;RUNX3;TLR4
Herpes NOS,6/86,1.807574331073348E-8,2.474211772393992E-7,0,0,34.883720930232556,621.9312190484338,IL6;STAT1;IL2RA;TNFRSF14;TNF;IL2
Bacterial sepsis,4/15,1.8420527330974853E-8,2.5178990627096085E-7,0,0,133.33333333333334,2374.6400237805997,CD14;HIF1A;TNF;TLR4
Left ventricular systolic dysfunction,4/15,1.8420527330974853E-8,2.5144019806780674E-7,0,0,133.33333333333334,2374.6400237805997,IL6;IL1B;TNF;INS
Liver and Intrahepatic Biliary Tract Carcinoma,11/607,1.909859595309076E-8,2.603342593994119E-7,0,0,9.060955518945633,161.04626125531917,IL6;TGFB1;IFNG;IRF1;MTHFR;AHR;HIF1A;TNF;TLR4;IL2;HLA-DRB1
Familial lichen amyloidosis,7/153,2.0150911163757774E-8,2.742979985005698E-7,0,0,22.87581699346405,405.3598506984219,IL21;IL10;IL6;IL15;VDR;TNF;IL2
Primary Effusion Lymphoma,7/153,2.0150911163757774E-8,2.739186098442758E-7,0,0,22.87581699346405,405.3598506984219,IL10;IL6;VDR;IL1B;HIF1A;TNF;IL6R
Hypercholesterolemia, Familial,7/154,2.1079912028903966E-8,2.861510710221936E-7,0,0,22.727272727272727,401.7033019655422,IL10;IL6;IL1B;MTHFR;CD14;TNF;TLR4
Macular dystrophy, corneal type 1,5/43,2.2478570458962434E-8,3.047164006492177E-7,0,0,58.13953488372093,1023.8781049782629,IL6;CD80;IL2RA;TNF;TLR4
Autoimmune hemolytic anemia,5/43,2.2478570458962434E-8,3.0429668108909476E-7,0,0,58.13953488372093,1023.8781049782629,IL10;IL6;STAT1;IL2RA;SOD1
Bacteremia,6/90,2.3797962068685025E-8,3.2171440331641876E-7,0,0,33.333333333333336,585.1221962433797,IL10;IL6;TGFB1;FUT2;TLR4;IL2
Severe periodontitis,4/16,2.4525453404201212E-8,3.3109362095671634E-7,0,0,125.0,2190.444293029584,IL6;IL1B;CD14;TNF
Tonsillitis,4/16,2.4525453404201212E-8,3.306394458936756E-7,0,0,125.0,2190.444293029584,IL6;IFNG;MTHFR;HIF1A
infertility tubal factor,4/16,2.4525453404201212E-8,3.3018651514587605E-7,0,0,125.0,2190.444293029584,IL10;IL6;IL12A;TLR4
Thyroiditis,5/44,2.5323494219368454E-8,3.404641603118375E-7,0,0,56.81818181818181,993.8371162981339,CXCL10;STAT1;CD80;IL2RA;HLA-DRB1
Neuromyelitis Optica,5/44,2.5323494219368454E-8,3.399990453387339E-7,0,0,56.81818181818181,993.8371162981339,IL10;IL6;HMGB1;HLA-DQA1;HLA-DRB1
Oral Submucous Fibrosis,5/44,2.5323494219368454E-8,3.3953519943786244E-7,0,0,56.81818181818181,993.8371162981339,TGFB1;IFNG;HIF1A;TNF;TGM2
Leukopenia,8/246,2.5595235949634046E-8,3.4271114293324713E-7,0,0,16.260162601626018,284.24161948774423,IL10;IL6;STAT1;MTHFR;TNF;TLR4;IL2;HLA-DRB1
Sporadic Breast Carcinoma,7/159,2.6288907444004233E-8,3.515202481083995E-7,0,0,22.0125786163522,384.2101613159087,VDR;IRF1;MTHFR;TNFRSF14;HIF1A;TNF;IL17A
Retinal Diseases,9/355,2.660593353794796E-8,3.5527597121053336E-7,0,0,12.67605633802817,221.0974425722249,IL6;IL1B;MTHFR;HIF1A;TNF;IL2;HLA-DRB1;INS;SOD1
Infectious Otitis Media,5/45,2.8447427527584616E-8,3.793504989702871E-7,0,0,55.55555555555555,965.2893389602953,IL6;IL1B;CD14;TNF;TLR4
Systemic candidiasis,5/46,3.187012713324009E-8,4.2441681499388016E-7,0,0,54.347826086956516,938.1302564894331,IL10;IL6;IL1B;TNF;IL17A
Sleep Apnea, Central,5/46,3.187012713324009E-8,4.23842502659653E-7,0,0,54.347826086956516,938.1302564894331,IL10;IFNG;IL2;HLA-DRB1;IL17A
Cutaneous Mastocytosis,5/46,3.187012713324009E-8,4.2326974252092375E-7,0,0,54.347826086956516,938.1302564894331,IL6;IL2RA;TNF;IL2;SOD1
Malonic aciduria,5/46,3.187012713324009E-8,4.226985282935001E-7,0,0,54.347826086956516,938.1302564894331,IL6;CD80;IL2RA;TNF;TLR4
Nodular Sclerosis Classical Hodgkin Lymphoma,5/46,3.187012713324009E-8,4.221288537270668E-7,0,0,54.347826086956516,938.1302564894331,DPP4;CXCL10;TGFB1;IFNG;HLA-DRB1
Colitis, Lymphocytic,4/17,3.2025705319511575E-8,4.2361861625862683E-7,0,0,117.6470588235294,2030.2031723973732,IL21;IFNG;IL15;IL1B
Cervical Intraepithelial Neoplasia Grade 2/3,4/17,3.2025705319511575E-8,4.230492363980642E-7,0,0,117.6470588235294,2030.2031723973732,IL6;IFNG;IL1B;MTHFR
Lobomycosis,4/17,3.2025705319511575E-8,4.2248138507403995E-7,0,0,117.6470588235294,2030.2031723973732,IL10;TGFB1;IFNG;IL17A
Lofgrens syndrome,4/17,3.2025705319511575E-8,4.219150561396243E-7,0,0,117.6470588235294,2030.2031723973732,TNF;IL2;HLA-DRB1;IL17A
Multiple Organ Failure,4/17,3.2025705319511575E-8,4.213502434808029E-7,0,0,117.6470588235294,2030.2031723973732,IL10;HMGB1;CD14;TNF
Nasal allergies,4/17,3.2025705319511575E-8,4.2078694101625633E-7,0,0,117.6470588235294,2030.2031723973732,IL10;IFNG;CD14;TNF
Rheumatism,6/95,3.297809056992461E-8,4.327218613100388E-7,0,0,31.57894736842105,544.0238658346522,IL6;IL1B;PRL;TNF;IL2;HLA-DRB1
Membranous glomerulonephritis,6/95,3.297809056992461E-8,4.3214489882829206E-7,0,0,31.57894736842105,544.0238658346522,CXCL10;IFNG;IL1B;TNF;HLA-DQA1;HLA-DRB1
Cardiac fibrosis,6/96,3.5125334592831014E-8,4.5966949184865935E-7,0,0,31.25,536.3857244863538,IL10;IL6;TGFB1;HIF1A;TNF;IL17A
Breast adenocarcinoma,7/168,3.842815616271678E-8,5.022232962329527E-7,0,0,20.833333333333332,355.718237763186,TGFB1;VDR;MTHFR;PRL;HIF1A;TNF;IL2
Alcoholic Steatohepatitis,5/48,3.969526606123971E-8,5.180943889108418E-7,0,0,52.083333333333336,887.6059322475618,CXCL10;IL6;TNF;TGM2;SOD1
Henoch-Schoenlein Purpura,6/98,3.9766878037905964E-8,5.18340686149257E-7,0,0,30.612244897959183,521.6397392215699,IL21;IL10;CXCL10;TLR4;HLA-DRB1;IL17A
Cryptosporidiosis,4/18,4.1116782749314184E-8,5.352261468347812E-7,0,0,111.1111111111111,1889.6499399325214,IL10;IFNG;IL1B;TNF
Pleural Diseases,4/18,4.1116782749314184E-8,5.345181757410844E-7,0,0,111.1111111111111,1889.6499399325214,IL6;TGFB1;IFNG;TNF
Dental caries,7/170,4.168919525016945E-8,5.412436075543796E-7,0,0,20.588235294117645,349.8563733499504,IL10;CXCL10;IL6;TGFB1;VDR;TNF;HLA-DRB1
Aortic Aneurysm, Thoracic,6/99,4.2270748782127414E-8,5.480698140247339E-7,0,0,30.303030303030305,514.5203184320047,IL10;TGFB1;IFNG;IL1B;HIF1A;TLR4
Malignant neoplasm of gastrointestinal tract,8/263,4.295428690988483E-8,5.561985925564534E-7,0,0,15.209125475285171,257.9943632221785,IL10;IL6;IRF1;AHR;CD14;HIF1A;TNF;RUNX3
Dryness of eye,5/49,4.414168159431455E-8,5.708216404064781E-7,0,0,51.02040816326531,864.074558163678,IFNG;VDR;IL1B;TNF;TGM2
Rhinitis,6/100,4.490330125051338E-8,5.799075488699677E-7,0,0,30.0,507.56263561172034,IL1B;IL2RA;CD14;HIF1A;TNF;IL17A
Neuralgia,6/100,4.490330125051338E-8,5.79146515341267E-7,0,0,30.0,507.56263561172034,IL10;HMGB1;TNF;TLR4;IL2;SOD1
Candidiasis,5/50,4.8974847988834866E-8,6.308319869387536E-7,0,0,50.0,841.5979488486449,STAT1;IL1B;FUT2;TNF;IL17A
Microscopic Polyarteritis,5/50,4.8974847988834866E-8,6.30006290620771E-7,0,0,50.0,841.5979488486449,IL10;IL1B;TNF;IL2;HLA-DRB1
Hypothyroidism,8/268,4.9682815072679364E-8,6.382780477572455E-7,0,0,14.925373134328357,251.0090557734729,IL10;STAT1;MTHFR;PRL;TNF;HLA-DRB1;SOD1;IL17A
Intervertebral Disc Degeneration,6/102,5.0575164617330033E-8,6.488938875445426E-7,0,0,29.41176470588235,494.1119176171417,IL21;IL6;TGFB1;VDR;IL1B;TNF
Malignant neoplasm of large intestine,10/516,5.065347684677967E-8,6.490513304434818E-7,0,0,9.689922480620154,162.77381748111713,IL21;IL10;IL6;TGFB1;STAT1;VDR;MTHFR;HIF1A;RUNX3;TGM2
Mesothelioma,9/383,5.1028782284069926E-8,6.530089482914574E-7,0,0,11.749347258485638,197.2818329557592,DPP4;CXCL10;IL6;IFNG;STAT1;IL1B;CD14;HIF1A;TNF
Hypothermia, natural,4/19,5.200646112146747E-8,6.646547462962059E-7,0,0,105.26315789473684,1765.4629340787108,IL6;IL12A;TNF;SOD1
Lupus Erythematosus, Cutaneous,4/19,5.200646112146747E-8,6.637915583140029E-7,0,0,105.26315789473684,1765.4629340787108,IL2RA;HMGB1;CCR4;HLA-DQA1
Angiolymphoid hyperplasia,4/19,5.200646112146747E-8,6.629306094705347E-7,0,0,105.26315789473684,1765.4629340787108,IL6;IL1B;IL6R;TLR4
Epidermolysis Bullosa Acquisita,4/19,5.200646112146747E-8,6.620718910644848E-7,0,0,105.26315789473684,1765.4629340787108,IL6;TGFB1;S100A9;HLA-DRB1
Filariasis,4/19,5.200646112146747E-8,6.612153944395632E-7,0,0,105.26315789473684,1765.4629340787108,IL10;IFNG;TNF;IL2
Peri-Implantitis,4/19,5.200646112146747E-8,6.603611109842148E-7,0,0,105.26315789473684,1765.4629340787108,IL10;IL1B;CD14;TNF
Endometrial Carcinoma,12/840,5.253561823133401E-8,6.662194270678072E-7,0,0,7.142857142857142,119.72696039203791,IL6;TGFB1;IL1B;MTHFR;AHR;PRL;ETS1;HIF1A;TNF;IL6R;RUNX3;IL17A
Premature coronary artery disease,5/51,5.421908121201423E-8,6.866818687521597E-7,0,0,49.01960784313725,820.1094577732525,IL6;MTHFR;HIF1A;INS;IL17A
Intrahepatic Cholangiocarcinoma,7/177,5.501270768878381E-8,6.958364107662384E-7,0,0,19.77401129943503,330.53647290000714,IL10;IL6;VDR;MTHFR;HMGB1;HIF1A;HLA-DRB1
X-linked agammaglobulinemia,5/52,5.989965671569145E-8,7.566758691540046E-7,0,0,48.07692307692308,799.5478395576043,IL10;IL6;CD80;CD14;TLR4
Idiopathic crescentic glomerulonephritis,5/52,5.989965671569145E-8,7.557045265748595E-7,0,0,48.07692307692308,799.5478395576043,TGFB1;IFNG;IL1B;TNF;IL17A
Hepatocarcinogenesis,10/527,6.171402962302201E-8,7.775967732500774E-7,0,0,9.487666034155597,157.50241506065638,IL6;TGFB1;IL1B;AHR;HIF1A;TNF;RUNX3;S100A9;TLR4;TGM2
Retinoic acid syndrome,4/20,6.491469921955933E-8,8.168779307680271E-7,0,0,100.0,1655.0191748595453,IL1B;AHR;HMGB1;TGM2
Acral pseudolymphomatous angiokeratoma of children (APACHE),4/20,6.491469921955933E-8,8.158333298335411E-7,0,0,100.0,1655.0191748595453,IL10;IL6;IL1B;TNF
Chronic Chagas' disease,4/20,6.491469921955933E-8,8.147913971006757E-7,0,0,100.0,1655.0191748595453,IL10;IFNG;IL2RA;HLA-DRB1
Chronic multifocal osteomyelitis,4/20,6.491469921955933E-8,8.137521223594759E-7,0,0,100.0,1655.0191748595453,IL10;STAT1;IL1B;TLR4
Pouchitis,4/20,6.491469921955933E-8,8.127154954520116E-7,0,0,100.0,1655.0191748595453,IL10;CD14;TNF;TLR4
Proteinuria,7/184,7.177541136252424E-8,8.974665939833184E-7,0,0,19.021739130434785,312.9023564069008,DPP4;CXCL10;TGFB1;IFNG;HLA-DQA1;HLA-DRB1;SOD1
Carcinoma, Transitional Cell,9/399,7.238137704576816E-8,9.038934861573184E-7,0,0,11.278195488721803,185.42838489210936,IL6;TGFB1;VDR;IL1B;AHR;HMGB1;HIF1A;TNF;TGM2
Cerebral Aneurysm,5/54,7.267582665250648E-8,9.064188126152713E-7,0,0,46.29629629629629,760.9841211073458,IL6;STAT1;ETS1;TNF;TLR4
Hyperalgesia, Thermal,6/109,7.528492442140299E-8,9.377696289145102E-7,0,0,27.522935779816514,451.430805387295,IL10;IL6;IL1B;HMGB1;TNF;S100A9
Retinoblastoma,10/539,7.616583506405716E-8,9.475415531766504E-7,0,0,9.27643784786642,152.04408936489847,IL6;TGFB1;VDR;IL1B;MTHFR;HMGB1;HIF1A;TNF;RUNX3;SOD1
Common Migraine,5/55,7.982690805228209E-8,9.918316717292394E-7,0,0,45.45454545454545,742.8820543495466,TGFB1;MTHFR;TNF;HLA-DRB1;SOD1
Respiratory Hypersensitivity,4/21,8.00735472373483E-8,9.936399270816402E-7,0,0,95.23809523809523,1556.220979441933,IL6;IL15;TNF;TLR4
SMITH-MCCORT DYSPLASIA 1,4/21,8.00735472373483E-8,9.923869133022183E-7,0,0,95.23809523809523,1556.220979441933,IL10;TGFB1;IL1B;TNF
allergic symptom,4/21,8.00735472373483E-8,9.911370557287897E-7,0,0,95.23809523809523,1556.220979441933,IL21;IFNG;IL2RA;IL17A
Erythema Chronicum Migrans,4/21,8.00735472373483E-8,9.898903424511435E-7,0,0,95.23809523809523,1556.220979441933,IL10;CXCL10;IFNG;TNF
Helicobacter-associated gastritis,4/21,8.00735472373483E-8,9.886467616189184E-7,0,0,95.23809523809523,1556.220979441933,CXCL10;IL15;TNF;TLR4
Infantile nystagmus syndrome,4/21,8.00735472373483E-8,9.874063014412283E-7,0,0,95.23809523809523,1556.220979441933,IL6;IFNG;IL2RA;INS
inflammatory joint disease,4/21,8.00735472373483E-8,9.861689501862894E-7,0,0,95.23809523809523,1556.220979441933,IL6;IL1B;TNF;IL2
Lung Injury,4/21,8.00735472373483E-8,9.8493469618105E-7,0,0,95.23809523809523,1556.220979441933,IL6;AHR;TNF;TLR4
Mycosis fungoides/Sezary syndrome NOS,4/21,8.00735472373483E-8,9.837035278108238E-7,0,0,95.23809523809523,1556.220979441933,IL15;IL2RA;IL2;IL17A
pathologic fistula,4/21,8.00735472373483E-8,9.82475433518925E-7,0,0,95.23809523809523,1556.220979441933,IL10;TGFB1;ETS1;TNF
Polymyalgia Rheumatica,4/21,8.00735472373483E-8,9.81250401806308E-7,0,0,95.23809523809523,1556.220979441933,IL6;IFNG;TNF;HLA-DRB1
Cystitis,5/56,8.752533578116806E-8,1.0712316314536982E-6,0,0,44.642857142857146,725.5061398977721,IL10;IL1B;TNF;IL2;SOD1
Gastrointestinal Diseases,5/56,8.752533578116806E-8,1.0698992538026364E-6,0,0,44.642857142857146,725.5061398977721,TGFB1;IL1B;MTHFR;TNF;TGM2
Hyperbilirubinemia,5/56,8.752533578116806E-8,1.0685701864066083E-6,0,0,44.642857142857146,725.5061398977721,IFNG;HMGB1;TNF;IL2;HLA-DRB1
Migraine Disorders,8/290,9.12261996279463E-8,1.1123710793343128E-6,0,0,13.793103448275861,223.58515454482668,IL10;TGFB1;MTHFR;IL12A;TNF;TLR4;HLA-DRB1;SOD1
Transient Ischemic Attack,7/191,9.266924070528196E-8,1.1285666637565194E-6,0,0,18.32460732984293,296.75289173927166,IL10;IL1B;MTHFR;PRL;HIF1A;TNF;SOD1
Diabetes Mellitus, Experimental,6/113,9.338389975796684E-8,1.1358625826996263E-6,0,0,26.548672566371682,429.7313332575846,IL6;TGFB1;IFNG;IL1B;TNF;SOD1
Streptozotocin Diabetes,6/113,9.338389975796684E-8,1.1344585498409123E-6,0,0,26.548672566371682,429.7313332575846,IL6;TGFB1;IFNG;IL1B;TNF;SOD1
Alloxan Diabetes,6/113,9.338389975796684E-8,1.1330579837299977E-6,0,0,26.548672566371682,429.7313332575846,IL6;TGFB1;IFNG;IL1B;TNF;SOD1
Carotid Artery Diseases,5/57,9.580141182925425E-8,1.160957183055377E-6,0,0,43.859649122807014,708.8152813517911,IL10;IL6;MTHFR;TNF;INS
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,5/57,9.580141182925425E-8,1.1595274328299395E-6,0,0,43.859649122807014,708.8152813517911,IL10;IL6;IL1B;TNF;IL2
Pneumocystis jiroveci pneumonia,5/57,9.580141182925425E-8,1.1581011998252286E-6,0,0,43.859649122807014,708.8152813517911,IL6;TGFB1;IL1B;TNF;SOD1
Rosacea,4/22,9.772705513333525E-8,1.1799281300373697E-6,0,0,90.9090909090909,1467.3715814298284,IL1B;TNF;HLA-DQA1;HLA-DRB1
Shock,4/22,9.772705513333525E-8,1.1784803654606367E-6,0,0,90.9090909090909,1467.3715814298284,IL6;IL1B;TNF;TLR4
Adult Hodgkin Lymphoma,4/22,9.772705513333525E-8,1.1770361493264938E-6,0,0,90.9090909090909,1467.3715814298284,IL6;IFNG;VDR;IL2
Carcinoma, Endometrioid,6/114,9.842810102148565E-8,1.1840286130222288E-6,0,0,26.31578947368421,424.5773551097795,IL6;TGFB1;IL2RA;IRF1;AHR;HIF1A
Mycoplasma Infections,5/58,1.0468648801793198E-7,1.2577735993156914E-6,0,0,43.10344827586207,692.7713698994883,IL6;IL1B;CD14;TNF;TLR4
Pancytopenia,6/116,1.0919122174666868E-7,1.3102946609600243E-6,0,0,25.862068965517242,414.5732369948813,IL6;IFNG;TNFRSF14;TNF;RUNX3;HLA-DRB1
SVEINSSON CHORIORETINAL ATROPHY,5/59,1.1421298065833376E-7,1.3688843584269564E-6,0,0,42.3728813559322,677.3390203463586,IL6;IFNG;TNF;TLR4;HLA-DRB1
Typhoid Fever,4/23,1.181311815265952E-7,1.4141208916484501E-6,0,0,86.95652173913044,1387.0843584450276,IL1B;TNF;TLR4;HLA-DRB1
Cholesteatoma,4/23,1.181311815265952E-7,1.4124005499311164E-6,0,0,86.95652173913044,1387.0843584450276,TGFB1;IL1B;HMGB1;TNF
Chronic arthritis,4/23,1.181311815265952E-7,1.4106843888740919E-6,0,0,86.95652173913044,1387.0843584450276,IL10;CD80;IL1B;TLR4
Chronic glomerulonephritis,4/23,1.181311815265952E-7,1.4089723932565261E-6,0,0,86.95652173913044,1387.0843584450276,IL6;TGFB1;HIF1A;TNF
Enthesitis-Related Arthritis,4/23,1.181311815265952E-7,1.4072645479313668E-6,0,0,86.95652173913044,1387.0843584450276,IL6;IL12A;TNF;TLR4
Granuloma,4/23,1.181311815265952E-7,1.4055608378249123E-6,0,0,86.95652173913044,1387.0843584450276,CXCL10;IFNG;TNF;S100A9
Hemorrhagic Fever with Renal Syndrome,4/23,1.181311815265952E-7,1.4038612479363695E-6,0,0,86.95652173913044,1387.0843584450276,IL6;IL2RA;TNF;HLA-DRB1
Choriocarcinoma,8/300,1.1833104113734702E-7,1.4045380100215537E-6,0,0,13.333333333333334,212.66372942662701,IL6;TGFB1;IFNG;STAT1;VDR;AHR;HIF1A;TNF
Hyperalgesia,6/119,1.2713964116591637E-7,1.5072718858608277E-6,0,0,25.210084033613445,400.285205490658,IL10;IL6;IL1B;HMGB1;TNF;S100A9
Leukemia, Large Granular Lymphocytic,5/61,1.353252885416502E-7,1.6023818503461905E-6,0,0,40.983606557377044,648.1796890185733,IFNG;IL15;IL2RA;TNF;IL2
Malignant neoplasm of skin,8/307,1.4119333936753013E-7,1.6698533565632804E-6,0,0,13.029315960912053,205.51316852922403,IL10;CXCL10;TGFB1;VDR;MTHFR;HIF1A;TNF;S100A9
Candidiasis, Chronic Mucocutaneous,4/24,1.415537028951582E-7,1.6721031154490564E-6,0,0,83.33333333333333,1314.215555508664,IL10;IFNG;STAT1;IL17A
Asymptomatic human immunodeficiency virus infection,4/24,1.415537028951582E-7,1.6700957887798498E-6,0,0,83.33333333333333,1314.215555508664,CXCL10;IL2RA;CD14;IL2
Helminthiasis,4/24,1.415537028951582E-7,1.6680932758436628E-6,0,0,83.33333333333333,1314.215555508664,IL10;TGFB1;IFNG;SOD1
Orchitis,4/24,1.415537028951582E-7,1.6660955593456465E-6,0,0,83.33333333333333,1314.215555508664,IL10;IL12A;IL6R;TLR4
Reticulosarcoma,5/62,1.4698138672175332E-7,1.7279103692600379E-6,0,0,40.32258064516129,634.3935435131143,IL10;IFNG;MTHFR;TNF;HLA-DRB1
Hemolytic-Uremic Syndrome,5/62,1.4698138672175332E-7,1.7258459602167163E-6,0,0,40.32258064516129,634.3935435131143,IL6;IL1B;IL2RA;TNF;HLA-DRB1
Polymyositis, Idiopathic,3/6,1.4758861410674168E-7,1.7309079945597342E-6,0,0,250.0,3932.2092669884314,IL6;IL1B;TNF
Thymic alymphoplasia,3/6,1.4758861410674168E-7,1.7288449337795675E-6,0,0,250.0,3932.2092669884314,IL21;IL15;IL2
Actinic prurigo,3/6,1.4758861410674168E-7,1.7267867850488776E-6,0,0,250.0,3932.2092669884314,IL1B;TNF;HLA-DRB1
Hemodynamic instability,3/6,1.4758861410674168E-7,1.7247335308454901E-6,0,0,250.0,3932.2092669884314,IL6;IFNG;TNF
Lesion of stomach,3/6,1.4758861410674168E-7,1.7226851537304718E-6,0,0,250.0,3932.2092669884314,RUNX3;TLR4;TNF
Localized vitiligo,3/6,1.4758861410674168E-7,1.720641636347636E-6,0,0,250.0,3932.2092669884314,TNF;HLA-DQA1;HLA-DRB1
Polymyositis Ossificans,3/6,1.4758861410674168E-7,1.7186029614230536E-6,0,0,250.0,3932.2092669884314,IL6;IL1B;TNF
Squamous cell carcinoma of skin,7/205,1.501391685915164E-7,1.7462340223874831E-6,0,0,17.073170731707318,268.2485909185417,IL10;IL6;TGFB1;ZMIZ1;STAT1;MTHFR;TNF
Fibroid Tumor,8/310,1.520971492275898E-7,1.7669158186864687E-6,0,0,12.903225806451612,202.56446942719612,IL6;TGFB1;IL1B;AHR;PRL;ETS1;TNF;IL2
Neurodegenerative Disorders,11/745,1.5321918544625055E-7,1.777849060880461E-6,0,0,7.382550335570469,115.84252343435672,IL10;IL6;IL15;IL1B;MTHFR;IL12A;HIF1A;TNF;TGM2;SOD1;IL17A
Rheumatic Fever,5/63,1.5941949513802624E-7,1.847611790349672E-6,0,0,39.68253968253968,621.1002688420189,TGFB1;IL1B;TNF;HLA-DQA1;HLA-DRB1
Inclusion Body Myopathy, Sporadic,5/63,1.5941949513802624E-7,1.8454355691596254E-6,0,0,39.68253968253968,621.1002688420189,CXCL10;IL1B;TLR4;HLA-DRB1;SOD1
Viral hepatitis,5/63,1.5941949513802624E-7,1.8432644684900258E-6,0,0,39.68253968253968,621.1002688420189,CXCL10;TGFB1;IFNG;VDR;TNF
Invasive Pulmonary Aspergillosis,4/25,1.6827412319672593E-7,1.9433584991509076E-6,0,0,80.0,1247.8137201280929,IL10;IL6;IL1B;TNF
Esophagitis,5/64,1.726775640148084E-7,1.991872182086311E-6,0,0,39.0625,608.2749911442048,IL10;IL6;TGFB1;IL1B;TNF
Paroxysmal nocturnal hemoglobinuria,5/65,1.8679469170957865E-7,2.1521901877159893E-6,0,0,38.46153846153846,595.8944510972199,IFNG;CD14;TNF;IL2;HLA-DRB1
Severe Aplastic Anemia,4/26,1.9858358400833406E-7,2.285338950390992E-6,0,0,76.92307692307692,1187.0812113323118,IL6;IFNG;IL1B;HLA-DRB1
Dermatitis Herpetiformis,4/26,1.9858358400833406E-7,2.282666039337903E-6,0,0,76.92307692307692,1187.0812113323118,IFNG;TNF;HLA-DQA1;TGM2
Thyroid Nodule,5/66,2.0181113781176382E-7,2.317055914035064E-6,0,0,37.87878787878788,583.9368764478058,DPP4;IL6;TGFB1;ETS1;IL6R
Uremia,5/67,2.17768336727797E-7,2.4973479735831844E-6,0,0,37.31343283582089,572.3818662223096,IL6;TGFB1;IL15;VDR;MTHFR
Gestational Diabetes,5/67,2.17768336727797E-7,2.494437311609311E-6,0,0,37.31343283582089,572.3818662223096,IL6;TGFB1;IL1B;TNF;INS
Metastatic Renal Cell Cancer,5/67,2.17768336727797E-7,2.491533426496844E-6,0,0,37.31343283582089,572.3818662223096,IL15;CD80;IL2RA;IL2;HLA-DRB1
Pustulosis of Palms and Soles,5/67,2.17768336727797E-7,2.4886362946055683E-6,0,0,37.31343283582089,572.3818662223096,IL6;IL1B;TNF;RUNX3;IL17A
Invasive Ductal Breast Carcinoma,7/218,2.2799710030528086E-7,2.6025034864114986E-6,0,0,16.055045871559635,245.54479468400226,TGFB1;VDR;IRF1;CD14;HIF1A;RUNX3;IL17A
Herpesviridae Infections,4/27,2.3278477479084735E-7,2.6540704949471552E-6,0,0,74.07407407407406,1131.3445573045024,IL10;IFNG;TNF;IL17A
Localized scleroderma,4/27,2.3278477479084735E-7,2.6509950946053854E-6,0,0,74.07407407407406,1131.3445573045024,IL6;TGFB1;IFNG;TNF
Reactive systemic amyloidosis,4/27,2.3278477479084735E-7,2.6479268132458884E-6,0,0,74.07407407407406,1131.3445573045024,IL1B;TLR4;HLA-DRB1;SOD1
precancerous lesions,6/132,2.3537141369640538E-7,2.6742546286800833E-6,0,0,22.727272727272727,346.8659337872246,IL6;TGFB1;VDR;IL1B;TNF;TLR4
Diarrhea,8/329,2.394713709939907E-7,2.717695882365982E-6,0,0,12.1580547112462,185.34750107963578,IL10;IL6;STAT1;IL1B;MTHFR;CD14;TNF;INS
Vesicular Stomatitis,6/133,2.4613162917200494E-7,2.7900595749740077E-6,0,0,22.556390977443606,343.2496097635087,IL6;IFNG;IL15;STAT1;IL2RA;TNF
Diabetic Angiopathies,5/69,2.5267668159360957E-7,2.8609521044953856E-6,0,0,36.231884057971016,550.4041704291177,MTHFR;AHR;HMGB1;TNF;SOD1
Acute Motor Axonal Neuropathy,3/7,2.5792382404323026E-7,2.9170026958537015E-6,0,0,214.28571428571428,3250.843189557368,TLR4;TNF;HLA-DRB1
Arthritis by pattern of joint involvement,3/7,2.5792382404323026E-7,2.913649819191801E-6,0,0,214.28571428571428,3250.843189557368,IL10;IL1B;TNF
Bronchopulmonary Aspergillosis,3/7,2.5792382404323026E-7,2.9103046414430157E-6,0,0,214.28571428571428,3250.843189557368,IFNG;IL15;TLR4
HIV Wasting Syndrome,3/7,2.5792382404323026E-7,2.90696713612026E-6,0,0,214.28571428571428,3250.843189557368,IL6;IL1B;TNF
IgE-mediated allergic asthma,3/7,2.5792382404323026E-7,2.9036372768578086E-6,0,0,214.28571428571428,3250.843189557368,TNFRSF9;TNF;HLA-DRB1
Addison's disease due to autoimmunity,4/28,2.7119184384888276E-7,3.0495119466210756E-6,0,0,71.42857142857142,1080.031382545424,IL2RA;IL2;HLA-DRB1;TGM2
Familial Hypophosphatemic Rickets,4/28,2.7119184384888276E-7,3.0460267901106514E-6,0,0,71.42857142857142,1080.031382545424,IFNG;VDR;TNF;IL17A
Hepatitis C Virus Infection,4/28,2.7119184384888276E-7,3.0425495905785614E-6,0,0,71.42857142857142,1080.031382545424,IL10;IFNG;IL15;VDR
Stromal Neoplasm,5/70,2.717166862302662E-7,3.044961906808502E-6,0,0,35.71428571428571,539.9466395796021,DPP4;IL6;IL15;TNFRSF9;HIF1A
Spontaneous abortion,6/138,3.0618583282454786E-7,3.4273284339403835E-6,0,0,21.73913043478261,326.0668178806928,CXCL10;IL6;TGFB1;IL1B;MTHFR;AHR
Ureteral obstruction,6/138,3.0618583282454786E-7,3.4234293117174706E-6,0,0,21.73913043478261,326.0668178806928,TGFB1;IFNG;IL1B;HMGB1;HIF1A;TLR4
West Nile viral infection,5/72,3.131996823250256E-7,3.497870997602672E-6,0,0,34.72222222222222,520.0147530249371,IL10;STAT1;IL1B;CD14;TNF
Upper Respiratory Infections,4/29,3.141303096428231E-7,3.5042822737453636E-6,0,0,68.9655172413793,1032.652271604405,IL10;IL6;IL1B;CD14
Autoinflammatory disorder,4/29,3.141303096428231E-7,3.5003091645914572E-6,0,0,68.9655172413793,1032.652271604405,IL6;STAT1;IL1B;TNF
Erythema Nodosum,4/29,3.141303096428231E-7,3.496345054552282E-6,0,0,68.9655172413793,1032.652271604405,IL10;TNF;IL2;HLA-DRB1
Intermittent Claudication,4/29,3.141303096428231E-7,3.4923899130878567E-6,0,0,68.9655172413793,1032.652271604405,IL6;MTHFR;HIF1A;TNF
Liver Cirrhosis, Experimental,11/801,3.1662442064354046E-7,3.5161410238245374E-6,0,0,6.866416978776529,102.75970358461356,IL10;CXCL10;TGFB1;IFNG;IL1B;TNF;S100A9;TLR4;HLA-DQA1;HLA-DRB1;INS
Mammary Neoplasms, Human,9/476,3.2243815833189753E-7,3.5766616479524706E-6,0,0,9.45378151260504,141.30902340953625,IL6;IFNG;VDR;IL1B;MTHFR;AHR;HIF1A;TNF;TGM2
Thyroid Neoplasm,9/476,3.2243815833189753E-7,3.5726293349333585E-6,0,0,9.45378151260504,141.30902340953625,DPP4;CXCL10;IL6;TGFB1;IL1B;ETS1;HIF1A;TNF;IL2
Urinary tract infection,5/73,3.357389253871258E-7,3.715813241784541E-6,0,0,34.24657534246575,510.5113694105008,IL10;IL6;TGFB1;HIF1A;TLR4
Hyperlipidemia,7/232,3.474557700539844E-7,3.841164576029875E-6,0,0,15.086206896551724,224.37155005008222,IL6;TGFB1;IL1B;AHR;HIF1A;TNF;IL17A
Metastasis from malignant tumor of prostate,7/232,3.474557700539844E-7,3.836848660775909E-6,0,0,15.086206896551724,224.37155005008222,DPP4;IL6;TGFB1;IL1B;AHR;HIF1A;TNF
Hemorrhagic Fevers, Viral,4/30,3.61936972167105E-7,3.992274480873522E-6,0,0,66.66666666666667,988.7863833543449,IL10;IL6;IL1B;TNF
Acute Chest Syndrome,4/30,3.61936972167105E-7,3.9877988368366676E-6,0,0,66.66666666666667,988.7863833543449,IL6;IL1B;MTHFR;TLR4
Tumor Initiation,7/234,3.681935214817873E-7,4.052190290171339E-6,0,0,14.957264957264957,221.58675244414763,TGFB1;AHR;HMGB1;ETS1;HIF1A;TNF;TGM2
Proliferative diabetic retinopathy,5/75,3.846629838995892E-7,4.228711192131054E-6,0,0,33.333333333333336,492.3632750836729,IL10;IL6;MTHFR;HMGB1;TNF
Inflammatory pain,5/76,4.111516639976629E-7,4.514858719295006E-6,0,0,32.89473684210526,483.6941999460084,IL6;IL1B;TNF;S100A9;TLR4
Primary infection NOS,5/76,4.111516639976629E-7,4.509819814474364E-6,0,0,32.89473684210526,483.6941999460084,IL6;IL1B;TNF;TLR4;IL2
Bronchiolitis, Viral,3/8,4.1210829690278975E-7,4.515273513891435E-6,0,0,187.5,2756.6211872957715,IL15;VDR;IL17A
Sensory denervation disorder,3/8,4.1210829690278975E-7,4.510245369666612E-6,0,0,187.5,2756.6211872957715,TGFB1;IFNG;STAT1
Multiple Sclerosis, Secondary Progressive,3/8,4.1210829690278975E-7,4.505228411524602E-6,0,0,187.5,2756.6211872957715,IFNG;IL2RA;TNF
Chronic iridocyclitis,3/8,4.1210829690278975E-7,4.500222602178463E-6,0,0,187.5,2756.6211872957715,IL6;HLA-DQA1;HLA-DRB1
Chronic pelvic pain of female,3/8,4.1210829690278975E-7,4.495227904506789E-6,0,0,187.5,2756.6211872957715,IL10;IL6;TNF
fertility disorders,3/8,4.1210829690278975E-7,4.4902442815527905E-6,0,0,187.5,2756.6211872957715,IL10;IL6;TLR4
Intestinal Graft Versus Host Disease,3/8,4.1210829690278975E-7,4.485271696523386E-6,0,0,187.5,2756.6211872957715,CXCL10;IL1B;TNF
Nephropathia Epidemica,3/8,4.1210829690278975E-7,4.480310112788293E-6,0,0,187.5,2756.6211872957715,IL1B;TNF;HLA-DRB1
Pulmonary Aspergillosis,3/8,4.1210829690278975E-7,4.475359493879135E-6,0,0,187.5,2756.6211872957715,IFNG;IL15;TLR4
Aggressive periodontitis, generalized,4/31,4.149598252892041E-7,4.501352276978254E-6,0,0,64.51612903225806,948.0699437376649,VDR;IL1B;TNF;TLR4
Invasive aspergillosis,4/31,4.149598252892041E-7,4.4963893747985645E-6,0,0,64.51612903225806,948.0699437376649,CXCL10;IFNG;IL1B;TLR4
Monosomy,6/147,4.4450083479369375E-7,4.811183044440994E-6,0,0,20.408163265306122,298.49620212128895,IL10;STAT1;VDR;IL1B;IL2;SOD1
Meningioma, benign, no ICD-O subtype,7/241,4.4918384161163806E-7,4.856522327127809E-6,0,0,14.522821576763485,212.26314336816745,IL6;TGFB1;MTHFR;RUNX3;TLR4;HLA-DRB1;TGM2
Chondrosarcoma,7/241,4.4918384161163806E-7,4.85118548940569E-6,0,0,14.522821576763485,212.26314336816745,IL6;TGFB1;IL1B;MTHFR;HMGB1;HIF1A;TNF
Metastatic Prostate Carcinoma,7/241,4.4918384161163806E-7,4.84586036812204E-6,0,0,14.522821576763485,212.26314336816745,DPP4;IL6;TGFB1;IL1B;AHR;HIF1A;TNF
Giant Cell Glioblastoma,5/78,4.684517084910941E-7,5.048183542818501E-6,0,0,32.05128205128205,467.11002620002273,IL1B;HIF1A;RUNX3;IL2;TGM2
Hyper-IgM Immunodeficiency Syndrome, Type 1,4/32,4.7355796896363487E-7,5.09762072176846E-6,0,0,62.5,910.1869690800154,IL10;CD80;IL2RA;TNF
African Trypanosomiasis,4/32,4.7355796896363487E-7,5.0920434562085385E-6,0,0,62.5,910.1869690800154,IL10;CXCL10;IL6;TNF
Hypereosinophilia,4/32,4.7355796896363487E-7,5.0864783813930095E-6,0,0,62.5,910.1869690800154,IL6;IFNG;IL2RA;IL2
Idiopathic Hypereosinophilic Syndrome,4/32,4.7355796896363487E-7,5.080925457395856E-6,0,0,62.5,910.1869690800154,TGFB1;IL2RA;IL2;IL17A
Malignant Squamous Cell Neoplasm,6/151,5.205906818152446E-7,5.579460437164911E-6,0,0,19.867549668874172,287.44970351283945,IL10;TGFB1;IFNG;MTHFR;ETS1;IL2
Malignant neoplasm of thyroid,9/505,5.292586734745759E-7,5.666181092492518E-6,0,0,8.91089108910891,128.7783137123327,DPP4;IL10;TGFB1;VDR;MTHFR;AHR;HIF1A;TNF;IL2
Dementia, Vascular,5/80,5.318898452896021E-7,5.688153862357138E-6,0,0,31.25,451.46341958657774,IL6;TGFB1;IL1B;MTHFR;TNF
Desmoplastic,5/80,5.318898452896021E-7,5.681971086419793E-6,0,0,31.25,451.46341958657774,TGFB1;IFNG;TNF;IL2;TGM2
Pneumonia, Interstitial,4/33,5.38101522087632E-7,5.742086600518184E-6,0,0,60.60606060606061,874.8617328376752,IL6;IFNG;IL2RA;TNF
Anemia of chronic disease,4/33,5.38101522087632E-7,5.735858740864694E-6,0,0,60.60606060606061,874.8617328376752,CXCL10;IL6;IL1B;TNF
Echinococcosis,4/33,5.38101522087632E-7,5.729644376031688E-6,0,0,60.60606060606061,874.8617328376752,IL21;IL10;TGFB1;IL2
Fulminant hepatitis,4/33,5.38101522087632E-7,5.723443462204814E-6,0,0,60.60606060606061,874.8617328376752,IL10;CXCL10;IFNG;TNF
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma,4/33,5.38101522087632E-7,5.717255955759186E-6,0,0,60.60606060606061,874.8617328376752,IL2RA;TNF;TLR4;HLA-DQA1
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder),7/249,5.596200703046798E-7,5.939466577704529E-6,0,0,14.056224899598392,202.3535223001042,IL6;IFNG;STAT1;IL1B;MTHFR;HIF1A;TNF
Hyperlipoproteinemia Type IIa,6/153,5.624609918850143E-7,5.963178671246948E-6,0,0,19.6078431372549,282.17537358887205,IL10;IL6;IL1B;MTHFR;CD14;TNF
Brain Diseases,7/250,5.74905364953883E-7,6.088545179705563E-6,0,0,14.0,201.16684549336446,IL10;IL6;TGFB1;IFNG;HMGB1;TNF;TLR4
Invasive Carcinoma,6/154,5.844091331064044E-7,6.182532788126742E-6,0,0,19.48051948051948,279.59736095484516,IL10;IL6;TGFB1;STAT1;PRL;TNF
Small cell carcinoma of lung,10/673,5.919242253976913E-7,6.255302459363989E-6,0,0,7.429420505200594,106.53705206459017,IL6;TGFB1;IFNG;IL15;IL2RA;MTHFR;AHR;HIF1A;TNF;IL2
Osteoporosis, Age-Related,5/82,6.019341785889964E-7,6.354252531871812E-6,0,0,30.48780487804878,436.6804187654709,IL6;TGFB1;VDR;MTHFR;IL6R
Focal glomerulosclerosis,6/155,6.070549368204547E-7,6.401433389561619E-6,0,0,19.35483870967742,277.05767505507123,IL10;IL6;TGFB1;CD80;IL1B;TNF
Biliary Cirrhosis, Secondary,4/34,6.089715357670421E-7,6.41476125779045E-6,0,0,58.8235294117647,841.8526064486829,CXCL10;CD80;IL12A;HIF1A
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,4/34,6.089715357670421E-7,6.407893205051916E-6,0,0,58.8235294117647,841.8526064486829,TGFB1;IL1B;HMGB1;HLA-DRB1
Malignant neoplasm of vulva,4/34,6.089715357670421E-7,6.401039843335284E-6,0,0,58.8235294117647,841.8526064486829,IL10;IL1B;TNF;IL2
Arthritis, Bacterial,3/9,6.173082690121319E-7,6.4817368246273845E-6,0,0,166.66666666666666,2382.982885364151,CXCL10;IFNG;TNF
Chronic periaortitis,3/9,6.173082690121319E-7,6.474819282658732E-6,0,0,166.66666666666666,2382.982885364151,TLR4;TNF;HLA-DRB1
Disturbance in mood,3/9,6.173082690121319E-7,6.467916490246516E-6,0,0,166.66666666666666,2382.982885364151,IL10;IL6;IFNG
Gram-Negative Bacterial Infections,3/9,6.173082690121319E-7,6.4610284002675525E-6,0,0,166.66666666666666,2382.982885364151,IL6;CD14;TLR4
Left sided colitis,3/9,6.173082690121319E-7,6.454154965799183E-6,0,0,166.66666666666666,2382.982885364151,IL10;VDR;HLA-DRB1
Luft Disease,3/9,6.173082690121319E-7,6.447296140118206E-6,0,0,166.66666666666666,2382.982885364151,IL6;IL1B;TNF
Megaconial Myopathies,3/9,6.173082690121319E-7,6.440451876699821E-6,0,0,166.66666666666666,2382.982885364151,IL6;IL1B;TNF
neurological disability,3/9,6.173082690121319E-7,6.433622129216577E-6,0,0,166.66666666666666,2382.982885364151,IL10;IL6;IL17A
Organ dysfunction syndrome,3/9,6.173082690121319E-7,6.426806851537322E-6,0,0,166.66666666666666,2382.982885364151,IL10;IL6;TLR4
Pleoconial Myopathies,3/9,6.173082690121319E-7,6.4200059977261715E-6,0,0,166.66666666666666,2382.982885364151,IL6;IL1B;TNF
Lymphoma, Large-Cell, Follicular,5/83,6.395858691517514E-7,6.64466165118754E-6,0,0,30.12048192771084,429.59171534606463,IL10;MTHFR;CD14;TNF;IL2
Hyperalgesia, Secondary,5/84,6.790744889714373E-7,7.047459427255846E-6,0,0,29.76190476190476,422.69449438899943,IL10;IL6;IL1B;HMGB1;TNF
Situs Inversus,5/84,6.790744889714373E-7,7.040025398324141E-6,0,0,29.76190476190476,422.69449438899943,IL10;IL6;TNF;IL2;IL17A
Allodynia,5/84,6.790744889714373E-7,7.032607036471323E-6,0,0,29.76190476190476,422.69449438899943,IL10;IL6;IL1B;HMGB1;TNF
Chronic sinusitis,5/84,6.790744889714373E-7,7.025204292222406E-6,0,0,29.76190476190476,422.69449438899943,IL6;IFNG;AHR;TNF;IL17A
COLORBLINDNESS, PARTIAL, DEUTAN SERIES,4/35,6.865599069041891E-7,7.095174306050863E-6,0,0,57.14285714285714,810.9469915028966,TGFB1;TNF;IL2;HLA-DRB1
Hepatitis B Virus-Related Hepatocellular Carcinoma,4/35,6.865599069041891E-7,7.087721391863835E-6,0,0,57.14285714285714,810.9469915028966,TLR4;HLA-DQA1;IL2;IL17A
HTLV-I Infections,4/35,6.865599069041891E-7,7.08028411862998E-6,0,0,57.14285714285714,810.9469915028966,IL10;IL6;TNF;IL2
Pre-renal acute kidney injury,4/35,6.865599069041891E-7,7.072862437163911E-6,0,0,57.14285714285714,810.9469915028966,IL6;HIF1A;SOD1;IL17A
Neuroendocrine Tumors,7/257,6.920606627964412E-7,7.12206512456903E-6,0,0,13.618677042801556,193.1617617805291,IL6;IL1B;IL12A;HIF1A;TNF;IL2;INS
Hyperalgesia, Primary,5/85,7.20464703977907E-7,7.406618316626433E-6,0,0,29.41176470588235,415.98145326294406,IL10;IL6;IL1B;HMGB1;TNF
Prostatic Hyperplasia,5/85,7.20464703977907E-7,7.398878903547408E-6,0,0,29.41176470588235,415.98145326294406,TGFB1;VDR;HMGB1;PRL;HIF1A
Glaucoma,8/381,7.273805478694765E-7,7.4621044096672395E-6,0,0,10.498687664041995,148.38652017586054,IL6;TGFB1;IL1B;MTHFR;TNF;TLR4;HLA-DRB1;TGM2
Malignant Pleural Mesothelioma,7/260,7.480831551726102E-7,7.66648722527259E-6,0,0,13.461538461538462,189.88511897295774,DPP4;CXCL10;IL6;STAT1;IL2RA;HIF1A;TNF
Familial multiple trichoepitheliomata,6/161,7.585599366370352E-7,7.765757351321648E-6,0,0,18.633540372670808,262.58094449670557,VDR;IL1B;AHR;TNF;RUNX3;S100A9
Recurrent urinary tract infection,5/86,7.63822577468413E-7,7.811496661144186E-6,0,0,29.069767441860463,409.4456483486505,IL10;IL6;TGFB1;HIF1A;TLR4
Paranoid Schizophrenia,4/36,7.712692921974454E-7,7.879453850017145E-6,0,0,55.55555555555555,781.9571248802913,IL6;IFNG;TNF;IL2
pricking of skin,4/36,7.712692921974454E-7,7.87127165494963E-6,0,0,55.55555555555555,781.9571248802913,IL2RA;CD14;HLA-DRB1;IL17A
Nephritis,6/162,7.865852960659464E-7,8.019253412589338E-6,0,0,18.518518518518515,260.28823463239195,CXCL10;TGFB1;IL1B;TNF;HLA-DRB1;IL17A
Invasive carcinoma of breast,8/385,7.868398899520046E-7,8.013536205645907E-6,0,0,10.38961038961039,146.02847847006333,IL6;TGFB1;VDR;IRF1;ETS1;HIF1A;TNF;TLR4
Chronic active hepatitis,5/87,8.092155803405715E-7,8.23288894781277E-6,0,0,28.735632183908045,403.0804735009631,TGFB1;IFNG;STAT1;IL1B;SOD1
Cervical intraepithelial neoplasia grade 1,4/37,8.635130224011378E-7,8.776221286616735E-6,0,0,54.054054054054056,754.7165869471596,IL10;IFNG;MTHFR;HLA-DRB1
Bone Diseases,6/165,8.757977381737486E-7,8.8918803417062E-6,0,0,18.18181818181818,253.6023757302821,IL6;VDR;IL1B;HIF1A;TNF;IL17A
Schistosomiasis japonica,3/10,8.806497495378952E-7,8.93191510676825E-6,0,0,150.0,2091.390877526115,IL10;TGFB1;IFNG
Schnitzler Syndrome,3/10,8.806497495378952E-7,8.922706946864364E-6,0,0,150.0,2091.390877526115,IL6;IL1B;TNF
Pancreatitis, Acute Necrotizing,3/10,8.806497495378952E-7,8.913517753304257E-6,0,0,150.0,2091.390877526115,IL10;TGFB1;IL1B
Tuberculoid leprosy,3/10,8.806497495378952E-7,8.90434746754983E-6,0,0,150.0,2091.390877526115,VDR;TNF;HLA-DRB1
Gangrene,3/10,8.806497495378952E-7,8.895196031303632E-6,0,0,150.0,2091.390877526115,IL6;CD14;TLR4
Invasive meningococcal disease,3/10,8.806497495378952E-7,8.886063386507632E-6,0,0,150.0,2091.390877526115,IL6;CD14;TLR4
Osteitis,3/10,8.806497495378952E-7,8.876949475341983E-6,0,0,150.0,2091.390877526115,IL1B;TNF;IL17A
Pressure Ulcer,3/10,8.806497495378952E-7,8.867854240223805E-6,0,0,150.0,2091.390877526115,IL10;VDR;HIF1A
Primary bacterial peritonitis,3/10,8.806497495378952E-7,8.85877762380597E-6,0,0,150.0,2091.390877526115,IFNG;TNF;SOD1
Proliferative glomerulonephritis,3/10,8.806497495378952E-7,8.849719568975903E-6,0,0,150.0,2091.390877526115,CXCL10;IL6;IFNG
Memory impairment,7/267,8.937878310405542E-7,8.97257079005778E-6,0,0,13.108614232209739,182.57412342280756,IL10;IL6;IL1B;TNF;S100A9;INS;SOD1
Adenomatous Polyposis Coli,8/392,9.009267632017692E-7,9.0350083966806E-6,0,0,10.204081632653061,142.03920271986323,IL10;TGFB1;IRF1;MTHFR;HIF1A;TNF;RUNX3;HLA-DRB1
Tactile Allodynia,5/89,9.063839569396922E-7,9.080470467689393E-6,0,0,28.089887640449437,390.8371580659235,IL10;IL6;IL1B;HMGB1;TNF
Cerebral Palsy,5/89,9.063839569396922E-7,9.071223552752844E-6,0,0,28.089887640449437,390.8371580659235,IL10;IL6;IL1B;MTHFR;TNF
Follicular thyroid carcinoma,6/167,9.397524124671689E-7,9.395612115694136E-6,0,0,17.964071856287426,249.29909079104615,DPP4;IL6;TGFB1;VDR;IL1B;ETS1
Hereditary hemochromatosis,6/167,9.397524124671689E-7,9.3860637293977E-6,0,0,17.964071856287426,249.29909079104615,IL6;TGFB1;IL1B;CD14;TNF;S100A9
Skin carcinoma,5/90,9.583014008946542E-7,9.561610322835189E-6,0,0,27.777777777777775,384.94731927066107,IL10;ZMIZ1;VDR;MTHFR;TNF
Takayasu Arteritis,4/38,9.637150172552146E-7,9.605873417428243E-6,0,0,52.63157894736842,729.0773795418711,IL6;MTHFR;TNF;HLA-DRB1
Coffin-Siris syndrome,4/38,9.637150172552146E-7,9.59614102288171E-6,0,0,52.63157894736842,729.0773795418711,IL10;TGFB1;TNF;HLA-DRB1
Idiopathic Membranous Glomerulonephritis,4/38,9.637150172552146E-7,9.586428329538714E-6,0,0,52.63157894736842,729.0773795418711,IL10;TNF;HLA-DQA1;HLA-DRB1
Lipoid nephrosis,4/38,9.637150172552146E-7,9.576735277638269E-6,0,0,52.63157894736842,729.0773795418711,CD80;IL1B;TLR4;IL17A
Ataxia Telangiectasia,8/396,9.722585443839115E-7,9.651875731520286E-6,0,0,10.101010101010102,139.83478864334444,CXCL10;IFNG;ETS1;HIF1A;S100A9;IL2;HLA-DRB1;SOD1
Childhood Leukemia,6/168,9.731351679329092E-7,9.650829899540496E-6,0,0,17.857142857142854,247.19183652981894,TGFB1;IFNG;IL15;IL2RA;MTHFR;HMGB1
Juvenile-Onset Still Disease,6/168,9.731351679329092E-7,9.641101240367572E-6,0,0,17.857142857142854,247.19183652981894,IL6;ZMIZ1;IL2RA;CD14;FUT2;HLA-DRB1
Rhabdomyosarcoma,8/397,9.908276593130979E-7,9.80649973386619E-6,0,0,10.075566750629722,139.29194179928717,TGFB1;IFNG;IL15;STAT1;HMGB1;HIF1A;TNF;HLA-DRB1
Osteoarthritis, Knee,5/93,1.1282695726135684E-6,1.1155566760207395E-5,0,0,26.881720430107528,368.14046910287107,IL6;TGFB1;VDR;IL1B;TNF
Subarachnoid Hemorrhage,5/93,1.1282695726135684E-6,1.1144355135322764E-5,0,0,26.881720430107528,368.14046910287107,IL6;IL1B;HMGB1;TNF;SOD1
Pregnancy Complications,5/93,1.1282695726135684E-6,1.1133166023741115E-5,0,0,26.881720430107528,368.14046910287107,IL10;IL6;MTHFR;HIF1A;TNF
Essential Hypertension,7/278,1.170582735347529E-6,1.1539104436304427E-5,0,0,12.589928057553957,171.95334906697016,IL6;TGFB1;VDR;MTHFR;TNF;HLA-DRB1;INS
Pneumonia, Bacterial,4/40,1.18974191539574E-6,1.1716215976462257E-5,0,0,50.0,682.0887076090468,IL10;IL6;HMGB1;IL17A
AIDS Dementia Complex,4/40,1.18974191539574E-6,1.1704488032541876E-5,0,0,50.0,682.0887076090468,CXCL10;IL6;TGFB1;TNF
Aspirin exacerbated respiratory disease,4/40,1.18974191539574E-6,1.1692783544509334E-5,0,0,50.0,682.0887076090468,IL10;IL1B;TNF;IL17A
Osteoarthritis of the hand,4/40,1.18974191539574E-6,1.1681102442067265E-5,0,0,50.0,682.0887076090468,IL6;TGFB1;VDR;IL1B
Polyglandular Type I Autoimmune Syndrome,4/40,1.18974191539574E-6,1.1669444655198935E-5,0,0,50.0,682.0887076090468,CXCL10;TNF;HLA-DRB1;IL17A
Yersinia infections,3/11,1.2092186606396902E-6,1.1848655031671859E-5,0,0,136.36363636363635,1858.0276557191985,IL10;IL6;TNF
Cerebral abscess,3/11,1.2092186606396902E-6,1.1836853582437127E-5,0,0,136.36363636363635,1858.0276557191985,IL1B;TLR4;TNF
Chills,3/11,1.2092186606396902E-6,1.1825075618673508E-5,0,0,136.36363636363635,1858.0276557191985,IL6;IFNG;TNF
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,8/408,1.2159632800871358E-6,1.1879211845622635E-5,0,0,9.80392156862745,133.52915658993146,IFNG;ZMIZ1;IL15;STAT1;ETS1;HIF1A;TNF;IL2
Ovarian Failure, Premature,6/175,1.2350618815637436E-6,1.2053811491567498E-5,0,0,17.142857142857142,233.21810541617617,MTHFR;AHR;PRL;TNF;IL2;HLA-DRB1
Liver Failure,6/176,1.2767852145000516E-6,1.2448655841375503E-5,0,0,17.045454545454543,231.32667938250094,IL1B;IL12A;TNF;TLR4;HLA-DRB1;IL17A
Mucosa-Associated Lymphoid Tissue Lymphoma,6/176,1.2767852145000516E-6,1.2436318224089699E-5,0,0,17.045454545454543,231.32667938250094,TGFB1;CD14;TNF;CCR4;TLR4;HLA-DQA1
TNF receptor-associated periodic fever syndrome (TRAPS),4/41,1.3164668411127082E-6,1.2810134766787818E-5,0,0,48.78048780487805,660.515075389294,IL10;IL6;CD14;TNF
AIDS related complex,4/41,1.3164668411127082E-6,1.2797464010341936E-5,0,0,48.78048780487805,660.515075389294,IL6;IL1B;MTHFR;TNF
Gastrointestinal mucositis,4/41,1.3164668411127082E-6,1.2784818294916697E-5,0,0,48.78048780487805,660.515075389294,TGFB1;MTHFR;HMGB1;TNF
Diffuse Scleroderma,4/42,1.4529499083265235E-6,1.4096339288285362E-5,0,0,47.61904761904761,640.0911737440584,IL10;IL6;HLA-DQA1;HLA-DRB1
Disease due to Parvoviridae,4/42,1.4529499083265235E-6,1.408243757301092E-5,0,0,47.61904761904761,640.0911737440584,TGFB1;IFNG;IL2;HLA-DRB1
Other ureteric obstruction,4/42,1.4529499083265235E-6,1.406856325027889E-5,0,0,47.61904761904761,640.0911737440584,IFNG;IL1B;IRF1;TNF
Cardiomyopathy, Dilated,8/419,1.4834411383427839E-6,1.43496648697174E-5,0,0,9.546539379474941,128.1254995280254,IL10;IL1B;IL2RA;IRF1;TNF;CCR4;TLR4;TGM2
Epilepsy, Temporal Lobe,6/181,1.5030867215632664E-6,1.4525404424310503E-5,0,0,16.574585635359114,222.23187430740998,VDR;IL1B;HMGB1;TNF;IL2;SOD1
insulinoma,6/181,1.5030867215632664E-6,1.4511135854149098E-5,0,0,16.574585635359114,222.23187430740998,TGFB1;STAT1;IL1B;PRL;INS;TGM2
Fanconi Anemia,7/290,1.5512430412352831E-6,1.4961350941374252E-5,0,0,12.068965517241379,161.43996190417116,IL6;IFNG;STAT1;IL1B;MTHFR;HIF1A;TNF
Nephrotic Syndrome,6/182,1.5520585004321045E-6,1.4954540139457571E-5,0,0,16.483516483516485,220.48233697807,TGFB1;CD80;IL1B;TNF;IL2;HLA-DRB1
Carcinoma of urinary bladder, superficial,4/43,1.599666716048022E-6,1.5398163061038156E-5,0,0,46.51162790697674,620.7309419947208,IL6;TNF;S100A9;IL2
CATARACT, ANTERIOR POLAR,4/43,1.599666716048022E-6,1.538309636528372E-5,0,0,46.51162790697674,620.7309419947208,IL10;IL6;TNF;TGM2
Malignant neoplasm of endometrium,9/577,1.6001347737150053E-6,1.5372555773285505E-5,0,0,7.79896013864818,104.08041966052598,IL6;TGFB1;IL1B;MTHFR;AHR;PRL;HIF1A;IL6R;IL17A
Arthritis, Infectious,3/12,1.6100609803032776E-6,1.5452811830488878E-5,0,0,125.0,1667.4048129650512,CXCL10;IFNG;TNF
Senile dementia,3/12,1.6100609803032776E-6,1.5437735916507913E-5,0,0,125.0,1667.4048129650512,IL1B;MTHFR;AHR
Small Fiber Neuropathy,3/12,1.6100609803032776E-6,1.54226893902735E-5,0,0,125.0,1667.4048129650512,IL10;IL6;TNF
Myasthenia Gravis, Ocular,3/12,1.6100609803032776E-6,1.5407672165940224E-5,0,0,125.0,1667.4048129650512,TNF;HLA-DQA1;HLA-DRB1
Acute viral hepatitis,3/12,1.6100609803032776E-6,1.5392684157996702E-5,0,0,125.0,1667.4048129650512,IL10;TNF;HLA-DRB1
Brain Abscess,3/12,1.6100609803032776E-6,1.5377725281263957E-5,0,0,125.0,1667.4048129650512,IL1B;TLR4;TNF
Carditis,3/12,1.6100609803032776E-6,1.5362795450893796E-5,0,0,125.0,1667.4048129650512,IL10;IL6;TNF
Complicated pneumoconiosis,3/12,1.6100609803032776E-6,1.5347894582367226E-5,0,0,125.0,1667.4048129650512,IL6;IL1B;TNF
Congenital laryngeal adductor palsy,3/12,1.6100609803032776E-6,1.5333022591492842E-5,0,0,125.0,1667.4048129650512,TGFB1;IL1B;TNF
Eye Infections,3/12,1.6100609803032776E-6,1.531817939440524E-5,0,0,125.0,1667.4048129650512,IL10;IFNG;IL17A
Immediate hypersensitivity,3/12,1.6100609803032776E-6,1.5303364907563455E-5,0,0,125.0,1667.4048129650512,IL10;CD14;TNF
Infarction,3/12,1.6100609803032776E-6,1.5288579047749382E-5,0,0,125.0,1667.4048129650512,MTHFR;PRL;TNF
Oligoarticular Arthritis,3/12,1.6100609803032776E-6,1.5273821732066226E-5,0,0,125.0,1667.4048129650512,IL10;TNF;HLA-DRB1
Pseudorabies,3/12,1.6100609803032776E-6,1.5259092877936943E-5,0,0,125.0,1667.4048129650512,IL1B;TNFRSF14;TNF
Uterine Corpus Cancer,9/579,1.6464245388916884E-6,1.5588690142801076E-5,0,0,7.772020725388601,103.49925829587869,IL6;TGFB1;IL1B;MTHFR;AHR;PRL;HIF1A;IL6R;IL17A
Hypertension, Portal,5/101,1.6996243835614124E-6,1.6076908990992838E-5,0,0,24.752475247524753,328.83919015251405,IL6;IL1B;IL12A;PRL;TNF
CARCINOMA OF VULVA,4/44,1.7571029492151712E-6,1.6604622870083367E-5,0,0,45.45454545454545,602.3565525785407,IL10;IL1B;TNF;IL2
Endometriosis of uterus,4/44,1.7571029492151712E-6,1.658867222371441E-5,0,0,45.45454545454545,602.3565525785407,IL10;IL6;TNF;TLR4
Muscle damage,4/44,1.7571029492151712E-6,1.657275219278954E-5,0,0,45.45454545454545,602.3565525785407,IL10;IL6;IL15;HLA-DRB1
Adenocarcinoma Of Esophagus,7/299,1.9005172004373947E-6,1.7908229190698672E-5,0,0,11.705685618729095,154.20349746914022,IL6;VDR;IRF1;MTHFR;TNF;RUNX3;TLR4
Seizures,12/1174,1.905129742329253E-6,1.7934497229513312E-5,0,0,5.110732538330494,67.31325610985596,IL10;CXCL10;IL6;IFNG;IL1B;MTHFR;HMGB1;TNF;TLR4;INS;TGM2;SOD1
Medulloblastoma,9/590,1.922307520177613E-6,1.8078888333306775E-5,0,0,7.627118644067797,100.38801554330654,IL6;IFNG;IRF1;AHR;HMGB1;PRL;HIF1A;TNF;S100A9
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA,4/45,1.92575429553883E-6,1.8093989690779753E-5,0,0,44.44444444444444,584.8974588949394,IFNG;HIF1A;TNF;IL17A
Ischemia,5/104,1.9646695724033077E-6,1.844199862233019E-5,0,0,24.03846153846154,315.86986738751693,IL10;IL6;HMGB1;HIF1A;SOD1
Leukoencephalopathy, Progressive Multifocal,5/105,2.0598950316406435E-6,1.9317412567713972E-5,0,0,23.809523809523807,311.73465552322165,CXCL10;IFNG;STAT1;HIF1A;TNF
Carotid Atherosclerosis,5/105,2.0598950316406435E-6,1.9298997493769537E-5,0,0,23.809523809523807,311.73465552322165,IL6;STAT1;MTHFR;CD14;TLR4
refractory plasma cell neoplasm,3/13,2.090182883227479E-6,1.9564111787009202E-5,0,0,115.38461538461539,1509.0298836783702,MTHFR;HIF1A;TNF
Hypothermia, Accidental,3/13,2.090182883227479E-6,1.954549702793498E-5,0,0,115.38461538461539,1509.0298836783702,IL12A;TNF;SOD1
Pemphigoid, Benign Mucous Membrane,3/13,2.090182883227479E-6,1.952691765813656E-5,0,0,115.38461538461539,1509.0298836783702,TGFB1;IFNG;IL1B
Reticuloendotheliosis, X-linked,3/13,2.090182883227479E-6,1.9508373576789803E-5,0,0,115.38461538461539,1509.0298836783702,IFNG;TNF;IL2
American cutaneous leishmaniasis,3/13,2.090182883227479E-6,1.948986468345319E-5,0,0,115.38461538461539,1509.0298836783702,IFNG;TNF;HLA-DRB1
Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site,3/13,2.090182883227479E-6,1.9471390878066033E-5,0,0,115.38461538461539,1509.0298836783702,IL10;IL1B;TLR4
Folliculitis,3/13,2.090182883227479E-6,1.945295206094665E-5,0,0,115.38461538461539,1509.0298836783702,IL10;IFNG;HLA-DRB1
Heymann Nephritis,3/13,2.090182883227479E-6,1.9434548132790598E-5,0,0,115.38461538461539,1509.0298836783702,IFNG;HLA-DQA1;HLA-DRB1
Idiopathic achalasia of esophagus,3/13,2.090182883227479E-6,1.9416178994668868E-5,0,0,115.38461538461539,1509.0298836783702,TNF;HLA-DQA1;HLA-DRB1
Immune Reconstitution Inflammatory Syndrome,3/13,2.090182883227479E-6,1.9397844548026122E-5,0,0,115.38461538461539,1509.0298836783702,IL10;IL1B;CD14
Insulin-dependent diabetes mellitus secretory diarrhea syndrome,3/13,2.090182883227479E-6,1.9379544694678927E-5,0,0,115.38461538461539,1509.0298836783702,IL10;IL2RA;IL2
Polymorphous light eruption,3/13,2.090182883227479E-6,1.9361279336814008E-5,0,0,115.38461538461539,1509.0298836783702,IL1B;TNF;HLA-DRB1
Hematopoietic Neoplasms,6/192,2.1175886114328416E-6,1.959666748885308E-5,0,0,15.625,204.14425881409352,DPP4;IL6;IRF1;ETS1;TNF;IL2
Head and Neck Neoplasms,5/107,2.2612351227886887E-6,2.0906320589621103E-5,0,0,23.36448598130841,303.7289574639363,IL6;IL2RA;AHR;HIF1A;TNF
Antiphospholipid Syndrome,4/47,2.2987346007492488E-6,2.1233048549025956E-5,0,0,42.5531914893617,552.4745429794671,MTHFR;TNF;TLR4;HLA-DRB1
Disseminated neuroblastoma,4/47,2.2987346007492488E-6,2.1213111414238138E-5,0,0,42.5531914893617,552.4745429794671,IL21;IL10;IL6;IL2
Hyperparathyroidism,4/47,2.2987346007492488E-6,2.119321168495649E-5,0,0,42.5531914893617,552.4745429794671,IL6;VDR;TNF;IL6R
Post MI,4/47,2.2987346007492488E-6,2.1173349256010887E-5,0,0,42.5531914893617,552.4745429794671,HMGB1;HIF1A;TNF;TLR4
Peripheral Neuropathy,7/309,2.363581957556873E-6,2.1750265429652572E-5,0,0,11.326860841423949,146.74324624067881,IL10;IL6;IFNG;IL2RA;MTHFR;TNF;INS
Waldenstrom Macroglobulinemia,5/108,2.3675464944943145E-6,2.1766367584555775E-5,0,0,23.148148148148145,299.8531567924317,IL10;IL6;IL1B;IL2RA;TNF
Mechanical Allodynia,5/108,2.3675464944943145E-6,2.174602518494404E-5,0,0,23.148148148148145,299.8531567924317,IL10;IL6;IL1B;HMGB1;TNF
Tuberous Sclerosis,6/197,2.4577369982663584E-6,2.2553351278208936E-5,0,0,15.228426395939087,196.69446016461094,IL21;IL6;IFNG;IL12A;TNF;IL17A
Fabry Disease,4/48,2.5041042119509804E-6,2.2957403167028205E-5,0,0,41.666666666666664,537.3991453083812,DPP4;IL10;IL6;VDR
Abortion, Tubal,5/110,2.591955729975935E-6,2.374067186785041E-5,0,0,22.727272727272727,292.34313316147035,CXCL10;IL6;TGFB1;IL1B;AHR
Post-Traumatic Stress Disorder,5/110,2.591955729975935E-6,2.3718566959221127E-5,0,0,22.727272727272727,292.34313316147035,IL6;IFNG;IL1B;TNF;IL2
Lymphoma, Extranodal NK-T-Cell,3/14,2.656550882962849E-6,2.428705309558966E-5,0,0,107.14285714285714,1375.5516361181399,CD14;CCR4;IL17A
Autoinflammatory Syndrome,3/14,2.656550882962849E-6,2.4264481484906023E-5,0,0,107.14285714285714,1375.5516361181399,IFNG;IL1B;TNF
Cardiopulmonary Arrest,3/14,2.656550882962849E-6,2.4241951789933967E-5,0,0,107.14285714285714,1375.5516361181399,IFNG;TNF;INS
Chronic active hepatitis C,3/14,2.656550882962849E-6,2.4219463894024935E-5,0,0,107.14285714285714,1375.5516361181399,IFNG;IL1B;HLA-DRB1
Genital ulcers,3/14,2.656550882962849E-6,2.419701768096282E-5,0,0,107.14285714285714,1375.5516361181399,MTHFR;CD14;HLA-DRB1
Granulomatous disorder,3/14,2.656550882962849E-6,2.4174613034961928E-5,0,0,107.14285714285714,1375.5516361181399,IFNG;TNF;IL2
Hemophagocytic Syndrome,3/14,2.656550882962849E-6,2.4152249840665014E-5,0,0,107.14285714285714,1375.5516361181399,IL10;TNF;IL2
Inflammatory neuropathy,3/14,2.656550882962849E-6,2.4129927983141294E-5,0,0,107.14285714285714,1375.5516361181399,IL10;CXCL10;IL6
Lambert-Eaton Myasthenic Syndrome,3/14,2.656550882962849E-6,2.410764734788447E-5,0,0,107.14285714285714,1375.5516361181399,IL10;IL2RA;TNF
Lymphoid interstitial pneumonia,3/14,2.656550882962849E-6,2.4085407820810776E-5,0,0,107.14285714285714,1375.5516361181399,CXCL10;IL6;TGFB1
Manganese Poisoning,3/14,2.656550882962849E-6,2.4063209288257033E-5,0,0,107.14285714285714,1375.5516361181399,IFNG;IL1B;TNF
Intracranial Hemorrhages,4/49,2.722770079535212E-6,2.464031707336286E-5,0,0,40.816326530612244,523.0147258894616,IL6;IL1B;HIF1A;TNF
Bronchiectasis,5/112,2.83277085823639E-6,2.5612209746777592E-5,0,0,22.321428571428573,285.1396255238034,TGFB1;STAT1;IL1B;TNF;IL17A
Moyamoya Disease,4/50,2.9552766795183953E-6,2.669527500579668E-5,0,0,40.0,509.27673122074503,IL10;TGFB1;IL1B;MTHFR
Obesity, Morbid,5/113,2.9595956772021096E-6,2.6709739500038876E-5,0,0,22.123893805309734,281.6472985508441,DPP4;IL6;PRL;HIF1A;TNF
Huntington Disease,9/627,3.1644000175151804E-6,2.8531856304714858E-5,0,0,7.177033492822966,90.88670159041219,IL10;IL6;TGFB1;VDR;IL1B;MTHFR;TNF;TGM2;SOD1
Lymphohistiocytosis, Hemophagocytic,4/51,3.202178006479703E-6,2.884601782555685E-5,0,0,39.2156862745098,496.14428833942,IL10;IFNG;TNF;IL2
Rabies (disorder),4/51,3.202178006479703E-6,2.881960205831733E-5,0,0,39.2156862745098,496.14428833942,CXCL10;IL6;STAT1;TNF
Carcinoma, Cribriform,5/115,3.226624197680604E-6,2.9013049052886527E-5,0,0,21.73913043478261,274.8711762457905,TGFB1;IL1B;PRL;TNF;RUNX3
Carcinoma, Granular Cell,5/115,3.226624197680604E-6,2.8986528898359208E-5,0,0,21.73913043478261,274.8711762457905,TGFB1;IL1B;PRL;TNF;RUNX3
Visual seizure,6/207,3.272192240639034E-6,2.936904597351637E-5,0,0,14.492753623188406,183.04420851736435,IL6;IFNG;IL1B;TNF;IL6R;INS
Heart Diseases,7/325,3.299238333077436E-6,2.958477585536956E-5,0,0,10.769230769230768,135.92728072312838,IL6;TGFB1;IL1B;IRF1;MTHFR;HIF1A;TNF
Recurrent hepatitis,3/15,3.3160919751159305E-6,2.9708798478978457E-5,0,0,100.0,1261.672358430992,IFNG;MTHFR;HLA-DRB1
Selective immunoglobulin A deficiency,3/15,3.3160919751159305E-6,2.9681741285463903E-5,0,0,100.0,1261.672358430992,IL10;IL21;TNF
Septicaemia due to gram-negative organism, unspecified,3/15,3.3160919751159305E-6,2.9654733331609976E-5,0,0,100.0,1261.672358430992,IL1B;CD14;TLR4
Stroke, Lacunar,3/15,3.3160919751159305E-6,2.9627774483126695E-5,0,0,100.0,1261.672358430992,IL6;IL1B;MTHFR
Chorioamnionitis,3/15,3.3160919751159305E-6,2.9600864606211958E-5,0,0,100.0,1261.672358430992,IL6;TNF;TLR4
Familial cold urticaria,3/15,3.3160919751159305E-6,2.9574003567549334E-5,0,0,100.0,1261.672358430992,IL6;IL1B;TNF
Foot-and-Mouth Disease,3/15,3.3160919751159305E-6,2.954719123430586E-5,0,0,100.0,1261.672358430992,IFNG;IL15;IL2
Granulocytosis,3/15,3.3160919751159305E-6,2.952042747412986E-5,0,0,100.0,1261.672358430992,IL1B;TNF;IL17A
Humoral hypercalcemia of malignancy (disorder),3/15,3.3160919751159305E-6,2.9493712155148746E-5,0,0,100.0,1261.672358430992,IL6;IFNG;TNF
Immunologic hypersensitivity,3/15,3.3160919751159305E-6,2.9467045145966878E-5,0,0,100.0,1261.672358430992,IL10;IL12A;TLR4
Pemphigus Foliaceus,3/15,3.3160919751159305E-6,2.9440426315663384E-5,0,0,100.0,1261.672358430992,IL6;TNF;HLA-DRB1
Ischemic cardiomyopathy,5/116,3.367050578597148E-6,2.9865860186329215E-5,0,0,21.551724137931036,271.5834783629265,IL6;TGFB1;HIF1A;TNF;IL6R
Trisomy,6/209,3.4588461366893043E-6,3.065242545661179E-5,0,0,14.354066985645932,180.49629920123846,IL6;IL15;IL2RA;MTHFR;CCR4;SOD1
Lymphocytic infiltration,4/52,3.4640374867537903E-6,3.067077515298762E-5,0,0,38.46153846153846,483.5798363658269,CXCL10;IL6;TNF;IL17A
Parasitic Diseases,4/52,3.4640374867537903E-6,3.06431686947041E-5,0,0,38.46153846153846,483.5798363658269,IL10;IFNG;TNF;TLR4
Adenocarcinoma, Basal Cell,5/117,3.512236246675288E-6,3.10415987700762E-5,0,0,21.367521367521366,268.36020547090396,TGFB1;IL1B;PRL;TNF;RUNX3
Anorexia,5/118,3.6622966822104768E-6,3.2338770703292514E-5,0,0,21.1864406779661,265.199578359145,IL6;IL1B;HMGB1;TNF;IL2
Erectile dysfunction,5/118,3.6622966822104768E-6,3.2309741286144134E-5,0,0,21.1864406779661,265.199578359145,IL6;TGFB1;MTHFR;PRL;TNF
Tachycardia,4/53,3.7414279057277544E-6,3.297825422196625E-5,0,0,37.73584905660377,471.5488009972411,IL6;AHR;TNF;INS
Congenital contractural arachnodactyly,6/212,3.7550253616568885E-6,3.3068449152655826E-5,0,0,14.150943396226415,176.77946488681064,IL6;VDR;MTHFR;CD14;TNF;S100A9
Aortic Valve Insufficiency,6/214,3.963717653747341E-6,3.4875037691162814E-5,0,0,14.018691588785046,174.36908651838797,IL10;IL6;TGFB1;IFNG;PRL;HIF1A
Malignant melanoma, metastatic,3/16,4.075693778113988E-6,3.5828191816909006E-5,0,0,93.75,1163.4815225123264,IL15;TNF;IL2
Other specified forms of pleural effusion, except tuberculous,3/16,4.075693778113988E-6,3.579617377238987E-5,0,0,93.75,1163.4815225123264,IL1B;TNF;IL17A
Balkan Nephropathy,3/16,4.075693778113988E-6,3.576421290295024E-5,0,0,93.75,1163.4815225123264,IL1B;TNF;HLA-DRB1
Congenital heart block,3/16,4.075693778113988E-6,3.5732309055579186E-5,0,0,93.75,1163.4815225123264,TGFB1;TNF;HLA-DRB1
Paracoccidioidomycosis,3/16,4.075693778113988E-6,3.570046207781129E-5,0,0,93.75,1163.4815225123264,IL10;IFNG;HLA-DRB1
Q Fever,3/16,4.075693778113988E-6,3.566867181772419E-5,0,0,93.75,1163.4815225123264,IL10;IFNG;TNF
Reactive hypoglycemia,3/16,4.075693778113988E-6,3.563693812393618E-5,0,0,93.75,1163.4815225123264,IL1B;TNF;INS
Mood Disorders,7/336,4.107593135102388E-6,3.588393362825446E-5,0,0,10.416666666666666,129.19451367594772,TGFB1;IFNG;IL1B;MTHFR;PRL;HIF1A;TNF
Adenocarcinoma, Oxyphilic,5/122,4.313654189157786E-6,3.7650615782453566E-5,0,0,20.491803278688522,253.15010601126843,TGFB1;IL1B;PRL;TNF;RUNX3
Adenocarcinoma, Tubular,5/125,4.859265234651453E-6,4.237520738789218E-5,0,0,20.0,244.6924663553476,TGFB1;IL1B;PRL;TNF;RUNX3
Biliary stricture,3/17,4.942204676055385E-6,4.306027265626979E-5,0,0,88.23529411764706,1078.0322678490922,IL10;TGFB1;IFNG
Ileal Diseases,3/17,4.942204676055385E-6,4.302213246791171E-5,0,0,88.23529411764706,1078.0322678490922,TNF;TLR4;HLA-DRB1
Parainfluenza,3/17,4.942204676055385E-6,4.298405978431179E-5,0,0,88.23529411764706,1078.0322678490922,IL6;IFNG;STAT1
Respiratory Distress Syndrome, Newborn,4/57,5.018077680116278E-6,4.360536466859662E-5,0,0,35.08771929824561,428.1566185910759,IL10;IL6;IL1B;TNF
Memory Loss,5/126,5.052682447276775E-6,4.3867281883247476E-5,0,0,19.84126984126984,241.97601742109842,IL6;IL1B;MTHFR;INS;SOD1
Recurrent tumor,7/347,5.07504887193232E-6,4.402257750516403E-5,0,0,10.086455331412104,122.96573605478056,IL6;IL15;IL1B;PRL;TNF;TGM2;IL17A
Interstitial lung fibrosis,5/127,5.252089495523338E-6,4.5518108961202264E-5,0,0,19.68503937007874,239.30875120854512,IL10;TGFB1;HIF1A;TNF;IL17A
Uterine Fibroids,7/349,5.26987846943794E-6,4.56320401741287E-5,0,0,10.02865329512894,121.8832704807054,TGFB1;VDR;IL1B;AHR;PRL;TNF;IL2
Respiratory Tract Diseases,4/58,5.382036485474957E-6,4.6562195932436514E-5,0,0,34.48275862068965,418.36012850054755,IL10;IFNG;CD14;TNF
Amnesia,4/58,5.382036485474957E-6,4.652124413302364E-5,0,0,34.48275862068965,418.36012850054755,IL6;MTHFR;IL2;SOD1
Inclusion Body Myositis (disorder),4/58,5.382036485474957E-6,4.648036430513873E-5,0,0,34.48275862068965,418.36012850054755,IL6;IFNG;HMGB1;HLA-DRB1
Biliary Tract Cancer,5/128,5.457618794344969E-6,4.7091727401951146E-5,0,0,19.53125,236.68941370286174,IL6;TGFB1;RUNX3;IL2;INS
Adenocarcinoma of pancreas,7/354,5.7844145518647774E-6,4.9867742294497396E-5,0,0,9.887005649717516,119.2406833679413,IL6;TGFB1;IL1B;IL2RA;ETS1;HIF1A;TLR4
Endometrioma,6/229,5.849727817439161E-6,5.038661261156185E-5,0,0,13.100436681222707,157.84867368650302,IL6;IL15;IL1B;PRL;ETS1;TNF
Tauopathies,5/130,5.88758243518339E-6,5.066826635112291E-5,0,0,19.23076923076923,231.58971340365574,IL10;IL6;IL1B;TNF;SOD1
Aortic Valve Stenosis,5/130,5.88758243518339E-6,5.0623937159214665E-5,0,0,19.23076923076923,231.58971340365574,IL10;VDR;TNF;IL6R;S100A9
Leprosy, Paucibacillary,3/18,5.922433959591772E-6,5.087909174376568E-5,0,0,83.33333333333333,1003.0635876450888,IL10;TNF;HLA-DRB1
Chronic Q Fever,3/18,5.922433959591772E-6,5.083465585577986E-5,0,0,83.33333333333333,1003.0635876450888,IL10;IFNG;TNF
Infection by Candida albicans,3/18,5.922433959591772E-6,5.079029751733677E-5,0,0,83.33333333333333,1003.0635876450888,IL1B;TNF;IL17A
Invasive Fungal Infections,3/18,5.922433959591772E-6,5.074601652560413E-5,0,0,83.33333333333333,1003.0635876450888,IL10;IL6;IFNG
Meningococcemia,3/18,5.922433959591772E-6,5.070181267845639E-5,0,0,83.33333333333333,1003.0635876450888,IL10;IL6;TNF
Disorder of eye,5/131,6.112290247346429E-6,5.228162624101018E-5,0,0,19.083969465648856,229.10704234951558,IFNG;PRL;TNF;HLA-DQA1;HLA-DRB1
Secondary malignant neoplasm of liver,8/508,6.164939160295653E-6,5.2686106145552766E-5,0,0,7.874015748031495,94.46167157450269,DPP4;IL6;MTHFR;PRL;HIF1A;TNF;IL2;TGM2
AURAL ATRESIA, CONGENITAL,4/60,6.168069292915718E-6,5.2667059088423704E-5,0,0,33.333333333333336,399.8708229168781,IL6;TGFB1;IL1B;TNF
Bullous pemphigoid,4/60,6.168069292915718E-6,5.2621341155187226E-5,0,0,33.333333333333336,399.8708229168781,IL2RA;TNF;S100A9;HLA-DRB1
Oropharyngeal Carcinoma,4/60,6.168069292915718E-6,5.257570252452357E-5,0,0,33.333333333333336,399.8708229168781,IL10;IL6;HLA-DQA1;HLA-DRB1
Post-Traumatic Osteoporosis,4/60,6.168069292915718E-6,5.253014299027355E-5,0,0,33.333333333333336,399.8708229168781,IL6;TGFB1;VDR;IL6R
Promyelocytic leukemia,6/233,6.459728631791719E-6,5.496641817597317E-5,0,0,12.875536480686694,153.86167272765687,IL10;CXCL10;IFNG;TNF;HLA-DQA1;SOD1
PACHYONYCHIA CONGENITA 3,5/133,6.581854560895171E-6,5.5957151059236795E-5,0,0,18.796992481203006,224.27056398831613,IL6;TGFB1;VDR;HIF1A;TNF
Hepatoblastoma,6/235,6.783557054385891E-6,5.7622125091188017E-5,0,0,12.76595744680851,151.92777388464373,IL6;IFNG;IL1B;AHR;TNF;TLR4
Thyroid Gland Follicular Adenoma,5/134,6.826994975310238E-6,5.7941024712736624E-5,0,0,18.656716417910445,221.91466334945898,CXCL10;IL6;IL1B;HIF1A;TNF
Anaplastic Large Cell Lymphoma, ALK-Positive,3/19,7.023151966271934E-6,5.9554389581122156E-5,0,0,78.94736842105263,936.8130349461773,IL21;STAT1;TNF
Somnolence,3/19,7.023151966271934E-6,5.9503049590103944E-5,0,0,78.94736842105263,936.8130349461773,CXCL10;TNF;HLA-DRB1
Tachyarrhythmia,3/19,7.023151966271934E-6,5.94517980400694E-5,0,0,78.94736842105263,936.8130349461773,AHR;TNF;INS
Chronic berylliosis,3/19,7.023151966271934E-6,5.9400634702685524E-5,0,0,78.94736842105263,936.8130349461773,TGFB1;TNF;HLA-DRB1
Inflammatory disease of mucous membrane,3/19,7.023151966271934E-6,5.934955935040462E-5,0,0,78.94736842105263,936.8130349461773,IL10;IL1B;MTHFR
Intestinal Volvulus,3/19,7.023151966271934E-6,5.929857175646098E-5,0,0,78.94736842105263,936.8130349461773,IL10;SOD1;IL17A
Pyoderma Gangrenosum,3/19,7.023151966271934E-6,5.924767169486745E-5,0,0,78.94736842105263,936.8130349461773,IL15;MTHFR;TNF
Amyotrophic Lateral Sclerosis, Sporadic,5/136,7.338715234869644E-6,6.18566838150076E-5,0,0,18.38235294117647,217.32255085992207,IL2RA;CD14;TNF;SOD1;IL17A
Bulbo-Spinal Atrophy, X-Linked,4/63,7.502078185369772E-6,6.317945536059478E-5,0,0,31.746031746031743,374.61366617213014,STAT1;HIF1A;TNF;SOD1
Kidney Calculi,4/63,7.502078185369772E-6,6.312536336114223E-5,0,0,31.746031746031743,374.61366617213014,IL6;VDR;IL1B;SOD1
Pituitary Diseases,6/240,7.651186098263115E-6,6.432494180815218E-5,0,0,12.5,147.25812345774443,IL6;IL1B;AHR;PRL;IL2;SOD1
Collecting Duct Carcinoma of the Kidney,5/138,7.880005799543118E-6,6.619204871616219E-5,0,0,18.115942028985508,212.88373040058204,IL6;VDR;IL6R;IL2;TGM2
Retinopathy of Prematurity,4/64,7.990709895122813E-6,6.706464291141504E-5,0,0,31.25,366.7884673182046,IL1B;PRL;HIF1A;TNF
Osteoporosis, Senile,4/64,7.990709895122813E-6,6.700742051985241E-5,0,0,31.25,366.7884673182046,IL6;TGFB1;VDR;IL6R
Febrile Convulsions,4/64,7.990709895122813E-6,6.695029569417478E-5,0,0,31.25,366.7884673182046,IL10;IL6;IL1B;TNF
Polyp of large intestine,4/64,7.990709895122813E-6,6.68932681850656E-5,0,0,31.25,366.7884673182046,IL10;AHR;TNF;RUNX3
Differentiated Thyroid Gland Carcinoma,5/139,8.162115711490347E-6,6.827001975534224E-5,0,0,17.985611510791365,210.71955295370807,VDR;MTHFR;ETS1;HIF1A;S100A9
Amebic colitis,3/20,8.251090223899674E-6,6.895553972830443E-5,0,0,75.0,877.8873913497774,IL1B;TNF;HLA-DRB1
Chronic small plaque psoriasis,3/20,8.251090223899674E-6,6.889695388316568E-5,0,0,75.0,877.8873913497774,IL1B;MTHFR;IL17A
Constitutional Symptom,3/20,8.251090223899674E-6,6.883846750465705E-5,0,0,75.0,877.8873913497774,CXCL10;TNF;IL2
Destructive Arthritis,3/20,8.251090223899674E-6,6.878008033968278E-5,0,0,75.0,877.8873913497774,IL1B;TNF;IL17A
Idiopathic Nephrotic Syndrome,3/20,8.251090223899674E-6,6.872179213600509E-5,0,0,75.0,877.8873913497774,IL6;IL1B;TNF
Intrinsic asthma,3/20,8.251090223899674E-6,6.866360264224048E-5,0,0,75.0,877.8873913497774,IL10;IFNG;HLA-DRB1
HEMOCHROMATOSIS, TYPE 1,4/65,8.502447238649656E-6,7.069547500968598E-5,0,0,30.76923076923077,359.2355853992888,IL6;FUT2;TNF;SOD1
Stress, Psychological,4/65,8.502447238649656E-6,7.063571552108946E-5,0,0,30.76923076923077,359.2355853992888,IL6;IFNG;IL1B;TNF
FRIEDREICH ATAXIA 1,4/65,8.502447238649656E-6,7.057605697757501E-5,0,0,30.76923076923077,359.2355853992888,IFNG;IL1B;MTHFR;HIF1A
Kidney Neoplasm,6/246,8.809133811417069E-6,7.3060056623297E-5,0,0,12.195121951219512,141.94782245908146,VDR;TNFRSF9;ETS1;HIF1A;TNF;IL2
Shigella Infections,4/66,9.037977548986918E-6,7.489480889666393E-5,0,0,30.303030303030305,351.9416706377876,IL10;IL6;IFNG;TNF
Proliferative vitreoretinopathy,4/66,9.037977548986918E-6,7.483171301722277E-5,0,0,30.303030303030305,351.9416706377876,IL6;TGFB1;TNF;TGM2
Skin blisters,4/67,9.597996439333004E-6,7.940160690720939E-5,0,0,29.850746268656714,344.8942144927877,IL10;IL12A;TLR4;HLA-DRB1
Toxic Epidermal Necrolysis,4/67,9.597996439333004E-6,7.933482675001241E-5,0,0,29.850746268656714,344.8942144927877,IFNG;TNF;HLA-DRB1;SOD1
Abnormal blistering of the skin,4/67,9.597996439333004E-6,7.926815882837375E-5,0,0,29.850746268656714,344.8942144927877,IL10;IL12A;TLR4;HLA-DRB1
Sialadenitis,3/21,9.612941590023713E-6,7.932492858669441E-5,0,0,71.42857142857142,825.1714489316764,IL10;IL21;TNF
Leukomalacia, Periventricular,3/21,9.612941590023713E-6,7.925838082781296E-5,0,0,71.42857142857142,825.1714489316764,IL6;TNF;IL2
Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Factor Negative,3/21,9.612941590023713E-6,7.919194463265134E-5,0,0,71.42857142857142,825.1714489316764,STAT1;IL2RA;IL6R
Allergic Conjunctivitis,3/21,9.612941590023713E-6,7.91256197208987E-5,0,0,71.42857142857142,825.1714489316764,IFNG;IRF1;IL17A
Periapical Granuloma,3/21,9.612941590023713E-6,7.905940581318247E-5,0,0,71.42857142857142,825.1714489316764,IFNG;IL1B;TNF
Primary HIV infection,3/21,9.612941590023713E-6,7.899330263106442E-5,0,0,71.42857142857142,825.1714489316764,IL2RA;IRF1;TNF
Thrombocythemia, Essential,5/145,1.0025056696788626E-5,8.231099182626451E-5,0,0,17.241379310344826,198.4555677456486,IL6;TGFB1;IFNG;STAT1;MTHFR
Skin bullae,4/68,1.0183207728279718E-5,8.353970413483562E-5,0,0,29.41176470588235,338.08148516076466,IL10;IL12A;TLR4;HLA-DRB1
Migraine with Aura,4/68,1.0183207728279718E-5,8.347002965265476E-5,0,0,29.41176470588235,338.08148516076466,TGFB1;MTHFR;TNF;SOD1
Persistent infection,4/68,1.0183207728279718E-5,8.340047129461089E-5,0,0,29.41176470588235,338.08148516076466,IL10;IL6;TNF;HLA-DRB1
Hematological Disease,5/147,1.0714748352991318E-5,8.768072174287983E-5,0,0,17.006802721088437,194.62396963950624,IL1B;MTHFR;AHR;PRL;HLA-DRB1
Renal Artery Stenosis,3/22,1.1115360392524813E-5,9.088332939911302E-5,0,0,68.18181818181817,777.762449120108,STAT1;MTHFR;HIF1A
Aspergillosis, Allergic Bronchopulmonary,3/22,1.1115360392524813E-5,9.080778215937976E-5,0,0,68.18181818181817,777.762449120108,IL10;IFNG;HLA-DRB1
Disorder of Achilles tendon,3/22,1.1115360392524813E-5,9.073236041340021E-5,0,0,68.18181818181817,777.762449120108,IL6;IL1B;TLR4
Hidradenitis Suppurativa,3/22,1.1115360392524813E-5,9.065706384874179E-5,0,0,68.18181818181817,777.762449120108,TNF;TLR4;HLA-DRB1
Peritoneal adhesion,3/22,1.1115360392524813E-5,9.058189215400817E-5,0,0,68.18181818181817,777.762449120108,TGFB1;IL15;IL1B
Benign Neoplasm,4/70,1.1432063349449686E-5,9.308559950156712E-5,0,0,28.57142857142857,325.11681645536106,VDR;IL1B;AHR;IL2
Cooley's anemia,4/70,1.1432063349449686E-5,9.300854188608569E-5,0,0,28.57142857142857,325.11681645536106,IL10;TGFB1;VDR;IL6R
Mild cognitive disorder,5/150,1.1818253171892024E-5,9.607096126828355E-5,0,0,16.666666666666668,189.09775571172761,IL1B;MTHFR;HIF1A;TNF;SOD1
Anxiety Disorders,7/396,1.2003658228501305E-5,9.749748187579407E-5,0,0,8.838383838383837,100.14153246946269,IL6;IFNG;IL1B;MTHFR;PRL;TNF;SOD1
Gout,4/71,1.2097155682736579E-5,9.817576056972344E-5,0,0,28.169014084507044,318.94479438131594,VDR;IL1B;CD14;S100A9
Astrocytoma,9/741,1.2205604944952875E-5,9.897416287045945E-5,0,0,6.0728744939271255,68.70616572880239,IL6;TGFB1;IFNG;IL1B;IL12A;ETS1;HIF1A;TNF;HLA-DRB1
Retinal Vein Occlusion,3/23,1.2764962564743568E-5,1.034246101288539E-4,0,0,65.21739130434783,734.9221591254454,IL6;IL1B;MTHFR
Severe hereditary factor VIII deficiency disease,3/23,1.2764962564743568E-5,1.03339416875041E-4,0,0,65.21739130434783,734.9221591254454,TGFB1;TNF;HLA-DRB1
Lupus Erythematosus, Subacute Cutaneous,3/23,1.2764962564743568E-5,1.0325436385703686E-4,0,0,65.21739130434783,734.9221591254454,IL1B;TNF;HLA-DRB1
Stomatitis,3/23,1.2764962564743568E-5,1.0316945072886496E-4,0,0,65.21739130434783,734.9221591254454,IL1B;MTHFR;TNF
Superficial spreading malignant melanoma of skin,3/23,1.2764962564743568E-5,1.0308467714568594E-4,0,0,65.21739130434783,734.9221591254454,IFNG;IL1B;CD14
Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome,3/23,1.2764962564743568E-5,1.0300004276379292E-4,0,0,65.21739130434783,734.9221591254454,IL2RA;CD14;TNF
Varicocele,3/23,1.2764962564743568E-5,1.0291554724060687E-4,0,0,65.21739130434783,734.9221591254454,STAT1;IL1B;HIF1A
Decreased Concentration,3/23,1.2764962564743568E-5,1.0283119023467195E-4,0,0,65.21739130434783,734.9221591254454,IL10;IFNG;CD14
Listeriosis,3/23,1.2764962564743568E-5,1.0274697140565093E-4,0,0,65.21739130434783,734.9221591254454,IL6;IL15;TNF
Neurocysticercosis,3/23,1.2764962564743568E-5,1.026628904143206E-4,0,0,65.21739130434783,734.9221591254454,IL10;IL2RA;TLR4
Osteophyte,3/23,1.2764962564743568E-5,1.0257894692256727E-4,0,0,65.21739130434783,734.9221591254454,TGFB1;VDR;IL1B
Epilepsy,11/1177,1.329278803402492E-5,1.0673326862614127E-4,0,0,4.672897196261681,52.468639826587705,IL6;TGFB1;VDR;IL1B;MTHFR;HMGB1;TLR4;IL2;INS;SOD1;IL17A
Premature Menopause,5/154,1.3425565828055423E-5,1.0771139670051323E-4,0,0,16.233766233766232,182.11606771292747,MTHFR;AHR;PRL;IL2;HLA-DRB1
mixed gliomas,4/73,1.3512348838475505E-5,1.0831922054203692E-4,0,0,27.397260273972602,307.1755222425573,IL12A;TNF;CCR4;SOD1
Trichohepatoenteric Syndrome,6/267,1.4033399227613808E-5,1.1240443977912675E-4,0,0,11.235955056179774,125.55135292584991,CXCL10;IL6;VDR;TNF;IL2;SOD1
Chronic heart failure,4/74,1.4263944912787476E-5,1.1415802166357924E-4,0,0,27.027027027027028,301.56150106448575,IL6;IFNG;CD14;TNF
Asthma, Occupational,3/24,1.4568325796714109E-5,1.1649919115549735E-4,0,0,62.5,696.0413032455576,TGFB1;TNF;HLA-DRB1
CONSTRICTING BANDS, CONGENITAL,3/24,1.4568325796714109E-5,1.1640447636594004E-4,0,0,62.5,696.0413032455576,IL10;IL6;TNF
Signs and Symptoms, Respiratory,3/24,1.4568325796714109E-5,1.1630991545906275E-4,0,0,62.5,696.0413032455576,AHR;CD14;TLR4
Cognitive changes,3/24,1.4568325796714109E-5,1.1621550806015118E-4,0,0,62.5,696.0413032455576,VDR;MTHFR;SOD1
Complications of Diabetes Mellitus,3/24,1.4568325796714109E-5,1.1612125379570661E-4,0,0,62.5,696.0413032455576,IL15;HIF1A;TNF
Lyme Arthritis,3/24,1.4568325796714109E-5,1.1602715229344105E-4,0,0,62.5,696.0413032455576,IL10;HLA-DRB1;IL17A
Autism Spectrum Disorders,8/572,1.4614218506528073E-5,1.1629841253616024E-4,0,0,6.9930069930069925,77.85675267722989,DPP4;IFNG;IL1B;MTHFR;PRL;TNF;HLA-DRB1;INS
Hypertriglyceridemia,5/157,1.4739248682511426E-5,1.1719849195123164E-4,0,0,15.92356687898089,177.1496280865906,IL10;IL6;TNF;IL2;INS
MYOTONIC DYSTROPHY 1,4/75,1.5045883694512242E-5,1.1953997166504958E-4,0,0,26.666666666666668,296.1174963426664,IL10;IL6;IFNG;TNF
Acromegaly,4/76,1.5858932011926304E-5,1.2589788676349895E-4,0,0,26.31578947368421,290.8362548023972,MTHFR;AHR;PRL;INS
Myopathy,7/415,1.6249144521366736E-5,1.2889151925423107E-4,0,0,8.433734939759036,93.00276152758192,TGFB1;IFNG;VDR;IL1B;HLA-DRB1;INS;SOD1
Human T-cell lymphotrophic virus, type I [HTLV-I],3/25,1.6531989659908523E-5,1.3102935030450077E-4,0,0,60.0,660.612797206451,IL15;TNF;IL2
Lymphoma, Intermediate-Grade,3/25,1.6531989659908523E-5,1.3092376662174131E-4,0,0,60.0,660.612797206451,IL10;MTHFR;HLA-DRB1
Cancer of Digestive System,3/25,1.6531989659908523E-5,1.3081835296101528E-4,0,0,60.0,660.612797206451,HIF1A;TNF;TLR4
Cervix Diseases,3/25,1.6531989659908523E-5,1.307131089119718E-4,0,0,60.0,660.612797206451,IL10;MTHFR;HLA-DRB1
Congenital infectious disease,3/25,1.6531989659908523E-5,1.3060803406557956E-4,0,0,60.0,660.612797206451,IL6;IL1B;TLR4
Enterocolitis,3/25,1.6531989659908523E-5,1.3050312801412124E-4,0,0,60.0,660.612797206451,IL10;STAT1;HLA-DRB1
ESR raised,3/25,1.6531989659908523E-5,1.3039839035118857E-4,0,0,60.0,660.612797206451,IL6;IL2RA;HLA-DRB1
Hepatic Form of Wilson Disease,3/25,1.6531989659908523E-5,1.302938206716768E-4,0,0,60.0,660.612797206451,IL10;IL6;TNF
Weight decreased,5/161,1.6644538410833717E-5,1.310757399853155E-4,0,0,15.527950310559005,170.86068973171749,IL10;CD14;HLA-DRB1;INS;SOD1
Congenital Heart Defects,6/277,1.727878308166733E-5,1.3596147327992516E-4,0,0,10.830324909747292,118.76568108934481,MTHFR;AHR;HIF1A;TNF;INS;SOD1
Cardiac Hypertrophy,4/78,1.7581462260740414E-5,1.3823248887884543E-4,0,0,25.64102564102564,280.7350126064046,IL1B;AHR;HIF1A;TNF
Marinesco-Sjogren syndrome,4/78,1.7581462260740414E-5,1.3812199128581678E-4,0,0,25.64102564102564,280.7350126064046,IL6;IFNG;RUNX3;IL17A
Neural Tube Defects,5/163,1.7666480084386345E-5,1.3867904654101356E-4,0,0,15.337423312883436,167.85032966866845,IL10;IFNG;MTHFR;AHR;INS
Osteitis Deformans,4/79,1.8492515330627423E-5,1.450474386826866E-4,0,0,25.31645569620253,275.9023920117995,IL6;VDR;IL1B;TNF
Arthritis, Gouty,3/26,1.866245576586816E-5,1.4626364853823946E-4,0,0,57.69230769230769,628.2113518451812,IL6;IL1B;TLR4
Carotid Artery Plaque,3/26,1.866245576586816E-5,1.4614710379836835E-4,0,0,57.69230769230769,628.2113518451812,STAT1;IL2RA;TLR4
Indian childhood cirrhosis,3/26,1.866245576586816E-5,1.4603074463929322E-4,0,0,57.69230769230769,628.2113518451812,IL10;MTHFR;HLA-DRB1
TARSAL-CARPAL COALITION SYNDROME,5/165,1.8736700119141408E-5,1.4649505868808414E-4,0,0,15.151515151515152,164.9246421851271,IL6;TGFB1;CD80;IL2RA;HIF1A
Eosinophilic esophagitis,4/80,1.9437820072624825E-5,1.5185603789646802E-4,0,0,25.0,271.2072475350391,TGFB1;IFNG;IL15;TNFRSF14
Prion Diseases,4/80,1.9437820072624825E-5,1.5173542150417535E-4,0,0,25.0,271.2072475350391,IL6;IL1B;CD14;SOD1
Transitional cell carcinoma of bladder,5/167,1.9856795678935148E-5,1.5488300629569416E-4,0,0,14.970059880239521,162.08030326102352,TGFB1;IFNG;HMGB1;HIF1A;IL2
Acute myelomonocytic leukemia,4/81,2.0418180375262358E-5,1.5913550890410663E-4,0,0,24.691358024691358,266.6440705957201,IRF1;AHR;CD14;ETS1
Streptococcal Infections,3/27,2.096618787378939E-5,1.632770954228226E-4,0,0,55.55555555555555,598.4777510608349,IL10;IFNG;TNF
Cryoglobulinemia,3/27,2.096618787378939E-5,1.6314781822929702E-4,0,0,55.55555555555555,598.4777510608349,CXCL10;IFNG;TNF
Cutaneous lymphoma,3/27,2.096618787378939E-5,1.6301874558829284E-4,0,0,55.55555555555555,598.4777510608349,IL10;IFNG;IL2
Elevated C-reactive protein,3/27,2.096618787378939E-5,1.6288987701470523E-4,0,0,55.55555555555555,598.4777510608349,IL6;IL2RA;HLA-DRB1
Elevated C-reactive protein level,3/27,2.096618787378939E-5,1.6276121202496219E-4,0,0,55.55555555555555,598.4777510608349,IL6;IL2RA;HLA-DRB1
Generalized vitiligo,3/27,2.096618787378939E-5,1.6263275013701827E-4,0,0,55.55555555555555,598.4777510608349,VDR;TNF;HLA-DQA1
Hereditary Leiomyomatosis and Renal Cell Cancer,3/27,2.096618787378939E-5,1.6250449087034868E-4,0,0,55.55555555555555,598.4777510608349,IL10;HIF1A;TNF
Noninfiltrating Intraductal Carcinoma,6/287,2.110580068061222E-5,1.634576903775074E-4,0,0,10.452961672473869,112.53619485879126,STAT1;IL2RA;IRF1;HIF1A;RUNX3;S100A9
Congenital Abnormality,8/607,2.2407267618864678E-5,1.734004930379544E-4,0,0,6.589785831960461,70.55107218750689,IL10;TGFB1;IFNG;STAT1;MTHFR;HMGB1;ETS1;SOD1
Sarcopenia,3/28,2.344961206460788E-5,1.8132398691657456E-4,0,0,53.57142857142857,571.1066039087094,MTHFR;TNF;SOD1
GASTRIC CANCER, INTESTINAL,3/28,2.344961206460788E-5,1.8118143661239485E-4,0,0,53.57142857142857,571.1066039087094,IL1B;IRF1;TLR4
Viral myocarditis,3/28,2.344961206460788E-5,1.8103911026784466E-4,0,0,53.57142857142857,571.1066039087094,IL6;TNF;IL17A
Agammaglobulinemia,3/28,2.344961206460788E-5,1.8089700735554652E-4,0,0,53.57142857142857,571.1066039087094,IL10;IL6;TNF
Anasarca,3/28,2.344961206460788E-5,1.8075512734977745E-4,0,0,53.57142857142857,571.1066039087094,IL6;TNF;INS
Chronic colitis,3/28,2.344961206460788E-5,1.8061346972646257E-4,0,0,53.57142857142857,571.1066039087094,IL10;AHR;TNF
Condylomata Acuminata,3/28,2.344961206460788E-5,1.8047203396316856E-4,0,0,53.57142857142857,571.1066039087094,IL6;IFNG;STAT1
Incontinentia Pigmenti Achromians,3/28,2.344961206460788E-5,1.8033081953909723E-4,0,0,53.57142857142857,571.1066039087094,IL10;IL6;IL1B
Paratuberculosis,3/28,2.344961206460788E-5,1.8018982593507918E-4,0,0,53.57142857142857,571.1066039087094,IL10;TLR4;INS
Rat Insulinoma,3/28,2.344961206460788E-5,1.800490526335674E-4,0,0,53.57142857142857,571.1066039087094,IFNG;IL1B;TNF
Thrombophilia,4/84,2.3577741118421042E-5,1.8089152202329585E-4,0,0,23.809523809523807,253.69541580829636,IL6;TGFB1;MTHFR;TNF
Mitochondrial Myopathies,4/84,2.3577741118421042E-5,1.8075042099207643E-4,0,0,23.809523809523807,253.69541580829636,IL6;IL1B;TNF;SOD1
Alzheimer's Disease, Focal Onset,4/85,2.4706505535554848E-5,1.8925606890368905E-4,0,0,23.52941176470588,249.61044628242408,IL1B;MTHFR;TNF;INS
Acute Confusional Senile Dementia,4/85,2.4706505535554848E-5,1.8910867321139644E-4,0,0,23.52941176470588,249.61044628242408,IL1B;MTHFR;TNF;INS
Demyelinating Diseases,4/85,2.4706505535554848E-5,1.8896150692874165E-4,0,0,23.52941176470588,249.61044628242408,IL10;IFNG;TNF;HLA-DRB1
Diabetic Neuropathies,4/86,2.587445159755565E-5,1.9774036570822468E-4,0,0,23.25581395348837,245.63382560234206,TGFB1;IL1B;TNF;TLR4
Epithelioma,6/298,2.607750296134941E-5,1.9913729534121367E-4,0,0,10.06711409395973,106.25272722318857,IL6;TGFB1;HMGB1;TNF;RUNX3;IL2
Spinal Cord Myelodysplasia,3/29,2.6119116855389384E-5,1.993002177443842E-4,0,0,51.724137931034484,545.836710267779,IFNG;MTHFR;INS
Anthracosis,3/29,2.6119116855389384E-5,1.9914560159407823E-4,0,0,51.724137931034484,545.836710267779,IL6;IL1B;TNF
Community acquired pneumonia,3/29,2.6119116855389384E-5,1.98991225158734E-4,0,0,51.724137931034484,545.836710267779,IL10;IL6;TNF
Diastematomyelia,3/29,2.6119116855389384E-5,1.988370878813066E-4,0,0,51.724137931034484,545.836710267779,IFNG;MTHFR;INS
Iniencephaly,3/29,2.6119116855389384E-5,1.9868318920647588E-4,0,0,51.724137931034484,545.836710267779,IFNG;MTHFR;INS
Lymphoid hyperplasia,3/29,2.6119116855389384E-5,1.985295285806395E-4,0,0,51.724137931034484,545.836710267779,IL10;CXCL10;IFNG
Neurenteric Cyst,3/29,2.6119116855389384E-5,1.9837610545190638E-4,0,0,51.724137931034484,545.836710267779,IFNG;MTHFR;INS
Refractory cancer,5/177,2.626337376673665E-5,1.9931771226215276E-4,0,0,14.124293785310734,148.97366132539312,IL6;ETS1;HIF1A;TNF;TLR4
Carcinoma of larynx,5/177,2.626337376673665E-5,1.9916391773108628E-4,0,0,14.124293785310734,148.97366132539312,CD80;IL1B;HIF1A;TNF;RUNX3
Cerebrovascular Disorders,5/178,2.6983023507895638E-5,2.0446349655790154E-4,0,0,14.044943820224718,147.75705967245207,IL10;IL1B;MTHFR;CD14;HLA-DRB1
Alcohol Use Disorder,4/88,2.8331279731939242E-5,2.1451449707665554E-4,0,0,22.727272727272727,237.98963801859264,IL6;IL1B;MTHFR;TLR4
Chordoma,4/88,2.8331279731939242E-5,2.1434935889568812E-4,0,0,22.727272727272727,237.98963801859264,TNFRSF9;TNFRSF14;HIF1A;TNF
Delirium, Dementia, Amnestic, Cognitive Disorders,3/30,2.89810533348164E-5,2.19096763211212E-4,0,0,50.0,522.4434137387592,IFNG;STAT1;INS
ST segment elevation myocardial infarction,3/30,2.89810533348164E-5,2.1892835678291743E-4,0,0,50.0,522.4434137387592,IL10;AHR;HLA-DRB1
Stomach Diseases,3/30,2.89810533348164E-5,2.1876020904345285E-4,0,0,50.0,522.4434137387592,IFNG;TNF;TLR4
Ventricular Dysfunction, Left,3/30,2.89810533348164E-5,2.1859231939721843E-4,0,0,50.0,522.4434137387592,IL6;TLR4;INS
Tobacco Dependence,3/30,2.89810533348164E-5,2.1842468725044142E-4,0,0,50.0,522.4434137387592,IL6;AHR;TLR4
Bone necrosis,3/30,2.89810533348164E-5,2.1825731201116904E-4,0,0,50.0,522.4434137387592,MTHFR;HIF1A;IL17A
Fasting Hypoglycemia,3/30,2.89810533348164E-5,2.1809019308926156E-4,0,0,50.0,522.4434137387592,IL1B;TNF;INS
Hypergammaglobulinemia,3/30,2.89810533348164E-5,2.179233298963853E-4,0,0,50.0,522.4434137387592,IL6;IFNG;TNF
Myocardial Diseases, Secondary,4/89,2.962187424630578E-5,2.2257169731857278E-4,0,0,22.47191011235955,234.31454999435604,IL6;IFNG;IL1B;TNF
Primary Myelofibrosis,5/182,3.0016335832843544E-5,2.2536329149364887E-4,0,0,13.736263736263735,143.0462746805235,IL6;TGFB1;IFNG;IL15;IL1B
Venous Thrombosis,4/90,3.095507516961995E-5,2.3223395325727087E-4,0,0,22.22222222222222,230.7327465032122,IL10;MTHFR;IL12A;TLR4
Adenovirus Infections,4/90,3.095507516961995E-5,2.3205681065371843E-4,0,0,22.22222222222222,230.7327465032122,IFNG;IL1B;HIF1A;TNF
Gaucher Disease,4/90,3.095507516961995E-5,2.3187993808462262E-4,0,0,22.22222222222222,230.7327465032122,IL6;VDR;CD14;TNF
Acute interstitial pneumonia,3/31,3.204173532237099E-5,2.398371475615096E-4,0,0,48.387096774193544,500.7324811020041,IL10;TNF;HLA-DRB1
Histiocytic sarcoma,3/31,3.204173532237099E-5,2.3965462309608987E-4,0,0,48.387096774193544,500.7324811020041,IFNG;CD14;TNF
Anxiety,7/464,3.3223633586441664E-5,2.483056052376796E-4,0,0,7.543103448275862,77.78636159691801,IL6;IFNG;IL1B;MTHFR;PRL;TNF;SOD1
Cardiomyopathies, Primary,4/92,3.37527940881001E-5,2.520687388281518E-4,0,0,21.73913043478261,223.83581209297603,IL6;IFNG;IL1B;TNF
Familial Alzheimer Disease (FAD),5/188,3.5055917161933635E-5,2.6160178729497626E-4,0,0,13.297872340425531,136.4171029007316,IL1B;MTHFR;TNF;INS;SOD1
Edema,4/93,3.521907726220909E-5,2.6261994790060015E-4,0,0,21.505376344086024,220.51446568807026,IL6;TNF;INS;SOD1
Acrania,3/32,3.530743947937635E-5,2.630792382132758E-4,0,0,46.875,480.5351655987063,IFNG;MTHFR;INS
Chronic Persistent Hepatitis,3/32,3.530743947937635E-5,2.6287993576008394E-4,0,0,46.875,480.5351655987063,TGFB1;IFNG;SOD1
Fibrillation,3/32,3.530743947937635E-5,2.626809350517114E-4,0,0,46.875,480.5351655987063,HIF1A;TNF;SOD1
Folic Acid Deficiency,3/32,3.530743947937635E-5,2.624822354034121E-4,0,0,46.875,480.5351655987063,TGFB1;MTHFR;IL2
Gilbert Disease (disorder),3/32,3.530743947937635E-5,2.6228383613251005E-4,0,0,46.875,480.5351655987063,IL6;IL1B;HLA-DRB1
Iron deficiency anemia,3/32,3.530743947937635E-5,2.620857365583918E-4,0,0,46.875,480.5351655987063,IL1B;TNF;SOD1
Omenn Syndrome,3/32,3.530743947937635E-5,2.618879360024987E-4,0,0,46.875,480.5351655987063,IL10;IFNG;IL2RA
Myelodysplasia,4/94,3.673149706678225E-5,2.7224521355379786E-4,0,0,21.27659574468085,217.27395617597082,IL6;IRF1;CD14;TNF
Psychotic Disorders,6/317,3.686155374582549E-5,2.730032782320821E-4,0,0,9.46372239747634,96.60890965915598,IL10;IL6;TGFB1;IFNG;VDR;MTHFR
Muscular Dystrophy, Duchenne,5/190,3.687394424570206E-5,2.7288940063762036E-4,0,0,13.157894736842104,134.31586018867347,IL10;IL6;TGFB1;TNF;TLR4
Anorexia Nervosa,4/95,3.829095204397058E-5,2.831628868985274E-4,0,0,21.052631578947366,214.1115142894176,DPP4;IL6;IFNG;TNF
X-Linked Combined Immunodeficiency Diseases,3/33,3.8784405466391934E-5,2.8659634355165405E-4,0,0,45.45454545454545,461.7041960498276,IL21;IL15;IL2
Albuminuria,3/33,3.8784405466391934E-5,2.8638101947685946E-4,0,0,45.45454545454545,461.7041960498276,IL6;TNF;INS
Chronic Airflow Obstruction,3/33,3.8784405466391934E-5,2.8616601871148643E-4,0,0,45.45454545454545,461.7041960498276,IL6;TGFB1;TNF
Retinal Detachment,4/96,3.989834699662948E-5,2.9416425677635E-4,0,0,20.833333333333332,211.02449299130308,IL10;IL6;HMGB1;TNF
Aortic Aneurysm,4/96,3.989834699662948E-5,2.939437438402358E-4,0,0,20.833333333333332,211.02449299130308,IL6;TGFB1;IFNG;TLR4
Neoplasms, Intracranial,4/97,4.155459292530534E-5,3.059165088164052E-4,0,0,20.618556701030926,208.01036088769774,TGFB1;PRL;IL2;TGM2
Ductal Breast Carcinoma,4/97,4.155459292530534E-5,3.0568752939363837E-4,0,0,20.618556701030926,208.01036088769774,IL6;PRL;HIF1A;RUNX3
Disseminated Malignant Neoplasm,5/195,4.173986737809832E-5,3.068208052295814E-4,0,0,12.82051282051282,129.2827414571,DPP4;IL6;TNF;IL2;TGM2
Gait abnormality,5/195,4.173986737809832E-5,3.065914922211886E-4,0,0,12.82051282051282,129.2827414571,IL10;VDR;MTHFR;IL12A;TLR4
Renal interstitial fibrosis,3/34,4.2478836064023835E-5,3.117864083922526E-4,0,0,44.11764705882353,444.110496221857,IL6;TGFB1;IL1B
Sarcoma, Spindle Cell,3/34,4.2478836064023835E-5,3.115537319680793E-4,0,0,44.11764705882353,444.110496221857,IL6;IFNG;TNF
Thrombosis,4/98,4.326060697033117E-5,3.1705089135303113E-4,0,0,20.408163265306122,205.06669605685306,IL6;IL1B;MTHFR;TNF
Frontotemporal Lobar Degeneration,4/98,4.326060697033117E-5,3.1681463882594246E-4,0,0,20.408163265306122,205.06669605685306,IL6;TNF;HLA-DRB1;SOD1
Right Middle Cerebral Artery Infarction,3/35,4.6396897309267905E-5,3.3952993801599776E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Embolic Infarction, Middle Cerebral Artery,3/35,4.6396897309267905E-5,3.3927731157402154E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Thrombotic Infarction, Middle Cerebral Artery,3/35,4.6396897309267905E-5,3.390250607847472E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Deficiency of glucose-6-phosphate dehydrogenase,3/35,4.6396897309267905E-5,3.3877318481091007E-4,0,0,42.857142857142854,427.6404843986826,IL10;IL6;TNF
Inflammatory abnormality of the eye,3/35,4.6396897309267905E-5,3.38521682817732E-4,0,0,42.857142857142854,427.6404843986826,IL6;HMGB1;TNF
Left Middle Cerebral Artery Infarction,3/35,4.6396897309267905E-5,3.382705539729117E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Middle Cerebral Artery Embolus,3/35,4.6396897309267905E-5,3.38019797446616E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Middle Cerebral Artery Syndrome,3/35,4.6396897309267905E-5,3.3776941241147034E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Middle Cerebral Artery Thrombosis,3/35,4.6396897309267905E-5,3.375193980425499E-4,0,0,42.857142857142854,427.6404843986826,IL6;IL1B;IL6R
Myalgia,4/100,4.682563824405718E-5,3.403863703125695E-4,0,0,20.0,199.38159358629377,IL10;IL12A;TNF;TLR4
Squamous intraepithelial lesion,3/36,5.0544718638741474E-5,3.6714966354881837E-4,0,0,41.666666666666664,412.19383733014683,IL10;MTHFR;TNF
Stage IV Skin Melanoma,3/36,5.0544718638741474E-5,3.6687850426997875E-4,0,0,41.666666666666664,412.19383733014683,IL10;IL2;TGM2
Tethered Cord Syndrome,3/36,5.0544718638741474E-5,3.666077452262371E-4,0,0,41.666666666666664,412.19383733014683,IFNG;MTHFR;INS
Avellino corneal dystrophy,3/36,5.0544718638741474E-5,3.663373855321174E-4,0,0,41.666666666666664,412.19383733014683,CXCL10;TGFB1;TNF
Craniorachischisis,3/36,5.0544718638741474E-5,3.66067424304754E-4,0,0,41.666666666666664,412.19383733014683,IFNG;MTHFR;INS
Endometriosis of ovary,3/36,5.0544718638741474E-5,3.657978606638816E-4,0,0,41.666666666666664,412.19383733014683,TGFB1;ETS1;HLA-DRB1
Exencephaly,3/36,5.0544718638741474E-5,3.655286937318258E-4,0,0,41.666666666666664,412.19383733014683,IFNG;MTHFR;INS
Hepatic Encephalopathy,3/36,5.0544718638741474E-5,3.652599226334935E-4,0,0,41.666666666666664,412.19383733014683,HIF1A;TNF;TLR4
Hepatitis E,3/36,5.0544718638741474E-5,3.649915464963639E-4,0,0,41.666666666666664,412.19383733014683,IL10;IFNG;TNF
Lichen Sclerosus et Atrophicus,3/36,5.0544718638741474E-5,3.647235644504781E-4,0,0,41.666666666666664,412.19383733014683,CXCL10;IL1B;TNF
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,4/102,5.060089817750042E-5,3.6486106184040656E-4,0,0,19.6078431372549,193.95178884872362,TGFB1;IL15;IL1B;HIF1A
Papilloma,5/204,5.173951427176466E-5,3.7279761456224567E-4,0,0,12.254901960784313,120.94716628820336,TGFB1;IFNG;IL2RA;MTHFR;HLA-DRB1
HIV Coinfection,4/103,5.256972010323026E-5,3.7850198474325786E-4,0,0,19.41747572815534,191.32757800806039,IL10;IFNG;IL2RA;IL2
Meningitis, Bacterial,3/37,5.492839302764769E-5,3.951949097186834E-4,0,0,40.54054054054054,397.681628349338,IL1B;CD14;TLR4
Combined immunodeficiency,3/37,5.492839302764769E-5,3.949058132229126E-4,0,0,40.54054054054054,397.681628349338,IFNG;STAT1;IL17A
Ovarian Hyperstimulation Syndrome,3/37,5.492839302764769E-5,3.9461713938283735E-4,0,0,40.54054054054054,397.681628349338,IL6;MTHFR;IL2
Polycythemia Vera,5/207,5.5454271100282246E-5,3.9810414636491886E-4,0,0,12.077294685990339,118.35690605047688,IL6;IFNG;STAT1;MTHFR;TNFRSF14
Mixed Salivary Gland Tumor,4/105,5.667451085379945E-5,4.065672209278401E-4,0,0,19.047619047619047,186.25116175867572,IL6;IFNG;HIF1A;RUNX3
Scleritis,2/6,5.820444578089953E-5,4.172379964512623E-4,0,0,166.66666666666666,1625.2581363593886,STAT1;IL2
Sclerosing lymphocytic lobulitis,2/6,5.820444578089953E-5,4.1693388712440283E-4,0,0,166.66666666666666,1625.2581363593886,TNF;HLA-DRB1
Varicella Zoster Virus Infection,2/6,5.820444578089953E-5,4.1663022078272443E-4,0,0,166.66666666666666,1625.2581363593886,IFNG;HLA-DRB1
Autoimmune enteropathy,2/6,5.820444578089953E-5,4.1632699645901064E-4,0,0,166.66666666666666,1625.2581363593886,IL2RA;IL17A
Borderline lepromatous leprosy,2/6,5.820444578089953E-5,4.160242131888587E-4,0,0,166.66666666666666,1625.2581363593886,IL2RA;TNF
Bursitis,2/6,5.820444578089953E-5,4.1572187001066906E-4,0,0,166.66666666666666,1625.2581363593886,IL6;IL1B
Campylobacter jejuni infection,2/6,5.820444578089953E-5,4.154199659656359E-4,0,0,166.66666666666666,1625.2581363593886,CD14;TLR4
Centrocytic lymphoma,2/6,5.820444578089953E-5,4.151185000977363E-4,0,0,166.66666666666666,1625.2581363593886,IL6;IL6R
Cervical lymphadenitis,2/6,5.820444578089953E-5,4.1481747145372057E-4,0,0,166.66666666666666,1625.2581363593886,IL1B;TNF
Disseminated Bacillus Calmette-Guerin infection,2/6,5.820444578089953E-5,4.145168790831019E-4,0,0,166.66666666666666,1625.2581363593886,IFNG;STAT1
Hantavirus infection in conditions classified elsewhere and of unspecified site,2/6,5.820444578089953E-5,4.1421672203814674E-4,0,0,166.66666666666666,1625.2581363593886,TNF;HLA-DRB1
Neonatal Early-Onset Sepsis,2/6,5.820444578089953E-5,4.1391699937386444E-4,0,0,166.66666666666666,1625.2581363593886,IL6;TNF
Subfertility,3/38,5.955397710089613E-5,4.232078719794701E-4,0,0,39.473684210526315,384.02476888751795,IL1B;MTHFR;CD14
Alcohol abuse,4/107,6.1008580923105006E-5,4.3323145470540176E-4,0,0,18.691588785046726,181.39244921146928,CD14;TNF;TLR4;IL17A
Basal cell carcinoma,4/107,6.1008580923105006E-5,4.329186522110296E-4,0,0,18.691588785046726,181.39244921146928,IL6;TGFB1;TNF;RUNX3
Carcinoid Tumor,5/213,6.350065373755594E-5,4.5027736286630575E-4,0,0,11.737089201877934,113.43263329857982,TGFB1;IL12A;PRL;ETS1;S100A9
Stage 4S neuroblastoma,3/39,6.442749129145759E-5,4.565201041185618E-4,0,0,38.46153846153846,371.15269740519386,IL21;IL10;IL6
Dislocations,3/39,6.442749129145759E-5,4.56191199144413E-4,0,0,38.46153846153846,371.15269740519386,VDR;IL2RA;MTHFR
Low Grade Lymphoma (neoplasm),3/39,6.442749129145759E-5,4.558627677555401E-4,0,0,38.46153846153846,371.15269740519386,MTHFR;TNF;HLA-DRB1
Blast Phase,5/214,6.49249925625861E-5,4.5905239345690366E-4,0,0,11.682242990654204,112.64343358609109,IL6;IL1B;ETS1;IL2;HLA-DRB1
Cataract,7/519,6.749125524234453E-5,4.7685410245992956E-4,0,0,6.74373795761079,64.76357191050623,IL6;TGFB1;IFNG;MTHFR;CD14;IL2;TGM2
Adenocarcinoma of prostate,5/216,6.78476520417426E-5,4.7902781915678606E-4,0,0,11.574074074074073,111.09080760896899,IFNG;HIF1A;TNF;TLR4;TGM2
Anemia, severe,3/40,6.955491996561275E-5,4.907291840789966E-4,0,0,37.5,359.0022713293771,IL10;HIF1A;IL2
Depression, Neurotic,3/40,6.955491996561275E-5,4.903771545351809E-4,0,0,37.5,359.0022713293771,IL6;MTHFR;SOD1
Malignant neoplasm of stomach stage IV,3/40,6.955491996561275E-5,4.900256296932203E-4,0,0,37.5,359.0022713293771,IL1B;RUNX3;TGM2
Cholera,4/112,7.289810988400193E-5,5.132110486676009E-4,0,0,17.857142857142854,170.11514012148044,IL6;TGFB1;IL1B;SOD1
Cleft Palate,4/112,7.289810988400193E-5,5.128436821331216E-4,0,0,17.857142857142854,170.11514012148044,TGFB1;MTHFR;AHR;ETS1
Glomerulosclerosis (disorder),4/112,7.289810988400193E-5,5.124768411587775E-4,0,0,17.857142857142854,170.11514012148044,IL6;TGFB1;IL1B;TNF
Nonorganic psychosis,5/220,7.399716296888241E-5,5.198313921788251E-4,0,0,11.363636363636363,108.08504322447023,IL10;IL6;TGFB1;VDR;MTHFR
alpha 1-Antitrypsin Deficiency,3/41,7.494221155228124E-5,5.260943250970144E-4,0,0,36.58536585365854,347.516826368109,IL10;TGFB1;TNF
Breaking out,3/41,7.494221155228124E-5,5.257188116601142E-4,0,0,36.58536585365854,347.516826368109,IL10;IL12A;TLR4
Chronic viral hepatitis,3/41,7.494221155228124E-5,5.253438339057205E-4,0,0,36.58536585365854,347.516826368109,CXCL10;TGFB1;TNF
Growth Hormone-Secreting Pituitary Adenoma,3/41,7.494221155228124E-5,5.249693906883964E-4,0,0,36.58536585365854,347.516826368109,IL6;AHR;PRL
Lytic lesion,3/41,7.494221155228124E-5,5.245954808659688E-4,0,0,36.58536585365854,347.516826368109,VDR;TNF;HLA-DRB1
Adenocarcinoma, Clear Cell,4/113,7.546468032702863E-5,5.278767816754715E-4,0,0,17.699115044247787,167.99727117530395,IL6;IL2RA;HIF1A;IL6R
Erythema,4/113,7.546468032702863E-5,5.275013358848062E-4,0,0,17.699115044247787,167.99727117530395,IL6;IL1B;TNF;HLA-DRB1
Head and Neck Carcinoma,4/114,7.809647606557321E-5,5.455097134132576E-4,0,0,17.543859649122805,165.92220391115657,IL10;MTHFR;TNF;IL2
Acute Erythroblastic Leukemia,5/224,8.056827149560115E-5,5.623756905246932E-4,0,0,11.160714285714286,105.20542008766137,IL6;TGFB1;STAT1;TNF;TGM2
Cervical intraepithelial neoplasia grade 2,3/42,8.059527868276588E-5,5.621649388887317E-4,0,0,35.71428571428571,336.64537454658205,IL10;IFNG;MTHFR
Drug Allergy,3/42,8.059527868276588E-5,5.617662403505128E-4,0,0,35.71428571428571,336.64537454658205,IL10;TNF;HLA-DRB1
Melancholia,3/42,8.059527868276588E-5,5.613681069413346E-4,0,0,35.71428571428571,336.64537454658205,IL6;MTHFR;SOD1
PITUITARY ADENOMA PREDISPOSITION (disorder),3/42,8.059527868276588E-5,5.609705374604979E-4,0,0,35.71428571428571,336.64537454658205,IL10;VDR;PRL
Undifferentiated spondyloarthropathy,2/7,8.138329442154036E-5,5.660545064224336E-4,0,0,142.85714285714283,1345.1915048935111,IL10;HLA-DRB1
Acute-Phase Reaction,2/7,8.138329442154036E-5,5.6565418498932E-4,0,0,142.85714285714283,1345.1915048935111,IL6;TNF
Acute glaucoma,2/7,8.138329442154036E-5,5.652544293815538E-4,0,0,142.85714285714283,1345.1915048935111,IL1B;TLR4
Bacterial keratitis,2/7,8.138329442154036E-5,5.648552384003522E-4,0,0,142.85714285714283,1345.1915048935111,IL6;IL1B
Bullous keratopathy,2/7,8.138329442154036E-5,5.644566108503166E-4,0,0,142.85714285714283,1345.1915048935111,IFNG;IL2
Chemical Burns,2/7,8.138329442154036E-5,5.640585455394207E-4,0,0,142.85714285714283,1345.1915048935111,IL6;IL1B
Childhood Hodgkin Lymphoma,2/7,8.138329442154036E-5,5.636610412789984E-4,0,0,142.85714285714283,1345.1915048935111,IFNG;VDR
Chronic synovitis,2/7,8.138329442154036E-5,5.632640968837315E-4,0,0,142.85714285714283,1345.1915048935111,IL10;IL1B
Cytokine release syndrome,2/7,8.138329442154036E-5,5.628677111716387E-4,0,0,142.85714285714283,1345.1915048935111,IL6;IFNG
Deficiency of vitamin D3,2/7,8.138329442154036E-5,5.624718829640637E-4,0,0,142.85714285714283,1345.1915048935111,IL2RA;IL2
Elliptocytosis 4,2/7,8.138329442154036E-5,5.620766110856631E-4,0,0,142.85714285714283,1345.1915048935111,S100A9;TLR4
Epstein-Barr virus associated gastric carcinoma,2/7,8.138329442154036E-5,5.616818943643951E-4,0,0,142.85714285714283,1345.1915048935111,IL10;TNF
Hemangioma of liver,2/7,8.138329442154036E-5,5.612877316315078E-4,0,0,142.85714285714283,1345.1915048935111,HIF1A;IL17A
Hepatorenal Syndrome,2/7,8.138329442154036E-5,5.608941217215278E-4,0,0,142.85714285714283,1345.1915048935111,TLR4;TNF
Joint Tuberculosis,2/7,8.138329442154036E-5,5.605010634722485E-4,0,0,142.85714285714283,1345.1915048935111,IFNG;TNF
Moderate obesity,2/7,8.138329442154036E-5,5.601085557247189E-4,0,0,142.85714285714283,1345.1915048935111,IL6;TNF
Peritoneal infections,2/7,8.138329442154036E-5,5.59716597323232E-4,0,0,142.85714285714283,1345.1915048935111,IFNG;IL1B
Polio and Post-Polio Syndrome,2/7,8.138329442154036E-5,5.593251871153138E-4,0,0,142.85714285714283,1345.1915048935111,IL10;IFNG
Gastrointestinal Carcinoid Tumor,5/225,8.227921171843001E-5,5.650874163303496E-4,0,0,11.11111111111111,104.50435637446074,TGFB1;STAT1;CD14;TNF;RUNX3
Alzheimer Disease, Early Onset,4/116,8.355979601819322E-5,5.734816168064266E-4,0,0,17.241379310344826,161.89565624863212,IL1B;MTHFR;TNF;INS
Complex partial seizures,4/116,8.355979601819322E-5,5.73081420283882E-4,0,0,17.241379310344826,161.89565624863212,IL6;IFNG;IL1B;INS
Hyperhomocysteinemia,4/117,8.639335900397582E-5,5.921017658933573E-4,0,0,17.094017094017094,159.94187604253528,IL6;TGFB1;MTHFR;TNF
Sarcoma, Epithelioid,3/43,8.65199983160333E-5,5.925564762717598E-4,0,0,34.883720930232556,326.3419177793979,IFNG;TNF;IL2
Acute intermittent porphyria,3/43,8.65199983160333E-5,5.921438324860553E-4,0,0,34.883720930232556,326.3419177793979,IL10;TNF;HLA-DRB1
Depressive Syndrome,3/43,8.65199983160333E-5,5.917317630132049E-4,0,0,34.883720930232556,326.3419177793979,IL6;MTHFR;SOD1
Dissection of aorta,3/43,8.65199983160333E-5,5.913202666550594E-4,0,0,34.883720930232556,326.3419177793979,IL6;STAT1;IL17A
High Grade Lymphoma (neoplasm),3/43,8.65199983160333E-5,5.909093422168001E-4,0,0,34.883720930232556,326.3419177793979,IL10;MTHFR;HLA-DRB1
intracranial glioma,3/43,8.65199983160333E-5,5.904989885069273E-4,0,0,34.883720930232556,326.3419177793979,TGFB1;IFNG;TNF
Proliferative retinopathy,3/43,8.65199983160333E-5,5.900892043372487E-4,0,0,34.883720930232556,326.3419177793979,MTHFR;ETS1;INS
Pulmonary Cystic Fibrosis,3/43,8.65199983160333E-5,5.896799885228678E-4,0,0,34.883720930232556,326.3419177793979,TGFB1;IL1B;TNF
Abnormal behavior,6/372,8.944913013918543E-5,6.092211025695872E-4,0,0,8.064516129032258,75.17613284358698,IL6;IL1B;MTHFR;HIF1A;INS;SOD1
Metastatic Neoplasm,7/544,9.062166622802804E-5,6.167795953525343E-4,0,0,6.4338235294117645,59.89128733769112,IL6;TGFB1;HMGB1;ETS1;HIF1A;TNF;RUNX3
Confusion,3/44,9.27222118763579E-5,6.306393760005852E-4,0,0,34.090909090909086,316.5648580833318,IL10;IL12A;TLR4
Japanese Encephalitis,3/44,9.27222118763579E-5,6.302032491845405E-4,0,0,34.090909090909086,316.5648580833318,IL6;IL1B;TNF
Neurocognitive Disorders,3/44,9.27222118763579E-5,6.297677251699001E-4,0,0,34.090909090909086,316.5648580833318,IFNG;STAT1;INS
Gallbladder Carcinoma,5/233,9.699707482682551E-5,6.583475493080395E-4,0,0,10.729613733905579,99.15053365171762,TGFB1;MTHFR;HIF1A;TNF;TLR4
Encephalopathies,5/234,9.89703859177814E-5,6.712774001379956E-4,0,0,10.683760683760683,98.51164406754539,IL10;IL6;TGFB1;IFNG;TNF
Age-related cataract,3/45,9.920772536011586E-5,6.724231205787715E-4,0,0,33.333333333333336,307.2764890030534,MTHFR;CD14;IL2
gallbladder neoplasm,3/45,9.920772536011586E-5,6.719597000959467E-4,0,0,33.333333333333336,307.2764890030534,TGFB1;IL1B;TNF
Purpura,3/45,9.920772536011586E-5,6.714969179333461E-4,0,0,33.333333333333336,307.2764890030534,IL6;IL1B;HLA-DRB1
Congenital heart disease,4/122,1.0162141979249696E-4,6.873608490851067E-4,0,0,16.393442622950822,150.72551180837712,TGFB1;MTHFR;ETS1;INS
Peripheral T-Cell Lymphoma,4/123,1.0488636905788137E-4,7.08956832944194E-4,0,0,16.260162601626018,148.98590232936814,IL6;TNF;CCR4;IL2
Cognition Disorders,5/237,1.0507621911445254E-4,7.097519460184465E-4,0,0,10.548523206751055,96.63317062040024,IL6;MTHFR;TNF;TLR4;SOD1
Disseminated Intravascular Coagulation,3/46,1.0598230951311158E-4,7.153805892135031E-4,0,0,32.608695652173914,298.44255551627816,IL6;HMGB1;TNF
Early gastric cancer,3/46,1.0598230951311158E-4,7.148895936134939E-4,0,0,32.608695652173914,298.44255551627816,IL6;TGFB1;TNF
Infiltrating Cervical Carcinoma,3/46,1.0598230951311158E-4,7.143992715328262E-4,0,0,32.608695652173914,298.44255551627816,IL10;MTHFR;TNF
Moyamoya disease 1,3/46,1.0598230951311158E-4,7.139096215866077E-4,0,0,32.608695652173914,298.44255551627816,IL10;IL1B;MTHFR
Obstructive nephropathy,3/46,1.0598230951311158E-4,7.134206423937401E-4,0,0,32.608695652173914,298.44255551627816,IFNG;CD14;TNF
CNS disorder,4/124,1.0822688174225837E-4,7.280313441224607E-4,0,0,16.129032258064516,147.2787222172828,IL6;TNF;HLA-DRB1;IL17A
Rheumatic disease of heart valve,2/8,1.0837395249617636E-4,7.285220281343511E-4,0,0,125.0,1141.2403485573532,TGFB1;HLA-DRB1
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS,2/8,1.0837395249617636E-4,7.280240636585245E-4,0,0,125.0,1141.2403485573532,HMGB1;TNF
Shock, Hemorrhagic,2/8,1.0837395249617636E-4,7.275267794620364E-4,0,0,125.0,1141.2403485573532,IL6;TNF
Thyroid Gland Spindle Cell Tumor with Thymus-Like Differentiation,2/8,1.0837395249617636E-4,7.270301741518234E-4,0,0,125.0,1141.2403485573532,IL10;IL17A
Very Low Birth Weight,2/8,1.0837395249617636E-4,7.265342463386229E-4,0,0,125.0,1141.2403485573532,IL6;CD14
Vitamin Deficiency,2/8,1.0837395249617636E-4,7.260389946369606E-4,0,0,125.0,1141.2403485573532,MTHFR;PRL
Acute respiratory infections,2/8,1.0837395249617636E-4,7.255444176651371E-4,0,0,125.0,1141.2403485573532,IL10;IL6
Avitaminosis,2/8,1.0837395249617636E-4,7.250505140452153E-4,0,0,125.0,1141.2403485573532,MTHFR;PRL
Bacteremia due to Staphylococcus aureus,2/8,1.0837395249617636E-4,7.245572824030077E-4,0,0,125.0,1141.2403485573532,IL10;IL1B
Chronic tonsillitis,2/8,1.0837395249617636E-4,7.240647213680634E-4,0,0,125.0,1141.2403485573532,IFNG;IL2RA
Claudication (finding),2/8,1.0837395249617636E-4,7.235728295736558E-4,0,0,125.0,1141.2403485573532,HIF1A;HLA-DRB1
Disorder characterized by fever,2/8,1.0837395249617636E-4,7.230816056567694E-4,0,0,125.0,1141.2403485573532,IL1B;TNF
Drug Hypersensitivity Syndrome,2/8,1.0837395249617636E-4,7.225910482580877E-4,0,0,125.0,1141.2403485573532,IL10;IL1B
Histoplasmosis,2/8,1.0837395249617636E-4,7.221011560219805E-4,0,0,125.0,1141.2403485573532,STAT1;TNF
Legionnaires' Disease,2/8,1.0837395249617636E-4,7.216119275964914E-4,0,0,125.0,1141.2403485573532,IFNG;TLR4
Popliteal pterygium syndrome,2/8,1.0837395249617636E-4,7.211233616333252E-4,0,0,125.0,1141.2403485573532,IL10;IFNG
Medullary carcinoma of thyroid,5/239,1.0930500127516251E-4,7.268264902112971E-4,0,0,10.460251046025103,95.41180341535379,TGFB1;IL12A;PRL;HIF1A;IL2
Hypertension, Renovascular,3/47,1.1305169994989168E-4,7.512319858739251E-4,0,0,31.914893617021274,290.0318719851896,CXCL10;STAT1;PRL
Diabetic Foot,3/47,1.1305169994989168E-4,7.507243966942806E-4,0,0,31.914893617021274,290.0318719851896,TGFB1;HIF1A;TLR4
Nodule,4/126,1.1513884011471694E-4,7.640678734959068E-4,0,0,15.873015873015872,143.9582833724239,TGFB1;HMGB1;TLR4;IL17A
Dupuytren Contracture,3/48,1.2042159724849146E-4,7.985853291215749E-4,0,0,31.25,282.0159894386179,TGFB1;IL1B;HLA-DRB1
tumor vasculature,4/129,1.2610013613833674E-4,8.356791220280334E-4,0,0,15.503875968992247,139.20053078120654,CXCL10;IL6;HIF1A;TNF
Endometrial adenocarcinoma,4/129,1.2610013613833674E-4,8.351159959350226E-4,0,0,15.503875968992247,139.20053078120654,IFNG;ETS1;HIF1A;TNF
Malignant neoplasm of larynx,4/129,1.2610013613833674E-4,8.345536282609923E-4,0,0,15.503875968992247,139.20053078120654,CD80;IL1B;HIF1A;RUNX3
Airway Obstruction,3/49,1.280976670992302E-4,8.472031441798347E-4,0,0,30.612244897959183,274.368904922048,CXCL10;CD14;CCR4
Endogenous depression,3/49,1.280976670992302E-4,8.466334043384225E-4,0,0,30.612244897959183,274.368904922048,IL6;MTHFR;SOD1
Polyarthritis,3/49,1.280976670992302E-4,8.460644302763672E-4,0,0,30.612244897959183,274.368904922048,IL2RA;TNF;HLA-DRB1
Neoplastic Cell Transformation,4/131,1.3381580441233142E-4,8.832382308693037E-4,0,0,15.267175572519083,136.1686457644595,IL6;TGFB1;VDR;SOD1
stage, prostate cancer,3/50,1.3608554044552048E-4,8.976165714755539E-4,0,0,30.0,267.0668068825577,IL6;TGFB1;IL15
Turcot syndrome (disorder),3/50,1.3608554044552048E-4,8.970145482887829E-4,0,0,30.0,267.0668068825577,TGFB1;CD80;HIF1A
Varicella zoster,3/50,1.3608554044552048E-4,8.964133321036027E-4,0,0,30.0,267.0668068825577,CD80;IRF1;HLA-DRB1
Fibromyalgia,3/50,1.3608554044552048E-4,8.958129212984429E-4,0,0,30.0,267.0668068825577,IL10;IL6;TNF
Giant Cell Tumors,3/50,1.3608554044552048E-4,8.952133142560745E-4,0,0,30.0,267.0668068825577,IL6;TGFB1;IL17A
Hepatitis D Infection,3/50,1.3608554044552048E-4,8.946145093635955E-4,0,0,30.0,267.0668068825577,IL10;IFNG;VDR
Nausea and vomiting,4/132,1.3779933617700765E-4,9.052753181468124E-4,0,0,15.151515151515152,134.6926063134764,IL10;IL12A;TLR4;HLA-DRB1
Hyper-Immunoglobulin E Syndrome, Autosomal Dominant,2/9,1.391618496477865E-4,9.136156702327627E-4,0,0,111.1111111111111,986.6525462499828,IFNG;IL17A
Spinal Cord Contusion,2/9,1.391618496477865E-4,9.130057799322069E-4,0,0,111.1111111111111,986.6525462499828,HIF1A;SOD1
Spinal Cord Injuries,2/9,1.391618496477865E-4,9.123967033612047E-4,0,0,111.1111111111111,986.6525462499828,HIF1A;SOD1
Spinal Cord Laceration,2/9,1.391618496477865E-4,9.117884388922973E-4,0,0,111.1111111111111,986.6525462499828,HIF1A;SOD1
Spinal Cord transection injury,2/9,1.391618496477865E-4,9.111809849023623E-4,0,0,111.1111111111111,986.6525462499828,HIF1A;SOD1
Tophus,2/9,1.391618496477865E-4,9.105743397726004E-4,0,0,111.1111111111111,986.6525462499828,IL6;TNF
Venous retinal branch occlusion,2/9,1.391618496477865E-4,9.099685018885201E-4,0,0,111.1111111111111,986.6525462499828,MTHFR;TNF
Acute inflammatory demyelinating polyneuropathy,2/9,1.391618496477865E-4,9.093634696399241E-4,0,0,111.1111111111111,986.6525462499828,TNF;HLA-DRB1
Wasting Syndrome,2/9,1.391618496477865E-4,9.087592414208942E-4,0,0,111.1111111111111,986.6525462499828,IL6;TNF
West Nile Fever,2/9,1.391618496477865E-4,9.081558156297781E-4,0,0,111.1111111111111,986.6525462499828,STAT1;TNF
Asthenia,2/9,1.391618496477865E-4,9.075531906691744E-4,0,0,111.1111111111111,986.6525462499828,PRL;IL2
Avascular Necrosis of Femur Head,2/9,1.391618496477865E-4,9.06951364945919E-4,0,0,111.1111111111111,986.6525462499828,STAT1;HIF1A
Brucella melitensis infection,2/9,1.391618496477865E-4,9.063503368710707E-4,0,0,111.1111111111111,986.6525462499828,IFNG;TNF
Collagen-vascular disease,2/9,1.391618496477865E-4,9.057501048598979E-4,0,0,111.1111111111111,986.6525462499828,TNF;HLA-DRB1
Cytomegalovirus Retinitis,2/9,1.391618496477865E-4,9.051506673318636E-4,0,0,111.1111111111111,986.6525462499828,IL10;TNF
Hemorrhagic cystitis,2/9,1.391618496477865E-4,9.045520227106123E-4,0,0,111.1111111111111,986.6525462499828,TLR4;TNF
Majeed syndrome,2/9,1.391618496477865E-4,9.039541694239563E-4,0,0,111.1111111111111,986.6525462499828,IL1B;TNF
Nephrogenic Fibrosing Dermopathy,2/9,1.391618496477865E-4,9.033571059038611E-4,0,0,111.1111111111111,986.6525462499828,TLR4;TGM2
Oropharyngeal Neoplasms,2/9,1.391618496477865E-4,9.027608305864329E-4,0,0,111.1111111111111,986.6525462499828,HLA-DQA1;HLA-DRB1
Post-Traumatic Myelopathy,2/9,1.391618496477865E-4,9.021653419119035E-4,0,0,111.1111111111111,986.6525462499828,HIF1A;SOD1
Skin Carcinogenesis,4/134,1.4602326326789607E-4,9.460228288707202E-4,0,0,14.925373134328357,131.8170837536934,STAT1;AHR;HMGB1;TNF
Coronary Stenosis,3/52,1.530190484388178E-4,9.90692495426022E-4,0,0,28.846153846153847,253.41196571311022,IL6;MTHFR;TLR4
Drug usage,3/52,1.530190484388178E-4,9.900402949682037E-4,0,0,28.846153846153847,253.41196571311022,IL10;VDR;IL1B
Hippocampal sclerosis,3/52,1.530190484388178E-4,9.893889526688825E-4,0,0,28.846153846153847,253.41196571311022,IL1B;TNF;SOD1
Malignant ascites,3/52,1.530190484388178E-4,9.887384668354382E-4,0,0,28.846153846153847,253.41196571311022,IL10;CD80;IL2
Non-arthropod borne lymphocytic choriomeningitis,3/52,1.530190484388178E-4,9.880888357796987E-4,0,0,28.846153846153847,253.41196571311022,IFNG;STAT1;TNF
Urothelial Carcinoma,5/257,1.5353147665000808E-4,9.907467843179773E-4,0,0,9.727626459143968,85.42417268822662,IL6;AHR;HMGB1;HIF1A;TNF
Narcolepsy,5/258,1.5633740694893916E-4,0.0010081916243400092,0,0,9.689922480620154,84.91757772560956,IFNG;VDR;TNF;HLA-DQA1;HLA-DRB1
Tumor-Associated Vasculature,3/53,1.6197577235511928E-4,0.0010438674693154836,0,0,28.30188679245283,247.0206732248935,IL6;TNF;IL6R
Drug habituation,4/138,1.6352944458286405E-4,0.001053189633918996,0,0,14.492753623188406,126.3553260094094,IL6;IL1B;MTHFR;HIF1A
Rotavirus Infections,3/54,1.7126647861235583E-4,0.00110229662855418,0,0,27.777777777777775,240.89694055493615,STAT1;FUT2;TLR4
Malignant neoplasm of nasopharynx,3/54,1.7126647861235583E-4,0.0011015752302370634,0,0,27.777777777777775,240.89694055493615,IL6;ETS1;HLA-DRB1
COPPER TOXICOSIS, IDIOPATHIC,2/10,1.7373245503849396E-4,0.0011167054075332365,0,0,100.0,865.7994056813733,S100A9;TLR4
Seropositive rheumatoid arthritis,2/10,1.7373245503849396E-4,0.0011159755347178552,0,0,100.0,865.7994056813733,TNF;HLA-DRB1
Hemoglobinuria, Paroxysmal,2/10,1.7373245503849396E-4,0.00111524661536141,0,0,100.0,865.7994056813733,HLA-DQA1;HLA-DRB1
Leprosy, Multibacillary,2/10,1.7373245503849396E-4,0.0011145186475968137,0,0,100.0,865.7994056813733,IL10;IFNG
Spondylitis,2/10,1.7373245503849396E-4,0.0011137916295618517,0,0,100.0,865.7994056813733,IL6;TNF
Toxoplasmosis, Cerebral,2/10,1.7373245503849396E-4,0.0011130655593991647,0,0,100.0,865.7994056813733,IL6;HLA-DRB1
Tuberculosis, Spinal,2/10,1.7373245503849396E-4,0.0011123404352562335,0,0,100.0,865.7994056813733,IFNG;VDR
Vitamin B 6 Deficiency,2/10,1.7373245503849396E-4,0.0011116162552853635,0,0,100.0,865.7994056813733,IFNG;MTHFR
Vitamin B6 measurement,2/10,1.7373245503849396E-4,0.0011108930176436686,0,0,100.0,865.7994056813733,MTHFR;FUT2
Anterior myocardial infarction,2/10,1.7373245503849396E-4,0.001110170720493055,0,0,100.0,865.7994056813733,TNF;IL17A
Atopic rhinitis,2/10,1.7373245503849396E-4,0.001109449362000207,0,0,100.0,865.7994056813733,IFNG;IL2
Familial psoriasis,2/10,1.7373245503849396E-4,0.0011087289403365706,0,0,100.0,865.7994056813733,IL10;HLA-DRB1
Genital infection,2/10,1.7373245503849396E-4,0.0011080094536783378,0,0,100.0,865.7994056813733,IFNG;IL2
Leukostasis,2/10,1.7373245503849396E-4,0.0011072909002064323,0,0,100.0,865.7994056813733,HMGB1;TNF
Liver Dysplastic Nodule,2/10,1.7373245503849396E-4,0.001106573278106493,0,0,100.0,865.7994056813733,IL15;VDR
Pustular psoriasis,2/10,1.7373245503849396E-4,0.0011058565855688591,0,0,100.0,865.7994056813733,IL1B;IL17A
Fetal Alcohol Syndrome,3/55,1.8089662634638277E-4,0.0011507132969140776,0,0,27.27272727272727,235.02504040938138,IL6;IFNG;TNF
Hypocholesterolemia,3/55,1.8089662634638277E-4,0.001149968980421895,0,0,27.27272727272727,235.02504040938138,CXCL10;IL6;TNF
Insulin Sensitivity,3/55,1.8089662634638277E-4,0.0011492256262005493,0,0,27.27272727272727,235.02504040938138,AHR;TNF;INS
Lymphocytic Choriomeningitis,3/55,1.8089662634638277E-4,0.0011484832323851743,0,0,27.27272727272727,235.02504040938138,IFNG;STAT1;TNF
Clear-cell metastatic renal cell carcinoma,4/142,1.8250609711554592E-4,0.0011579534683354327,0,0,14.084507042253522,121.24967572742938,VDR;AHR;HIF1A;IL2
Lymphatic Metastasis,4/142,1.8250609711554592E-4,0.001157206401581668,0,0,14.084507042253522,121.24967572742938,IL6;TGFB1;HIF1A;TNF
Caries (morphologic abnormality),3/56,1.9087164058820475E-4,0.0012094690417155875,0,0,26.785714285714285,229.39043021362917,IL10;CXCL10;TNF
Familial Mediterranean Fever,3/56,1.9087164058820475E-4,0.0012086897446526264,0,0,26.785714285714285,229.39043021362917,IL1B;TNF;TLR4
Malignant neoplasm of colon stage IV,3/57,2.011969126931025E-4,0.0012732538686077344,0,0,26.31578947368421,223.9796437980026,IFNG;TNFRSF9;MTHFR
Heart valve disease,3/58,2.1187780017250157E-4,0.00133998392541528,0,0,25.862068965517242,218.78019475250414,TGFB1;IL1B;TNF
Secondary Sj??gren's syndrome,2/11,2.12071277436947E-4,0.001340345025498595,0,0,90.9090909090909,768.96255686131,HLA-DRB1;IL17A
Sexual Dysfunction,2/11,2.12071277436947E-4,0.0013394836212405623,0,0,90.9090909090909,768.96255686131,TGFB1;PRL
Spontaneous pneumothorax,2/11,2.12071277436947E-4,0.001338623323474833,0,0,90.9090909090909,768.96255686131,TGFB1;HIF1A
Sleep Apnea, Mixed Central and Obstructive,2/11,2.12071277436947E-4,0.0013377641300708054,0,0,90.9090909090909,768.96255686131,IL10;IL1B
Alopecia totalis,2/11,2.12071277436947E-4,0.001336906038903345,0,0,90.9090909090909,768.96255686131,VDR;HLA-DRB1
HIV-Associated Lipodystrophy Syndrome,2/11,2.12071277436947E-4,0.001336049047852766,0,0,90.9090909090909,768.96255686131,IL6;TNF
Hyperplastic lymph node,2/11,2.12071277436947E-4,0.0013351931548048143,0,0,90.9090909090909,768.96255686131,IFNG;IL2
Hypersomnia with Periodic Respiration,2/11,2.12071277436947E-4,0.0013343383576506498,0,0,90.9090909090909,768.96255686131,IL10;IL1B
Immunoglobulin G4 related sclerosing disease,2/11,2.12071277436947E-4,0.0013334846542868298,0,0,90.9090909090909,768.96255686131,IL10;TGFB1
Indolent Systemic Mastocytosis,2/11,2.12071277436947E-4,0.001332632042615291,0,0,90.9090909090909,768.96255686131,IL6;IL2RA
Inflammatory polyarthritis,2/11,2.12071277436947E-4,0.0013317805205433323,0,0,90.9090909090909,768.96255686131,TNF;HLA-DRB1
Lymphohistiocytosis,2/11,2.12071277436947E-4,0.0013309300859835984,0,0,90.9090909090909,768.96255686131,IFNG;IL2
Multi-centric Castleman's Disease,2/11,2.12071277436947E-4,0.001330080736854062,0,0,90.9090909090909,768.96255686131,IL6;TLR4
Pathological Dilatation,2/11,2.12071277436947E-4,0.001329232471078007,0,0,90.9090909090909,768.96255686131,IL6;HLA-DRB1
Plasma cell inflammation,2/11,2.12071277436947E-4,0.001328385286584012,0,0,90.9090909090909,768.96255686131,IL10;IL6
Postherpetic neuralgia,2/11,2.12071277436947E-4,0.0013275391813059331,0,0,90.9090909090909,768.96255686131,TNF;HLA-DRB1
Dwarfism,5/277,2.175158520254143E-4,0.0013607548018496319,0,0,9.025270758122744,76.11226378353696,TGFB1;STAT1;VDR;PRL;SOD1
Chromophobe Renal Cell Carcinoma,4/149,2.194708295898175E-4,0.0013721115223974088,0,0,13.422818791946309,113.07773461862489,IL6;HIF1A;IL6R;TGM2
Sleep Apnea Syndromes,3/59,2.2291962695649187E-4,0.0013927870907364287,0,0,25.423728813559322,213.78048988234374,IL10;IL1B;SOD1
Chronic lung disease,3/59,2.2291962695649187E-4,0.0013919022196495568,0,0,25.423728813559322,213.78048988234374,IL6;TGFB1;HLA-DRB1
Monoclonal Gammopathy of Undetermined Significance,4/150,2.2515997735880313E-4,0.0014049982587189314,0,0,13.333333333333334,111.98265863899319,IL6;IL1B;IL2RA;TNF
Pheochromocytoma,5/280,2.2863938825846484E-4,0.001425804510028041,0,0,8.928571428571427,74.85146892279322,CXCL10;TGFB1;IFNG;HIF1A;TNF
Pulmonary Hypertension,4/151,2.309547028315399E-4,0.0014393296255094318,0,0,13.245033112582782,110.90448951403066,IL6;HMGB1;HIF1A;TNF
Androgenetic Alopecia,3/60,2.3432768351734756E-4,0.0014594248882183092,0,0,25.0,208.96975163200412,TGFB1;VDR;MTHFR
Anaplasia,5/283,2.4019186633024875E-4,0.0014950004194386858,0,0,8.8339222614841,73.62254868342721,TGFB1;VDR;IL1B;ETS1;HIF1A
Viremia,3/61,2.461072269097227E-4,0.001530849257005541,0,0,24.59016393442623,204.33794840788337,IFNG;IL2;HLA-DRB1
Brain Infarction,3/61,2.461072269097227E-4,0.0015298809779056006,0,0,24.59016393442623,204.33794840788337,IL6;IL1B;TNF
Gastrointestinal Hemorrhage,3/61,2.461072269097227E-4,0.0015289139229258879,0,0,24.59016393442623,204.33794840788337,IL10;IL12A;TLR4
Hemiparesis,3/61,2.461072269097227E-4,0.0015279480897465285,0,0,24.59016393442623,204.33794840788337,IL10;IL12A;TLR4
Dyssomnias,2/12,2.5416386531107297E-4,0.0015769712552255208,0,0,83.33333333333333,689.7942799948735,IL6;IL1B
Focal Emphysema,2/12,2.5416386531107297E-4,0.0015759763206796371,0,0,83.33333333333333,689.7942799948735,TGFB1;TNF
Foot Ulcer,2/12,2.5416386531107297E-4,0.0015749826407800915,0,0,83.33333333333333,689.7942799948735,TGFB1;HIF1A
Idiopathic urticaria,2/12,2.5416386531107297E-4,0.0015739902131551512,0,0,83.33333333333333,689.7942799948735,TLR4;TNF
Nevus sebaceous,2/12,2.5416386531107297E-4,0.0015729990354390586,0,0,83.33333333333333,689.7942799948735,HMGB1;TNF
Onchocerciasis,2/12,2.5416386531107297E-4,0.0015720091052720106,0,0,83.33333333333333,689.7942799948735,IL10;IL2
Panacinar Emphysema,2/12,2.5416386531107297E-4,0.0015710204203001415,0,0,83.33333333333333,689.7942799948735,TGFB1;TNF
Other specified transient cerebral ischemias,4/155,2.5521264922218734E-4,0.001576511575459244,0,0,12.903225806451612,106.75372182973324,IL10;IL1B;HIF1A;TNF
Arsenic Poisoning, Inorganic,3/62,2.582634811033408E-4,0.0015943552087208754,0,0,24.193548387096772,199.87573184447314,IL1B;MTHFR;TNF
Nervous System, Organic Arsenic Poisoning,3/62,2.582634811033408E-4,0.0015933543579934927,0,0,24.193548387096772,199.87573184447314,IL1B;MTHFR;TNF
Arsenic Encephalopathy,3/62,2.582634811033408E-4,0.0015923547630386661,0,0,24.193548387096772,199.87573184447314,IL1B;MTHFR;TNF
Arsenic Induced Polyneuropathy,3/62,2.582634811033408E-4,0.0015913564214944413,0,0,24.193548387096772,199.87573184447314,IL1B;MTHFR;TNF
Arsenic Poisoning,3/62,2.582634811033408E-4,0.001590359331004783,0,0,24.193548387096772,199.87573184447314,IL1B;MTHFR;TNF
Cancer of Nasopharynx,3/62,2.582634811033408E-4,0.0015893634892195578,0,0,24.193548387096772,199.87573184447314,IL6;ETS1;HLA-DRB1
Precursor cell lymphoblastic lymphoma,3/62,2.582634811033408E-4,0.0015883688937945143,0,0,24.193548387096772,199.87573184447314,MTHFR;TNF;IL2
Dystrophia myotonica 2,3/63,2.708016367972711E-4,0.0016644393286076177,0,0,23.809523809523807,195.57438030098453,VDR;TNF;TLR4
Iron deficiency,3/63,2.708016367972711E-4,0.0016633990540272378,0,0,23.809523809523807,195.57438030098453,IL1B;HIF1A;TNF
Lymphangioleiomyomatosis,3/63,2.708016367972711E-4,0.0016623600789778766,0,0,23.809523809523807,195.57438030098453,PRL;HIF1A;TNF
Papule,3/63,2.708016367972711E-4,0.0016613224010259553,0,0,23.809523809523807,195.57438030098453,IL10;IL12A;TLR4
Cardiomegaly,4/159,2.8125326516434125E-4,0.0017243649969027736,0,0,12.578616352201259,102.8459747803751,IL1B;AHR;HIF1A;TNF
Diaphragmatic Hernia,3/64,2.837268518273068E-4,0.0017384460721688103,0,0,23.4375,191.42574778030507,IL6;TGFB1;TNF
Mastocytosis,3/64,2.837268518273068E-4,0.0017373629281986116,0,0,23.4375,191.42574778030507,IL6;IL2RA;IL6R
Turner Syndrome,4/160,2.8805079581776285E-4,0.0017627417318162972,0,0,12.5,101.90467148766533,TNF;HLA-DRB1;INS;SOD1
Juvenile psoriatic arthritis,4/161,2.949656467645758E-4,0.0018039342728078727,0,0,12.422360248447204,100.97703925529166,ZMIZ1;IL2RA;CD14;FUT2
Multiple, subcutaneous nodules,3/65,2.9704425115584785E-4,0.0018155167290793985,0,0,23.076923076923077,187.42221776467645,IL10;IL12A;TLR4
Subcutaneous nodule,3/65,2.9704425115584785E-4,0.0018143883780979942,0,0,23.076923076923077,187.42221776467645,IL10;IL12A;TLR4
Hepatic methionine adenosyltransferase deficiency,3/65,2.9704425115584785E-4,0.0018132614287948278,0,0,23.076923076923077,187.42221776467645,TGFB1;VDR;HLA-DRB1
Secondary Trigeminal Neuralgia,2/13,2.999958070148033E-4,0.0018301420182132134,0,0,76.92307692307692,623.9801584633129,IL1B;TNF
Skin symptom,2/13,2.999958070148033E-4,0.001829006694380575,0,0,76.92307692307692,623.9801584633129,IFNG;TNF
Trigeminal Neuralgia, Idiopathic,2/13,2.999958070148033E-4,0.001827872778265026,0,0,76.92307692307692,623.9801584633129,IL1B;TNF
Urolithiasis,2/13,2.999958070148033E-4,0.0018267402672499918,0,0,76.92307692307692,623.9801584633129,IL6;VDR
Acute asthma,2/13,2.999958070148033E-4,0.001825609158725379,0,0,76.92307692307692,623.9801584633129,IL10;CD14
Alopecia universalis,2/13,2.999958070148033E-4,0.0018244794500875538,0,0,76.92307692307692,623.9801584633129,VDR;HLA-DRB1
Autoinflammatory disease,2/13,2.999958070148033E-4,0.001823351138739324,0,0,76.92307692307692,623.9801584633129,IL1B;TNF
Cow milk allergy,2/13,2.999958070148033E-4,0.0018222242220899177,0,0,76.92307692307692,623.9801584633129,IL2RA;HLA-DRB1
Liver and Intrahepatic Bile Duct Epithelial Neoplasm,2/13,2.999958070148033E-4,0.001821098697554964,0,0,76.92307692307692,623.9801584633129,IL10;MTHFR
Liver and Intrahepatic Bile Duct Neoplasm,2/13,2.999958070148033E-4,0.0018199745625564734,0,0,76.92307692307692,623.9801584633129,IL10;MTHFR
Lysinuric Protein Intolerance,2/13,2.999958070148033E-4,0.0018188518145228173,0,0,76.92307692307692,623.9801584633129,CXCL10;TLR4
Morphea,2/13,2.999958070148033E-4,0.0018177304508887094,0,0,76.92307692307692,623.9801584633129,TGFB1;TNF
Musculoskeletal Diseases,2/13,2.999958070148033E-4,0.001816610469095186,0,0,76.92307692307692,623.9801584633129,VDR;TNF
Pemphigus and fogo selvagem,2/13,2.999958070148033E-4,0.0018154918665895855,0,0,76.92307692307692,623.9801584633129,IL6;HLA-DRB1
Diffuse Astrocytoma,3/66,3.107589269041786E-4,0.001879469989916472,0,0,22.727272727272727,183.55666138685666,TGFB1;ETS1;HIF1A
Tongue Carcinoma,3/67,3.2487593877538796E-4,0.001963641283077806,0,0,22.388059701492537,179.82239944826273,PRL;HIF1A;CCR4
Keratoconus,4/166,3.31341425925819E-4,0.0020014895722181617,0,0,12.048192771084338,96.53447248133352,IL6;IL1B;TNF;SOD1
Carcinoma, Large Cell,3/68,3.3940031385696067E-4,0.0020489104942175733,0,0,22.058823529411764,176.2131679505288,IL10;IL6;TNF
Wiskott-Aldrich Syndrome,3/68,3.3940031385696067E-4,0.002047652722275144,0,0,22.058823529411764,176.2131679505288,IL6;IL2RA;IL2
Human papilloma virus infection,3/68,3.3940031385696067E-4,0.0020463964936111713,0,0,22.058823529411764,176.2131679505288,IL10;TGFB1;HLA-DRB1
Osteoarthritis of hip,3/68,3.3940031385696067E-4,0.0020451418053870074,0,0,22.058823529411764,176.2131679505288,IL6;TGFB1;IL1B
Multiple Sclerosis, Primary Progressive,2/14,3.4955273047183893E-4,0.002105027104826736,0,0,71.42857142857142,568.4897238318184,TNF;HLA-DRB1
Tuberculosis, Multidrug-Resistant,2/14,3.4955273047183893E-4,0.0021037380496492547,0,0,71.42857142857142,568.4897238318184,VDR;HLA-DRB1
Vasculitis of the skin,2/14,3.4955273047183893E-4,0.0021024505722626883,0,0,71.42857142857142,568.4897238318184,IL10;HLA-DRB1
Acute myocarditis,2/14,3.4955273047183893E-4,0.002101164669772008,0,0,71.42857142857142,568.4897238318184,IL10;IL17A
AIDS-Related Non-Hodgkin Lymphoma,2/14,3.4955273047183893E-4,0.002099880339289262,0,0,71.42857142857142,568.4897238318184,IL6;TNF
Allergy to peanuts,2/14,3.4955273047183893E-4,0.002098597577933557,0,0,71.42857142857142,568.4897238318184,AHR;HLA-DRB1
Angioedema,2/14,3.4955273047183893E-4,0.0020973163828310335,0,0,71.42857142857142,568.4897238318184,DPP4;HLA-DRB1
ARTERIAL TORTUOSITY SYNDROME,2/14,3.4955273047183893E-4,0.002096036751114846,0,0,71.42857142857142,568.4897238318184,TGFB1;MTHFR
Centriacinar Emphysema,2/14,3.4955273047183893E-4,0.002094758679925142,0,0,71.42857142857142,568.4897238318184,TGFB1;TNF
Deficiency of mevalonate kinase,2/14,3.4955273047183893E-4,0.002093482166409039,0,0,71.42857142857142,568.4897238318184,IL1B;TNF
Drug-induced depressive state,2/14,3.4955273047183893E-4,0.0020922072077206046,0,0,71.42857142857142,568.4897238318184,IL6;IFNG
Enterovirus 71 infection,2/14,3.4955273047183893E-4,0.0020909338010208357,0,0,71.42857142857142,568.4897238318184,IL10;CXCL10
Female pattern alopecia (disorder),2/14,3.4955273047183893E-4,0.0020896619434776355,0,0,71.42857142857142,568.4897238318184,VDR;MTHFR
Hashimoto's encephalitis,2/14,3.4955273047183893E-4,0.002088391632265795,0,0,71.42857142857142,568.4897238318184,IL10;HIF1A
Hip Dysplasia,2/14,3.4955273047183893E-4,0.0020871228645669704,0,0,71.42857142857142,568.4897238318184,IL6;TGFB1
Mastitis-metritis-agalactia syndrome,2/14,3.4955273047183893E-4,0.0020858556375696617,0,0,71.42857142857142,568.4897238318184,IL1B;TNF
Milk-Alkali Syndrome,2/14,3.4955273047183893E-4,0.0020845899484691947,0,0,71.42857142857142,568.4897238318184,IL6;TNF
Oral Mucositis,2/14,3.4955273047183893E-4,0.0020833257944676974,0,0,71.42857142857142,568.4897238318184,MTHFR;TNF
POEMS Syndrome,2/14,3.4955273047183893E-4,0.0020820631727740805,0,0,71.42857142857142,568.4897238318184,IL6;IL1B
Radiation Damage,2/14,3.4955273047183893E-4,0.0020808020806040175,0,0,71.42857142857142,568.4897238318184,IL1B;TNF
Diphtheria,3/69,3.5433704688318525E-4,0.002108005143322,0,0,21.73913043478261,172.72308669478417,IL2RA;TNF;IL2
Chromosome 8, trisomy,3/70,3.6969110044934205E-4,0.0021980182306207707,0,0,21.428571428571427,169.34663067148233,IL10;CD14;TNF
Squamous cell carcinoma of oropharynx,3/70,3.6969110044934205E-4,0.0021966893199613867,0,0,21.428571428571427,169.34663067148233,IL10;TNF;S100A9
Blood Coagulation Disorders,4/171,3.708296898856671E-4,0.002202123378970596,0,0,11.695906432748536,92.39494336453413,IL1B;MTHFR;HIF1A;TLR4
Pterygium,3/71,3.854674048883194E-4,0.0022876652507502434,0,0,21.12676056338028,166.07860397227958,IL6;HMGB1;S100A9
Cholestasis,5/315,3.930774288457704E-4,0.0023314212255257888,0,0,7.936507936507936,62.234158297913524,IL6;VDR;CD14;TNF;IL2
Contact hypersensitivity,3/72,4.0167085866975067E-4,0.002380953678532153,0,0,20.833333333333332,162.91411592166432,AHR;TLR4;SOD1
Hyperuricemia,3/72,4.0167085866975067E-4,0.002379518504524599,0,0,20.833333333333332,162.91411592166432,IL6;MTHFR;TNF
Rectal Neoplasms,3/72,4.0167085866975067E-4,0.002378085059642355,0,0,20.833333333333332,162.91411592166432,VDR;MTHFR;TNF
Reproductive tract infection,2/15,4.0282030348904685E-4,0.002383454510951446,0,0,66.66666666666667,521.1346661672503,TNF;TLR4
Down Syndrome, Partial Trisomy 21,2/15,4.0282030348904685E-4,0.002382020422798046,0,0,66.66666666666667,521.1346661672503,MTHFR;SOD1
Heart Failure, Diastolic,2/15,4.0282030348904685E-4,0.00238058805934477,0,0,66.66666666666667,521.1346661672503,IL6;TNF
Stromal keratitis,2/15,4.0282030348904685E-4,0.002379157417482183,0,0,66.66666666666667,521.1346661672503,CXCL10;IFNG
Symmetric Diabetic Proximal Motor Neuropathy,2/15,4.0282030348904685E-4,0.0023777284941083198,0,0,66.66666666666667,521.1346661672503,TGFB1;TLR4
Trisomy 21, Meiotic Nondisjunction,2/15,4.0282030348904685E-4,0.002376301286128663,0,0,66.66666666666667,521.1346661672503,MTHFR;SOD1
Trisomy 21, Mitotic Nondisjunction,2/15,4.0282030348904685E-4,0.00237487579045612,0,0,66.66666666666667,521.1346661672503,MTHFR;SOD1
Aspergillosis,2/15,4.0282030348904685E-4,0.0023734520040110028,0,0,66.66666666666667,521.1346661672503,IFNG;TLR4
Asymmetric Diabetic Proximal Motor Neuropathy,2/15,4.0282030348904685E-4,0.002372029923721002,0,0,66.66666666666667,521.1346661672503,TGFB1;TLR4
Diabetic Amyotrophy,2/15,4.0282030348904685E-4,0.002370609546521169,0,0,66.66666666666667,521.1346661672503,TGFB1;TLR4
Diabetic Asymmetric Polyneuropathy,2/15,4.0282030348904685E-4,0.0023691908693538916,0,0,66.66666666666667,521.1346661672503,TGFB1;TLR4
Diabetic Autonomic Neuropathy,2/15,4.0282030348904685E-4,0.002367773889168871,0,0,66.66666666666667,521.1346661672503,TGFB1;TLR4
Diabetic Mononeuropathy,2/15,4.0282030348904685E-4,0.0023663586029231036,0,0,66.66666666666667,521.1346661672503,TGFB1;TLR4
Dysmorphism,2/15,4.0282030348904685E-4,0.002364945007580856,0,0,66.66666666666667,521.1346661672503,MTHFR;ETS1
Group B streptococcal pneumonia,2/15,4.0282030348904685E-4,0.002363533100113643,0,0,66.66666666666667,521.1346661672503,IL10;IFNG
Leptospirosis,2/15,4.0282030348904685E-4,0.0023621228775002104,0,0,66.66666666666667,521.1346661672503,IL1B;TNF
Malignant tumor of peritoneum,2/15,4.0282030348904685E-4,0.0023607143367265072,0,0,66.66666666666667,521.1346661672503,IL10;TNF
Middle East Respiratory Syndrome,2/15,4.0282030348904685E-4,0.002359307474785669,0,0,66.66666666666667,521.1346661672503,DPP4;TNF
Nicotine Use Disorder,2/15,4.0282030348904685E-4,0.0023579022886779945,0,0,66.66666666666667,521.1346661672503,IL6;AHR
orbit (eye disorders),2/15,4.0282030348904685E-4,0.002356498775410924,0,0,66.66666666666667,521.1346661672503,IL10;IFNG
Patent ductus arteriosus - persisting type,2/15,4.0282030348904685E-4,0.0023550969319990197,0,0,66.66666666666667,521.1346661672503,MTHFR;CD14
Periodic fever,2/15,4.0282030348904685E-4,0.0023536967554639433,0,0,66.66666666666667,521.1346661672503,IL6;TNF
Plasmacytosis,2/15,4.0282030348904685E-4,0.002352298242834434,0,0,66.66666666666667,521.1346661672503,IL6;TGM2
Multiple malignancy,4/176,4.135815182623096E-4,0.0024137049652505813,0,0,11.363636363636363,88.53018091841936,ETS1;HIF1A;IL6R;TGM2
Hepatitis, Alcoholic,3/73,4.183063282338499E-4,0.002439830619514704,0,0,20.54794520547945,159.8485592706754,TNF;TLR4;IL17A
Marfan Syndrome,3/73,4.183063282338499E-4,0.0024383835076407334,0,0,20.54794520547945,159.8485592706754,TGFB1;MTHFR;SOD1
Photoreceptor degeneration,3/74,4.353786484560862E-4,0.0025363967735781948,0,0,20.27027027027027,156.87759018814896,HMGB1;INS;IL17A
Breast Fibrocystic Disease,3/75,4.528926224719671E-4,0.0026368653398427086,0,0,20.0,153.99710994129103,IL10;MTHFR;PRL
Malignant Fibrous Histiocytoma,3/75,4.528926224719671E-4,0.0026353041407072187,0,0,20.0,153.99710994129103,STAT1;CD14;TNF
Sacroiliitis,2/16,4.597842333580924E-4,0.0026738221570670605,0,0,62.5,480.29707727752503,TNF;HLA-DRB1
Depression, Postpartum,2/16,4.597842333580924E-4,0.002672240949404691,0,0,62.5,480.29707727752503,IL10;MTHFR
Neuralgia, Atypical,2/16,4.597842333580924E-4,0.002670661610782111,0,0,62.5,480.29707727752503,HMGB1;TNF
Neuralgia, Iliohypogastric Nerve,2/16,4.597842333580924E-4,0.0026690841378873786,0,0,62.5,480.29707727752503,HMGB1;TNF
Neuralgia, Ilioinguinal,2/16,4.597842333580924E-4,0.002667508527416371,0,0,62.5,480.29707727752503,HMGB1;TNF
Neuralgia, Perineal,2/16,4.597842333580924E-4,0.0026659347760727625,0,0,62.5,480.29707727752503,HMGB1;TNF
Neuralgia, Stump,2/16,4.597842333580924E-4,0.0026643628805680026,0,0,62.5,480.29707727752503,HMGB1;TNF
Neuralgia, Supraorbital,2/16,4.597842333580924E-4,0.002662792837621292,0,0,62.5,480.29707727752503,HMGB1;TNF
Neuralgia, Vidian,2/16,4.597842333580924E-4,0.0026612246439595595,0,0,62.5,480.29707727752503,HMGB1;TNF
Steroid-sensitive nephrotic syndrome,2/16,4.597842333580924E-4,0.002659658296317441,0,0,62.5,480.29707727752503,TNF;HLA-DQA1
Achalasia,2/16,4.597842333580924E-4,0.002658093791437254,0,0,62.5,480.29707727752503,TNF;HLA-DQA1
Acute type B viral hepatitis,2/16,4.597842333580924E-4,0.0026565311260689783,0,0,62.5,480.29707727752503,IL6;IFNG
Adenosine deaminase deficiency,2/16,4.597842333580924E-4,0.0026549702969702305,0,0,62.5,480.29707727752503,DPP4;TLR4
Common Cold,2/16,4.597842333580924E-4,0.002653411300906243,0,0,62.5,480.29707727752503,CXCL10;IL6
Desmoplastic Small Round Cell Tumor,2/16,4.597842333580924E-4,0.002651854134649843,0,0,62.5,480.29707727752503,IL15;IL2
Latent Autoimmune Diabetes in Adults,2/16,4.597842333580924E-4,0.0026502987949814263,0,0,62.5,480.29707727752503,IL6;IFNG
Paroxysmal Nerve Pain,2/16,4.597842333580924E-4,0.0026487452786889405,0,0,62.5,480.29707727752503,HMGB1;TNF
Rachischisis,2/16,4.597842333580924E-4,0.002647193582567857,0,0,62.5,480.29707727752503,IL10;MTHFR
Respiration Disorders,3/76,4.708530218453342E-4,0.0027093346011100375,0,0,19.736842105263158,151.2032480561327,IL10;CD14;TNF
Hypertrophic Cardiomyopathy,5/328,4.727265384339158E-4,0.0027185233585304415,0,0,7.621951219512195,58.361230788926854,IL10;TGFB1;HIF1A;TNF;INS
Mental disorders,5/329,4.7932197603780895E-4,0.0027548399885962494,0,0,7.598784194528875,58.07855625055236,IL10;IL6;IL1B;MTHFR;TGM2
Niemann-Pick Disease, Type C,3/77,4.892645868866266E-4,0.0028103403623154686,0,0,19.48051948051948,148.49234683132352,IFNG;IL12A;TNF
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME,2/17,5.204302673761171E-4,0.0029876102031381304,0,0,58.8235294117647,444.7561559567371,IL10;TNF
Acute hepatitis C,2/17,5.204302673761171E-4,0.002985866122459124,0,0,58.8235294117647,444.7561559567371,CXCL10;IFNG
Acute malaria,2/17,5.204302673761171E-4,0.002984124076880093,0,0,58.8235294117647,444.7561559567371,DPP4;IL2RA
Zollinger-Ellison syndrome,2/17,5.204302673761171E-4,0.0029823840628410954,0,0,58.8235294117647,444.7561559567371,IL6;TNF
Aggressive natural killer-cell leukemia,2/17,5.204302673761171E-4,0.002980646076790489,0,0,58.8235294117647,444.7561559567371,IFNG;IL2
Complement deficiency disease,2/17,5.204302673761171E-4,0.0029789101151849033,0,0,58.8235294117647,444.7561559567371,IL1B;TLR4
Coronary Restenosis,2/17,5.204302673761171E-4,0.0029771761744892193,0,0,58.8235294117647,444.7561559567371,MTHFR;TNF
Erythema Multiforme,2/17,5.204302673761171E-4,0.002975444251176544,0,0,58.8235294117647,444.7561559567371,IFNG;TNF
Macroangiopathy,2/17,5.204302673761171E-4,0.0029737143417281854,0,0,58.8235294117647,444.7561559567371,MTHFR;SOD1
Meningoencephalitis,2/17,5.204302673761171E-4,0.002971986442633631,0,0,58.8235294117647,444.7561559567371,IL10;TNF
Mesangial proliferative glomerulonephritis,2/17,5.204302673761171E-4,0.002970260550390522,0,0,58.8235294117647,444.7561559567371,IL6;IL1B
Mycobacterium avium-intracellulare Infection,2/17,5.204302673761171E-4,0.002968536661504631,0,0,58.8235294117647,444.7561559567371,TNFRSF9;HLA-DRB1
Nerve Pain,2/17,5.204302673761171E-4,0.002966814772489837,0,0,58.8235294117647,444.7561559567371,HMGB1;TNF
Oral infection,2/17,5.204302673761171E-4,0.002965094879868104,0,0,58.8235294117647,444.7561559567371,IFNG;IL15
Pediatric Crohn's disease,2/17,5.204302673761171E-4,0.002963376980169455,0,0,58.8235294117647,444.7561559567371,TNF;S100A9
Post-transplant lymphoproliferative disorder,2/17,5.204302673761171E-4,0.002961661069931951,0,0,58.8235294117647,444.7561559567371,IL10;TNF
Pseudopelade,2/17,5.204302673761171E-4,0.002959947145701666,0,0,58.8235294117647,444.7561559567371,VDR;MTHFR
Dyspnea,4/188,5.304157410164595E-4,0.0030149947384093484,0,0,10.638297872340425,80.2324408712782,TGFB1;MTHFR;HLA-DRB1;SOD1
Muscle Weakness,5/339,5.491666225213217E-4,0.003119774315687601,0,0,7.374631268436578,55.36215826431995,TGFB1;MTHFR;HLA-DRB1;INS;SOD1
Insulin Resistance,3/81,5.675162160009338E-4,0.0032221544603449896,0,0,18.518518518518515,138.41187471418468,AHR;TNF;INS
Primary immune deficiency disorder,3/81,5.675162160009338E-4,0.0032202940940283934,0,0,18.518518518518515,138.41187471418468,STAT1;IL1B;TLR4
Refractory anemia with excess blasts in transformation (clinical),2/18,5.847441918510701E-4,0.0033161372865045105,0,0,55.55555555555555,413.57422695854274,IL6;TNF
Residual Cancer,2/18,5.847441918510701E-4,0.003314224865924058,0,0,55.55555555555555,413.57422695854274,HIF1A;IL2
Sexually Transmitted Diseases,2/18,5.847441918510701E-4,0.0033123146498630065,0,0,55.55555555555555,413.57422695854274,CXCL10;IL1B
Small intestine biopsy shows villous atrophy,2/18,5.847441918510701E-4,0.003310406634511703,0,0,55.55555555555555,413.57422695854274,STAT1;IL2RA
Stenosis,2/18,5.847441918510701E-4,0.0033085008160692667,0,0,55.55555555555555,413.57422695854274,TGFB1;TLR4
Tactile Amnesia,2/18,5.847441918510701E-4,0.003306597190743565,0,0,55.55555555555555,413.57422695854274,IL6;IL2
Temporary Amnesia,2/18,5.847441918510701E-4,0.0033046957547511885,0,0,55.55555555555555,413.57422695854274,IL6;IL2
Thymus Hyperplasia,2/18,5.847441918510701E-4,0.003302796504317423,0,0,55.55555555555555,413.57422695854274,HMGB1;HLA-DRB1
Tobacco Use Disorder,2/18,5.847441918510701E-4,0.00330089943567623,0,0,55.55555555555555,413.57422695854274,IL6;AHR
Tooth Loss,2/18,5.847441918510701E-4,0.0032990045450702163,0,0,55.55555555555555,413.57422695854274,VDR;IL1B
Variable degree of villous atrophy,2/18,5.847441918510701E-4,0.0032971118287506117,0,0,55.55555555555555,413.57422695854274,STAT1;IL2RA
Villous atrophy,2/18,5.847441918510701E-4,0.003295221282977246,0,0,55.55555555555555,413.57422695854274,STAT1;IL2RA
Villous atrophy of intestine,2/18,5.847441918510701E-4,0.0032933329040185193,0,0,55.55555555555555,413.57422695854274,STAT1;IL2RA
Vitamin B 12 Deficiency,2/18,5.847441918510701E-4,0.003291446688151384,0,0,55.55555555555555,413.57422695854274,MTHFR;FUT2
Amnestic State,2/18,5.847441918510701E-4,0.0032895626316613146,0,0,55.55555555555555,413.57422695854274,IL6;IL2
Biopsy shows villous atrophy,2/18,5.847441918510701E-4,0.0032876807308422863,0,0,55.55555555555555,413.57422695854274,STAT1;IL2RA
Canarypox (disorder),2/18,5.847441918510701E-4,0.0032858009819967506,0,0,55.55555555555555,413.57422695854274,IFNG;TNF
Compression of spinal cord,2/18,5.847441918510701E-4,0.0032839233814356095,0,0,55.55555555555555,413.57422695854274,TNF;SOD1
Congenital bilateral aplasia of vas deferens,2/18,5.847441918510701E-4,0.0032820479254781934,0,0,55.55555555555555,413.57422695854274,TGFB1;TNF
Coxsackievirus Infections,2/18,5.847441918510701E-4,0.0032801746104522355,0,0,55.55555555555555,413.57422695854274,IL6;TNF
Degeneration of lumbar intervertebral disc,2/18,5.847441918510701E-4,0.0032783034326938484,0,0,55.55555555555555,413.57422695854274,IL1B;HIF1A
Diabetic Neuralgia,2/18,5.847441918510701E-4,0.003276434388547501,0,0,55.55555555555555,413.57422695854274,TGFB1;TLR4
Disease due to Papilloma virus,2/18,5.847441918510701E-4,0.003274567474365992,0,0,55.55555555555555,413.57422695854274,TGFB1;TNF
Dissociative Amnesia,2/18,5.847441918510701E-4,0.0032727026865104307,0,0,55.55555555555555,413.57422695854274,IL6;IL2
Duodenal villous atrophy,2/18,5.847441918510701E-4,0.0032708400213502086,0,0,55.55555555555555,413.57422695854274,STAT1;IL2RA
Global Amnesia,2/18,5.847441918510701E-4,0.0032689794752629787,0,0,55.55555555555555,413.57422695854274,IL6;IL2
Hysterical amnesia,2/18,5.847441918510701E-4,0.0032671210446346315,0,0,55.55555555555555,413.57422695854274,IL6;IL2
Immunosuppression,2/18,5.847441918510701E-4,0.0032652647258592706,0,0,55.55555555555555,413.57422695854274,IL10;TLR4
Infective vaginitis,2/18,5.847441918510701E-4,0.0032634105153391915,0,0,55.55555555555555,413.57422695854274,IL6;FUT2
Pleocytosis,2/18,5.847441918510701E-4,0.003261558409484856,0,0,55.55555555555555,413.57422695854274,IL6;IL1B
Primary antiphospholipid syndrome,2/18,5.847441918510701E-4,0.00325970840471487,0,0,55.55555555555555,413.57422695854274,HLA-DRB1;IL17A
Malignant neoplasm of tongue,3/82,5.88253622315865E-4,0.003277413038616962,0,0,18.29268292682927,136.0674214498671,PRL;HIF1A;CCR4
Adverse reaction to drug,3/83,6.094699830789859E-4,0.0033936946139944894,0,0,18.072289156626503,133.78772636187645,MTHFR;HMGB1;SOD1
Drug toxicity,3/83,6.094699830789859E-4,0.003391772929615104,0,0,18.072289156626503,133.78772636187645,MTHFR;HMGB1;SOD1
Maturity onset diabetes mellitus in young,3/83,6.094699830789859E-4,0.0033898534203170762,0,0,18.072289156626503,133.78772636187645,IL6R;INS;TGM2
MRSA - Methicillin resistant Staphylococcus aureus infection,3/83,6.094699830789859E-4,0.003387936082409657,0,0,18.072289156626503,133.78772636187645,IL1B;FUT2;IL17A
Protein Deficiency,3/83,6.094699830789859E-4,0.003386020912210443,0,0,18.072289156626503,133.78772636187645,IFNG;STAT1;SOD1
Arteriovenous Malformations, Cerebral,2/19,6.527118331915355E-4,0.003624210111077068,0,0,52.63157894736842,386.01972752026137,IL6;IL1B
Research-Related Injuries,2/19,6.527118331915355E-4,0.0036221636909127106,0,0,52.63157894736842,386.01972752026137,IL6;TNF
Hand, Foot and Mouth Disease,2/19,6.527118331915355E-4,0.003620119580477658,0,0,52.63157894736842,386.01972752026137,IL6;VDR
THANATOPHORIC DYSPLASIA, TYPE I (disorder),2/19,6.527118331915355E-4,0.0036180777758637395,0,0,52.63157894736842,386.01972752026137,STAT1;TNF
Thyrotoxicosis,2/19,6.527118331915355E-4,0.0036160382731715954,0,0,52.63157894736842,386.01972752026137,IL10;MTHFR
Traumatic injury,2/19,6.527118331915355E-4,0.0036140010685106537,0,0,52.63157894736842,386.01972752026137,IL6;TNF
Wounds and Injuries,2/19,6.527118331915355E-4,0.003611966157999105,0,0,52.63157894736842,386.01972752026137,IL6;TNF
Cavitation,2/19,6.527118331915355E-4,0.0036099335377638773,0,0,52.63157894736842,386.01972752026137,TNF;HLA-DRB1
Cerebral Small Vessel Diseases,2/19,6.527118331915355E-4,0.003607903203940613,0,0,52.63157894736842,386.01972752026137,TGFB1;MTHFR
Eosinophilic leukemia,2/19,6.527118331915355E-4,0.0036058751526736425,0,0,52.63157894736842,386.01972752026137,IFNG;TNF
Gastric Cardia Carcinoma,2/19,6.527118331915355E-4,0.0036038493801159605,0,0,52.63157894736842,386.01972752026137,TLR4;IL2
Injury wounds,2/19,6.527118331915355E-4,0.0036018258824292025,0,0,52.63157894736842,386.01972752026137,IL6;TNF
Hip Dislocation, Congenital,3/85,6.533576327403233E-4,0.0036033663381436014,0,0,17.64705882352941,129.41269239052198,IL6;TGFB1;VDR
Hypogammaglobulinemia,3/85,6.533576327403233E-4,0.003601345381139595,0,0,17.64705882352941,129.41269239052198,IL21;IL10;TGFB1
Malignant neoplasm of gallbladder,4/203,7.073839063017471E-4,0.003896955734940342,0,0,9.852216748768473,71.46735992063044,MTHFR;HIF1A;TNF;TLR4
Anaplastic carcinoma,4/204,7.204968607247876E-4,0.003966970950814125,0,0,9.80392156862745,70.93695587855785,TGFB1;ETS1;HIF1A;TLR4
Brain Tumor, Primary,3/88,7.228933733743304E-4,0.003977937331199843,0,0,17.045454545454543,123.27696860327161,MTHFR;IL2;TGM2
5,10-Methylenetetrahydrofolate reductase deficiency,2/20,7.243190568082219E-4,0.003983552149026975,0,0,50.0,361.51392882265003,IL1B;MTHFR
Rift Valley Fever,2/20,7.243190568082219E-4,0.003981324211583448,0,0,50.0,361.51392882265003,IL1B;TNF
stage, gastric cancer,2/20,7.243190568082219E-4,0.003979098764846957,0,0,50.0,361.51392882265003,IL1B;TNF
Arteriosclerosis Obliterans,2/20,7.243190568082219E-4,0.003976875804643131,0,0,50.0,361.51392882265003,HMGB1;HIF1A
Autoimmune gastritis,2/20,7.243190568082219E-4,0.003974655326806927,0,0,50.0,361.51392882265003,IL2RA;HLA-DRB1
Autoimmune pancreatitis,2/20,7.243190568082219E-4,0.003972437327182592,0,0,50.0,361.51392882265003,IL10;HLA-DRB1
Corneal pannus,2/20,7.243190568082219E-4,0.003970221801623651,0,0,50.0,361.51392882265003,IL1B;TNF
Cutaneous Fibrous Histiocytoma,2/20,7.243190568082219E-4,0.0039680087459928685,0,0,50.0,361.51392882265003,TGFB1;IL1B
Eczema Herpeticum,2/20,7.243190568082219E-4,0.003965798156162231,0,0,50.0,361.51392882265003,IFNG;CD14
Filarial Elephantiases,2/20,7.243190568082219E-4,0.0039635900280129205,0,0,50.0,361.51392882265003,IL10;TLR4
Peyronie Disease,2/20,7.243190568082219E-4,0.003961384357435284,0,0,50.0,361.51392882265003,TGFB1;HIF1A
Prune Belly Syndrome,2/20,7.243190568082219E-4,0.003959181140328813,0,0,50.0,361.51392882265003,IFNG;HIF1A
Non-obstructive azoospermia,3/89,7.470773989519929E-4,0.004081309992718281,0,0,16.85393258426966,121.33722076085462,IL1B;MTHFR;HLA-DRB1
Liver Dysfunction,4/207,7.608698625146863E-4,0.004154349449330187,0,0,9.661835748792269,69.3821084371817,MTHFR;AHR;TNF;SOD1
Degenerative disorder,3/90,7.717714102118617E-4,0.0042115321596680605,0,0,16.666666666666668,119.44703587579703,IL6;IL1B;SOD1
Colorectal cancer metastatic,4/208,7.746764528126629E-4,0.004225038944640872,0,0,9.615384615384615,68.87562592328644,MTHFR;HIF1A;TNF;IL17A
Lymphadenopathy,3/91,7.969797201838036E-4,0.004344268824163296,0,0,16.483516483516485,117.60463722012365,IL6;IL2RA;HLA-DRB1
Prolactinoma,3/91,7.969797201838036E-4,0.004341860692886043,0,0,16.483516483516485,117.60463722012365,IL6;TGFB1;PRL
Anaplastic large cell lymphoma, ALK negative,2/21,7.995517676019706E-4,0.004353459707474885,0,0,47.61904761904761,339.5932989435837,IL21;CCR4
Regurgitation,2/21,7.995517676019706E-4,0.004351049153927002,0,0,47.61904761904761,339.5932989435837,TNF;HLA-DRB1
Severe diarrhea,2/21,7.995517676019706E-4,0.004348641268396329,0,0,47.61904761904761,339.5932989435837,VDR;MTHFR
Siderosis,2/21,7.995517676019706E-4,0.004346236046455844,0,0,47.61904761904761,339.5932989435837,TNF;INS
Chagas Cardiomyopathy,2/21,7.995517676019706E-4,0.004343833483688318,0,0,47.61904761904761,339.5932989435837,CXCL10;IL6
Chediak-Higashi Syndrome,2/21,7.995517676019706E-4,0.00434143357568628,0,0,47.61904761904761,339.5932989435837,IL6;TLR4
Diabetic Ketoacidosis,2/21,7.995517676019706E-4,0.004339036318051997,0,0,47.61904761904761,339.5932989435837,HLA-DRB1;INS
Herpes encephalitis,2/21,7.995517676019706E-4,0.004336641706397443,0,0,47.61904761904761,339.5932989435837,STAT1;TNF
Lumbar disc disease,2/21,7.995517676019706E-4,0.004334249736344273,0,0,47.61904761904761,339.5932989435837,VDR;HIF1A
Neonatal Systemic lupus erythematosus,2/21,7.995517676019706E-4,0.004331860403523797,0,0,47.61904761904761,339.5932989435837,TNF;HLA-DQA1
Otitis Media with Effusion,2/21,7.995517676019706E-4,0.004329473703576951,0,0,47.61904761904761,339.5932989435837,IL1B;TNF
Papillon-Lefevre Disease,2/21,7.995517676019706E-4,0.004327089632154277,0,0,47.61904761904761,339.5932989435837,IL2;SOD1
Raynaud Phenomenon,2/21,7.995517676019706E-4,0.004324708184915887,0,0,47.61904761904761,339.5932989435837,IL1B;HLA-DRB1
Premature aging syndrome,3/92,8.227066124479392E-4,0.0044475030732334135,0,0,16.304347826086957,115.808329994441,VDR;IL1B;SOD1
Growth failure,4/212,8.316811550718451E-4,0.004493547219376632,0,0,9.433962264150942,66.90623978934374,IL21;IL6;VDR;SOD1
Recurrent respiratory infections,4/213,8.463832464968848E-4,0.004570469531083178,0,0,9.389671361502348,66.4275895858453,IL21;TGFB1;STAT1;IL2RA
PARKINSON DISEASE, LATE-ONSET,3/93,8.48956340775112E-4,0.004581846741975729,0,0,16.129032258064516,114.05649673013475,IL6;TGFB1;MTHFR
Coughing,3/93,8.48956340775112E-4,0.004579332007210648,0,0,16.129032258064516,114.05649673013475,TGFB1;IL1B;HLA-DRB1
Intraepithelial Neoplasia,3/93,8.48956340775112E-4,0.004576820031342733,0,0,16.129032258064516,114.05649673013475,TGFB1;PRL;S100A9
Mucinous Adenocarcinoma,3/93,8.48956340775112E-4,0.004574310809834321,0,0,16.129032258064516,114.05649673013475,AHR;ETS1;HIF1A
Panic Disorder,3/93,8.48956340775112E-4,0.004571804338157699,0,0,16.129032258064516,114.05649673013475,IL10;HLA-DRB1;INS
Parkinsonian Disorders,4/214,8.612682384784104E-4,0.004635566400747983,0,0,9.345794392523363,65.95424821596035,PRL;TNF;HLA-DRB1;SOD1
AMYOTROPHIC LATERAL SCLEROSIS 1,3/94,8.757331296734359E-4,0.004710840283760552,0,0,15.957446808510637,112.34759297766323,TNF;SOD1;IL17A
Severe depression,2/22,8.78395909700633E-4,0.004722579321957233,0,0,45.45454545454545,319.88241562516987,IL1B;MTHFR
Lymphoma, Mixed-Cell,2/22,8.78395909700633E-4,0.004719997266559771,0,0,45.45454545454545,319.88241562516987,MTHFR;HLA-DRB1
Tuberculosis, extrapulmonary,2/22,8.78395909700633E-4,0.004717418033080776,0,0,45.45454545454545,319.88241562516987,IL10;TNF
Abnormality of the immune system,2/22,8.78395909700633E-4,0.00471484161689668,0,0,45.45454545454545,319.88241562516987,IL2;INS
Adult Rickets,2/22,8.78395909700633E-4,0.004712268013394007,0,0,45.45454545454545,319.88241562516987,TGFB1;VDR
Anti-nuclear factor positive,2/22,8.78395909700633E-4,0.0047096972179693514,0,0,45.45454545454545,319.88241562516987,IL2RA;IL12A
Cluster Headache,2/22,8.78395909700633E-4,0.004707129226029346,0,0,45.45454545454545,319.88241562516987,MTHFR;IL2
Diabetic Polyneuropathies,2/22,8.78395909700633E-4,0.004704564032990638,0,0,45.45454545454545,319.88241562516987,TGFB1;TLR4
Epidermodysplasia Verruciformis,2/22,8.78395909700633E-4,0.004702001634279859,0,0,45.45454545454545,319.88241562516987,IL10;SOD1
Gastrointestinal inflammation,2/22,8.78395909700633E-4,0.004699442025333599,0,0,45.45454545454545,319.88241562516987,VDR;IRF1
Herpes zoster disease,2/22,8.78395909700633E-4,0.004696885201598379,0,0,45.45454545454545,319.88241562516987,IL10;HLA-DRB1
Lower respiratory tract infection,2/22,8.78395909700633E-4,0.004694331158530626,0,0,45.45454545454545,319.88241562516987,IL10;IL2
Pneumoconiosis,2/22,8.78395909700633E-4,0.004691779891596642,0,0,45.45454545454545,319.88241562516987,IL6;TNF
Carcinoma,4/216,8.915919966614546E-4,0.004759677427044419,0,0,9.259259259259258,65.02316604509961,TGFB1;HIF1A;RUNX3;TLR4
Rotting teeth,3/95,9.030411744885328E-4,0.004818180598736863,0,0,15.789473684210526,110.68014328652502,TGFB1;VDR;HLA-DRB1
Agenesis,3/95,9.030411744885328E-4,0.004815566284792893,0,0,15.789473684210526,110.68014328652502,IL10;IFNG;TNF
Intermittent migraine headaches,3/95,9.030411744885328E-4,0.004812954806330424,0,0,15.789473684210526,110.68014328652502,IL10;IL12A;TLR4
synovial sarcoma,4/217,9.070333002260409E-4,0.004831611530960179,0,0,9.216589861751151,64.56526630258679,IL6;IL1B;MTHFR;TNF
Neoplasm, Residual,4/220,9.544901413225243E-4,0.005081651738308651,0,0,9.09090909090909,63.22121130438145,IL15;MTHFR;TNF;IL2
Skin Diseases, Infectious,2/23,9.608374667470638E-4,0.005112674944878258,0,0,43.47826086956522,302.0741431562353,IL15;HIF1A
Alveolitis,2/23,9.608374667470638E-4,0.005109908345882113,0,0,43.47826086956522,302.0741431562353,TNF;IL2
beta^0^ Thalassemia,2/23,9.608374667470638E-4,0.005107144739421386,0,0,43.47826086956522,302.0741431562353,IL6;TNF
Camurati-Engelmann Syndrome,2/23,9.608374667470638E-4,0.005104384120643321,0,0,43.47826086956522,302.0741431562353,TGFB1;TLR4
Capillary malformation (disorder),2/23,9.608374667470638E-4,0.0051016264847056425,0,0,43.47826086956522,302.0741431562353,STAT1;IL17A
Chronic urticaria,2/23,9.608374667470638E-4,0.005098871826776536,0,0,43.47826086956522,302.0741431562353,HLA-DRB1;IL17A
Cryptogenic Chronic Hepatitis,2/23,9.608374667470638E-4,0.005096120142034616,0,0,43.47826086956522,302.0741431562353,TGFB1;SOD1
Diffuse Mixed-Cell Lymphoma,2/23,9.608374667470638E-4,0.005093371425668901,0,0,43.47826086956522,302.0741431562353,MTHFR;HLA-DRB1
Esophageal Achalasia,2/23,9.608374667470638E-4,0.005090625672878784,0,0,43.47826086956522,302.0741431562353,TNF;HLA-DQA1
Exfoliation Syndrome,2/23,9.608374667470638E-4,0.005087882878874,0,0,43.47826086956522,302.0741431562353,MTHFR;TLR4
Functional Gastrointestinal Disorders,2/23,9.608374667470638E-4,0.005085143038874606,0,0,43.47826086956522,302.0741431562353,MTHFR;TLR4
Meningomyelocele,2/23,9.608374667470638E-4,0.005082406148110949,0,0,43.47826086956522,302.0741431562353,MTHFR;SOD1
Multi-infarct dementia,2/23,9.608374667470638E-4,0.005079672201823638,0,0,43.47826086956522,302.0741431562353,IL6;IL1B
Status Epilepticus,4/221,9.706909649038684E-4,0.005129005808104956,0,0,9.049773755656108,62.78282719551607,IL1B;TNF;S100A9;TLR4
Myelofibrosis,3/98,9.881943586653454E-4,0.00521868573721817,0,0,15.306122448979592,105.91272184080921,TGFB1;IFNG;IL1B
Nephrolithiasis,3/99,0.0010176687967361172,0.005371454851945521,0,0,15.151515151515152,104.39758728497266,IL6;VDR;IL1B
Secondary hypothyroidism,2/24,0.0010468624608583276,0.005522578779020743,0,0,41.666666666666664,285.9149050295893,PRL;TNF
Severe combined immunodeficiency due to adenosine deaminase deficiency,2/24,0.0010468624608583276,0.005519616022165045,0,0,41.666666666666664,285.9149050295893,DPP4;TLR4
Lymphoma, Undifferentiated,2/24,0.0010468624608583276,0.005516656442528496,0,0,41.666666666666664,285.9149050295893,MTHFR;HLA-DRB1
Acute Lung Injury,2/24,0.0010468624608583276,0.005513700035003025,0,0,41.666666666666664,285.9149050295893,TGFB1;IL1B
Candidemia,2/24,0.0010468624608583276,0.005510746794491508,0,0,41.666666666666664,285.9149050295893,IL10;TLR4
Congenital hypoplasia of adrenal gland,2/24,0.0010468624608583276,0.005507796715907732,0,0,41.666666666666664,285.9149050295893,CXCL10;IFNG
Dupuytren's Disease,2/24,0.0010468624608583276,0.005504849794176375,0,0,41.666666666666664,285.9149050295893,TGFB1;HLA-DRB1
Elastosis perforans serpiginosa,2/24,0.0010468624608583276,0.005501906024232965,0,0,41.666666666666664,285.9149050295893,TGFB1;TLR4
Eosinophilic granulomatosis with polyangiitis,2/24,0.0010468624608583276,0.0054989654010238614,0,0,41.666666666666664,285.9149050295893,IL10;HLA-DRB1
Familial primary pulmonary hypertension,2/24,0.0010468624608583276,0.00549602791950622,0,0,41.666666666666664,285.9149050295893,IL6;TGFB1
Healing ulcer,2/24,0.0010468624608583276,0.005493093574647968,0,0,41.666666666666664,285.9149050295893,TGFB1;IL1B
Heart Block,2/24,0.0010468624608583276,0.005490162361427772,0,0,41.666666666666664,285.9149050295893,TGFB1;TNF
Paroxysmal nonkinesigenic dyskinesia,2/24,0.0010468624608583276,0.00548723427483501,0,0,41.666666666666664,285.9149050295893,HMGB1;HIF1A
Penis carcinoma,2/24,0.0010468624608583276,0.005484309309869747,0,0,41.666666666666664,285.9149050295893,RUNX3;TLR4
POLYCYSTIC KIDNEY DISEASE 1,2/24,0.0010468624608583276,0.005481387461542698,0,0,41.666666666666664,285.9149050295893,IL6;TNF
Oral Cavity Carcinoma,3/100,0.0010476950310726527,0.005482825753664553,0,0,15.0,102.917441044757,IL6;TGFB1;TNF
Single Seizure,3/101,0.0010782770834010882,0.005639865447400689,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Sleep disturbances,3/101,0.0010782770834010882,0.005636865518971221,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;AHR
Seizures, Auditory,3/101,0.0010782770834010882,0.005633868780258317,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Seizures, Clonic,3/101,0.0010782770834010882,0.005630875226177415,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Seizures, Sensory,3/101,0.0010782770834010882,0.005627884851654751,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Seizures, Somatosensory,3/101,0.0010782770834010882,0.005624897651627333,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Vertiginous seizure,3/101,0.0010782770834010882,0.005621913621042915,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Atonic Absence Seizures,3/101,0.0010782770834010882,0.005618932754859965,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Generalized Absence Seizures,3/101,0.0010782770834010882,0.005615955048047639,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Gustatory seizure,3/101,0.0010782770834010882,0.00561298049558575,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Hemangioma,3/101,0.0010782770834010882,0.005610009092464741,0,0,14.85148514851485,101.47115056675547,TGFB1;CD14;HIF1A
Jacksonian Seizure,3/101,0.0010782770834010882,0.0056070408336856585,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Non-epileptic convulsion,3/101,0.0010782770834010882,0.005604075714260124,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Nonepileptic Seizures,3/101,0.0010782770834010882,0.005601113729210304,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Olfactory seizure,3/101,0.0010782770834010882,0.005598154873568882,0,0,14.85148514851485,101.47115056675547,IL6;IL1B;INS
Childhood Acute Myeloid Leukemia,3/102,0.0011094189470398966,0.00575679483184166,0,0,14.705882352941176,100.05763046841133,IL6;RUNX3;TLR4
Ductal Carcinoma,4/230,0.0011253383907705624,0.005836319632977883,0,0,8.695652173913043,59.040621710943306,PRL;HIF1A;RUNX3;S100A9
T-Cell Large Granular Lymphocyte Leukemia,2/25,0.0011364569536468786,0.005890874968587301,0,0,40.0,271.1935916653839,IL15;IL2
Temporomandibular Joint Disorders,2/25,0.0011364569536468786,0.005887769604871651,0,0,40.0,271.1935916653839,IL6;TGFB1
Type II Mucolipidosis,2/25,0.0011364569536468786,0.005884667513404385,0,0,40.0,271.1935916653839,IL6;TNF
Diabetic foot ulcer,2/25,0.0011364569536468786,0.005881568689016073,0,0,40.0,271.1935916653839,HIF1A;TLR4
Lupus anticoagulant disorder,2/25,0.0011364569536468786,0.005878473126548169,0,0,40.0,271.1935916653839,MTHFR;HLA-DRB1
Quadriplegia,2/25,0.0011364569536468786,0.005875380820852984,0,0,40.0,271.1935916653839,MTHFR;TNF
Epileptic Seizures,3/103,0.001141124586940991,0.0058964103262124385,0,0,14.563106796116505,98.67584014156816,IL6;IL1B;INS
Tonic Seizures,3/104,0.0011733979394470786,0.00605998683598838,0,0,14.423076923076923,97.32478150279816,IL6;IL1B;INS
Chronic myeloproliferative disorder,4/233,0.0011805226920143335,0.006093580366132809,0,0,8.583690987124463,57.869510551484176,CXCL10;TGFB1;TNF;RUNX3
Tuberculosis, Meningeal,2/26,0.0012296070457520425,0.006343610522651482,0,0,38.46153846153846,257.7331013707369,IFNG;TNF
Tick-Borne Encephalitis,2/26,0.0012296070457520425,0.006340282290478004,0,0,38.46153846153846,257.7331013707369,IL10;IL2
Zinc deficiency,2/26,0.0012296070457520425,0.006336957548846919,0,0,38.46153846153846,257.7331013707369,IL6;SOD1
Drug Eruptions,2/26,0.0012296070457520425,0.006333636292269955,0,0,38.46153846153846,257.7331013707369,IFNG;MTHFR
MUTYH-Associate Polyposis,2/26,0.0012296070457520425,0.006330318515270337,0,0,38.46153846153846,257.7331013707369,IL10;TNF
Undifferentiated carcinoma,4/237,0.0012570240185159505,0.006468079609410871,0,0,8.438818565400844,56.36293874892446,IL10;TGFB1;HIF1A;TLR4
Retinitis Pigmentosa,5/410,0.0012879295533312835,0.006623637702846601,0,0,6.097560975609756,40.57755699642896,IFNG;IL1B;TLR4;INS;SOD1
Secondary Neoplasm,3/108,0.0013082462226310636,0.006724604537666367,0,0,13.888888888888888,92.20927500084726,IL6;TNF;IL6R
Respiratory Distress Syndrome,2/27,0.0013262988762919497,0.006813834477886712,0,0,37.03703703703703,245.38381539683732,IL10;IL6
Chronic Infantile Neurological, Cutaneous, and Articular Syndrome,2/27,0.0013262988762919497,0.006810274480771829,0,0,37.03703703703703,245.38381539683732,IL1B;CD14
Skin toxicity,2/27,0.0013262988762919497,0.006806718201669598,0,0,37.03703703703703,245.38381539683732,TGFB1;MTHFR
stage, neuroblastoma,2/27,0.0013262988762919497,0.006803165634758497,0,0,37.03703703703703,245.38381539683732,IFNG;STAT1
Benign neoplasm of breast,2/27,0.0013262988762919497,0.00679961677422915,0,0,37.03703703703703,245.38381539683732,TGFB1;PRL
Cervical dysplasia,2/27,0.0013262988762919497,0.006796071614284297,0,0,37.03703703703703,245.38381539683732,IL10;MTHFR
Corneal Diseases,2/27,0.0013262988762919497,0.00679253014913876,0,0,37.03703703703703,245.38381539683732,TGFB1;IL17A
Extramedullary Hematopoiesis (disorder),2/27,0.0013262988762919497,0.006788992373019417,0,0,37.03703703703703,245.38381539683732,IL6;TNF
Gastroenteritis,2/27,0.0013262988762919497,0.006785458280165165,0,0,37.03703703703703,245.38381539683732,IFNG;FUT2
Idiopathic Interstitial Pneumonias,2/27,0.0013262988762919497,0.006781927864826889,0,0,37.03703703703703,245.38381539683732,TGFB1;IFNG
Leg Ulcer,2/27,0.0013262988762919497,0.006778401121267437,0,0,37.03703703703703,245.38381539683732,IL6;IL1B
Mumps,2/27,0.0013262988762919497,0.006774878043761581,0,0,37.03703703703703,245.38381539683732,IL6;STAT1
Primary Malignant Liver Neoplasm,2/27,0.0013262988762919497,0.00677135862659599,0,0,37.03703703703703,245.38381539683732,IL6;MTHFR
Convulsive Seizures,3/109,0.0013434162038973147,0.0068551892273638676,0,0,13.761467889908257,90.99825004607726,IL6;IL1B;INS
Oligospermia,3/109,0.0013434162038973147,0.0068516317861457236,0,0,13.761467889908257,90.99825004607726,MTHFR;TNF;IL2
Deep Vein Thrombosis,3/110,0.0013791769289365897,0.007030368702068882,0,0,13.636363636363635,89.81275071891761,IL6;MTHFR;IL17A
Hydronephrosis,3/111,0.0014155321394573206,0.00721194912731288,0,0,13.513513513513514,88.6520236256187,TGFB1;IL1B;AHR
Multiple Endocrine Neoplasia Type 1,3/111,0.0014155321394573206,0.007208212366107019,0,0,13.513513513513514,88.6520236256187,VDR;PRL;INS
Seborrheic keratosis,2/28,0.0014265186232744749,0.007260396183087281,0,0,35.71428571428571,234.0185118633476,TNF;IL2
Lymphoma, Small Noncleaved-Cell,2/28,0.0014265186232744749,0.007256638214048416,0,0,35.71428571428571,234.0185118633476,MTHFR;HLA-DRB1
Tumor Expansion,2/28,0.0014265186232744749,0.007252884133234112,0,0,35.71428571428571,234.0185118633476,IL6;HIF1A
Agranulocytosis,2/28,0.0014265186232744749,0.007249133934612999,0,0,35.71428571428571,234.0185118633476,TNF;HLA-DRB1
Aortic valve disorder,2/28,0.0014265186232744749,0.007245387612166171,0,0,35.71428571428571,234.0185118633476,IL6;TGFB1
Ovarian epithelial cancer recurrent,2/28,0.0014265186232744749,0.007241645159887159,0,0,35.71428571428571,234.0185118633476,IL10;IFNG
Pseudomonas aeruginosa infection,2/28,0.0014265186232744749,0.0072379065717819,0,0,35.71428571428571,234.0185118633476,IL1B;IL17A
Gastroesophageal reflux disease,4/246,0.001441759131814848,0.007311459622020808,0,0,8.130081300813009,53.186108062179656,IL6;IL1B;TLR4;HLA-DRB1
Bilateral cataracts (disorder),3/112,0.0014524855496341484,0.00736205672088933,0,0,13.392857142857142,87.51534398979189,TGFB1;IFNG;TGM2
Lipodystrophy,3/113,0.0014900408458142906,0.00754851620240353,0,0,13.274336283185841,86.40201432879194,IL6;TNF;INS
Testicular Germ Cell Tumor,3/114,0.0015282016878974342,0.007737849659276653,0,0,13.157894736842104,85.31136318751405,TGFB1;TNF;HLA-DRB1
Renal hypertension,2/29,0.00153025250365294,0.007744243875335271,0,0,34.48275862068965,223.52836283197584,IL6;TNF
Scrub Typhus,2/29,0.00153025250365294,0.007740258160525525,0,0,34.48275862068965,223.52836283197584,IL6;IL1B
Sterility, Postpartum,2/29,0.00153025250365294,0.00773627654624542,0,0,34.48275862068965,223.52836283197584,MTHFR;PRL
Subfertility, Female,2/29,0.00153025250365294,0.007732299026170229,0,0,34.48275862068965,223.52836283197584,MTHFR;PRL
Acute monocytic/monoblastic leukemia,2/29,0.00153025250365294,0.00772832559398823,0,0,34.48275862068965,223.52836283197584,VDR;TLR4
Asbestosis,2/29,0.00153025250365294,0.007724356243400666,0,0,34.48275862068965,223.52836283197584,IL1B;TNF
Cardiac Lymphoma,2/29,0.00153025250365294,0.007720390968121713,0,0,34.48275862068965,223.52836283197584,IL6;IL6R
Collagen Diseases,2/29,0.00153025250365294,0.007716429761878449,0,0,34.48275862068965,223.52836283197584,TNF;HLA-DRB1
Disease of capillaries,2/29,0.00153025250365294,0.007712472618410818,0,0,34.48275862068965,223.52836283197584,MTHFR;INS
Dysgerminoma,2/29,0.00153025250365294,0.0077085195314716025,0,0,34.48275862068965,223.52836283197584,CD14;TLR4
Female sterility,2/29,0.00153025250365294,0.007704570494826381,0,0,34.48275862068965,223.52836283197584,MTHFR;PRL
High Grade Cervical Intraepithelial Neoplasia,2/29,0.00153025250365294,0.007700625502253505,0,0,34.48275862068965,223.52836283197584,IL1B;HLA-DRB1
Malignant melanoma of eye,2/29,0.00153025250365294,0.007696684547544061,0,0,34.48275862068965,223.52836283197584,IFNG;CD80
Muckle-Wells Syndrome,2/29,0.00153025250365294,0.007692747624501839,0,0,34.48275862068965,223.52836283197584,IL1B;TNF
Oral candidiasis,2/29,0.00153025250365294,0.0076888147269433,0,0,34.48275862068965,223.52836283197584,SOD1;IL17A
Epileptic drop attack,3/115,0.0015669717086120097,0.007869288682799607,0,0,13.043478260869565,84.24274395994716,IL6;IL1B;INS
Pancreatic intraepithelial neoplasia,3/115,0.0015669717086120097,0.007865269638528514,0,0,13.043478260869565,84.24274395994716,IL6;HIF1A;IL17A
Liver Neoplasms, Experimental,3/116,0.0016063545128377145,0.008058832134848933,0,0,12.931034482758621,83.1955337725779,IL6;TGFB1;TNF
Experimental Hepatoma,3/116,0.0016063545128377145,0.00805472048580054,0,0,12.931034482758621,83.1955337725779,IL6;TGFB1;TNF
Stage II Colon Cancer AJCC v7,2/30,0.0016374867723787483,0.00820663946911695,0,0,33.333333333333336,213.8197556141379,IL6;IL1B
Tongue Neoplasms,2/30,0.0016374867723787483,0.008202456676319234,0,0,33.333333333333336,213.8197556141379,PRL;HIF1A
Arteriovenous fistula,2/30,0.0016374867723787483,0.008198278145154527,0,0,33.333333333333336,213.8197556141379,IL6;MTHFR
gastritis h pylori,2/30,0.0016374867723787483,0.008194103869113206,0,0,33.333333333333336,213.8197556141379,IL6;TNF
Generalized osteoarthritis,2/30,0.0016374867723787483,0.0081899338416989,0,0,33.333333333333336,213.8197556141379,VDR;IL1B
Lymphadenitis,2/30,0.0016374867723787483,0.008185768056428453,0,0,33.333333333333336,213.8197556141379,CXCL10;IFNG
Prostatic Hypertrophy,2/30,0.0016374867723787483,0.008181606506831895,0,0,33.333333333333336,213.8197556141379,HMGB1;PRL
Convulsions,3/118,0.0016869727606948642,0.008424577384201791,0,0,12.711864406779661,81.16296129843167,IL6;IL1B;INS
Hepatoma, Novikoff,3/119,0.0017282152808485096,0.008626155297196117,0,0,12.605042016806722,80.17646259498937,IL6;TGFB1;TNF
Recurrent upper respiratory tract infection,2/31,0.0017482077236044978,0.00872151548608376,0,0,32.25806451612903,204.81174754177738,STAT1;CD14
Alopecia, Male Pattern,2/31,0.0017482077236044978,0.008717090567014208,0,0,32.25806451612903,204.81174754177738,VDR;MTHFR
Major depression, single episode,2/31,0.0017482077236044978,0.008712670135692194,0,0,32.25806451612903,204.81174754177738,PRL;TNF
Stage II Colon Cancer,2/31,0.0017482077236044978,0.008708254185293971,0,0,32.25806451612903,204.81174754177738,IL6;IL1B
Autoimmune Lymphoproliferative Syndrome,2/31,0.0017482077236044978,0.008703842709009629,0,0,32.25806451612903,204.81174754177738,IL10;IFNG
Chronic interstitial cystitis,2/31,0.0017482077236044978,0.008699435700043041,0,0,32.25806451612903,204.81174754177738,CXCL10;IL6
HIV Encephalopathy,2/31,0.0017482077236044978,0.008695033151611844,0,0,32.25806451612903,204.81174754177738,IL6;TNF
Pulmonary Eosinophilia,2/31,0.0017482077236044978,0.008690635056947399,0,0,32.25806451612903,204.81174754177738,IL1B;IL17A
Neurologic Symptoms,3/120,0.0017700847391496836,0.008794940756503078,0,0,12.5,79.20909822895715,IL10;IL6;SOD1
Hepatoma, Morris,3/121,0.0018125846073229798,0.009001557110040548,0,0,12.396694214876034,78.2603490796188,IL6;TGFB1;TNF
Adult Acute Lymphocytic Leukemia,3/121,0.0018125846073229798,0.00899701086907588,0,0,12.396694214876034,78.2603490796188,IL15;IL2RA;MTHFR
Juvenile Myelomonocytic Leukemia,3/121,0.0018125846073229798,0.008992469217955702,0,0,12.396694214876034,78.2603490796188,IL1B;IRF1;TNF
Columnar Cell Change of the Breast,2/32,0.0018624016893370927,0.009234956509992405,0,0,31.25,196.43401229225742,TGFB1;RUNX3
Giant Cell Fibroblastoma,2/32,0.0018624016893370927,0.009230299446699418,0,0,31.25,196.43401229225742,TGFB1;TNF
Hallopeau-Siemens Disease,2/32,0.0018624016893370927,0.009225647078026688,0,0,31.25,196.43401229225742,HMGB1;TGM2
Lipid Metabolism Disorders,2/32,0.0018624016893370927,0.009220999396879067,0,0,31.25,196.43401229225742,IL6;TNF
Lymphoproliferative Disorder of the Skin,2/32,0.0018624016893370927,0.009216356396175704,0,0,31.25,196.43401229225742,IL6;HLA-DRB1
Oropharyngeal disorders,2/32,0.0018624016893370927,0.00921171806885,0,0,31.25,196.43401229225742,IL10;TNF
Myeloproliferative disease,4/264,0.0018667774825656402,0.009228716850430137,0,0,7.575757575757576,47.60258792432614,IFNG;IL2RA;TNF;RUNX3
Absence Seizures,3/123,0.0018994893300323184,0.009385711983689102,0,0,12.195121951219512,76.41670978784218,IL6;IL1B;INS
Chromosome 5, trisomy 5q,2/33,0.0019800550402056874,0.009778884892030902,0,0,30.303030303030305,188.62517080540525,IRF1;CD14
Spastic,2/33,0.0019800550402056874,0.009773973347635105,0,0,30.303030303030305,188.62517080540525,IL6;SOD1
Nephritis, Interstitial,2/33,0.0019800550402056874,0.009769066734508782,0,0,30.303030303030305,188.62517080540525,HLA-DQA1;HLA-DRB1
Trigeminal Neuralgia,2/33,0.0019800550402056874,0.00976416504522905,0,0,30.303030303030305,188.62517080540525,IL1B;TNF
Epithelial hyperplasia,2/33,0.0019800550402056874,0.00975926827238791,0,0,30.303030303030305,188.62517080540525,IL10;IL17A
Metabolic Bone Disorder,2/33,0.0019800550402056874,0.009754376408592228,0,0,30.303030303030305,188.62517080540525,IL6;TNF
Osteomalacia,2/33,0.0019800550402056874,0.009749489446463675,0,0,30.303030303030305,188.62517080540525,TGFB1;VDR
Primary angle-closure glaucoma,2/33,0.0019800550402056874,0.009744607378638706,0,0,30.303030303030305,188.62517080540525,IL1B;MTHFR
Myotonic Dystrophy,3/125,0.0019889567000972498,0.009783516741018903,0,0,12.0,74.64174058838286,IL6;TNF;SOD1
Generalized seizures,3/126,0.0020346597799215,0.010003319818443473,0,0,11.904761904761903,73.77888879021657,IL6;IL1B;INS
Renal glomerular disease,3/127,0.002081013552327446,0.010226100596137069,0,0,11.811023622047244,72.93189235252879,TGFB1;IL1B;TNF
Rickets,2/34,0.0021011541850646455,0.010319911709552891,0,0,29.41176470588235,181.33142568525105,VDR;HLA-DRB1
Cholangitis,2/34,0.0021011541850646455,0.01031475690849917,0,0,29.41176470588235,181.33142568525105,IFNG;FUT2
Cleft Lip with or without Cleft Palate,2/34,0.0021011541850646455,0.01030960725452588,0,0,29.41176470588235,181.33142568525105,TGFB1;MTHFR
Female infertility,2/34,0.0021011541850646455,0.010304462739927812,0,0,29.41176470588235,181.33142568525105,MTHFR;PRL
Idiopathic osteoarthritis,2/34,0.0021011541850646455,0.01029932335701513,0,0,29.41176470588235,181.33142568525105,VDR;IL1B
Monocytosis,2/34,0.0021011541850646455,0.010294189098113329,0,0,29.41176470588235,181.33142568525105,IL10;CD14
Myelodysplastic Syndrome with Isolated del(5q),2/34,0.0021011541850646455,0.010289059955563196,0,0,29.41176470588235,181.33142568525105,IRF1;CD14
Neuroectodermal Tumors,2/34,0.0021011541850646455,0.010283935921720784,0,0,29.41176470588235,181.33142568525105,IL6;IFNG
Nonnuclear polymorphic congenital cataract,2/34,0.0021011541850646455,0.01027881698895736,0,0,29.41176470588235,181.33142568525105,CXCL10;TGFB1
Sarcomatoid Renal Cell Carcinoma,3/128,0.002128021306262236,0.01040507134226132,0,0,11.71875,72.10034408451077,IL6;IL6R;TGM2
beta^+^ Thalassemia,3/128,0.002128021306262236,0.010399897264020514,0,0,11.71875,72.10034408451077,DPP4;VDR;HLA-DQA1
Hereditary Nonpolyposis Colorectal Cancer,3/128,0.002128021306262236,0.010394728328998636,0,0,11.71875,72.10034408451077,TGFB1;MTHFR;ETS1
Seizures, Focal,3/129,0.0021756863065532065,0.01062227770531789,0,0,11.627906976744185,71.2838502438597,IL6;IL1B;INS
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,2/35,0.0022256855706671488,0.01086099195060414,0,0,28.57142857142857,174.50543683358578,IL6;CD80
Varicose Ulcer,2/35,0.0022256855706671488,0.01085560188015719,0,0,28.57142857142857,174.50543683358578,TGFB1;HIF1A
Ventricular Fibrillation,2/35,0.0022256855706671488,0.01085021715700235,0,0,28.57142857142857,174.50543683358578,IL6;INS
Excessive daytime somnolence,2/35,0.0022256855706671488,0.010844837773186285,0,0,28.57142857142857,174.50543683358578,TNF;HLA-DRB1
Multinodular goiter,2/35,0.0022256855706671488,0.010839463720771426,0,0,28.57142857142857,174.50543683358578,CXCL10;IL15
Sleep Apnea, Obstructive,3/132,0.0023226570411441594,0.011306128479625954,0,0,11.363636363636363,68.92094854860608,IL6;IRF1;TNF
Mouth Neoplasms,3/132,0.0023226570411441594,0.011300531386319208,0,0,11.363636363636363,68.92094854860608,IL10;IL1B;TLR4
Benign neoplasm of brain, unspecified,2/36,0.0023536356819974097,0.011445587077026493,0,0,27.777777777777775,168.10539021189143,IL2;TGM2
EAR, PATELLA, SHORT STATURE SYNDROME,2/36,0.0023536356819974097,0.011439926549293048,0,0,27.777777777777775,168.10539021189143,TGFB1;TLR4
5q-syndrome,2/36,0.0023536356819974097,0.01143427161773136,0,0,27.777777777777775,168.10539021189143,IRF1;CD14
Autoimmune state,2/36,0.0023536356819974097,0.01142862227404671,0,0,27.777777777777775,168.10539021189143,IL6;HLA-DRB1
Low Tension Glaucoma,2/36,0.0023536356819974097,0.011422978509960761,0,0,27.777777777777775,168.10539021189143,TLR4;SOD1
Parvovirus B19 (disease),2/36,0.0023536356819974097,0.01141734031721152,0,0,27.777777777777775,168.10539021189143,IFNG;HLA-DRB1
Peripheral arterial occlusive disease,2/36,0.0023536356819974097,0.0114117076875533,0,0,27.777777777777775,168.10539021189143,IL6;MTHFR
beta Thalassemia,3/133,0.0023729831564073714,0.011499841450281878,0,0,11.278195488721803,68.16098570943586,DPP4;VDR;HLA-DQA1
Lewy Body Disease,3/133,0.0023729831564073714,0.011494173711765228,0,0,11.278195488721803,68.16098570943586,IL6;INS;SOD1
Squamous cell carcinoma of lung,4/283,0.002402535636762463,0.011631586324187924,0,0,7.067137809187279,42.62353769632551,IL6;STAT1;TNF;HLA-DQA1
Rubella,2/37,0.0024849910419855246,0.01202486064039081,0,0,27.027027027027028,162.09422227769844,IL6;IFNG
Sessile Serrated Adenoma/Polyp,2/37,0.0024849910419855246,0.012018942894012665,0,0,27.027027027027028,162.09422227769844,AHR;IL17A
ACTH-Secreting Pituitary Adenoma,2/37,0.0024849910419855246,0.012013030969323038,0,0,27.027027027027028,162.09422227769844,IL6;IFNG
Aggressive Non-Hodgkin Lymphoma,2/37,0.0024849910419855246,0.012007124857735366,0,0,27.027027027027028,162.09422227769844,IL10;HMGB1
Chronic leukemia (category),2/37,0.0024849910419855246,0.012001224550679968,0,0,27.027027027027028,162.09422227769844,IL10;TNF
Mitochondrial abnormalities,2/37,0.0024849910419855246,0.011995330039603996,0,0,27.027027027027028,162.09422227769844,HIF1A;SOD1
Paget Disease,2/37,0.0024849910419855246,0.011989441315971397,0,0,27.027027027027028,162.09422227769844,IL6;VDR
Hyperparathyroidism, Secondary,2/38,0.0026197382113525482,0.012633359735609835,0,0,26.31578947368421,156.43897067190758,IL6;VDR
Vitamin D Deficiency,2/38,0.0026197382113525482,0.012627163875023465,0,0,26.31578947368421,156.43897067190758,TGFB1;VDR
Bladder neck obstruction,2/38,0.0026197382113525482,0.012620974088810218,0,0,26.31578947368421,156.43897067190758,TGFB1;HIF1A
Common acute lymphoblastic leukemia,2/38,0.0026197382113525482,0.01261479036804157,0,0,26.31578947368421,156.43897067190758,IL10;HLA-DQA1
Milroy Disease,2/38,0.0026197382113525482,0.012608612703806487,0,0,26.31578947368421,156.43897067190758,IL6;IL6R
Pelvic Inflammatory Disease,2/38,0.0026197382113525482,0.012602441087211378,0,0,26.31578947368421,156.43897067190758,IFNG;TLR4
Abdominal discomfort,3/138,0.0026347733833137557,0.012668567911549702,0,0,10.869565217391305,64.5538924263556,IL10;IL12A;TLR4
Gastrointestinal pain,3/140,0.0027442876968701894,0.013188684344665145,0,0,10.714285714285714,63.19536138017422,IL10;IL12A;TLR4
hearing impairment,4/294,0.002756891250908813,0.013242779674453475,0,0,6.802721088435374,40.09286797576713,TGFB1;STAT1;TLR4;SOD1
Recurrent Brain Neoplasm,2/39,0.002757863788759554,0.013240979636506544,0,0,25.64102564102564,151.1102279107059,IL2;TGM2
Skin lesion,2/39,0.002757863788759554,0.013234514314418406,0,0,25.64102564102564,151.1102279107059,IFNG;IL2
Sweet Syndrome,2/39,0.002757863788759554,0.013228055303039969,0,0,25.64102564102564,151.1102279107059,MTHFR;TNF
Benign Ovarian Neoplasm,2/39,0.002757863788759554,0.013221602593136046,0,0,25.64102564102564,151.1102279107059,IL10;HIF1A
Primary malignant neoplasm of brain,2/39,0.002757863788759554,0.013215156175489465,0,0,25.64102564102564,151.1102279107059,IL2;TGM2
Adenocarcinoma of large intestine,4/297,0.0028594397295652317,0.01369521133633874,0,0,6.7340067340067336,39.44194998043406,TGFB1;PRL;ETS1;TNF
Muscular Dystrophy, Oculopharyngeal,2/40,0.0028993544104051667,0.013879617703585962,0,0,25.0,146.08167959685602,TGM2;SOD1
Purpura, Thrombotic Thrombocytopenic,2/40,0.0028993544104051667,0.013872860343457633,0,0,25.0,146.08167959685602,IFNG;HLA-DRB1
stage, ovarian epithelial cancer,2/40,0.0028993544104051667,0.013866109559835513,0,0,25.0,146.08167959685602,IL6;ETS1
Chemical Carcinogenesis,2/40,0.0028993544104051667,0.013859365343123532,0,0,25.0,146.08167959685602,IL10;IL1B
Chronic rejection of renal transplant,2/40,0.0028993544104051667,0.013852627683744278,0,0,25.0,146.08167959685602,TGFB1;IFNG
Motor symptoms,2/40,0.0028993544104051667,0.01384589657213896,0,0,25.0,146.08167959685602,TNF;SOD1
Congenital chromosomal disease,5/497,0.00298227578153838,0.014234971530334725,0,0,5.030181086519114,29.250848012293268,IL6;TGFB1;IL15;MTHFR;TNF
Nerve Degeneration,3/145,0.0030302773974003098,0.01445707100080109,0,0,10.344827586206897,59.990701172629656,IFNG;TNF;SOD1
Arterial Occlusive Diseases,2/41,0.003044196749720607,0.014516431662423158,0,0,24.390243902439025,141.32971233695181,MTHFR;TLR4
Hemophilia B,2/41,0.003044196749720607,0.014509391685865241,0,0,24.390243902439025,141.32971233695181,IL10;TLR4
Malabsorption Syndrome,2/41,0.003044196749720607,0.014502358534296718,0,0,24.390243902439025,141.32971233695181,INS;TGM2
MELAS Syndrome,2/41,0.003044196749720607,0.014495332197797542,0,0,24.390243902439025,141.32971233695181,IL1B;SOD1
Microcalcification,2/41,0.003044196749720607,0.01448831266646689,0,0,24.390243902439025,141.32971233695181,TGFB1;IL1B
Memory Disorder, Semantic,2/42,0.0031923775191860316,0.015186198576263464,0,0,23.809523809523807,136.83307942776858,IL1B;INS
Memory Disorder, Spatial,2/42,0.0031923775191860316,0.015178851600658112,0,0,23.809523809523807,136.83307942776858,IL1B;INS
Parkinsonism, Juvenile,2/42,0.0031923775191860316,0.015171511730445028,0,0,23.809523809523807,136.83307942776858,PRL;INS
Vascular Neoplasms,2/42,0.0031923775191860316,0.015164178955321564,0,0,23.809523809523807,136.83307942776858,IFNG;HIF1A
Age-Related Memory Disorders,2/42,0.0031923775191860316,0.015156853265004985,0,0,23.809523809523807,136.83307942776858,IL1B;INS
Anaphylaxis (non medication),2/42,0.0031923775191860316,0.015149534649232408,0,0,23.809523809523807,136.83307942776858,IL10;TNF
Chronic diarrhea,2/42,0.0031923775191860316,0.015142223097760771,0,0,23.809523809523807,136.83307942776858,IL21;IL2RA
Clear Cell Sarcoma of Soft Tissue,2/42,0.0031923775191860316,0.01513491860036677,0,0,23.809523809523807,136.83307942776858,IL6;HIF1A
Ewings sarcoma-primitive neuroectodermal tumor (PNET),2/42,0.0031923775191860316,0.015127621146846825,0,0,23.809523809523807,136.83307942776858,IL1B;TNF
Acute respiratory failure,2/43,0.003343883466309401,0.01583792130452472,0,0,23.25581395348837,132.5726147199673,IL10;IL6
Becker Muscular Dystrophy,2/43,0.003343883466309401,0.01583029224801965,0,0,23.25581395348837,132.5726147199673,TGFB1;TNF
Tumoral calcinosis,2/44,0.0034987013786665277,0.016555241766747535,0,0,22.727272727272727,128.5309866819061,TGFB1;IL1B
Alkaline phosphatase raised,2/44,0.0034987013786665277,0.016547274855406465,0,0,22.727272727272727,128.5309866819061,VDR;IL12A
HELLP Syndrome,2/44,0.0034987013786665277,0.016539315608241765,0,0,22.727272727272727,128.5309866819061,TNF;TLR4
Memory Disorders,2/44,0.0034987013786665277,0.016531364014199343,0,0,22.727272727272727,128.5309866819061,IL1B;INS
Mixed anxiety and depressive disorder,2/44,0.0034987013786665277,0.01652342006224634,0,0,22.727272727272727,128.5309866819061,IL6;MTHFR
Monoclonal Gammapathies,2/44,0.0034987013786665277,0.0165154837413711,0,0,22.727272727272727,128.5309866819061,IL1B;HIF1A
Abdominal Pain,3/153,0.0035248664625393217,0.016631007006162483,0,0,9.80392156862745,55.37169339610834,IL10;IL12A;TLR4
Cervical Squamous Cell Carcinoma,3/153,0.0035248664625393217,0.016623026676505014,0,0,9.80392156862745,55.37169339610834,IL6;HMGB1;TLR4
Breast Cancer, Familial,3/154,0.0035899504722669293,0.01692183848510282,0,0,9.74025974025974,54.83393057730235,CXCL10;PRL;HIF1A
Icterus,3/154,0.0035899504722669293,0.016913726386116674,0,0,9.74025974025974,54.83393057730235,IL12A;CD14;TNF
Adenoma, Microcystic,2/45,0.0036568180781167098,0.017220511773709164,0,0,22.22222222222222,124.69248638356555,PRL;S100A9
Granulomatous Disease, Chronic, X-Linked,2/45,0.0036568180781167098,0.01721226440217003,0,0,22.22222222222222,124.69248638356555,IFNG;IL1B
Sleeplessness,2/45,0.0036568180781167098,0.017204024926630458,0,0,22.22222222222222,124.69248638356555,AHR;HLA-DRB1
Abetalipoproteinemia,2/45,0.0036568180781167098,0.017195793335756472,0,0,22.22222222222222,124.69248638356555,PRL;HIF1A
Ascites,2/45,0.0036568180781167098,0.017187569618235785,0,0,22.22222222222222,124.69248638356555,DPP4;IL6
Bronchogenic Carcinoma,2/45,0.0036568180781167098,0.017179353762777735,0,0,22.22222222222222,124.69248638356555,IL6;SOD1
Enteritis,2/45,0.0036568180781167098,0.017171145758113245,0,0,22.22222222222222,124.69248638356555,IL10;TLR4
Hypopituitarism,2/45,0.0036568180781167098,0.01716294559299476,0,0,22.22222222222222,124.69248638356555,PRL;SOD1
Lipoatrophy,2/45,0.0036568180781167098,0.01715475325619619,0,0,22.22222222222222,124.69248638356555,TNF;INS
Mammary adenocarcinoma,2/45,0.0036568180781167098,0.017146568736512893,0,0,22.22222222222222,124.69248638356555,HIF1A;TNF
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency,2/45,0.0036568180781167098,0.017138392022761576,0,0,22.22222222222222,124.69248638356555,THEMIS;HIF1A
Myoclonic Seizures,3/156,0.0037223214126018297,0.017437070945210097,0,0,9.615384615384615,53.78276701616063,IL6;IL1B;INS
Thrombasthenia,2/46,0.003818220426103208,0.017877784825032075,0,0,21.73913043478261,121.04284395543048,IL6;MTHFR
Hypoalbuminemia,2/46,0.003818220426103208,0.017869271594163013,0,0,21.73913043478261,121.04284395543048,IL6;TNF
Intestinal Neoplasms,3/158,0.003857646861449497,0.01804519436188751,0,0,9.49367088607595,52.7629547732868,IFNG;HIF1A;TLR4
Carcinoma, Pancreatic Ductal,2/47,0.003982895320046974,0.018622214655290993,0,0,21.27659574468085,117.56906929390253,HIF1A;TGM2
Rhinovirus infection,2/47,0.003982895320046974,0.018613359584128228,0,0,21.27659574468085,117.56906929390253,CXCL10;IL17A
ATRICHIA WITH PAPULAR LESIONS,2/47,0.003982895320046974,0.01860451293033349,0,0,21.27659574468085,117.56906929390253,VDR;HLA-DRB1
Carcinoma in situ of uterine cervix,2/47,0.003982895320046974,0.01859567468191053,0,0,21.27659574468085,117.56906929390253,IFNG;MTHFR
Cholestasis of pregnancy,2/47,0.003982895320046974,0.01858684482688588,0,0,21.27659574468085,117.56906929390253,IL6;TNF
Colonic Polyps,2/47,0.003982895320046974,0.018578023353308812,0,0,21.27659574468085,117.56906929390253,VDR;RUNX3
Male sterility,2/47,0.003982895320046974,0.018569210249251265,0,0,21.27659574468085,117.56906929390253,MTHFR;AHR
Muscular Atrophy,2/47,0.003982895320046974,0.018560405502807808,0,0,21.27659574468085,117.56906929390253,TNF;SOD1
Right Ventricular Hypertrophy,2/48,0.004150829694409033,0.01933381717376871,0,0,20.833333333333332,114.25931329913583,TGFB1;TLR4
Sleep Disorders,2/48,0.004150829694409033,0.0193246585678124,0,0,20.833333333333332,114.25931329913583,IL1B;AHR
keratoacanthoma,2/48,0.004150829694409033,0.0193155086347784,0,0,20.833333333333332,114.25931329913583,TNF;S100A9
Manic Disorder,2/48,0.004150829694409033,0.01930636736235304,0,0,20.833333333333332,114.25931329913583,MTHFR;INS
Paresthesia,2/48,0.004150829694409033,0.019297234738245968,0,0,20.833333333333332,114.25931329913583,MTHFR;INS
Psychotic symptom,2/48,0.004150829694409033,0.01928811075019006,0,0,20.833333333333332,114.25931329913583,IL6;MTHFR
androgen independent prostate cancer,3/163,0.00420901954947832,0.01954926471279439,0,0,9.202453987730062,50.342259612144396,IL6;HIF1A;TNF
cardiac event,2/49,0.0043220105204802226,0.020064581669947866,0,0,20.408163265306122,111.10274666797933,MTHFR;TLR4
Chronic schizophrenia,2/49,0.0043220105204802226,0.020055108307497464,0,0,20.408163265306122,111.10274666797933,IL6;TNF
Female Breast Carcinoma,2/49,0.0043220105204802226,0.02004564388639907,0,0,20.408163265306122,111.10274666797933,TGFB1;VDR
Malignant hyperpyrexia due to anesthesia,2/49,0.0043220105204802226,0.020036188393999826,0,0,20.408163265306122,111.10274666797933,IL6;TLR4
invasive cancer,3/166,0.004428896656576308,0.020522016190868436,0,0,9.036144578313252,48.97233241867804,MTHFR;HIF1A;TNF
Atypical Ductal Breast Hyperplasia,2/50,0.004496424806807151,0.020825100377615778,0,0,20.0,108.0894537070882,IRF1;HIF1A
Calcinosis,2/50,0.004496424806807151,0.020815291098116195,0,0,20.0,108.0894537070882,TGFB1;IL1B
Erythroblastosis,2/50,0.004496424806807151,0.020805491055226312,0,0,20.0,108.0894537070882,VDR;ETS1
Nephrosis,2/50,0.004496424806807151,0.020795700235906205,0,0,20.0,108.0894537070882,IL1B;SOD1
Papillary Renal Cell Carcinoma,3/169,0.004655642932836626,0.02152194672808954,0,0,8.875739644970414,47.65983959624254,IL6;IL6R;TGM2
Amaurosis congenita of Leber, type 1,2/51,0.004674059598481964,0.021596924181420188,0,0,19.6078431372549,105.21033905648777,VDR;IRF1
Pain, Crushing,2/51,0.004674059598481964,0.02158677525088381,0,0,19.6078431372549,105.21033905648777,TNF;IL2
Pain, Migratory,2/51,0.004674059598481964,0.021576635854335717,0,0,19.6078431372549,105.21033905648777,TNF;IL2
Pain, Splitting,2/51,0.004674059598481964,0.021566505978347767,0,0,19.6078431372549,105.21033905648777,TNF;IL2
Suffering, Physical,2/51,0.004674059598481964,0.021556385609517007,0,0,19.6078431372549,105.21033905648777,TNF;IL2
Ache,2/51,0.004674059598481964,0.02154627473446564,0,0,19.6078431372549,105.21033905648777,TNF;IL2
Angioimmunoblastic Lymphadenopathy,2/51,0.004674059598481964,0.02153617333984095,0,0,19.6078431372549,105.21033905648777,IL21;IL6
Hyperpigmentation,2/51,0.004674059598481964,0.02152608141231525,0,0,19.6078431372549,105.21033905648777,IL12A;AHR
Malignant neoplasm of female breast,2/51,0.004674059598481964,0.02151599893858583,0,0,19.6078431372549,105.21033905648777,TGFB1;VDR
Radiating pain,2/51,0.004674059598481964,0.02150592590537488,0,0,19.6078431372549,105.21033905648777,TNF;IL2
Carcinomatosis of peritoneal cavity,2/52,0.004854901976284097,0.02232755106360323,0,0,19.23076923076923,102.457045532758,IFNG;CD80
Chronic progressive external ophthalmoplegia,2/52,0.004854901976284097,0.02231710786853139,0,0,19.23076923076923,102.457045532758,IL1B;SOD1
Decreased antibody level in blood,2/52,0.004854901976284097,0.022306674438017815,0,0,19.23076923076923,102.457045532758,IL21;TGFB1
Tonic - clonic seizures,3/173,0.004968764626175879,0.022819167638344177,0,0,8.670520231213871,45.993503201731926,IL6;IL1B;INS
Rous Sarcoma,2/53,0.00503893905931115,0.02313063665339093,0,0,18.867924528301884,99.82188156911111,TGFB1;PRL
Hyperparathyroidism, Primary,2/53,0.00503893905931115,0.023119838036839393,0,0,18.867924528301884,99.82188156911111,IL6;VDR
Pain, Burning,2/53,0.00503893905931115,0.02310904949832477,0,0,18.867924528301884,99.82188156911111,TNF;IL2
Thrombocytosis,2/53,0.00503893905931115,0.023098271023745325,0,0,18.867924528301884,99.82188156911111,IL6;IFNG
Interstitial Cystitis,2/53,0.00503893905931115,0.02308750259902563,0,0,18.867924528301884,99.82188156911111,CXCL10;IL6
Nodular glomerulosclerosis,2/53,0.00503893905931115,0.023076744210116486,0,0,18.867924528301884,99.82188156911111,TGFB1;INS
Anaplastic thyroid carcinoma,3/176,0.005211779398598339,0.023857181150174416,0,0,8.522727272727272,44.80256204221994,DPP4;IL10;TNF
Carcinomatosis,3/176,0.005211779398598339,0.023846074455039327,0,0,8.522727272727272,44.80256204221994,TGFB1;HIF1A;TLR4
Hemophilia, NOS,2/54,0.0052261580017125345,0.02390073561695244,0,0,18.518518518518515,97.29775701046125,DPP4;TNF
Xeroderma Pigmentosum, Complementation Group D,2/54,0.0052261580017125345,0.023889618995735253,0,0,18.518518518518515,97.29775701046125,MTHFR;AHR
Diabetic Cardiomyopathies,2/54,0.0052261580017125345,0.023878512710753506,0,0,18.518518518518515,97.29775701046125,TNF;INS
Bone Diseases, Developmental,2/55,0.005416545994675769,0.02473690243293376,0,0,18.18181818181818,94.87812612779396,IL6;TGFB1
Lymphoma, Diffuse,2/55,0.005416545994675769,0.024725412928784697,0,0,18.18181818181818,94.87812612779396,MTHFR;HLA-DRB1
Scoliosis, unspecified,2/55,0.005416545994675769,0.02471393409269891,0,0,18.18181818181818,94.87812612779396,IL6;TGFB1
Agnosia for Pain,2/55,0.005416545994675769,0.024702465909825267,0,0,18.18181818181818,94.87812612779396,IL6;IL2
Bone pain,2/55,0.005416545994675769,0.024691008365340193,0,0,18.18181818181818,94.87812612779396,TGFB1;VDR
Holoprosencephaly,2/56,0.005610090264869439,0.025561412667193716,0,0,17.857142857142854,92.55693695682895,IL10;SOD1
Hyperandrogenism,2/56,0.005610090264869439,0.025549567712296963,0,0,17.857142857142854,92.55693695682895,IL6;TNF
Paralysed,2/56,0.005610090264869439,0.02553773373003096,0,0,17.857142857142854,92.55693695682895,INS;SOD1
Photodysphoria,3/181,0.005632545656665183,0.025628082737826584,0,0,8.287292817679557,42.92149541236044,IL10;IL12A;TLR4
Ameloblastoma,2/57,0.005806778075904712,0.026408614035164972,0,0,17.543859649122805,90.32858613989478,IL6;TNF
Cardiac defects,2/57,0.005806778075904712,0.0263963991350562,0,0,17.543859649122805,90.32858613989478,MTHFR;HIF1A
Respiratory Failure,3/185,0.005983475867809443,0.027187055399367176,0,0,8.108108108108109,41.50340781958122,TNF;TLR4;SOD1
Adrenocortical carcinoma,3/185,0.005983475867809443,0.027174492065079114,0,0,8.108108108108109,41.50340781958122,CXCL10;TNF;HLA-DRB1
MIXED LINEAGE LEUKEMIA,3/185,0.005983475867809443,0.027161940336642588,0,0,8.108108108108109,41.50340781958122,TGFB1;CD14;TNF
Carcinoma of Male Breast,2/58,0.006006596726879575,0.027254308694262448,0,0,17.241379310344826,88.18787860744115,PRL;HIF1A
Congenital defects,2/58,0.006006596726879575,0.02724173171747691,0,0,17.241379310344826,88.18787860744115,MTHFR;HMGB1
Hepatosplenomegaly,2/58,0.006006596726879575,0.02722916634306848,0,0,17.241379310344826,88.18787860744115,STAT1;IL2RA
Nausea,2/58,0.006006596726879575,0.02721661255498961,0,0,17.241379310344826,88.18787860744115,IFNG;TNF
Fibromatosis, Aggressive,2/59,0.00620953355419871,0.028123177774499963,0,0,16.949152542372882,86.12999148988301,TGFB1;TNF
Waddling gait,2/59,0.00620953355419871,0.028110223754336673,0,0,16.949152542372882,86.12999148988301,TGFB1;SOD1
AICARDI-GOUTIERES SYNDROME 1,2/59,0.00620953355419871,0.02809728166236875,0,0,16.949152542372882,86.12999148988301,IL6;TNF
Angina Pectoris,2/59,0.00620953355419871,0.02808435148212836,0,0,16.949152542372882,86.12999148988301,TGFB1;IL6R
Carcinoma, Spindle-Cell,3/188,0.006255109324930496,0.02827746754618993,0,0,7.978723404255319,40.48688822241643,TGFB1;HIF1A;TLR4
Photophobia,3/188,0.006255109324930496,0.028264466411685934,0,0,7.978723404255319,40.48688822241643,IL10;IL12A;TLR4
Cavernous Hemangioma of Brain,2/60,0.00641557592818846,0.02897623171977766,0,0,16.666666666666668,84.15044177638269,IL6;TLR4
Depression, Bipolar,2/61,0.0066247112568029905,0.029907056606274594,0,0,16.393442622950822,82.24505724489264,MTHFR;INS
Sinusitis,2/61,0.0066247112568029905,0.02989332517532589,0,0,16.393442622950822,82.24505724489264,IL1B;HIF1A
MYELOPROLIFERATIVE SYNDROME, TRANSIENT,2/61,0.0066247112568029905,0.029879606347801648,0,0,16.393442622950822,82.24505724489264,IL10;TGFB1
Bile duct carcinoma,2/61,0.0066247112568029905,0.0298659001063577,0,0,16.393442622950822,82.24505724489264,ETS1;IL2
Developmental delay (disorder),3/193,0.006724053237359606,0.030299860255282075,0,0,7.772020725388601,38.87614621207605,IL2RA;MTHFR;S100A9
Xerostomia,2/62,0.0068369269831757085,0.03079437139809847,0,0,16.129032258064516,80.40995031880452,HLA-DRB1;SOD1
Carcinoma, Papillary,3/196,0.007015233499083458,0.03158301183187917,0,0,7.653061224489796,37.95666796145062,IL6;HIF1A;TNF
Adenocarcinoma, Endometrioid,2/64,0.0072705495770056024,0.032717473096525215,0,0,15.625,76.93630304855337,TGFB1;AHR
Unspecified visual loss,2/64,0.0072705495770056024,0.03270249942462749,0,0,15.625,76.93630304855337,IL12A;INS
Cortical Dysplasia,2/64,0.0072705495770056024,0.03268753945233809,0,0,15.625,76.93630304855337,IL6;IFNG
High-Grade Squamous Intraepithelial Lesions,2/64,0.0072705495770056024,0.03267259316086468,0,0,15.625,76.93630304855337,IFNG;HLA-DRB1
Multiple Endocrine Neoplasia Type 2a,2/64,0.0072705495770056024,0.0326576605314493,0,0,15.625,76.93630304855337,PRL;TGM2
Aplasia Cutis Congenita,3/199,0.007313832701386363,0.03283707071230022,0,0,7.537688442211055,37.070260049754225,CD14;RUNX3;TLR4
Limitation of joint mobility,2/65,0.007491931509876717,0.033621325515556334,0,0,15.384615384615385,75.29120978784212,TGFB1;IL2RA
Lymphocytosis,2/65,0.007491931509876717,0.03360598031906361,0,0,15.384615384615385,75.29120978784212,IL2;HLA-DRB1
Mammary Ductal Carcinoma,2/65,0.007491931509876717,0.03359064912366257,0,0,15.384615384615385,75.29120978784212,IL6;HIF1A
Bronchitis, Chronic,2/66,0.007716343966064588,0.03458104354695977,0,0,15.151515151515152,73.70325161583281,IL15;TNF
stage, non-small cell lung cancer,2/66,0.007716343966064588,0.034565281904504454,0,0,15.151515151515152,73.70325161583281,VDR;CD14
Melanocytic nevus,3/203,0.007723584891835793,0.03458195549747707,0,0,7.389162561576354,35.937019644101376,TGFB1;HIF1A;TLR4
Embryonal Carcinoma,3/205,0.007933470531627235,0.035505532051380906,0,0,7.317073170731708,35.39022946258363,IL6;IFNG;TLR4
Arteriopathic disease,2/67,0.007943774569279919,0.03553546493713384,0,0,14.925373134328357,72.1696526884224,MTHFR;IL17A
Cervical Adenocarcinoma,2/67,0.007943774569279919,0.03551929775563378,0,0,14.925373134328357,72.1696526884224,IL6;HIF1A
Congenital Hypothyroidism,2/67,0.007943774569279919,0.03550314527825514,0,0,14.925373134328357,72.1696526884224,PRL;TNF
Childhood Osteosarcoma,3/206,0.008039671323576617,0.035915404440050445,0,0,7.281553398058253,35.121604928002725,IL6;IL1B;IL6R
Addictive Behavior,3/208,0.008254596624464393,0.036858780384023654,0,0,7.211538461538462,34.593642311491465,TGFB1;IL15;MTHFR
Adenoid Cystic Carcinoma,3/208,0.008254596624464393,0.036842041610007294,0,0,7.211538461538462,34.593642311491465,TGFB1;HIF1A;RUNX3
Myxoid cyst,3/209,0.008363324185877916,0.03731037226455205,0,0,7.177033492822966,34.334205509782095,TNF;RUNX3;SOD1
Optic Atrophy, Hereditary, Leber,2/69,0.008407640867576695,0.03749105918627212,0,0,14.492753623188406,69.25528057246983,IL1B;SOD1
Adenomatous Polyps,2/69,0.008407640867576695,0.03747405643834184,0,0,14.492753623188406,69.25528057246983,TGFB1;MTHFR
hiv-infection/aids,2/69,0.008407640867576695,0.037457069105414215,0,0,14.492753623188406,69.25528057246983,IL10;TNF
Anemia, Diamond-Blackfan,2/70,0.00864405198097742,0.03849286038470598,0,0,14.285714285714285,67.86976895461129,IL1B;TNF
Leukoplakia, Oral,2/70,0.00864405198097742,0.0384754270240245,0,0,14.285714285714285,67.86976895461129,IL1B;TNF
Philadelphia chromosome-positive acute lymphoblastic leukemia,2/70,0.00864405198097742,0.038458009447282074,0,0,14.285714285714285,67.86976895461129,IL2RA;TNF
Leukemia, Myeloid, Chronic-Phase,2/71,0.00888343207228369,0.03950514498027335,0,0,14.084507042253522,66.52911692987784,TGFB1;IRF1
Tracheal Diseases,2/71,0.00888343207228369,0.039487277433923156,0,0,14.084507042253522,66.52911692987784,IL6;TNF
Essential Tremor,2/71,0.00888343207228369,0.03946942604267816,0,0,14.084507042253522,66.52911692987784,MTHFR;SOD1
Craniosynostosis,3/214,0.008919670513114528,0.03961252679750998,0,0,7.009345794392523,33.08058133923426,IL6;IFNG;TNF
Familial primary gastric lymphoma,2/72,0.009125768938000465,0.04050951089551426,0,0,13.888888888888888,65.23129327619066,TNF;CCR4
Withdrawal Symptoms,2/73,0.009371050408149586,0.041579541043473646,0,0,13.698630136986301,63.97438473548656,MTHFR;PRL
Bone neoplasms,2/73,0.009371050408149586,0.041560777712677854,0,0,13.698630136986301,63.97438473548656,IL6;HIF1A
Chorea,2/73,0.009371050408149586,0.041542031308657704,0,0,13.698630136986301,63.97438473548656,CXCL10;HLA-DRB1
Failure to Thrive,2/73,0.009371050408149586,0.04152330180851854,0,0,13.698630136986301,63.97438473548656,IL6;SOD1
Hypopigmentation disorder,2/73,0.009371050408149586,0.041504589189407,0,0,13.698630136986301,63.97438473548656,IL2RA;IL17A
Inborn Errors of Metabolism,2/73,0.009371050408149586,0.04148589342851087,0,0,13.698630136986301,63.97438473548656,MTHFR;PRL
Hereditary gingival fibromatosis,2/74,0.009619264347877736,0.04256556956818657,0,0,13.513513513513514,62.75658768031307,IL6;IFNG
Angiogenic Switch,2/75,0.009870398658249511,0.0436571908250568,0,0,13.333333333333334,61.57620047260932,TGFB1;HIF1A
Endometrial Hyperplasia,2/75,0.009870398658249511,0.04363755196278731,0,0,13.333333333333334,61.57620047260932,PRL;TNF
Ovarian Cysts,2/75,0.009870398658249511,0.0436179307613652,0,0,13.333333333333334,61.57620047260932,IL6;AHR
Machado-Joseph Disease,2/76,0.010124441272591002,0.044720453405404204,0,0,13.157894736842104,60.431616453501896,TNF;SOD1
Recurrent otitis media,2/77,0.010381380159978023,0.04583477278178976,0,0,12.987012987012987,59.32131748953536,IL6;TNF
aggressive cancer,2/77,0.010381380159978023,0.045814191384043114,0,0,12.987012987012987,59.32131748953536,IL2RA;HIF1A
PANIC DISORDER 1,2/77,0.010381380159978023,0.04579362846151886,0,0,12.987012987012987,59.32131748953536,IL10;HLA-DRB1
Neurogenic Muscular Atrophy,3/228,0.010591351899483506,0.04669888132262175,0,0,6.578947368421052,29.9191938776126,TGFB1;TNF;SOD1
Pulmonary Embolism,2/78,0.010641203324266749,0.04689764406766529,0,0,12.82051282051282,58.243868039453254,IL6;MTHFR
Malignancy,2/79,0.010903898802162078,0.04803384913834555,0,0,12.658227848101266,57.197909688993526,HIF1A;IL17A
Bloom Syndrome,2/80,0.011169454665643046,0.04918163102775083,0,0,12.5,56.18215610539822,IFNG;SOD1
Extrahepatic Cholangiocarcinoma,2/80,0.011169454665643046,0.04915960611461704,0,0,12.5,56.18215610539822,IL10;IL6
Sensory neuropathy,2/81,0.01143785902073671,0.05031838784950779,0,0,12.345679012345679,55.19538838372789,TNF;SOD1
Connective Tissue Diseases,2/81,0.01143785902073671,0.05029587402944089,0,0,12.345679012345679,55.19538838372789,TGFB1;TNF
Hyperlipidemia, Familial Combined,2/82,0.011709100006669398,0.05146557909908177,0,0,12.195121951219512,54.23645074565182,IL6;TNF
Thalassemia,2/82,0.011709100006669398,0.051442572581826926,0,0,12.195121951219512,54.23645074565182,VDR;TNF
Refractory cytopenia with multilineage dysplasia,1/6,0.011941531104995351,0.052440289410140443,0,0,83.33333333333333,368.9777454991391,CD14
Anoxia-Ischemia, Brain,1/6,0.011941531104995351,0.05241686811071653,0,0,83.33333333333333,368.9777454991391,HIF1A
Anoxia-Ischemia, Cerebral,1/6,0.011941531104995351,0.05239346772316711,0,0,83.33333333333333,368.9777454991391,HIF1A
Renal cancer metastatic,1/6,0.011941531104995351,0.052370088219497686,0,0,83.33333333333333,368.9777454991391,IL2
Autoimmune Syndrome Type II, Polyglandular,1/6,0.011941531104995351,0.05234672957176374,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Blood Coagulation Disorders, Inherited,1/6,0.011941531104995351,0.05232339175207058,0,0,83.33333333333333,368.9777454991391,MTHFR
Retinal Neoplasms,1/6,0.011941531104995351,0.052300074732573226,0,0,83.33333333333333,368.9777454991391,VDR
Retro-Ocular Headache,1/6,0.011941531104995351,0.05227677848547631,0,0,83.33333333333333,368.9777454991391,IL6
Rheumatoid Vasculitis,1/6,0.011941531104995351,0.05225350298303398,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Developmental Delay, Epilepsy, and Neonatal Diabetes,1/6,0.011941531104995351,0.05223024819754976,0,0,83.33333333333333,368.9777454991391,INS
DIABETES MELLITUS, INSULIN-DEPENDENT, 4,1/6,0.011941531104995351,0.05220701410137647,0,0,83.33333333333333,368.9777454991391,INS
EHLERS-DANLOS SYNDROME, PROGEROID FORM,1/6,0.011941531104995351,0.0521838006669161,0,0,83.33333333333333,368.9777454991391,TGFB1
Secondary Peritonitis,1/6,0.011941531104995351,0.0521606078666197,0,0,83.33333333333333,368.9777454991391,IFNG
Sequoiosis,1/6,0.011941531104995351,0.05213743567298726,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Gastritis, Hypertrophic,1/6,0.011941531104995351,0.052114284058567634,0,0,83.33333333333333,368.9777454991391,RUNX3
Sharp Headache,1/6,0.011941531104995351,0.05209115299595842,0,0,83.33333333333333,368.9777454991391,IL6
Somatostatinoma,1/6,0.011941531104995351,0.052068042457805816,0,0,83.33333333333333,368.9777454991391,IFNG
Sparse bone trabeculae,1/6,0.011941531104995351,0.052044952416804575,0,0,83.33333333333333,368.9777454991391,VDR
Squamous cell carcinoma of pharynx,1/6,0.011941531104995351,0.05202188284569784,0,0,83.33333333333333,368.9777454991391,IL6
Osteoarthritis, Spine,1/6,0.011941531104995351,0.05199883371727706,0,0,83.33333333333333,368.9777454991391,VDR
PERIODONTITIS, LOCALIZED AGGRESSIVE,1/6,0.011941531104995351,0.05197580500438189,0,0,83.33333333333333,368.9777454991391,IL1B
Stunned Myocardium,1/6,0.011941531104995351,0.0519527966799001,0,0,83.33333333333333,368.9777454991391,TNF
PITUITARY ADENOMA, FAMILIAL ISOLATED (disorder),1/6,0.011941531104995351,0.051929808716767396,0,0,83.33333333333333,368.9777454991391,PRL
Temporal Arteritis,1/6,0.011941531104995351,0.05190684108796741,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Tension Headache,1/6,0.011941531104995351,0.051883893766531526,0,0,83.33333333333333,368.9777454991391,TNF
Spina Bifida, X-Linked,1/6,0.011941531104995351,0.051860966725538804,0,0,83.33333333333333,368.9777454991391,MTHFR
Thickening of pleura,1/6,0.011941531104995351,0.05183805993811586,0,0,83.33333333333333,368.9777454991391,TGFB1
Throbbing Headache,1/6,0.011941531104995351,0.05181517337743678,0,0,83.33333333333333,368.9777454991391,IL6
22q13.3 Deletion Syndrome,1/6,0.011941531104995351,0.051792307016723,0,0,83.33333333333333,368.9777454991391,INS
Trichiasis,1/6,0.011941531104995351,0.05176946082924319,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Trichinellosis,1/6,0.011941531104995351,0.05174663478831319,0,0,83.33333333333333,368.9777454991391,TLR4
Triple vessel disease,1/6,0.011941531104995351,0.05172382886729587,0,0,83.33333333333333,368.9777454991391,IL6
Tumor necrosis factor receptor associated periodic syndrome [TRAPS],1/6,0.011941531104995351,0.05170104303960102,0,0,83.33333333333333,368.9777454991391,TNF
Ulcerative Colitis-Associated Colorectal Adenocarcinoma,1/6,0.011941531104995351,0.0516782772786853,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Upper motor neuron signs,1/6,0.011941531104995351,0.051655531558052074,0,0,83.33333333333333,368.9777454991391,SOD1
Acanthamoeba Keratitis,1/6,0.011941531104995351,0.05163280585125135,0,0,83.33333333333333,368.9777454991391,TLR4
Ventricular Remodeling,1/6,0.011941531104995351,0.051610100131879645,0,0,83.33333333333333,368.9777454991391,TGFB1
Vertex Headache,1/6,0.011941531104995351,0.05158741437357992,0,0,83.33333333333333,368.9777454991391,IL6
Acromicric Dysplasia,1/6,0.011941531104995351,0.05156474855004144,0,0,83.33333333333333,368.9777454991391,TGFB1
Acute and subacute liver necrosis (disorder),1/6,0.011941531104995351,0.0515421026349997,0,0,83.33333333333333,368.9777454991391,IFNG
Vitamin D-resistant rickets,1/6,0.011941531104995351,0.05151947660223631,0,0,83.33333333333333,368.9777454991391,VDR
Adiponectin Deficiency,1/6,0.011941531104995351,0.0514968704255789,0,0,83.33333333333333,368.9777454991391,IL17A
Anemia in malignant neoplastic disease,1/6,0.011941531104995351,0.05147428407890101,0,0,83.33333333333333,368.9777454991391,TNF
Anoxic-Ischemic Encephalopathy,1/6,0.011941531104995351,0.051451717536122016,0,0,83.33333333333333,368.9777454991391,HIF1A
Anterior subcapsular cataract,1/6,0.011941531104995351,0.051429170771206976,0,0,83.33333333333333,368.9777454991391,TGFB1
Bacterial sepsis of newborn,1/6,0.011941531104995351,0.05140664375816659,0,0,83.33333333333333,368.9777454991391,IL6
Bacteriuria,1/6,0.011941531104995351,0.05138413647105706,0,0,83.33333333333333,368.9777454991391,TLR4
Beta-cell dysfunction,1/6,0.011941531104995351,0.05136164888398001,0,0,83.33333333333333,368.9777454991391,INS
Bilateral Headache,1/6,0.011941531104995351,0.05133918097108238,0,0,83.33333333333333,368.9777454991391,IL6
Bonnevie-Ullrich Syndrome,1/6,0.011941531104995351,0.051316732706556324,0,0,83.33333333333333,368.9777454991391,SOD1
Bulging epiphyses,1/6,0.011941531104995351,0.051294304064639126,0,0,83.33333333333333,368.9777454991391,VDR
Calcium Pyrophosphate Dihydrate Deposition,1/6,0.011941531104995351,0.05127189501961307,0,0,83.33333333333333,368.9777454991391,TGFB1
carotid disease,1/6,0.011941531104995351,0.05124950554580538,0,0,83.33333333333333,368.9777454991391,IL6
Cerebral Hypoxia-Ischemia,1/6,0.011941531104995351,0.05122713561758809,0,0,83.33333333333333,368.9777454991391,HIF1A
Chagas' disease without mention of organ involvement,1/6,0.011941531104995351,0.051204785209377976,0,0,83.33333333333333,368.9777454991391,IFNG
Childhood Malignant Peripheral Nerve Sheath Tumor,1/6,0.011941531104995351,0.05118245429563642,0,0,83.33333333333333,368.9777454991391,HIF1A
Chronic Alcoholic Hepatitis,1/6,0.011941531104995351,0.05116014285086936,0,0,83.33333333333333,368.9777454991391,TNF
Chronic kidney disease stage 3,1/6,0.011941531104995351,0.05113785084962715,0,0,83.33333333333333,368.9777454991391,VDR
Cowpox,1/6,0.011941531104995351,0.051115578266504494,0,0,83.33333333333333,368.9777454991391,TNF
CYSTIC FIBROSIS MODIFIER 1,1/6,0.011941531104995351,0.05109332507614032,0,0,83.33333333333333,368.9777454991391,TGFB1
Diffuse infiltrative lymphocytosis syndrome,1/6,0.011941531104995351,0.05107109125321772,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Early Inflammatory Arthritis,1/6,0.011941531104995351,0.051048876772463815,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Eisenmenger Complex,1/6,0.011941531104995351,0.051026681608649704,0,0,83.33333333333333,368.9777454991391,TGFB1
End stage renal disease due to hypertension,1/6,0.011941531104995351,0.051004505736590315,0,0,83.33333333333333,368.9777454991391,MTHFR
Enlargement of the ankles,1/6,0.011941531104995351,0.05098234913114436,0,0,83.33333333333333,368.9777454991391,VDR
Epiglottitis,1/6,0.011941531104995351,0.05096021176721421,0,0,83.33333333333333,368.9777454991391,IL10
Exercise-induced angina,1/6,0.011941531104995351,0.0509380936197458,0,0,83.33333333333333,368.9777454991391,HIF1A
Familial neurocardiogenic syncope,1/6,0.011941531104995351,0.05091599466372855,0,0,83.33333333333333,368.9777454991391,TNF
Generalized Headache,1/6,0.011941531104995351,0.05089391487419528,0,0,83.33333333333333,368.9777454991391,IL6
Gingival Recession,1/6,0.011941531104995351,0.05087185422622207,0,0,83.33333333333333,368.9777454991391,IL1B
Granuloma Annulare,1/6,0.011941531104995351,0.05084981269492821,0,0,83.33333333333333,368.9777454991391,IL1B
Hairy cell leukemia variant,1/6,0.011941531104995351,0.0508277902554761,0,0,83.33333333333333,368.9777454991391,IL2RA
Headache associated with sexual activity,1/6,0.011941531104995351,0.050805786883071136,0,0,83.33333333333333,368.9777454991391,IL6
Hemicrania,1/6,0.011941531104995351,0.050783802552961624,0,0,83.33333333333333,368.9777454991391,IL6
Histiocytic Necrotizing Lymphadenitis,1/6,0.011941531104995351,0.050761837240438715,0,0,83.33333333333333,368.9777454991391,CXCL10
Hydroa Vacciniforme,1/6,0.011941531104995351,0.05073989092083628,0,0,83.33333333333333,368.9777454991391,CCR4
Immune dysregulation,1/6,0.011941531104995351,0.050717963569530816,0,0,83.33333333333333,368.9777454991391,STAT1
INFLAMMATORY BOWEL DISEASE 5,1/6,0.011941531104995351,0.05069605516194139,0,0,83.33333333333333,368.9777454991391,IRF1
Kaposi's sarcoma-associated herpesvirus infection,1/6,0.011941531104995351,0.050674165673529496,0,0,83.33333333333333,368.9777454991391,ETS1
Left Ventricle Remodeling,1/6,0.011941531104995351,0.050652295079799015,0,0,83.33333333333333,368.9777454991391,TGFB1
LEPTIN RECEPTOR DEFICIENCY,1/6,0.011941531104995351,0.05063044335629608,0,0,83.33333333333333,368.9777454991391,IL6
Lichen disease,1/6,0.011941531104995351,0.05060861047860902,0,0,83.33333333333333,368.9777454991391,IFNG
Lung Melanoma,1/6,0.011941531104995351,0.05058679642236824,0,0,83.33333333333333,368.9777454991391,TNF
Malignant neoplasm of thymus,1/6,0.011941531104995351,0.05056500116324615,0,0,83.33333333333333,368.9777454991391,HIF1A
Myocardial necrosis,1/6,0.011941531104995351,0.05054322467695707,0,0,83.33333333333333,368.9777454991391,IL6
Necrotizing vasculitis,1/6,0.011941531104995351,0.05052146693925713,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Nephrogenic Systemic Fibrosis,1/6,0.011941531104995351,0.0504997279259442,0,0,83.33333333333333,368.9777454991391,TLR4
Neuropsychiatric Systemic Lupus Erythematosus,1/6,0.011941531104995351,0.05047800761285777,0,0,83.33333333333333,368.9777454991391,IL10
Ocular Headache,1/6,0.011941531104995351,0.0504563059758789,0,0,83.33333333333333,368.9777454991391,IL6
Orthostatic Headache,1/6,0.011941531104995351,0.050434622990930086,0,0,83.33333333333333,368.9777454991391,IL6
Periodic syndrome,1/6,0.011941531104995351,0.05041295863397522,0,0,83.33333333333333,368.9777454991391,TNF
Periorbital Headache,1/6,0.011941531104995351,0.05039131288101946,0,0,83.33333333333333,368.9777454991391,IL6
Persistent pulmonary hypertension,1/6,0.011941531104995351,0.05036968570810915,0,0,83.33333333333333,368.9777454991391,SOD1
Pleural Neoplasms,1/6,0.011941531104995351,0.05034807709133175,0,0,83.33333333333333,368.9777454991391,IL1B
Primary Hypothyroidism,1/6,0.011941531104995351,0.050326487006815745,0,0,83.33333333333333,368.9777454991391,STAT1
Proctitis,1/6,0.011941531104995351,0.050304915430730526,0,0,83.33333333333333,368.9777454991391,HLA-DRB1
Prostate Stromal Proliferation of Uncertain Malignant Potential,1/6,0.011941531104995351,0.05028336233928634,0,0,83.33333333333333,368.9777454991391,IL1B
Carcinoma, Neuroendocrine,2/83,0.011983165799176857,0.05043706786908358,0,0,12.048192771084338,53.304246556362926,ETS1;TNF
HIV-1 infection,2/83,0.011983165799176857,0.05041547665852318,0,0,12.048192771084338,53.304246556362926,IL2RA;TNF
Skin Ulcer,2/84,0.01226004460412224,0.051558287706167466,0,0,11.904761904761903,52.39773464640237,IL2;HLA-DRB1
Soft Tissue Neoplasms,2/84,0.01226004460412224,0.051536235401759355,0,0,11.904761904761903,52.39773464640237,IFNG;TNF
Venous Thromboembolism,2/84,0.01226004460412224,0.051514201953532866,0,0,11.904761904761903,52.39773464640237,MTHFR;TNF
Hurthle Cell Tumor,2/85,0.012539724665186928,0.052666843593785095,0,0,11.76470588235294,51.51592588873622,VDR;PRL
Cystadenocarcinoma, Serous,2/86,0.012822194254667357,0.05383021150571157,0,0,11.627906976744185,50.65788003982781,DPP4;AHR
Myocardial Reperfusion Injury,2/86,0.012822194254667357,0.053807226786879075,0,0,11.627906976744185,50.65788003982781,HMGB1;HIF1A
Actinic keratosis,2/87,0.013107441683449876,0.05498076690778719,0,0,11.494252873563218,49.82270278879698,VDR;TNF
Hemangiosarcoma,2/87,0.013107441683449876,0.05495731094920878,0,0,11.494252873563218,49.82270278879698,CXCL10;HIF1A
Lipoma,2/87,0.013107441683449876,0.05493387499571232,0,0,11.494252873563218,49.82270278879698,IRF1;HMGB1
Nevus,2/87,0.013107441683449876,0.05491045902171585,0,0,11.494252873563218,49.82270278879698,AHR;TLR4
Splenomegaly,3/247,0.013133404111479377,0.054995779977681854,0,0,6.0728744939271255,26.311313940254713,IL2RA;AHR;HLA-DRB1
Spina Bifida,2/88,0.01339545529550235,0.05606922259122534,0,0,11.363636363636363,49.00954302959199,IL10;MTHFR
Iron Overload,2/88,0.01339545529550235,0.05604535319037765,0,0,11.363636363636363,49.00954302959199,HIF1A;TNF
Osteoarthrosis Deformans,2/89,0.013686223463598855,0.05723753370223385,0,0,11.235955056179774,48.21759032233811,IL1B;TGM2
Patent ductus arteriosus,3/251,0.013709272101641275,0.05730953901102954,0,0,5.9760956175298805,25.63555505576159,MTHFR;CD14;TNF
Abortion, Habitual,1/7,0.013918230466079547,0.05815832016183239,0,0,71.42857142857142,305.32541098901413,MTHFR
Charcot-Marie-Tooth disease, Type 1C,1/7,0.013918230466079547,0.05813360349368031,0,0,71.42857142857142,305.32541098901413,TNF
Rheumatic mitral stenosis,1/7,0.013918230466079547,0.05810890782524629,0,0,71.42857142857142,305.32541098901413,HLA-DQA1
Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive,1/7,0.013918230466079547,0.058084233129779096,0,0,71.42857142857142,305.32541098901413,HMGB1
Scrapie,1/7,0.013918230466079547,0.05805957938057291,0,0,71.42857142857142,305.32541098901413,SOD1
DYSTONIA, DOPA-RESPONSIVE, WITH OR WITHOUT HYPERPHENYLALANINEMIA, AUTOSOMAL RECESSIVE (disorder),1/7,0.013918230466079547,0.058034946550967234,0,0,71.42857142857142,305.32541098901413,PRL
Sepsis of the newborn,1/7,0.013918230466079547,0.058010334614346806,0,0,71.42857142857142,305.32541098901413,IL6
Infections, Parvovirus,1/7,0.013918230466079547,0.05798574354414149,0,0,71.42857142857142,305.32541098901413,HLA-DRB1
Sore Throat,1/7,0.013918230466079547,0.05796117331382618,0,0,71.42857142857142,305.32541098901413,TNF
Spina bifida aperta of cervical spine,1/7,0.013918230466079547,0.0579366238969207,0,0,71.42857142857142,305.32541098901413,MTHFR
Spina Bifida, Folate-Sensitive,1/7,0.013918230466079547,0.05791209526698974,0,0,71.42857142857142,305.32541098901413,MTHFR
Thrombotic stroke,1/7,0.013918230466079547,0.05788758739764273,0,0,71.42857142857142,305.32541098901413,MTHFR
Abdominal sepsis,1/7,0.013918230466079547,0.057863100262533745,0,0,71.42857142857142,305.32541098901413,S100A9
Tularemia,1/7,0.013918230466079547,0.057838633835361426,0,0,71.42857142857142,305.32541098901413,IL2
Ulcer of esophagus,1/7,0.013918230466079547,0.05781418808986888,0,0,71.42857142857142,305.32541098901413,HIF1A
Abnormality of the humerus,1/7,0.013918230466079547,0.05778976299984359,0,0,71.42857142857142,305.32541098901413,TGFB1
Acquired haemophilia,1/7,0.013918230466079547,0.0577653585391173,0,0,71.42857142857142,305.32541098901413,HLA-DRB1
Viral gastroenteritis due to Rotavirus,1/7,0.013918230466079547,0.057740974681565964,0,0,71.42857142857142,305.32541098901413,FUT2
Acute peritonitis,1/7,0.013918230466079547,0.05771661140110961,0,0,71.42857142857142,305.32541098901413,IL1B
Acute urticaria,1/7,0.013918230466079547,0.05769226867171226,0,0,71.42857142857142,305.32541098901413,IL6
Adenitis,1/7,0.013918230466079547,0.05766794646738186,0,0,71.42857142857142,305.32541098901413,CXCL10
Angiodysplasia,1/7,0.013918230466079547,0.057643644762170154,0,0,71.42857142857142,305.32541098901413,HIF1A
Angiodysplasia of colon,1/7,0.013918230466079547,0.05761936353017261,0,0,71.42857142857142,305.32541098901413,HIF1A
Anterior Horn Cell Disease,1/7,0.013918230466079547,0.05759510274552833,0,0,71.42857142857142,305.32541098901413,SOD1
Anterior Ischemic Optic Neuropathy,1/7,0.013918230466079547,0.057570862382419936,0,0,71.42857142857142,305.32541098901413,MTHFR
Autoimmune Lymphoproliferative Syndrome Type 2B,1/7,0.013918230466079547,0.057546642415073526,0,0,71.42857142857142,305.32541098901413,TLR4
Basal Cell Cancer,1/7,0.013918230466079547,0.05752244281775853,0,0,71.42857142857142,305.32541098901413,VDR
Blast cell proliferation,1/7,0.013918230466079547,0.05749826356478763,0,0,71.42857142857142,305.32541098901413,IL2
Brachydactyly type C,1/7,0.013918230466079547,0.05747410463051671,0,0,71.42857142857142,305.32541098901413,IL2
brain cyst,1/7,0.013918230466079547,0.057449965989344716,0,0,71.42857142857142,305.32541098901413,IL21
Bronchial Diseases,1/7,0.013918230466079547,0.05742584761571359,0,0,71.42857142857142,305.32541098901413,S100A9
Bronchiolitis Obliterans Organizing Pneumonia,1/7,0.013918230466079547,0.05740174948410817,0,0,71.42857142857142,305.32541098901413,TNF
Cerebral Atherosclerosis,1/7,0.013918230466079547,0.05737767156905611,0,0,71.42857142857142,305.32541098901413,MTHFR
Cholangiolocellular Carcinoma,1/7,0.013918230466079547,0.057353613845127785,0,0,71.42857142857142,305.32541098901413,MTHFR
Chronic osteomyelitis,1/7,0.013918230466079547,0.0573295762869362,0,0,71.42857142857142,305.32541098901413,TLR4
Circadian Rhythm Disorders,1/7,0.013918230466079547,0.057305558869136894,0,0,71.42857142857142,305.32541098901413,AHR
Complicated malaria,1/7,0.013918230466079547,0.05728156156642788,0,0,71.42857142857142,305.32541098901413,TLR4
Conjunctivochalasis,1/7,0.013918230466079547,0.05725758435354951,0,0,71.42857142857142,305.32541098901413,TNF
Coxiella burnetii Infection,1/7,0.013918230466079547,0.057233627205284424,0,0,71.42857142857142,305.32541098901413,TNF
Deficiency of butyryl-CoA dehydrogenase,1/7,0.013918230466079547,0.057209690096457454,0,0,71.42857142857142,305.32541098901413,TGFB1
Dianzani autoimmune lymphoproliferative syndrome,1/7,0.013918230466079547,0.05718577300193552,0,0,71.42857142857142,305.32541098901413,IL17A
Endotoxic shock,1/7,0.013918230466079547,0.05716187589662757,0,0,71.42857142857142,305.32541098901413,TNF
Enthesitis,1/7,0.013918230466079547,0.05713799875548445,0,0,71.42857142857142,305.32541098901413,TNF
Extravascular Hemolysis,1/7,0.013918230466079547,0.05711414155349886,0,0,71.42857142857142,305.32541098901413,SOD1
Familial intrahepatic cholestasis of pregnancy,1/7,0.013918230466079547,0.05709030426570525,0,0,71.42857142857142,305.32541098901413,TNF
Familial Motor Neuron Disease,1/7,0.013918230466079547,0.057066486867179717,0,0,71.42857142857142,305.32541098901413,SOD1
Fat redistribution,1/7,0.013918230466079547,0.057042689333039936,0,0,71.42857142857142,305.32541098901413,IL6
Fatigability,1/7,0.013918230466079547,0.057018911638445094,0,0,71.42857142857142,305.32541098901413,SOD1
Frigidity,1/7,0.013918230466079547,0.05699515375859574,0,0,71.42857142857142,305.32541098901413,PRL
Fungemia,1/7,0.013918230466079547,0.05697141566873377,0,0,71.42857142857142,305.32541098901413,IL10
Hemolysis (disorder),1/7,0.013918230466079547,0.05694769734414229,0,0,71.42857142857142,305.32541098901413,SOD1
Hepatitis B and hepatitis C,1/7,0.013918230466079547,0.056923998760145554,0,0,71.42857142857142,305.32541098901413,TNF
High urine albumin levels,1/7,0.013918230466079547,0.05690031989210889,0,0,71.42857142857142,305.32541098901413,INS
Hypoactive Sexual Desire Disorder,1/7,0.013918230466079547,0.05687666071543857,0,0,71.42857142857142,305.32541098901413,PRL
Hypocalcemic seizures,1/7,0.013918230466079547,0.056853021205581784,0,0,71.42857142857142,305.32541098901413,VDR
Hypothalamic Dysfunction Syndromes,1/7,0.013918230466079547,0.0568294013380265,0,0,71.42857142857142,305.32541098901413,PRL
Immunodeficiency congenital,1/7,0.013918230466079547,0.056805801088301404,0,0,71.42857142857142,305.32541098901413,IFNG
Incontinence,1/7,0.013918230466079547,0.05678222043197583,0,0,71.42857142857142,305.32541098901413,IL6
Intraocular Lymphoma,1/7,0.013918230466079547,0.05675865934465966,0,0,71.42857142857142,305.32541098901413,IL10
Lead Poisoning,1/7,0.013918230466079547,0.05673511780200322,0,0,71.42857142857142,305.32541098901413,VDR
Loose stool,1/7,0.013918230466079547,0.056711595779697255,0,0,71.42857142857142,305.32541098901413,IL1B
Macroprolactinoma,1/7,0.013918230466079547,0.05668809325347276,0,0,71.42857142857142,305.32541098901413,PRL
Malignant neoplasm of muscle,1/7,0.013918230466079547,0.05666461019910098,0,0,71.42857142857142,305.32541098901413,TNF
Mature T ALL,1/7,0.013918230466079547,0.056641146592393284,0,0,71.42857142857142,305.32541098901413,IL2
Microalbuminuria,1/7,0.013918230466079547,0.05661770240920107,0,0,71.42857142857142,305.32541098901413,INS
Monogenic diabetes,1/7,0.013918230466079547,0.05659427762541571,0,0,71.42857142857142,305.32541098901413,INS
Mucocutaneous candidiasis,1/7,0.013918230466079547,0.05657087221696847,0,0,71.42857142857142,305.32541098901413,IL17A
Multiple fibrofolliculomas,1/7,0.013918230466079547,0.056547486159830414,0,0,71.42857142857142,305.32541098901413,HIF1A
Mycobacterium avium infection,1/7,0.013918230466079547,0.0565241194300123,0,0,71.42857142857142,305.32541098901413,TNFRSF9
Narrow foramen obturatorium,1/7,0.013918230466079547,0.05650077200356455,0,0,71.42857142857142,305.32541098901413,HLA-DRB1
Neointimal hyperplasia,1/7,0.013918230466079547,0.05647744385657712,0,0,71.42857142857142,305.32541098901413,HMGB1
Neural tube defects X-linked,1/7,0.013918230466079547,0.05645413496517943,0,0,71.42857142857142,305.32541098901413,MTHFR
Neuroborreliosis,1/7,0.013918230466079547,0.056430845305540336,0,0,71.42857142857142,305.32541098901413,CD80
Nose symptoms,1/7,0.013918230466079547,0.05640757485386795,0,0,71.42857142857142,305.32541098901413,IL6
Null Cell Pituitary Gland Adenoma,1/7,0.013918230466079547,0.056384323586409636,0,0,71.42857142857142,305.32541098901413,PRL
Orgasmic Disorder,1/7,0.013918230466079547,0.056361091479451904,0,0,71.42857142857142,305.32541098901413,PRL
Overriding aorta,1/7,0.013918230466079547,0.05633787850932034,0,0,71.42857142857142,305.32541098901413,TGFB1
Oxalosis,1/7,0.013918230466079547,0.05631468465237949,0,0,71.42857142857142,305.32541098901413,IL6
Pain in lower limb,1/7,0.013918230466079547,0.05629150988503283,0,0,71.42857142857142,305.32541098901413,IL6
Papillary adenocarcinoma,1/7,0.013918230466079547,0.056268354183722655,0,0,71.42857142857142,305.32541098901413,IL1B
Periodontal infection,1/7,0.013918230466079547,0.05624521752493,0,0,71.42857142857142,305.32541098901413,IFNG
Persistent Mullerian duct syndrome,1/7,0.013918230466079547,0.05622209988517459,0,0,71.42857142857142,305.32541098901413,VDR
Placenta Disorders,1/7,0.013918230466079547,0.0561990012410147,0,0,71.42857142857142,305.32541098901413,TNF
Postpartum Amenorrhea,1/7,0.013918230466079547,0.05617592156904713,0,0,71.42857142857142,305.32541098901413,PRL
Primary osteoporosis,1/7,0.013918230466079547,0.056152860845907135,0,0,71.42857142857142,305.32541098901413,VDR
Psychosexual Disorders,1/7,0.013918230466079547,0.05612981904826827,0,0,71.42857142857142,305.32541098901413,PRL
Pure Autonomic Failure,1/7,0.013918230466079547,0.0561067961528424,0,0,71.42857142857142,305.32541098901413,SOD1
Pycnodysostosis,1/7,0.013918230466079547,0.05608379213637957,0,0,71.42857142857142,305.32541098901413,IL6R
Rasmussen subacute encephalitis,1/7,0.013918230466079547,0.05606080697566794,0,0,71.42857142857142,305.32541098901413,IFNG
Rasmussen Syndrome,1/7,0.013918230466079547,0.056037840647533706,0,0,71.42857142857142,305.32541098901413,IFNG
Motor neuron atrophy,2/90,0.013979734599830922,0.05626242082192396,0,0,11.11111111111111,47.44607251813338,HIF1A;SOD1
Manic,2/93,0.014876610400345573,0.059847452728037785,0,0,10.752688172043012,45.24693624948676,MTHFR;INS
Muscle degeneration,3/259,0.014903904895095806,0.05993272393985335,0,0,5.7915057915057915,24.3598379934534,IL10;TGFB1;SOD1
Traditional Serrated Adenoma,2/94,0.015180978163385584,0.061021944126688564,0,0,10.638297872340425,44.55012841968069,VDR;RUNX3
Fragile X Syndrome,2/95,0.015488031436759258,0.06223073301736304,0,0,10.526315789473683,43.870397038953044,IL6;SOD1
Polyneuropathy,2/95,0.015488031436759258,0.06220530157763383,0,0,10.526315789473683,43.870397038953044,TNF;HLA-DRB1
Male infertility,3/263,0.015522763111818987,0.06231932837539093,0,0,5.7034220532319395,23.75730652767015,MTHFR;AHR;TNF
Steroid Sulfatase Deficiency Disease,2/96,0.015797758830742272,0.06339745765150472,0,0,10.416666666666666,43.20715828297798,HIF1A;TNF
PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE,2/96,0.015797758830742272,0.06337158113817758,0,0,10.416666666666666,43.20715828297798,IL1B;PRL
Werner Syndrome,2/96,0.015797758830742272,0.06334572573991638,0,0,10.416666666666666,43.20715828297798,TGFB1;IL1B
Recurrent mycobacterial infections,1/8,0.015891074726793453,0.06369391615616887,0,0,62.5,258.87485408141214,STAT1
Reduced pancreatic beta cells,1/8,0.015891074726793453,0.0636679504341321,0,0,62.5,258.87485408141214,INS
Reflux nephropathy (disorder),1/8,0.015891074726793453,0.063642005874053,0,0,62.5,258.87485408141214,TNF
relapsing chronic myelogenous leukemia,1/8,0.015891074726793453,0.06361608245007172,0,0,62.5,258.87485408141214,IL2
Aplastic anemia, idiopathic,1/8,0.015891074726793453,0.06359018013637055,0,0,62.5,258.87485408141214,IFNG
Renal Osteodystrophy,1/8,0.015891074726793453,0.06356429890717381,0,0,62.5,258.87485408141214,IL6
Sclerosis of skull base,1/8,0.015891074726793453,0.06353843873674779,0,0,62.5,258.87485408141214,TGFB1
Severe T-cell immunodeficiency,1/8,0.015891074726793453,0.06351259959940059,0,0,62.5,258.87485408141214,IL10
Sexual Arousal Disorder,1/8,0.015891074726793453,0.06348678146948214,0,0,62.5,258.87485408141214,PRL
Sleep-Related Neurogenic Tachypnea,1/8,0.015891074726793453,0.06346098432138401,0,0,62.5,258.87485408141214,IL1B
Motor Neuron Disease, Upper,1/8,0.015891074726793453,0.06343520812953943,0,0,62.5,258.87485408141214,SOD1
Spinal Cord Ischemia,1/8,0.015891074726793453,0.06340945286842309,0,0,62.5,258.87485408141214,SOD1
Ophthalmia, Sympathetic,1/8,0.015891074726793453,0.06338371851255116,0,0,62.5,258.87485408141214,HLA-DRB1
Subwakefullness Syndrome,1/8,0.015891074726793453,0.06335800503648116,0,0,62.5,258.87485408141214,IL1B
Sinus Thrombosis, Intracranial,1/8,0.015891074726793453,0.06333231241481187,0,0,62.5,258.87485408141214,MTHFR
Somatotrophinoma, Familial,1/8,0.015891074726793453,0.06330664062218325,0,0,62.5,258.87485408141214,PRL
stage, bladder cancer,1/8,0.015891074726793453,0.06328098963327636,0,0,62.5,258.87485408141214,TGFB1
Thanatophoric dysplasia, type 2,1/8,0.015891074726793453,0.06325535942281331,0,0,62.5,258.87485408141214,STAT1
Total Hypotrichosis, Mari type,1/8,0.015891074726793453,0.06322974996555711,0,0,62.5,258.87485408141214,TLR4
Abdominal symptom,1/8,0.015891074726793453,0.06320416123631165,0,0,62.5,258.87485408141214,TNF
Traveler's diarrhea,1/8,0.015891074726793453,0.06317859320992154,0,0,62.5,258.87485408141214,CD14
Tuberculous pleural effusion,1/8,0.015891074726793453,0.06315304586127217,0,0,62.5,258.87485408141214,IL1B
Urethral Obstruction,1/8,0.015891074726793453,0.06312751916528943,0,0,62.5,258.87485408141214,TGFB1
Uterine Diseases,1/8,0.015891074726793453,0.06310201309693982,0,0,62.5,258.87485408141214,TLR4
Vasogenic Brain Edema,1/8,0.015891074726793453,0.06307652763123023,0,0,62.5,258.87485408141214,TNF
Vasogenic Cerebral Edema,1/8,0.015891074726793453,0.06305106274320793,0,0,62.5,258.87485408141214,TNF
Visually threatening diabetic retinopathy,1/8,0.015891074726793453,0.06302561840796048,0,0,62.5,258.87485408141214,TNF
acute aortic dissection,1/8,0.015891074726793453,0.0630001946006156,0,0,62.5,258.87485408141214,IL6
Acute Q fever,1/8,0.015891074726793453,0.06297479129634115,0,0,62.5,258.87485408141214,VDR
Adenofibroma,1/8,0.015891074726793453,0.06294940847034505,0,0,62.5,258.87485408141214,TNF
Adult Fibrosarcoma,1/8,0.015891074726793453,0.06292404609787512,0,0,62.5,258.87485408141214,IL17A
Alcohol Withdrawal Seizures,1/8,0.015891074726793453,0.06289870415421911,0,0,62.5,258.87485408141214,MTHFR
Altitude Sickness,1/8,0.015891074726793453,0.06287338261470453,0,0,62.5,258.87485408141214,HIF1A
Aseptic Meningitis,1/8,0.015891074726793453,0.06284808145469861,0,0,62.5,258.87485408141214,IL6
Birdshot chorioretinopathy,1/8,0.015891074726793453,0.06282280064960823,0,0,62.5,258.87485408141214,HLA-DRB1
Candidiasis of the esophagus,1/8,0.015891074726793453,0.0627975401748798,0,0,62.5,258.87485408141214,IL1B
Chiari-Frommel Syndrome,1/8,0.015891074726793453,0.06277230000599922,0,0,62.5,258.87485408141214,PRL
Compression of optic nerve,1/8,0.015891074726793453,0.06274708011849178,0,0,62.5,258.87485408141214,TGFB1
Cytomegalovirus encephalitis,1/8,0.015891074726793453,0.06272188048792211,0,0,62.5,258.87485408141214,CXCL10
Cytotoxic Brain Edema,1/8,0.015891074726793453,0.06269670108989404,0,0,62.5,258.87485408141214,TNF
Cytotoxic Cerebral Edema,1/8,0.015891074726793453,0.06267154190005059,0,0,62.5,258.87485408141214,TNF
Deficiency of testosterone biosynthesis,1/8,0.015891074726793453,0.06264640289407383,0,0,62.5,258.87485408141214,IL6
Disorder of lymph node,1/8,0.015891074726793453,0.06262128404768487,0,0,62.5,258.87485408141214,CD80
Disruptive Behavior Disorder,1/8,0.015891074726793453,0.06259618533664371,0,0,62.5,258.87485408141214,PRL
Early Awakening,1/8,0.015891074726793453,0.06257110673674922,0,0,62.5,258.87485408141214,AHR
Effects of heat,1/8,0.015891074726793453,0.06254604822383904,0,0,62.5,258.87485408141214,IL1B
Emotional problems,1/8,0.015891074726793453,0.06252100977378945,0,0,62.5,258.87485408141214,MTHFR
Enlargement of the wrists,1/8,0.015891074726793453,0.06249599136251543,0,0,62.5,258.87485408141214,VDR
Felty Syndrome,1/8,0.015891074726793453,0.062470992965970425,0,0,62.5,258.87485408141214,HLA-DRB1
Fibrocystic Disease of Pancreas,1/8,0.015891074726793453,0.06244601456014637,0,0,62.5,258.87485408141214,TGFB1
Fibular bowing,1/8,0.015891074726793453,0.06242105612107356,0,0,62.5,258.87485408141214,VDR
Geleophysic dysplasia,1/8,0.015891074726793453,0.06239611762482064,0,0,62.5,258.87485408141214,TGFB1
Grade III Chondrosarcoma,1/8,0.015891074726793453,0.062371199047494434,0,0,62.5,258.87485408141214,HIF1A
Hand eczema,1/8,0.015891074726793453,0.06234630036523994,0,0,62.5,258.87485408141214,TNF
Human metapneumovirus infection,1/8,0.015891074726793453,0.062321421554240246,0,0,62.5,258.87485408141214,TNF
HyperCalcification of skull base,1/8,0.015891074726793453,0.06229656259071642,0,0,62.5,258.87485408141214,TGFB1
Hyperhomocystinemia,1/8,0.015891074726793453,0.062271723450927456,0,0,62.5,258.87485408141214,MTHFR
Hyperimmunoglobulinemia D,1/8,0.015891074726793453,0.06224690411117021,0,0,62.5,258.87485408141214,TNF
HyperMineralization of skull base,1/8,0.015891074726793453,0.06222210454777931,0,0,62.5,258.87485408141214,TGFB1
Immune Complex Diseases,1/8,0.015891074726793453,0.062197324737127066,0,0,62.5,258.87485408141214,IFNG
Infantile Colic,1/8,0.015891074726793453,0.06217256465562343,0,0,62.5,258.87485408141214,IL17A
Infection - suppurative,1/8,0.015891074726793453,0.0621478242797159,0,0,62.5,258.87485408141214,IL1B
Juvenile pauciarticular chronic arthritis,1/8,0.015891074726793453,0.06212310358588944,0,0,62.5,258.87485408141214,IL2RA
Lichen planus follicularis,1/8,0.015891074726793453,0.062098402550666426,0,0,62.5,258.87485408141214,HLA-DRB1
Limb joint contracture,1/8,0.015891074726793453,0.06207372115060654,0,0,62.5,258.87485408141214,INS
Liquid Tumor,1/8,0.015891074726793453,0.06204905936230674,0,0,62.5,258.87485408141214,HMGB1
Long Sleeper Syndrome,1/8,0.015891074726793453,0.06202441716240114,0,0,62.5,258.87485408141214,IL1B
Melanoma recurrent,1/8,0.015891074726793453,0.061999794527560964,0,0,62.5,258.87485408141214,IFNG
Methylmalonic acidemia with homocystinuria,1/8,0.015891074726793453,0.06197519143449447,0,0,62.5,258.87485408141214,MTHFR
Mitochondrial pathology,1/8,0.015891074726793453,0.06195060785994687,0,0,62.5,258.87485408141214,SOD1
Motor disturbances,1/8,0.015891074726793453,0.06192604378070026,0,0,62.5,258.87485408141214,SOD1
MYD88 Deficiency,1/8,0.015891074726793453,0.06190149917357355,0,0,62.5,258.87485408141214,IL6
Myocardial Stunning,1/8,0.015891074726793453,0.06187697401542237,0,0,62.5,258.87485408141214,TNF
Neonatal disorder,1/8,0.015891074726793453,0.061852468283139034,0,0,62.5,258.87485408141214,TGFB1
Neonatal encephalopathy,1/8,0.015891074726793453,0.06182798195365244,0,0,62.5,258.87485408141214,TLR4
Neonatal infection,1/8,0.015891074726793453,0.061803515003928,0,0,62.5,258.87485408141214,IL6
Neutrophilic dermatosis,1/8,0.015891074726793453,0.061779067410967586,0,0,62.5,258.87485408141214,IL1B
Non-obstructive reflux-associated chronic pyelonephritis (disorder),1/8,0.015891074726793453,0.06175463915180943,0,0,62.5,258.87485408141214,TNF
Opsoclonus-Myoclonus Syndrome,1/8,0.015891074726793453,0.06173023020352809,0,0,62.5,258.87485408141214,CCR4
Opticospinal Multiple Sclerosis,1/8,0.015891074726793453,0.06170584054323432,0,0,62.5,258.87485408141214,HLA-DRB1
Pain in limb,1/8,0.015891074726793453,0.06168147014807506,0,0,62.5,258.87485408141214,TGFB1
Pleural Mesothelioma,1/8,0.015891074726793453,0.061657118995233344,0,0,62.5,258.87485408141214,TNF
Portal hypertensive gastropathy,1/8,0.015891074726793453,0.0616327870619282,0,0,62.5,258.87485408141214,TNF
Poxviridae Infections,1/8,0.015891074726793453,0.06160847432541462,0,0,62.5,258.87485408141214,IL6
Pseudo-Hurler Polydystrophy,1/8,0.015891074726793453,0.06158418076298346,0,0,62.5,258.87485408141214,IL2
Qualitative abnormality of granulocyte,1/8,0.015891074726793453,0.061559906351961395,0,0,62.5,258.87485408141214,HIF1A
Adult Hepatocellular Carcinoma,2/97,0.01611014898620261,0.06238398118061436,0,0,10.309278350515463,42.55985395648193,IL10;HIF1A
Gilles de la Tourette syndrome,2/97,0.01611014898620261,0.06235941088475748,0,0,10.309278350515463,42.55985395648193,IL2;HLA-DRB1
Childhood Neuroblastoma,2/100,0.017063182912830144,0.06602242585326562,0,0,10.0,40.70832182642732,TGFB1;HIF1A
Rash and Dermatitis Adverse Event Associated with Chemoradiation,2/100,0.017063182912830144,0.06599644300169015,0,0,10.0,40.70832182642732,MTHFR;TNF
Uranostaphyloschisis,3/274,0.017299072364359153,0.06688248748895427,0,0,5.474452554744525,22.210414595656815,MTHFR;AHR;ETS1
Adult Acute Myeloblastic Leukemia,2/102,0.017711645882981793,0.06845067075813806,0,0,9.80392156862745,39.544440159532385,MTHFR;HIF1A
Inflammatory Breast Carcinoma,2/102,0.017711645882981793,0.06842376404793438,0,0,9.80392156862745,39.544440159532385,IL10;VDR
Recurrent seizures,1/9,0.01786007107272191,0.06897005049222434,0,0,55.55555555555555,223.62154022811023,IL1B
Amyotrophy, monomelic,1/9,0.01786007107272191,0.06894296092015355,0,0,55.55555555555555,223.62154022811023,SOD1
Rhegmatogenous retinal detachment,1/9,0.01786007107272191,0.06891589261983154,0,0,55.55555555555555,223.62154022811023,TNF
Rumination Disorders,1/9,0.01786007107272191,0.06888884556621308,0,0,55.55555555555555,223.62154022811023,MTHFR
Seronegative rheumatoid arthritis,1/9,0.01786007107272191,0.06886181973429224,0,0,55.55555555555555,223.62154022811023,TNF
Gait, Scissors,1/9,0.01786007107272191,0.06883481509910233,0,0,55.55555555555555,223.62154022811023,SOD1
Severe Bronchopulmonary Dysplasia,1/9,0.01786007107272191,0.06880783163571577,0,0,55.55555555555555,223.62154022811023,TNF
Hyperbilirubinemia, Hereditary,1/9,0.01786007107272191,0.0687808693192441,0,0,55.55555555555555,223.62154022811023,HMGB1
Short Sleeper Syndrome,1/9,0.01786007107272191,0.06875392812483781,0,0,55.55555555555555,223.62154022811023,IL1B
Lymphoproliferative Syndrome, X-Linked, 2,1/9,0.01786007107272191,0.06872700802768635,0,0,55.55555555555555,223.62154022811023,TNF
Snoring,1/9,0.01786007107272191,0.06870010900301798,0,0,55.55555555555555,223.62154022811023,TNF
Multiple Sclerosis, Chronic Progressive,1/9,0.01786007107272191,0.06867323102609973,0,0,55.55555555555555,223.62154022811023,IL10
Myasthenia Gravis, Generalized,1/9,0.01786007107272191,0.06864637407223736,0,0,55.55555555555555,223.62154022811023,HLA-DRB1
Spinal Diseases,1/9,0.01786007107272191,0.0686195381167752,0,0,55.55555555555555,223.62154022811023,TNF
Spindle cell hemangioma,1/9,0.01786007107272191,0.06859272313509611,0,0,55.55555555555555,223.62154022811023,HIF1A
Neural tube defect, folate-sensitive,1/9,0.01786007107272191,0.06856592910262146,0,0,55.55555555555555,223.62154022811023,MTHFR
Optic Neuropathy, Ischemic,1/9,0.01786007107272191,0.06853915599481099,0,0,55.55555555555555,223.62154022811023,MTHFR
Status Asthmaticus,1/9,0.01786007107272191,0.06851240378716274,0,0,55.55555555555555,223.62154022811023,CD14
Pachyonychia Congenita, Jadassohn Lewandowsky Type,1/9,0.01786007107272191,0.068485672455213,0,0,55.55555555555555,223.62154022811023,INS
Peroxisome Biogenesis Disorder, Complementation Group C,1/9,0.01786007107272191,0.06845896197453624,0,0,55.55555555555555,223.62154022811023,TGM2
Polyposis, Gastric,1/9,0.01786007107272191,0.068432272320745,0,0,55.55555555555555,223.62154022811023,SOD1
Thalassemia trait,1/9,0.01786007107272191,0.06840560346948985,0,0,55.55555555555555,223.62154022811023,IL6
Abdominal wall muscle weakness,1/9,0.01786007107272191,0.06837895539645926,0,0,55.55555555555555,223.62154022811023,VDR
Transposition of Great Vessels,1/9,0.01786007107272191,0.06835232807737965,0,0,55.55555555555555,223.62154022811023,HIF1A
Abnormal rapid eye movement sleep,1/9,0.01786007107272191,0.06832572148801516,0,0,55.55555555555555,223.62154022811023,HLA-DRB1
Abruptio Placentae,1/9,0.01786007107272191,0.06829913560416769,0,0,55.55555555555555,223.62154022811023,MTHFR
Vasculitic neuropathy,1/9,0.01786007107272191,0.06827257040167675,0,0,55.55555555555555,223.62154022811023,IL6
Acquired hypothyroidism,1/9,0.01786007107272191,0.06824602585641949,0,0,55.55555555555555,223.62154022811023,IFNG
VITAMIN B12 MEASUREMENT,1/9,0.01786007107272191,0.0682195019443105,0,0,55.55555555555555,223.62154022811023,FUT2
Vulvar Vestibulitis,1/9,0.01786007107272191,0.06819299864130184,0,0,55.55555555555555,223.62154022811023,IFNG
Aggressive Systemic Mastocytosis,1/9,0.01786007107272191,0.06816651592338288,0,0,55.55555555555555,223.62154022811023,TGFB1
Asthma attack,1/9,0.01786007107272191,0.06814005376658033,0,0,55.55555555555555,223.62154022811023,AHR
Atresia,1/9,0.01786007107272191,0.06811361214695806,0,0,55.55555555555555,223.62154022811023,STAT1
Bile Duct Diseases,1/9,0.01786007107272191,0.06808719104061713,0,0,55.55555555555555,223.62154022811023,HLA-DRB1
Bone Resorption,1/9,0.01786007107272191,0.06806079042369559,0,0,55.55555555555555,223.62154022811023,AHR
Buruli Ulcer,1/9,0.01786007107272191,0.06803441027236858,0,0,55.55555555555555,223.62154022811023,IFNG
Capillary Leak Syndrome,1/9,0.01786007107272191,0.0680080505628481,0,0,55.55555555555555,223.62154022811023,CXCL10
Carbamoyl-Phosphate Synthase I Deficiency Disease,1/9,0.01786007107272191,0.06798171127138301,0,0,55.55555555555555,223.62154022811023,IFNG
Cardiovirus Infections,1/9,0.01786007107272191,0.06795539237425897,0,0,55.55555555555555,223.62154022811023,TNF
Childhood nephrotic syndrome,1/9,0.01786007107272191,0.06792909384779836,0,0,55.55555555555555,223.62154022811023,CD14
Childhood Renal Cell Carcinoma,1/9,0.01786007107272191,0.06790281566836014,0,0,55.55555555555555,223.62154022811023,IL6
Cranioectodermal Dysplasia,1/9,0.01786007107272191,0.06787655781233988,0,0,55.55555555555555,223.62154022811023,TGFB1
Craniofacial dysostosis type 1,1/9,0.01786007107272191,0.06785032025616967,0,0,55.55555555555555,223.62154022811023,TGM2
Cutaneous Candidiasis,1/9,0.01786007107272191,0.06782410297631798,0,0,55.55555555555555,223.62154022811023,CXCL10
Degeneration of the lateral corticospinal tracts,1/9,0.01786007107272191,0.06779790594928967,0,0,55.55555555555555,223.62154022811023,SOD1
Difficulty standing,1/9,0.01786007107272191,0.06777172915162584,0,0,55.55555555555555,223.62154022811023,VDR
Dilatation of the cerebral artery,1/9,0.01786007107272191,0.06774557255990388,0,0,55.55555555555555,223.62154022811023,STAT1
Diseases of mitral valve,1/9,0.01786007107272191,0.06771943615073725,0,0,55.55555555555555,223.62154022811023,TGFB1
Dyggve-Melchior-Clausen syndrome,1/9,0.01786007107272191,0.06769331990077553,0,0,55.55555555555555,223.62154022811023,HMGB1
Dysglycemia,1/9,0.01786007107272191,0.0676672237867043,0,0,55.55555555555555,223.62154022811023,INS
Enteritis due to Norovirus,1/9,0.01786007107272191,0.06764114778524506,0,0,55.55555555555555,223.62154022811023,FUT2
Fatal Familial Insomnia,1/9,0.01786007107272191,0.06761509187315522,0,0,55.55555555555555,223.62154022811023,PRL
Fetal Diseases,1/9,0.01786007107272191,0.06758905602722794,0,0,55.55555555555555,223.62154022811023,S100A9
Food Allergy,1/9,0.01786007107272191,0.06756304022429212,0,0,55.55555555555555,223.62154022811023,CD14
Galactorrhea,1/9,0.01786007107272191,0.06753704444121236,0,0,55.55555555555555,223.62154022811023,PRL
Hyperventilation,1/9,0.01786007107272191,0.06751106865488882,0,0,55.55555555555555,223.62154022811023,AHR
Idiopathic hypercalciuria,1/9,0.01786007107272191,0.06748511284225718,0,0,55.55555555555555,223.62154022811023,VDR
Ileal Pouches,1/9,0.01786007107272191,0.0674591769802886,0,0,55.55555555555555,223.62154022811023,TNF
Influenza-like symptoms,1/9,0.01786007107272191,0.06743326104598961,0,0,55.55555555555555,223.62154022811023,IL6
Limb-girdle muscular dystrophy type 2H,1/9,0.01786007107272191,0.06740736501640204,0,0,55.55555555555555,223.62154022811023,TNF
Mild hereditary factor VIII deficiency disease,1/9,0.01786007107272191,0.06738148886860304,0,0,55.55555555555555,223.62154022811023,HLA-DRB1
Myocardial hypoxia,1/9,0.01786007107272191,0.06735563257970488,0,0,55.55555555555555,223.62154022811023,HIF1A
Ocular Cicatricial Pemphigoid,1/9,0.01786007107272191,0.06732979612685498,0,0,55.55555555555555,223.62154022811023,HLA-DRB1
Oropharyngeal candidiasis,1/9,0.01786007107272191,0.0673039794872358,0,0,55.55555555555555,223.62154022811023,TLR4
Other emphysema,1/9,0.01786007107272191,0.06727818263806475,0,0,55.55555555555555,223.62154022811023,TLR4
Other specified peritonitis,1/9,0.01786007107272191,0.06725240555659423,0,0,55.55555555555555,223.62154022811023,TNF
Preterm Premature Rupture of Fetal Membranes,1/9,0.01786007107272191,0.06722664822011143,0,0,55.55555555555555,223.62154022811023,TNF
psychosocial stressor,1/9,0.01786007107272191,0.06720091060593833,0,0,55.55555555555555,223.62154022811023,IL6
Radicular Cyst,1/9,0.01786007107272191,0.06717519269143166,0,0,55.55555555555555,223.62154022811023,IFNG
Ichthyosis, X-Linked,2/103,0.018039775887824815,0.06782514056065121,0,0,9.70873786407767,38.982293082469944,HIF1A;TNF
Carcinoid tumor no ICD-O subtype,2/104,0.018370490051506164,0.06904213240007748,0,0,9.615384615384615,38.43278560944445,PRL;ETS1
Pick Disease of the Brain,2/105,0.018703777270415414,0.0702678604792212,0,0,9.523809523809524,37.89552173761054,TNF;SOD1
Atrial Premature Complexes,2/106,0.019039626484846625,0.071502273249168,0,0,9.433962264150942,37.37012138871557,IRF1;TNF
Severe myopia,2/108,0.019718966776120977,0.07402521217559853,0,0,9.259259259259258,36.35346598055861,IL10;TGFB1
Vesico-Ureteral Reflux,2/108,0.019718966776120977,0.07399694748977356,0,0,9.259259259259258,36.35346598055861,TGFB1;TNF
Malabsorption,2/108,0.019718966776120977,0.07396870438004464,0,0,9.259259259259258,36.35346598055861,TGFB1;HLA-DRB1
Rickettsia Infections,1/10,0.019825226718581047,0.07433892719962401,0,0,50.0,196.0400037766308,TLR4
Encephalomyelitis, Acute Disseminated,1/10,0.019825226718581047,0.07431057520603147,0,0,50.0,196.0400037766308,HLA-DRB1
Small cell carcinoma of the cervix,1/10,0.019825226718581047,0.07428224483042871,0,0,50.0,196.0400037766308,HIF1A
Meningitis, Cryptococcal,1/10,0.019825226718581047,0.07425393604810004,0,0,50.0,196.0400037766308,IFNG
Splenic Hypoplasia,1/10,0.019825226718581047,0.07422564883436744,0,0,50.0,196.0400037766308,IL1B
Sporadic Parkinson disease,1/10,0.019825226718581047,0.07419738316459044,0,0,50.0,196.0400037766308,VDR
Stage 0 Skin Melanoma,1/10,0.019825226718581047,0.07416913901416616,0,0,50.0,196.0400037766308,IL10
Symptomatic dermographism,1/10,0.019825226718581047,0.07414091635852911,0,0,50.0,196.0400037766308,IL12A
Thrombocytosis, Autosomal Dominant,1/10,0.019825226718581047,0.07411271517315121,0,0,50.0,196.0400037766308,TGFB1
Tuberculosis, Central Nervous System,1/10,0.019825226718581047,0.07408453543354164,0,0,50.0,196.0400037766308,TNF
Vasculitis, Leukocytoclastic, Cutaneous,1/10,0.019825226718581047,0.07405637711524687,0,0,50.0,196.0400037766308,HLA-DRB1
Todd Paralysis,1/10,0.019825226718581047,0.0740282401938505,0,0,50.0,196.0400037766308,INS
Abnormality of tibia morphology,1/10,0.019825226718581047,0.07400012464497323,0,0,50.0,196.0400037766308,TGFB1
Vascular insufficiency of intestine,1/10,0.019825226718581047,0.07397203044427278,0,0,50.0,196.0400037766308,IL17A
Ventricular Dysfunction,1/10,0.019825226718581047,0.07394395756744383,0,0,50.0,196.0400037766308,TNF
Xanthoma tendinosum,1/10,0.019825226718581047,0.07391590599021795,0,0,50.0,196.0400037766308,IL6
Ankyloglossia,1/10,0.019825226718581047,0.07388787568836348,0,0,50.0,196.0400037766308,ETS1
Arthus Reaction,1/10,0.019825226718581047,0.07385986663768557,0,0,50.0,196.0400037766308,TNF
Asymptomatic bacteriuria,1/10,0.019825226718581047,0.07383187881402596,0,0,50.0,196.0400037766308,TLR4
Bisphosphonate-associated osteonecrosis,1/10,0.019825226718581047,0.07380391219326307,0,0,50.0,196.0400037766308,TNF
cervical cancer metastasis,1/10,0.019825226718581047,0.07377596675131182,0,0,50.0,196.0400037766308,TGFB1
Chronic idiopathic pulmonary fibrosis,1/10,0.019825226718581047,0.07374804246412359,0,0,50.0,196.0400037766308,IFNG
Chronic skin ulcer,1/10,0.019825226718581047,0.07372013930768616,0,0,50.0,196.0400037766308,TNF
Congenital hypoplasia,1/10,0.019825226718581047,0.07369225725802364,0,0,50.0,196.0400037766308,VDR
Congenital nystagmus,1/10,0.019825226718581047,0.07366439629119642,0,0,50.0,196.0400037766308,AHR
Constitutional delay of growth and puberty,1/10,0.019825226718581047,0.07363655638330102,0,0,50.0,196.0400037766308,SOD1
COPD exacerbation,1/10,0.019825226718581047,0.07360873751047016,0,0,50.0,196.0400037766308,IL10
Corneal fibrosis,1/10,0.019825226718581047,0.07358093964887255,0,0,50.0,196.0400037766308,TGFB1
Denys-Drash Syndrome,1/10,0.019825226718581047,0.07355316277471291,0,0,50.0,196.0400037766308,VDR
Diabetes mellitus autosomal dominant type II (disorder),1/10,0.019825226718581047,0.0735254068642319,0,0,50.0,196.0400037766308,TGFB1
Disorder of vein,1/10,0.019825226718581047,0.07349767189370597,0,0,50.0,196.0400037766308,MTHFR
Distemper,1/10,0.019825226718581047,0.0734699578394474,0,0,50.0,196.0400037766308,STAT1
Friend leukemia,1/10,0.019825226718581047,0.0734422646778042,0,0,50.0,196.0400037766308,ETS1
Gastrointestinal tract vascular insufficiency,1/10,0.019825226718581047,0.07341459238515996,0,0,50.0,196.0400037766308,IL17A
Generalized osteoporosis with pathologic fractures,1/10,0.019825226718581047,0.07338694093793391,0,0,50.0,196.0400037766308,STAT1
Hemoptysis,1/10,0.019825226718581047,0.07335931031258076,0,0,50.0,196.0400037766308,TNF
Hookworm Infections,1/10,0.019825226718581047,0.0733317004855907,0,0,50.0,196.0400037766308,HLA-DRB1
Humoral immune defect,1/10,0.019825226718581047,0.07330411143348928,0,0,50.0,196.0400037766308,IL10
Hypoadiponectinemia,1/10,0.019825226718581047,0.07327654313283735,0,0,50.0,196.0400037766308,TNF
Idiopathic Hypoparathyroidism,1/10,0.019825226718581047,0.07324899556023103,0,0,50.0,196.0400037766308,HLA-DRB1
Induced hypothermia (finding),1/10,0.019825226718581047,0.07322146869230159,0,0,50.0,196.0400037766308,TNF
Intrauterine infection,1/10,0.019825226718581047,0.07319396250571544,0,0,50.0,196.0400037766308,HLA-DRB1
LATE-ONSET RETINAL DEGENERATION (disorder),1/10,0.019825226718581047,0.07316647697717406,0,0,50.0,196.0400037766308,TNF
Liver mass,1/10,0.019825226718581047,0.07313901208341386,0,0,50.0,196.0400037766308,IL6
Merkel Cell Polyomavirus Infection,1/10,0.019825226718581047,0.0731115678012062,0,0,50.0,196.0400037766308,IL1B
Nematode infections,1/10,0.019825226718581047,0.07308414410735728,0,0,50.0,196.0400037766308,IL10
Night sweats,1/10,0.019825226718581047,0.07305674097870811,0,0,50.0,196.0400037766308,HLA-DRB1
Oculocutaneous albinism type 1,1/10,0.019825226718581047,0.07302935839213438,0,0,50.0,196.0400037766308,HIF1A
Oliguria,1/10,0.019825226718581047,0.07300199632454646,0,0,50.0,196.0400037766308,HLA-DRB1
Paraneoplastic pemphigus,1/10,0.019825226718581047,0.07297465475288933,0,0,50.0,196.0400037766308,HLA-DRB1
Perihilar Cholangiocarcinoma,1/10,0.019825226718581047,0.07294733365414247,0,0,50.0,196.0400037766308,HIF1A
Prostatic Adenoma,1/10,0.019825226718581047,0.07292003300531981,0,0,50.0,196.0400037766308,PRL
Weight Gain,2/110,0.020408423025084537,0.07503703011243204,0,0,9.09090909090909,35.380068817840794,AHR;TNF
Hyperplastic Polyp,2/110,0.020408423025084537,0.07500896839586044,0,0,9.09090909090909,35.380068817840794,IRF1;RUNX3
Paresis,2/113,0.02146138379068478,0.07884952519433645,0,0,8.849557522123893,33.99557576578702,HLA-DRB1;SOD1
Brain Stem Ischemia, Transient,1/11,0.02178654888216798,0.08001427593944205,0,0,45.45454545454545,173.93011469901603,SOD1
Colitis, Ischemic,1/11,0.02178654888216798,0.07998438640789948,0,0,45.45454545454545,173.93011469901603,HIF1A
Rotator cuff syndrome,1/11,0.02178654888216798,0.07995451919863589,0,0,45.45454545454545,173.93011469901603,IL6
Depressive episode, unspecified,1/11,0.02178654888216798,0.07992467428665431,0,0,45.45454545454545,173.93011469901603,TLR4
Gait, Shuffling,1/11,0.02178654888216798,0.07989485164699511,0,0,45.45454545454545,173.93011469901603,SOD1
Sturge-Weber Syndrome,1/11,0.02178654888216798,0.07986505125473588,0,0,45.45454545454545,173.93011469901603,HIF1A
Supraventricular tachycardia,1/11,0.02178654888216798,0.07983527308499139,0,0,45.45454545454545,173.93011469901603,MTHFR
Transient Ischemic Attack, Anterior Circulation,1/11,0.02178654888216798,0.07980551711291349,0,0,45.45454545454545,173.93011469901603,SOD1
Transient Ischemic Attack, Vertebrobasilar Circulation,1/11,0.02178654888216798,0.07977578331369109,0,0,45.45454545454545,173.93011469901603,SOD1
Tuberculosis of intestines,1/11,0.02178654888216798,0.07974607166255006,0,0,45.45454545454545,173.93011469901603,IL2RA
Abnormality of the intrahepatic bile duct,1/11,0.02178654888216798,0.07971638213475313,0,0,45.45454545454545,173.93011469901603,IL12A
Abnormality of the ulna,1/11,0.02178654888216798,0.07968671470559989,0,0,45.45454545454545,173.93011469901603,TGFB1
Vascular System Injuries,1/11,0.02178654888216798,0.07965706935042667,0,0,45.45454545454545,173.93011469901603,TNF
Wolcott-Rallison syndrome,1/11,0.02178654888216798,0.0796274460446065,0,0,45.45454545454545,173.93011469901603,INS
Akathisia,1/11,0.02178654888216798,0.07959784476354903,0,0,45.45454545454545,173.93011469901603,PRL
AROMATASE EXCESS SYNDROME,1/11,0.02178654888216798,0.07956826548270045,0,0,45.45454545454545,173.93011469901603,IL6
Arterial aneurysm,1/11,0.02178654888216798,0.07953870817754342,0,0,45.45454545454545,173.93011469901603,IL6
Burn scar,1/11,0.02178654888216798,0.07950917282359707,0,0,45.45454545454545,173.93011469901603,TGFB1
Carotid Circulation Transient Ischemic Attack,1/11,0.02178654888216798,0.07947965939641681,0,0,45.45454545454545,173.93011469901603,SOD1
Choledochal Cyst,1/11,0.02178654888216798,0.0794501678715944,0,0,45.45454545454545,173.93011469901603,CD14
Chronic cough,1/11,0.02178654888216798,0.07942069822475775,0,0,45.45454545454545,173.93011469901603,TGFB1
Congenital cytomegalovirus infection,1/11,0.02178654888216798,0.07939125043157097,0,0,45.45454545454545,173.93011469901603,TNF
Crescendo Transient Ischemic Attacks,1/11,0.02178654888216798,0.07936182446773421,0,0,45.45454545454545,173.93011469901603,SOD1
Cutaneous hypersensitivity,1/11,0.02178654888216798,0.07933242030898366,0,0,45.45454545454545,173.93011469901603,HLA-DRB1
Degeneration of anterior horn cells,1/11,0.02178654888216798,0.07930303793109145,0,0,45.45454545454545,173.93011469901603,SOD1
Dengue Shock Syndrome,1/11,0.02178654888216798,0.07927367730986556,0,0,45.45454545454545,173.93011469901603,IL1B
Diabetic macular edema,1/11,0.02178654888216798,0.07924433842114985,0,0,45.45454545454545,173.93011469901603,IL1B
Ectromelia,1/11,0.02178654888216798,0.07921502124082386,0,0,45.45454545454545,173.93011469901603,TLR4
Erosive esophagitis,1/11,0.02178654888216798,0.07918572574480284,0,0,45.45454545454545,173.93011469901603,IL1B
HODGKIN'S AND NON-HODGKIN'S LYMPHOMA,1/11,0.02178654888216798,0.07915645190903767,0,0,45.45454545454545,173.93011469901603,IL6
Idiopathic chronic pancreatitis,1/11,0.02178654888216798,0.07912719970951475,0,0,45.45454545454545,173.93011469901603,TNF
IgG Deficiency disorder,1/11,0.02178654888216798,0.07909796912225597,0,0,45.45454545454545,173.93011469901603,IL10
Intestinal Perforation,1/11,0.02178654888216798,0.07906876012331865,0,0,45.45454545454545,173.93011469901603,IL6
Leukemic Infiltration,1/11,0.02178654888216798,0.07903957268879547,0,0,45.45454545454545,173.93011469901603,CD14
Muscle fibrosis,1/11,0.02178654888216798,0.07901040679481436,0,0,45.45454545454545,173.93011469901603,TGFB1
Nasopharyngeal Angiofibroma,1/11,0.02178654888216798,0.07898126241753851,0,0,45.45454545454545,173.93011469901603,IL6
Neonatal insulin-dependent diabetes mellitus,1/11,0.02178654888216798,0.07895213953316627,0,0,45.45454545454545,173.93011469901603,INS
Non-Hereditary Clear Cell Renal Cell Carcinoma,1/11,0.02178654888216798,0.07892303811793104,0,0,45.45454545454545,173.93011469901603,HIF1A
Osteochondritis Dissecans,1/11,0.02178654888216798,0.0788939581481013,0,0,45.45454545454545,173.93011469901603,TNF
Parapsoriasis,1/11,0.02178654888216798,0.07886489959998044,0,0,45.45454545454545,173.93011469901603,IL15
Pediatric Neoplasm,1/11,0.02178654888216798,0.07883586244990681,0,0,45.45454545454545,173.93011469901603,IL6
Pigmented villonodular synovitis,1/11,0.02178654888216798,0.07880684667425356,0,0,45.45454545454545,173.93011469901603,TNF
Polyomavirus Infections,1/11,0.02178654888216798,0.07877785224942858,0,0,45.45454545454545,173.93011469901603,IL15
Posterior Circulation Transient Ischemic Attack,1/11,0.02178654888216798,0.07874887915187455,0,0,45.45454545454545,173.93011469901603,SOD1
Primary Hyperthyroidism,1/11,0.02178654888216798,0.07871992735806871,0,0,45.45454545454545,173.93011469901603,SOD1
Pyogenic granuloma,1/11,0.02178654888216798,0.07869099684452294,0,0,45.45454545454545,173.93011469901603,IL6
Neuroectodermal Tumor, Primitive,2/114,0.021817334337322827,0.0787732409504808,0,0,8.771929824561402,33.55307431636512,IFNG;IL1B
Lymphocyte Count measurement,2/114,0.021817334337322827,0.07874431210694409,0,0,8.771929824561402,33.55307431636512,IL2RA;ETS1
Acute Myeloid Leukemia, M1,2/116,0.02253661613189777,0.08131052251993072,0,0,8.620689655172413,32.69494749039419,CD14;RUNX3
Fetal Growth Retardation,3/304,0.02270266210494568,0.08187954611647931,0,0,4.934210526315789,18.6773343159135,TNF;INS;SOD1
Carcinoma, Small Cell,2/117,0.022899925912785064,0.08256070134660734,0,0,8.547008547008547,32.278817125442195,TGFB1;MTHFR
Leukemia, B-Cell,2/117,0.022899925912785064,0.08253042606191845,0,0,8.547008547008547,32.278817125442195,IL6;TNF
Von Hippel-Lindau Syndrome,2/119,0.023633829787244216,0.08514416391093702,0,0,8.403361344537815,31.47122796487689,HIF1A;TGM2
Recurrent respiratory papillomatosis,1/12,0.02374404479036207,0.085509883546969,0,0,41.666666666666664,155.85098023385015,HLA-DRB1
Alport Syndrome, X-Linked,1/12,0.02374404479036207,0.08547856124530345,0,0,41.666666666666664,155.85098023385015,MTHFR
ARTHROGRYPOSIS, DISTAL, TYPE 2B,1/12,0.02374404479036207,0.08544726188197672,0,0,41.666666666666664,155.85098023385015,HIF1A
Autoimmune polyendocrinopathy syndrome, type 1,1/12,0.02374404479036207,0.0854159854318003,0,0,41.666666666666664,155.85098023385015,IL17A
Cerebral Infarction, Left Hemisphere,1/12,0.02374404479036207,0.08538473186962255,0,0,41.666666666666664,155.85098023385015,VDR
Cerebral Infarction, Right Hemisphere,1/12,0.02374404479036207,0.08535350117032861,0,0,41.666666666666664,155.85098023385015,VDR
Secondary pulmonary hypertension,1/12,0.02374404479036207,0.08532229330884038,0,0,41.666666666666664,155.85098023385015,TGFB1
Sickle Cell Dactylitis,1/12,0.02374404479036207,0.08529110826011638,0,0,41.666666666666664,155.85098023385015,MTHFR
Immunoglobulin Deficiency, Late-Onset,1/12,0.02374404479036207,0.08525994599915178,0,0,41.666666666666664,155.85098023385015,IL21
Sleep Wake Disorders,1/12,0.02374404479036207,0.08522880650097824,0,0,41.666666666666664,155.85098023385015,IL1B
Melanoma, Experimental,1/12,0.02374404479036207,0.0851976897406639,0,0,41.666666666666664,155.85098023385015,HIF1A
MYCOBACTERIUM TUBERCULOSIS, PROTECTION AGAINST,1/12,0.02374404479036207,0.0851665956933133,0,0,41.666666666666664,155.85098023385015,IFNG
MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO (finding),1/12,0.02374404479036207,0.08513552433406728,0,0,41.666666666666664,155.85098023385015,IFNG
Tay-Sachs Disease,1/12,0.02374404479036207,0.085104475638103,0,0,41.666666666666664,155.85098023385015,SOD1
Thrombophilia, hereditary,1/12,0.02374404479036207,0.08507344958063377,0,0,41.666666666666664,155.85098023385015,MTHFR
Thyrotoxic periodic paralysis,1/12,0.02374404479036207,0.08504244613690905,0,0,41.666666666666664,155.85098023385015,HLA-DRB1
Trichoepithelioma,1/12,0.02374404479036207,0.08501146528221436,0,0,41.666666666666664,155.85098023385015,HIF1A
Trismus,1/12,0.02374404479036207,0.08498050699187124,0,0,41.666666666666664,155.85098023385015,TGFB1
Acute mountain sickness,1/12,0.02374404479036207,0.08494957124123714,0,0,41.666666666666664,155.85098023385015,HIF1A
Amebiasis,1/12,0.02374404479036207,0.08491865800570539,0,0,41.666666666666664,155.85098023385015,HLA-DRB1
Anterior Choroidal Artery Infarction,1/12,0.02374404479036207,0.08488776726070514,0,0,41.666666666666664,155.85098023385015,VDR
Asperger Syndrome,1/12,0.02374404479036207,0.08485689898170125,0,0,41.666666666666664,155.85098023385015,MTHFR
Aspiration Pneumonia,1/12,0.02374404479036207,0.08482605314419427,0,0,41.666666666666664,155.85098023385015,TNF
Bleeding ulcer,1/12,0.02374404479036207,0.08479522972372036,0,0,41.666666666666664,155.85098023385015,IL1B
Breast cancer stage II,1/12,0.02374404479036207,0.08476442869585123,0,0,41.666666666666664,155.85098023385015,IL6R
Cardiac sarcoidosis,1/12,0.02374404479036207,0.08473365003619406,0,0,41.666666666666664,155.85098023385015,IL2
Chronic calcifying pancreatitis,1/12,0.02374404479036207,0.08470289372039144,0,0,41.666666666666664,155.85098023385015,HLA-DRB1
Contractures of the joints of the lower limbs,1/12,0.02374404479036207,0.08467215972412134,0,0,41.666666666666664,155.85098023385015,INS
Female Genital Diseases,1/12,0.02374404479036207,0.08464144802309699,0,0,41.666666666666664,155.85098023385015,IL6
Frontotemporal Dementia With Motor Neuron Disease,1/12,0.02374404479036207,0.08461075859306687,0,0,41.666666666666664,155.85098023385015,SOD1
Gastric adenoma,1/12,0.02374404479036207,0.08458009140981458,0,0,41.666666666666664,155.85098023385015,ETS1
Gigantism,1/12,0.02374404479036207,0.08454944644915885,0,0,41.666666666666664,155.85098023385015,PRL
Glycogen Storage Disease Type VII,1/12,0.02374404479036207,0.08451882368695343,0,0,41.666666666666664,155.85098023385015,HIF1A
Hospital acquired pneumonia,1/12,0.02374404479036207,0.08448822309908705,0,0,41.666666666666664,155.85098023385015,TNF
hyperparathyroid,1/12,0.02374404479036207,0.08445764466148332,0,0,41.666666666666664,155.85098023385015,VDR
Ichthyosis Bullosa of Siemens,1/12,0.02374404479036207,0.08442708835010074,0,0,41.666666666666664,155.85098023385015,TNF
Inflammatory cardiomyopathy,1/12,0.02374404479036207,0.08439655414093253,0,0,41.666666666666664,155.85098023385015,TLR4
Influenza A,1/12,0.02374404479036207,0.08436604201000666,0,0,41.666666666666664,155.85098023385015,HIF1A
Intracranial Arteriovenous Malformation,1/12,0.02374404479036207,0.08433555193338577,0,0,41.666666666666664,155.85098023385015,IL6
Lymphoblastic leukemia in children,1/12,0.02374404479036207,0.08430508388716706,0,0,41.666666666666664,155.85098023385015,MTHFR
OROFACIAL CLEFT 1,1/12,0.02374404479036207,0.08427463784748228,0,0,41.666666666666664,155.85098023385015,MTHFR
Palmar-plantar erythrodysesthesia syndrome,1/12,0.02374404479036207,0.08424421379049762,0,0,41.666666666666664,155.85098023385015,MTHFR
Pharyngitis,1/12,0.02374404479036207,0.08421381169241372,0,0,41.666666666666664,155.85098023385015,TNF
Placental dysfunction,1/12,0.02374404479036207,0.08418343152946552,0,0,41.666666666666664,155.85098023385015,TNF
Posterior Choroidal Artery Infarction,1/12,0.02374404479036207,0.08415307327792226,0,0,41.666666666666664,155.85098023385015,VDR
Priapism,1/12,0.02374404479036207,0.08412273691408739,0,0,41.666666666666664,155.85098023385015,TGFB1
Primary immunoglobulin A nephropathy (disorder),1/12,0.02374404479036207,0.08409242241429853,0,0,41.666666666666664,155.85098023385015,HLA-DRB1
Progressive multiple sclerosis,1/12,0.02374404479036207,0.08406212975492738,0,0,41.666666666666664,155.85098023385015,IL21
PTEN Hamartoma Tumor Syndrome,1/12,0.02374404479036207,0.0840318589123797,0,0,41.666666666666664,155.85098023385015,TNF
Raynaud Disease,1/12,0.02374404479036207,0.08400160986309518,0,0,41.666666666666664,155.85098023385015,IL1B
Gastrointestinal Neoplasms,2/122,0.02475273700569283,0.08753864674053585,0,0,8.196721311475411,30.31819024584451,IL1B;RUNX3
Pilocytic Astrocytoma,2/122,0.02475273700569283,0.08750715801868673,0,0,8.196721311475411,30.31819024584451,HIF1A;TNF
Agenesis of corpus callosum,3/317,0.025299615497674854,0.08940834991411307,0,0,4.73186119873817,17.398893128160143,CD14;RUNX3;TLR4
Nicotine Dependence,2/124,0.02551058617115038,0.09012151002518545,0,0,8.064516129032258,29.585982008060398,IL6;AHR
Relapsing Fever,1/13,0.025697721668678748,0.09074998510951302,0,0,38.46153846153846,140.82126700134117,TNF
Breast Cancer, Familial Male,1/13,0.025697721668678748,0.09071738813210299,0,0,38.46153846153846,140.82126700134117,HIF1A
Diabetes Mellitus, Transient Neonatal, 1,1/13,0.025697721668678748,0.0906848145636534,0,0,38.46153846153846,140.82126700134117,INS
DISORGANIZATION, MOUSE, HOMOLOG OF,1/13,0.025697721668678748,0.09065226437895718,0,0,38.46153846153846,140.82126700134117,SOD1
Secondary malignant neoplasm of skin,1/13,0.025697721668678748,0.09061973755284346,0,0,38.46153846153846,140.82126700134117,TGFB1
Eosinophilia, Tropical,1/13,0.025697721668678748,0.09058723406017745,0,0,38.46153846153846,140.82126700134117,TLR4
Sheehan Syndrome,1/13,0.025697721668678748,0.09055475387586043,0,0,38.46153846153846,140.82126700134117,PRL
Jaundice, Chronic Idiopathic,1/13,0.025697721668678748,0.09052229697482965,0,0,38.46153846153846,140.82126700134117,DPP4
Stage III Cutaneous Melanoma AJCC v6,1/13,0.025697721668678748,0.0904898633320583,0,0,38.46153846153846,140.82126700134117,IFNG
Status Dysraphicus,1/13,0.025697721668678748,0.09045745292255541,0,0,38.46153846153846,140.82126700134117,MTHFR
Pneumonia, Ventilator-Associated,1/13,0.025697721668678748,0.09042506572136581,0,0,38.46153846153846,140.82126700134117,TNF
Polycystic kidney disease, type 2,1/13,0.025697721668678748,0.09039270170357006,0,0,38.46153846153846,140.82126700134117,IFNG
Subependymal Glioma,1/13,0.025697721668678748,0.09036036084428434,0,0,38.46153846153846,140.82126700134117,HIF1A
Scleroderma, Limited,1/13,0.025697721668678748,0.09032804311866048,0,0,38.46153846153846,140.82126700134117,HLA-DRB1
Thin bony cortex,1/13,0.025697721668678748,0.09029574850188585,0,0,38.46153846153846,140.82126700134117,VDR
Transformed migraine,1/13,0.025697721668678748,0.09026347696918324,0,0,38.46153846153846,140.82126700134117,SOD1
Trophoblastic Neoplasms,1/13,0.025697721668678748,0.0902312284958109,0,0,38.46153846153846,140.82126700134117,TNF
Acute appendicitis NOS (disorder),1/13,0.025697721668678748,0.0901990030570624,0,0,38.46153846153846,140.82126700134117,IL2RA
Adrenal Gland Diseases,1/13,0.025697721668678748,0.0901668006282666,0,0,38.46153846153846,140.82126700134117,TGM2
Alphavirus Infections,1/13,0.025697721668678748,0.09013462118478756,0,0,38.46153846153846,140.82126700134117,HLA-DRB1
cancer angiogenesis,1/13,0.025697721668678748,0.09010246470202452,0,0,38.46153846153846,140.82126700134117,HIF1A
Cartilage Diseases,1/13,0.025697721668678748,0.09007033115541181,0,0,38.46153846153846,140.82126700134117,IL10
Cells in urine,1/13,0.025697721668678748,0.0900382205204188,0,0,38.46153846153846,140.82126700134117,IL2
Cholera Infantum,1/13,0.025697721668678748,0.09000613277254979,0,0,38.46153846153846,140.82126700134117,MTHFR
Chronic superficial gastritis,1/13,0.025697721668678748,0.08997406788734404,0,0,38.46153846153846,140.82126700134117,AHR
Congenital absence of liver,1/13,0.025697721668678748,0.08994202584037561,0,0,38.46153846153846,140.82126700134117,IL6
Curling Ulcer,1/13,0.025697721668678748,0.08991000660725337,0,0,38.46153846153846,140.82126700134117,TGFB1
Diabetes in children,1/13,0.025697721668678748,0.0898780101636209,0,0,38.46153846153846,140.82126700134117,HLA-DQA1
Disseminated eosinophilic collagen disease,1/13,0.025697721668678748,0.08984603648515643,0,0,38.46153846153846,140.82126700134117,IL2
Extramedullary Plasmacytoma,1/13,0.025697721668678748,0.08981408554757281,0,0,38.46153846153846,140.82126700134117,IL6
Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma,1/13,0.025697721668678748,0.08978215732661739,0,0,38.46153846153846,140.82126700134117,STAT1
Hydrosalpinx (disease),1/13,0.025697721668678748,0.08975025179807204,0,0,38.46153846153846,140.82126700134117,TNF
Infection in children,1/13,0.025697721668678748,0.089718368937753,0,0,38.46153846153846,140.82126700134117,IL6
Kearns-Sayre syndrome,1/13,0.025697721668678748,0.0896865087215109,0,0,38.46153846153846,140.82126700134117,IL1B
Keratoconjunctivitis,1/13,0.025697721668678748,0.08965467112523064,0,0,38.46153846153846,140.82126700134117,IFNG
Lenticulostriate Disorders,1/13,0.025697721668678748,0.08962285612483134,0,0,38.46153846153846,140.82126700134117,PRL
Lower Urinary Tract Symptoms,1/13,0.025697721668678748,0.08959106369626631,0,0,38.46153846153846,140.82126700134117,VDR
Macrophage Activation Syndrome,1/13,0.025697721668678748,0.08955929381552295,0,0,38.46153846153846,140.82126700134117,IL6
Macular retinal edema,1/13,0.025697721668678748,0.08952754645862274,0,0,38.46153846153846,140.82126700134117,IL10
Mediastinal lymphadenopathy,1/13,0.025697721668678748,0.08949582160162109,0,0,38.46153846153846,140.82126700134117,HLA-DRB1
Mycetoma,1/13,0.025697721668678748,0.08946411922060742,0,0,38.46153846153846,140.82126700134117,IL10
Occupational Diseases,1/13,0.025697721668678748,0.08943243929170493,0,0,38.46153846153846,140.82126700134117,TGFB1
Osteitis Fibrosa Disseminata,1/13,0.025697721668678748,0.0894007817910707,0,0,38.46153846153846,140.82126700134117,IL6
OVERLAP CONNECTIVE TISSUE DISEASE,1/13,0.025697721668678748,0.08936914669489551,0,0,38.46153846153846,140.82126700134117,AHR
Laryngeal Squamous Cell Carcinoma,2/126,0.02627786619852836,0.09135439299580358,0,0,7.936507936507936,28.881176853517225,AHR;TNF
Gastrointestinal Stromal Tumors,3/323,0.026550363016184648,0.09226908335327536,0,0,4.643962848297213,16.85160305787161,HMGB1;ETS1;HIF1A
Rett Syndrome,2/129,0.027446286773429394,0.09534892414608133,0,0,7.751937984496124,27.87228211276933,IL15;IL1B
Pervasive Development Disorder,2/129,0.027446286773429394,0.09531523194673643,0,0,7.751937984496124,27.87228211276933,MTHFR;TNF
Refractory Neoplasm,1/14,0.027647586728505463,0.09598038939164666,0,0,35.71428571428571,128.1506012171872,CCR4
Anemia, Hemolytic, Congenital,1/14,0.027647586728505463,0.09594649801121176,0,0,35.71428571428571,128.1506012171872,IFNG
Depressive Disorder, Treatment-Resistant,1/14,0.027647586728505463,0.09591263055691905,0,0,35.71428571428571,128.1506012171872,TNF
ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT,1/14,0.027647586728505463,0.09587878700344096,0,0,35.71428571428571,128.1506012171872,TNF
ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL DOMINANT,1/14,0.027647586728505463,0.0958449673254856,0,0,35.71428571428571,128.1506012171872,TNF
Semantic Dementia,1/14,0.027647586728505463,0.09581117149779679,0,0,35.71428571428571,128.1506012171872,SOD1
Huntington Disease, Late Onset,1/14,0.027647586728505463,0.09577739949515393,0,0,35.71428571428571,128.1506012171872,HLA-DRB1
Hydatidiform Mole, Partial,1/14,0.027647586728505463,0.09574365129237199,0,0,35.71428571428571,128.1506012171872,HLA-DRB1
Skin callus,1/14,0.027647586728505463,0.09570992686430141,0,0,35.71428571428571,128.1506012171872,VDR
Subcortical Infarction,1/14,0.027647586728505463,0.09567622618582806,0,0,35.71428571428571,128.1506012171872,VDR
Syringomyelia,1/14,0.027647586728505463,0.09564254923187317,0,0,35.71428571428571,128.1506012171872,VDR
Testicular embryonal carcinoma,1/14,0.027647586728505463,0.09560889597739328,0,0,35.71428571428571,128.1506012171872,TNF
Testicular Feminization,1/14,0.027647586728505463,0.09557526639738012,0,0,35.71428571428571,128.1506012171872,TGM2
Toxoplasmosis, Congenital,1/14,0.027647586728505463,0.09554166046686065,0,0,35.71428571428571,128.1506012171872,TLR4
Transient neonatal diabetes mellitus,1/14,0.027647586728505463,0.0955080781608969,0,0,35.71428571428571,128.1506012171872,INS
Abnormality of lipid metabolism,1/14,0.027647586728505463,0.09547451945458597,0,0,35.71428571428571,128.1506012171872,IL12A
Urinary Bladder Diseases,1/14,0.027647586728505463,0.09544098432305995,0,0,35.71428571428571,128.1506012171872,INS
Urticaria Pigmentosa,1/14,0.027647586728505463,0.09540747274148584,0,0,35.71428571428571,128.1506012171872,IL2RA
Abnormality of the thyroid gland,1/14,0.027647586728505463,0.09537398468506553,0,0,35.71428571428571,128.1506012171872,IL12A
Uterine Polyp,1/14,0.027647586728505463,0.09534052012903568,0,0,35.71428571428571,128.1506012171872,TNF
Absence of sensation,1/14,0.027647586728505463,0.09530707904866773,0,0,35.71428571428571,128.1506012171872,TNF
Venous Engorgement,1/14,0.027647586728505463,0.09527366141926777,0,0,35.71428571428571,128.1506012171872,IL1B
Active Hyperemia,1/14,0.027647586728505463,0.09524026721617655,0,0,35.71428571428571,128.1506012171872,IL1B
Adult B Acute Lymphoblastic Leukemia,1/14,0.027647586728505463,0.09520689641476934,0,0,35.71428571428571,128.1506012171872,MTHFR
ALZHEIMER DISEASE 5,1/14,0.027647586728505463,0.09517354899045594,0,0,35.71428571428571,128.1506012171872,IL1B
Atherosclerotic occlusive disease,1/14,0.027647586728505463,0.09514022491868056,0,0,35.71428571428571,128.1506012171872,IL2RA
B lymphocytopenia,1/14,0.027647586728505463,0.09510692417492184,0,0,35.71428571428571,128.1506012171872,STAT1
Cancer Relapse,1/14,0.027647586728505463,0.09507364673469268,0,0,35.71428571428571,128.1506012171872,HIF1A
Central retinal vein occlusion,1/14,0.027647586728505463,0.09504039257354029,0,0,35.71428571428571,128.1506012171872,MTHFR
Cherubism,1/14,0.027647586728505463,0.09500716166704605,0,0,35.71428571428571,128.1506012171872,TNF
Copper-Overload Cirrhosis,1/14,0.027647586728505463,0.09497395399082548,0,0,35.71428571428571,128.1506012171872,TGFB1
Delayed epiphyseal ossification,1/14,0.027647586728505463,0.0949407695205282,0,0,35.71428571428571,128.1506012171872,VDR
Delayed maturation of end part of long bone,1/14,0.027647586728505463,0.09490760823183782,0,0,35.71428571428571,128.1506012171872,VDR
Dyspareunia,1/14,0.027647586728505463,0.09487447010047195,0,0,35.71428571428571,128.1506012171872,HLA-DRB1
Eye Neoplasms,1/14,0.027647586728505463,0.09484135510218208,0,0,35.71428571428571,128.1506012171872,TGFB1
Fulminant Hepatic Failure with Cerebral Edema,1/14,0.027647586728505463,0.09480826321275355,0,0,35.71428571428571,128.1506012171872,TNF
Gastric Gastrointestinal Stromal Tumor,1/14,0.027647586728505463,0.09477519440800547,0,0,35.71428571428571,128.1506012171872,DPP4
Hepatic Stupor,1/14,0.027647586728505463,0.09474214866379069,0,0,35.71428571428571,128.1506012171872,TNF
Homocysteinemia,1/14,0.027647586728505463,0.0947091259559957,0,0,35.71428571428571,128.1506012171872,MTHFR
Hyperimmunoglobulin M syndrome,1/14,0.027647586728505463,0.09467612626054066,0,0,35.71428571428571,128.1506012171872,IL2RA
Intravascular hemolysis,1/14,0.027647586728505463,0.0946431495533792,0,0,35.71428571428571,128.1506012171872,SOD1
Ketoacidosis,1/14,0.027647586728505463,0.0946101958104985,0,0,35.71428571428571,128.1506012171872,INS
Loeys-Dietz Syndrome,1/14,0.027647586728505463,0.09457726500791915,0,0,35.71428571428571,128.1506012171872,TGFB1
Lone atrial fibrillation,1/14,0.027647586728505463,0.0945443571216951,0,0,35.71428571428571,128.1506012171872,TGFB1
Myxoma of heart,1/14,0.027647586728505463,0.09451147212791362,0,0,35.71428571428571,128.1506012171872,IL6
Neuritis,1/14,0.027647586728505463,0.0944786100026953,0,0,35.71428571428571,128.1506012171872,IFNG
Neuroma,1/14,0.027647586728505463,0.09444577072219384,0,0,35.71428571428571,128.1506012171872,SOD1
Other specified iron deficiency anemias,1/14,0.027647586728505463,0.09441295426259613,0,0,35.71428571428571,128.1506012171872,IL6
Paramyotonia Congenita (disorder),1/14,0.027647586728505463,0.09438016060012215,0,0,35.71428571428571,128.1506012171872,TGFB1
Pigmented lesions,1/14,0.027647586728505463,0.0943473897110249,0,0,35.71428571428571,128.1506012171872,HIF1A
Poikiloderma with Neutropenia,1/14,0.027647586728505463,0.09431464157159031,0,0,35.71428571428571,128.1506012171872,TNF
Pure Red-Cell Aplasia,1/14,0.027647586728505463,0.0942819161581373,0,0,35.71428571428571,128.1506012171872,HLA-DRB1
Reactive Hyperemia,1/14,0.027647586728505463,0.09424921344701757,0,0,35.71428571428571,128.1506012171872,IL1B
Delayed Puberty,2/130,0.027840385674840203,0.09487354729969816,0,0,7.6923076923076925,27.548212233453352,TGFB1;STAT1
Triglycerides measurement,3/336,0.029373179948376443,0.10006225737699953,0,0,4.4642857142857135,15.748541373399869,TNFRSF9;IL2RA;HIF1A
Reiter Syndrome,1/15,0.029593647188767416,0.10077836610228903,0,0,33.333333333333336,117.33985208959405,IL10
Atrophy, Muscular, Spinobulbar,1/15,0.029593647188767416,0.10074345845902534,0,0,33.333333333333336,117.33985208959405,SOD1
Gaucher Disease, Type 1,1/15,0.029593647188767416,0.10070857499002983,0,0,33.333333333333336,117.33985208959405,TNF
Stage 0 Breast Carcinoma,1/15,0.029593647188767416,0.10067371567019943,0,0,33.333333333333336,117.33985208959405,CXCL10
Peroxisome Biogenesis Disorder, Complementation Group D,1/15,0.029593647188767416,0.1006388804744658,0,0,33.333333333333336,117.33985208959405,IL1B
PNEUMOTHORAX, PRIMARY SPONTANEOUS,1/15,0.029593647188767416,0.10060406937779529,0,0,33.333333333333336,117.33985208959405,HIF1A
Pyogenic Arthritis, Pyoderma Gangrenosum and Acne,1/15,0.029593647188767416,0.10056928235518885,0,0,33.333333333333336,117.33985208959405,TNF
Systemic amyloidosis,1/15,0.029593647188767416,0.10053451938168205,0,0,33.333333333333336,117.33985208959405,TNF
Thanatophoric Dysplasia,1/15,0.029593647188767416,0.1004997804323449,0,0,33.333333333333336,117.33985208959405,STAT1
Tic disorder,1/15,0.029593647188767416,0.10046506548228192,0,0,33.333333333333336,117.33985208959405,INS
Transient ischemia,1/15,0.029593647188767416,0.10043037450663196,0,0,33.333333333333336,117.33985208959405,TLR4
Trichomonas Infections,1/15,0.029593647188767416,0.10039570748056822,0,0,33.333333333333336,117.33985208959405,TLR4
Uterine Corpus Carcinosarcoma,1/15,0.029593647188767416,0.10036106437929819,0,0,33.333333333333336,117.33985208959405,TGFB1
Widely patent fontanelles and sutures,1/15,0.029593647188767416,0.10032644517806352,0,0,33.333333333333336,117.33985208959405,VDR
X-Linked Lissencephaly,1/15,0.029593647188767416,0.10029184985214006,0,0,33.333333333333336,117.33985208959405,IL12A
Alkaline phosphatase measurement,1/15,0.029593647188767416,0.10025727837683769,0,0,33.333333333333336,117.33985208959405,FUT2
Atypical meningioma,1/15,0.029593647188767416,0.1002227307275004,0,0,33.333333333333336,117.33985208959405,TGFB1
Bilateral ptosis,1/15,0.029593647188767416,0.10018820687950608,0,0,33.333333333333336,117.33985208959405,INS
Budd-Chiari Syndrome,1/15,0.029593647188767416,0.10015370680826659,0,0,33.333333333333336,117.33985208959405,MTHFR
Complex Regional Pain Syndromes,1/15,0.029593647188767416,0.10011923048922759,0,0,33.333333333333336,117.33985208959405,HLA-DRB1
Congenital Thrombotic Thrombocytopenic Purpura,1/15,0.029593647188767416,0.1000847778978686,0,0,33.333333333333336,117.33985208959405,HLA-DRB1
Duchenne and Becker Muscular Dystrophy,1/15,0.029593647188767416,0.10005034900970283,0,0,33.333333333333336,117.33985208959405,TGFB1
Epithelial cyst,1/15,0.029593647188767416,0.10001594380027722,0,0,33.333333333333336,117.33985208959405,VDR
Familial Periodic Paralysis,1/15,0.029593647188767416,0.09998156224517228,0,0,33.333333333333336,117.33985208959405,HLA-DRB1
Fast acetylator due to N-acetyltransferase enzyme variant,1/15,0.029593647188767416,0.09994720432000212,0,0,33.333333333333336,117.33985208959405,MTHFR
Fetal Distress,1/15,0.029593647188767416,0.09991287000041434,0,0,33.333333333333336,117.33985208959405,IL6
Glycogen Storage Disease Type V,1/15,0.029593647188767416,0.09987855926209002,0,0,33.333333333333336,117.33985208959405,HIF1A
Helicobacter Infections,1/15,0.029593647188767416,0.09984427208074362,0,0,33.333333333333336,117.33985208959405,IL1B
Hepatic Coma,1/15,0.029593647188767416,0.09981000843212291,0,0,33.333333333333336,117.33985208959405,TNF
Hepatic Vein Thrombosis,1/15,0.029593647188767416,0.09977576829200897,0,0,33.333333333333336,117.33985208959405,MTHFR
Hereditary Paraganglioma,1/15,0.029593647188767416,0.0997415516362161,0,0,33.333333333333336,117.33985208959405,HIF1A
Hypoplastic anemia,1/15,0.029593647188767416,0.09970735844059175,0,0,33.333333333333336,117.33985208959405,IFNG
Hypovolemia,1/15,0.029593647188767416,0.0996731886810165,0,0,33.333333333333336,117.33985208959405,INS
Iridocyclitis,1/15,0.029593647188767416,0.09963904233340395,0,0,33.333333333333336,117.33985208959405,IL2RA
Jacobsen Distal 11q Deletion Syndrome,1/15,0.029593647188767416,0.09960491937370074,0,0,33.333333333333336,117.33985208959405,ETS1
Keratoderma,1/15,0.029593647188767416,0.0995708197778864,0,0,33.333333333333336,117.33985208959405,VDR
Malignant histiocytosis,1/15,0.029593647188767416,0.09953674352197336,0,0,33.333333333333336,117.33985208959405,CD14
Maternal hypertension,1/15,0.029593647188767416,0.09950269058200689,0,0,33.333333333333336,117.33985208959405,MTHFR
Meningococcal meningitis,1/15,0.029593647188767416,0.09946866093406503,0,0,33.333333333333336,117.33985208959405,TLR4
Monoblastic leukemia,1/15,0.029593647188767416,0.09943465455425851,0,0,33.333333333333336,117.33985208959405,IRF1
Neurogenic Inflammation,1/15,0.029593647188767416,0.09940067141873074,0,0,33.333333333333336,117.33985208959405,TNF
Nodular melanoma,1/15,0.029593647188767416,0.09936671150365772,0,0,33.333333333333336,117.33985208959405,HIF1A
Oestrogen receptor positive breast cancer,1/15,0.029593647188767416,0.099332774785248,0,0,33.333333333333336,117.33985208959405,HIF1A
Paraneoplastic Syndromes,1/15,0.029593647188767416,0.09929886123974263,0,0,33.333333333333336,117.33985208959405,IL6
Phobic anxiety disorder,1/15,0.029593647188767416,0.09926497084341507,0,0,33.333333333333336,117.33985208959405,PRL
Primary gout,1/15,0.029593647188767416,0.09923110357257119,0,0,33.333333333333336,117.33985208959405,IL1B
Pulmonary Fibrosis - from Asbestos Exposure,1/15,0.029593647188767416,0.09919725940354916,0,0,33.333333333333336,117.33985208959405,TNF
Pulmonary Pathology,1/15,0.029593647188767416,0.09916343831271945,0,0,33.333333333333336,117.33985208959405,TNF
Cerebral atrophy,3/338,0.029821147285506607,0.09989169581525525,0,0,4.437869822485207,15.588184156922768,CD14;TNF;HLA-DRB1
Motor Neuron Disease,2/135,0.029845108143576455,0.0999378953441463,0,0,7.407407407407407,26.012846917487057,INS;SOD1
Pruritus,2/137,0.03066277991670126,0.10264094040236377,0,0,7.299270072992701,25.43580832467395,IL1B;IL12A
Reoviridae Infections,1/16,0.031535910249890484,0.10552772418655897,0,0,31.25,108.01963670416018,STAT1
Replication Error Phenotype,1/16,0.031535910249890484,0.1054918059686602,0,0,31.25,108.01963670416018,MTHFR
Guillain-Barre Syndrome, Familial,1/16,0.031535910249890484,0.10545591219323705,0,0,31.25,108.01963670416018,IL1B
Heart Failure, Systolic,1/16,0.031535910249890484,0.10542004283534818,0,0,31.25,108.01963670416018,VDR
Skin Manifestations,1/16,0.031535910249890484,0.10538419787008625,0,0,31.25,108.01963670416018,TNF
Slender build,1/16,0.031535910249890484,0.10534837727257773,0,0,31.25,108.01963670416018,TGFB1
Macular Edema, Cystoid,1/16,0.031535910249890484,0.1053125810179829,0,0,31.25,108.01963670416018,IL10
social stress,1/16,0.031535910249890484,0.10527680908149581,0,0,31.25,108.01963670416018,IL6
Sore to touch,1/16,0.031535910249890484,0.1052410614383442,0,0,31.25,108.01963670416018,VDR
Subcapsular cataract,1/16,0.031535910249890484,0.10520533806378943,0,0,31.25,108.01963670416018,TGFB1
RETINOSCHISIS 1, X-LINKED, JUVENILE,1/16,0.031535910249890484,0.10516963893312646,0,0,31.25,108.01963670416018,CXCL10
SPHEROCYTOSIS, TYPE 1 (disorder),1/16,0.031535910249890484,0.10513396402168375,0,0,31.25,108.01963670416018,IL1B
Thinking and speaking disturbances,1/16,0.031535910249890484,0.10509831330482322,0,0,31.25,108.01963670416018,HIF1A
Tracheal Stenosis,1/16,0.031535910249890484,0.10506268675794023,0,0,31.25,108.01963670416018,TGFB1
Vital Capacity Adverse Event,1/16,0.031535910249890484,0.10502708435646346,0,0,31.25,108.01963670416018,ZMIZ1
Waxy flexibility,1/16,0.031535910249890484,0.1049915060758549,0,0,31.25,108.01963670416018,PRL
Widespread Chronic Pain,1/16,0.031535910249890484,0.10495595189160978,0,0,31.25,108.01963670416018,IL10
AIDS (Disease),1/16,0.031535910249890484,0.10492042177925649,0,0,31.25,108.01963670416018,VDR
BREAST CANCER 3,1/16,0.031535910249890484,0.10488491571435657,0,0,31.25,108.01963670416018,HIF1A
Carotid Artery Thrombosis,1/16,0.031535910249890484,0.10484943367250463,0,0,31.25,108.01963670416018,SOD1
Central nervous system lymphoma,1/16,0.031535910249890484,0.10481397562932826,0,0,31.25,108.01963670416018,IL10
Cervical Squamous Intraepithelial Neoplasia 1,1/16,0.031535910249890484,0.10477854156048806,0,0,31.25,108.01963670416018,IL10
Choroidal Neovascularization,1/16,0.031535910249890484,0.10474313144167749,0,0,31.25,108.01963670416018,HIF1A
Chronic rhinitis,1/16,0.031535910249890484,0.10470774524862286,0,0,31.25,108.01963670416018,IFNG
Cystathionine beta-Synthase Deficiency Disease,1/16,0.031535910249890484,0.10467238295708331,0,0,31.25,108.01963670416018,MTHFR
cystic disease,1/16,0.031535910249890484,0.10463704454285067,0,0,31.25,108.01963670416018,PRL
Diplopia,1/16,0.031535910249890484,0.10460172998174946,0,0,31.25,108.01963670416018,TGFB1
Familial Hemiplegic Migraine,1/16,0.031535910249890484,0.10456643924963686,0,0,31.25,108.01963670416018,TNF
Group B Streptococcal Infection,1/16,0.031535910249890484,0.10453117232240258,0,0,31.25,108.01963670416018,IL1B
Hypereosinophilic syndrome,1/16,0.031535910249890484,0.10449592917596887,0,0,31.25,108.01963670416018,IL2
Hyperoxaluria,1/16,0.031535910249890484,0.10446070978629042,0,0,31.25,108.01963670416018,IL6
Idiopathic bronchiectasis,1/16,0.031535910249890484,0.10442551412935434,0,0,31.25,108.01963670416018,HLA-DRB1
Infantile Neuroaxonal Dystrophy,1/16,0.031535910249890484,0.10439034218118008,0,0,31.25,108.01963670416018,IL6
Lateral Sclerosis,1/16,0.031535910249890484,0.10435519391781942,0,0,31.25,108.01963670416018,SOD1
Lhermitte-Duclos disease,1/16,0.031535910249890484,0.10432006931535634,0,0,31.25,108.01963670416018,HIF1A
Mammary Analogue Secretory Carcinoma,1/16,0.031535910249890484,0.10428496834990703,0,0,31.25,108.01963670416018,IL6
Methamphetamine dependence,1/16,0.031535910249890484,0.1042498909976198,0,0,31.25,108.01963670416018,TNF
Microsatellite Instability,1/16,0.031535910249890484,0.10421483723467508,0,0,31.25,108.01963670416018,MTHFR
Myxoma of the Endocardium,1/16,0.031535910249890484,0.10417980703728527,0,0,31.25,108.01963670416018,IL6
Nephropathic cystinosis,1/16,0.031535910249890484,0.10414480038169478,0,0,31.25,108.01963670416018,IL1B
Obstructive Ureterocele,1/16,0.031535910249890484,0.10410981724417993,0,0,31.25,108.01963670416018,TLR4
Osteoblastoma,1/16,0.031535910249890484,0.10407485760104891,0,0,31.25,108.01963670416018,IL6
Papillary neoplasm,1/16,0.031535910249890484,0.10403992142864171,0,0,31.25,108.01963670416018,AHR
periodic paralysis (finding),1/16,0.031535910249890484,0.10400500870333008,0,0,31.25,108.01963670416018,HLA-DRB1
Pertussis,1/16,0.031535910249890484,0.1039701194015175,0,0,31.25,108.01963670416018,VDR
premalignant lesion,1/16,0.031535910249890484,0.10393525349963906,0,0,31.25,108.01963670416018,TNF
Primary Systemic Amyloidosis,1/16,0.031535910249890484,0.10390041097416147,0,0,31.25,108.01963670416018,TNF
Prothrombin G20210A mutation,1/16,0.031535910249890484,0.103865591801583,0,0,31.25,108.01963670416018,MTHFR
psychological distress,1/16,0.031535910249890484,0.10383079595843339,0,0,31.25,108.01963670416018,HLA-DRB1
Pyle metaphyseal dysplasia,1/16,0.031535910249890484,0.10379602342127384,0,0,31.25,108.01963670416018,TGFB1
Muscle Spasticity,3/353,0.03329688460584518,0.10955533374832487,0,0,4.2492917847025495,14.457329072602016,IL6;HLA-DRB1;SOD1
Recurrent fungal infections,1/17,0.033474383104990776,0.1101024890079817,0,0,29.41176470588235,99.91102400305108,IL2RA
Affective Disorders, Psychotic,1/17,0.033474383104990776,0.11006565311336544,0,0,29.41176470588235,99.91102400305108,MTHFR
Retinal damage,1/17,0.033474383104990776,0.11002884185814359,0,0,29.41176470588235,99.91102400305108,TNF
Rhinosinusitis,1/17,0.033474383104990776,0.10999205521760258,0,0,29.41176470588235,99.91102400305108,IL10
Cutis Laxa, Autosomal Recessive, Type I,1/17,0.033474383104990776,0.10995529316706194,0,0,29.41176470588235,99.91102400305108,TGFB1
DIABETES MELLITUS, PERMANENT NEONATAL,1/17,0.033474383104990776,0.10991855568187414,0,0,29.41176470588235,99.91102400305108,INS
Gonadal Dysgenesis, 45,X,1/17,0.033474383104990776,0.10988184273742463,0,0,29.41176470588235,99.91102400305108,SOD1
Keratoconjunctivitis, Vernal,1/17,0.033474383104990776,0.10984515430913167,0,0,29.41176470588235,99.91102400305108,TGFB1
Motor Neuron Disease, Lower,1/17,0.033474383104990776,0.10980849037244637,0,0,29.41176470588235,99.91102400305108,SOD1
Testicular dysfunction,1/17,0.033474383104990776,0.10977185090285263,0,0,29.41176470588235,99.91102400305108,TNF
SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder),1/17,0.033474383104990776,0.10973523587586702,0,0,29.41176470588235,99.91102400305108,IL1B
Vocal Cord Paralysis,1/17,0.033474383104990776,0.10969864526703879,0,0,29.41176470588235,99.91102400305108,SOD1
Acute monoblastic leukemia,1/17,0.033474383104990776,0.10966207905194977,0,0,29.41176470588235,99.91102400305108,IL2
Adrenocorticotropic hormone (ACTH) deficiency (disorder),1/17,0.033474383104990776,0.10962553720621437,0,0,29.41176470588235,99.91102400305108,PRL
Adult Solid Neoplasm,1/17,0.033474383104990776,0.10958901970547945,0,0,29.41176470588235,99.91102400305108,HLA-DRB1
Anxiety state,1/17,0.033474383104990776,0.10955252652542435,0,0,29.41176470588235,99.91102400305108,TNF
Bone Cysts,1/17,0.033474383104990776,0.10951605764176076,0,0,29.41176470588235,99.91102400305108,VDR
Central Nervous System Infection,1/17,0.033474383104990776,0.10947961303023272,0,0,29.41176470588235,99.91102400305108,TNF
Color blindness,1/17,0.033474383104990776,0.10944319266661655,0,0,29.41176470588235,99.91102400305108,INS
Dysesthesia,1/17,0.033474383104990776,0.10940679652672076,0,0,29.41176470588235,99.91102400305108,INS
Endomyocardial Fibrosis,1/17,0.033474383104990776,0.10937042458638607,0,0,29.41176470588235,99.91102400305108,TGFB1
Fragmented sleep,1/17,0.033474383104990776,0.10933407682148531,0,0,29.41176470588235,99.91102400305108,HLA-DRB1
Lesch-Nyhan Syndrome,1/17,0.033474383104990776,0.10929775320792336,0,0,29.41176470588235,99.91102400305108,IL2
Leydig Cell Tumor,1/17,0.033474383104990776,0.1092614537216371,0,0,29.41176470588235,99.91102400305108,PRL
McCune-Albright Syndrome,1/17,0.033474383104990776,0.1092251783385954,0,0,29.41176470588235,99.91102400305108,IL6
Memory dysfunction,1/17,0.033474383104990776,0.10918892703479897,0,0,29.41176470588235,99.91102400305108,TNF
Metastatic hepatocellular carcinoma,1/17,0.033474383104990776,0.10915269978628046,0,0,29.41176470588235,99.91102400305108,TGFB1
Mucosal telangiectasiae,1/17,0.033474383104990776,0.10911649656910426,0,0,29.41176470588235,99.91102400305108,HLA-DRB1
Mucosal ulcer,1/17,0.033474383104990776,0.10908031735936649,0,0,29.41176470588235,99.91102400305108,TNF
Myoepithelioma,1/17,0.033474383104990776,0.109044162133195,0,0,29.41176470588235,99.91102400305108,IL6
Neonatal Deformity,1/17,0.033474383104990776,0.10900803086674928,0,0,29.41176470588235,99.91102400305108,IL10
Non-Functioning Pituitary Gland Neoplasm,1/17,0.033474383104990776,0.10897192353622037,0,0,29.41176470588235,99.91102400305108,PRL
Non-ST Elevated Myocardial Infarction,1/17,0.033474383104990776,0.1089358401178309,0,0,29.41176470588235,99.91102400305108,CD14
Occlusive vascular disease,1/17,0.033474383104990776,0.10889978058783494,0,0,29.41176470588235,99.91102400305108,MTHFR
Otosclerosis,1/17,0.033474383104990776,0.10886374492251798,0,0,29.41176470588235,99.91102400305108,TGFB1
Parasitic infection,1/17,0.033474383104990776,0.10882773309819693,0,0,29.41176470588235,99.91102400305108,IFNG
Portal vein thrombosis,1/17,0.033474383104990776,0.10879174509122001,0,0,29.41176470588235,99.91102400305108,MTHFR
Pulmonary Thromboembolisms,1/17,0.033474383104990776,0.10875578087796672,0,0,29.41176470588235,99.91102400305108,MTHFR
Frontotemporal dementia,2/145,0.03402163968368293,0.11049724878097682,0,0,6.896551724137931,23.315575831288054,TNF;SOD1
Generalized osteopenia,2/145,0.03402163968368293,0.11046074489964844,0,0,6.896551724137931,23.315575831288054,TGFB1;STAT1
Recurrent Carcinoma,1/18,0.03540907294557409,0.11492746661463084,0,0,27.777777777777775,92.79964427176472,TNF
Reduced subcutaneous adipose tissue,1/18,0.03540907294557409,0.11488952423542495,0,0,27.777777777777775,92.79964427176472,TGFB1
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE (disorder),1/18,0.03540907294557409,0.11485160690069379,0,0,27.777777777777775,92.79964427176472,SOD1
Retinal ischemia,1/18,0.03540907294557409,0.11481371458564901,0,0,27.777777777777775,92.79964427176472,HIF1A
Carney Complex, Type 1,1/18,0.03540907294557409,0.11477584726553502,0,0,27.777777777777775,92.79964427176472,TNFRSF9
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE,1/18,0.03540907294557409,0.11473800491562881,0,0,27.777777777777775,92.79964427176472,TNF
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE,1/18,0.03540907294557409,0.11470018751124,0,0,27.777777777777775,92.79964427176472,TNF
Smoldering myeloma,1/18,0.03540907294557409,0.11466239502771076,0,0,27.777777777777775,92.79964427176472,IL1B
Papillary renal cell carcinoma, sporadic,1/18,0.03540907294557409,0.11462462744041574,0,0,27.777777777777775,92.79964427176472,HIF1A
Venous malformation,1/18,0.03540907294557409,0.114586884724762,0,0,27.777777777777775,92.79964427176472,STAT1
Xanthomatosis,1/18,0.03540907294557409,0.114549166856189,0,0,27.777777777777775,92.79964427176472,CXCL10
Adrenomyeloneuropathy,1/18,0.03540907294557409,0.11451147381016853,0,0,27.777777777777775,92.79964427176472,IFNG
Aneurysmal disease,1/18,0.03540907294557409,0.11447380556220467,0,0,27.777777777777775,92.79964427176472,IL6
Benign neoplasm of stomach,1/18,0.03540907294557409,0.11443616208783366,0,0,27.777777777777775,92.79964427176472,IRF1
Carcinoma in situ of stomach,1/18,0.03540907294557409,0.11439854336262399,0,0,27.777777777777775,92.79964427176472,IRF1
Elevated circulating parathyroid hormone level,1/18,0.03540907294557409,0.1143609493621762,0,0,27.777777777777775,92.79964427176472,VDR
Erythroid hyperplasia,1/18,0.03540907294557409,0.11432338006212292,0,0,27.777777777777775,92.79964427176472,TNF
Human immunodeficiency virus II infection,1/18,0.03540907294557409,0.1142858354381288,0,0,27.777777777777775,92.79964427176472,FUT2
Hypocupremia,1/18,0.03540907294557409,0.11424831546589041,0,0,27.777777777777775,92.79964427176472,SOD1
Idiopathic scoliosis,1/18,0.03540907294557409,0.11421082012113626,0,0,27.777777777777775,92.79964427176472,IL1B
Increased IgM level,1/18,0.03540907294557409,0.1141733493796267,0,0,27.777777777777775,92.79964427176472,IL12A
Low Back Pain,1/18,0.03540907294557409,0.11413590321715388,0,0,27.777777777777775,92.79964427176472,IL1B
Malignant neoplasm of other specified sites of female breast,1/18,0.03540907294557409,0.1140984816095417,0,0,27.777777777777775,92.79964427176472,STAT1
Malignant neoplasm tonsil,1/18,0.03540907294557409,0.11406108453264575,0,0,27.777777777777775,92.79964427176472,HIF1A
Neoplasm of uncertain or unknown behavior of stomach,1/18,0.03540907294557409,0.11402371196235327,0,0,27.777777777777775,92.79964427176472,IRF1
Niemann-Pick Diseases,1/18,0.03540907294557409,0.1139863638745831,0,0,27.777777777777775,92.79964427176472,TLR4
Onychomycosis,1/18,0.03540907294557409,0.11394904024528558,0,0,27.777777777777775,92.79964427176472,IL12A
Oppositional Defiant Disorder,1/18,0.03540907294557409,0.1139117410504426,0,0,27.777777777777775,92.79964427176472,INS
Pancreatic carcinoma resectable,1/18,0.03540907294557409,0.11387446626606747,0,0,27.777777777777775,92.79964427176472,TNF
Papillomatosis,1/18,0.03540907294557409,0.11383721586820483,0,0,27.777777777777775,92.79964427176472,TGFB1
Precocious exfoliation of primary tooth,1/18,0.03540907294557409,0.11379998983293073,0,0,27.777777777777775,92.79964427176472,VDR
Pyothorax-Associated Lymphoma,1/18,0.03540907294557409,0.11376278813635246,0,0,27.777777777777775,92.79964427176472,IL1B
Aneurysm, Dissecting,1/19,0.0373399869476018,0.1199272521964152,0,0,26.31578947368421,86.51817080063184,MTHFR
Rough bone trabeculation,1/19,0.0373399869476018,0.11988807308756307,0,0,26.31578947368421,86.51817080063184,VDR
Melanoma, Amelanotic,1/19,0.0373399869476018,0.11984891956924576,0,0,26.31578947368421,86.51817080063184,HIF1A
Squamous cell carcinoma of vulva,1/19,0.0373399869476018,0.11980979161639913,0,0,26.31578947368421,86.51817080063184,IL2
Staphylococcal Infections,1/19,0.0373399869476018,0.11977068920399168,0,0,26.31578947368421,86.51817080063184,IFNG
Papilloma, Squamous Cell,1/19,0.0373399869476018,0.11973161230702464,0,0,26.31578947368421,86.51817080063184,TGFB1
T-Lymphocytopenia,1/19,0.0373399869476018,0.1196925609005318,0,0,26.31578947368421,86.51817080063184,IL2RA
stage, cervical cancer,1/19,0.0373399869476018,0.11965353495957956,0,0,26.31578947368421,86.51817080063184,IL6
THROMBOCYTOPENIA 1 (disorder),1/19,0.0373399869476018,0.1196145344592668,0,0,26.31578947368421,86.51817080063184,IL2
Thrombosis of cerebral veins,1/19,0.0373399869476018,0.11957555937472483,0,0,26.31578947368421,86.51817080063184,MTHFR
ABLEPHARON-MACROSTOMIA SYNDROME,1/19,0.0373399869476018,0.11953660968111744,0,0,26.31578947368421,86.51817080063184,HIF1A
Venoocclusive disease,1/19,0.0373399869476018,0.11949768535364068,0,0,26.31578947368421,86.51817080063184,IL1B
Adult Non-Hodgkin Lymphoma,1/19,0.0373399869476018,0.11945878636752295,0,0,26.31578947368421,86.51817080063184,MTHFR
Alloimmunisation,1/19,0.0373399869476018,0.1194199126980249,0,0,26.31578947368421,86.51817080063184,HLA-DRB1
Anhydrotic Ectodermal Dysplasias,1/19,0.0373399869476018,0.11938106432043934,0,0,26.31578947368421,86.51817080063184,TNF
Anti-Glomerular Basement Membrane Disease,1/19,0.0373399869476018,0.11934224121009122,0,0,26.31578947368421,86.51817080063184,HLA-DRB1
Aortic Rupture,1/19,0.0373399869476018,0.11930344334233763,0,0,26.31578947368421,86.51817080063184,STAT1
Asymmetric Septal Hypertrophy,1/19,0.0373399869476018,0.1192646706925676,0,0,26.31578947368421,86.51817080063184,TLR4
Bipolar II disorder,1/19,0.0373399869476018,0.11922592323620225,0,0,26.31578947368421,86.51817080063184,MTHFR
CADASIL Syndrome,1/19,0.0373399869476018,0.11918720094869455,0,0,26.31578947368421,86.51817080063184,SOD1
Classical phenylketonuria,1/19,0.0373399869476018,0.1191485038055294,0,0,26.31578947368421,86.51817080063184,SOD1
Endocarditis,1/19,0.0373399869476018,0.11910983178222348,0,0,26.31578947368421,86.51817080063184,TNF
Endogenous Hyperinsulinism,1/19,0.0373399869476018,0.11907118485432529,0,0,26.31578947368421,86.51817080063184,INS
Exogenous Hyperinsulinism,1/19,0.0373399869476018,0.11903256299741503,0,0,26.31578947368421,86.51817080063184,INS
Homocysteine measurement,1/19,0.0373399869476018,0.11899396618710457,0,0,26.31578947368421,86.51817080063184,MTHFR
Hypertrophy,1/19,0.0373399869476018,0.11895539439903745,0,0,26.31578947368421,86.51817080063184,AHR
Infective cystitis,1/19,0.0373399869476018,0.1189168476088887,0,0,26.31578947368421,86.51817080063184,IL10
Legg-Calve-Perthes Disease,1/19,0.0373399869476018,0.11887832579236493,0,0,26.31578947368421,86.51817080063184,MTHFR
Mixed Connective Tissue Disease,1/19,0.0373399869476018,0.11883982892520419,0,0,26.31578947368421,86.51817080063184,HLA-DRB1
Parathyroid hyperplasia,1/19,0.0373399869476018,0.11880135698317595,0,0,26.31578947368421,86.51817080063184,VDR
Pulmonary Infiltrate,1/19,0.0373399869476018,0.11876290994208108,0,0,26.31578947368421,86.51817080063184,HLA-DRB1
Squamous cell carcinoma of tongue,2/153,0.03751777233855221,0.11928976594736046,0,0,6.5359477124183005,21.45712764213467,HIF1A;TNF
Myoclonus,2/154,0.037964191869343016,0.12067014155624294,0,0,6.4935064935064934,21.24098625159379,IL10;IL6
Recurrent viral infection,1/20,0.039267132268101,0.1247712175657603,0,0,25.0,80.9341859770283,IL2RA
Amnesia, Transient Global,1/20,0.039267132268101,0.12473089073396788,0,0,25.0,80.9341859770283,HLA-DRB1
Asthma, Aspirin-Induced,1/20,0.039267132268101,0.1246905899615175,0,0,25.0,80.9341859770283,HLA-DRB1
Sick Sinus Syndrome,1/20,0.039267132268101,0.12465031522315782,0,0,25.0,80.9341859770283,IL6
Jaundice, Obstructive,1/20,0.039267132268101,0.12461006649367021,0,0,25.0,80.9341859770283,CD14
Psychosis, Involutional,1/20,0.039267132268101,0.1245698437478685,0,0,25.0,80.9341859770283,IL2
Thymoma, type C,1/20,0.039267132268101,0.12452964696059911,0,0,25.0,80.9341859770283,HMGB1
Tonsillar Carcinoma,1/20,0.039267132268101,0.12448947610674085,0,0,25.0,80.9341859770283,HIF1A
Vulval intraepithelial neoplasia,1/20,0.039267132268101,0.12444933116120498,0,0,25.0,80.9341859770283,HLA-DRB1
Asthmatic pulmonary eosinophilia,1/20,0.039267132268101,0.12440921209893509,0,0,25.0,80.9341859770283,IL17A
Autoimmune liver disease,1/20,0.039267132268101,0.12436911889490707,0,0,25.0,80.9341859770283,TNF
Basal Ganglia Diseases,1/20,0.039267132268101,0.12432905152412907,0,0,25.0,80.9341859770283,PRL
Candidiasis of vagina,1/20,0.039267132268101,0.12428900996164143,0,0,25.0,80.9341859770283,IL1B
Carcinoma ex pleomorphic adenoma,1/20,0.039267132268101,0.12424899418251663,0,0,25.0,80.9341859770283,IL6
Central hypothyroidism,1/20,0.039267132268101,0.12420900416185923,0,0,25.0,80.9341859770283,PRL
Chronic ulcerative colitis,1/20,0.039267132268101,0.12416903987480588,0,0,25.0,80.9341859770283,IL2
Compensatory Hyperinsulinemia,1/20,0.039267132268101,0.12412910129652513,0,0,25.0,80.9341859770283,INS
Congenital abnormality of vein,1/20,0.039267132268101,0.12408918840221757,0,0,25.0,80.9341859770283,STAT1
Coronary Artery Vasospasm,1/20,0.039267132268101,0.1240493011671156,0,0,25.0,80.9341859770283,IL6
Dyslipoproteinemias,1/20,0.039267132268101,0.1240094395664835,0,0,25.0,80.9341859770283,AHR
Gastric dysplasia,1/20,0.039267132268101,0.1239696035756173,0,0,25.0,80.9341859770283,TGFB1
Hypophosphatemic Rickets,1/20,0.039267132268101,0.12392979316984477,0,0,25.0,80.9341859770283,VDR
Hypoplasia of the pituitary gland,1/20,0.039267132268101,0.1238900083245254,0,0,25.0,80.9341859770283,PRL
Involutional Depression,1/20,0.039267132268101,0.12385024901505028,0,0,25.0,80.9341859770283,IL2
Involutional paraphrenia,1/20,0.039267132268101,0.12381051521684204,0,0,25.0,80.9341859770283,IL2
Ketonuria,1/20,0.039267132268101,0.12377080690535491,0,0,25.0,80.9341859770283,INS
Mastocytoma,1/20,0.039267132268101,0.12373112405607459,0,0,25.0,80.9341859770283,IL2
Morbilliform Drug Reaction,1/20,0.039267132268101,0.12369146664451815,0,0,25.0,80.9341859770283,MTHFR
Morphologically abnormal structure (morphologic abnormality),1/20,0.039267132268101,0.12365183464623411,0,0,25.0,80.9341859770283,S100A9
Ovarian Clear Cell Adenocarcinoma,1/20,0.039267132268101,0.12361222803680226,0,0,25.0,80.9341859770283,IL6
Panic Attacks,1/20,0.039267132268101,0.1235726467918337,0,0,25.0,80.9341859770283,INS
Protuberant abdomen,1/20,0.039267132268101,0.12353309088697076,0,0,25.0,80.9341859770283,VDR
Mammary Neoplasms, Experimental,2/160,0.04068558128670468,0.12795452572343474,0,0,6.25,20.011759484008152,IL10;PRL
Sandhoff Disease,1/21,0.041190516066627526,0.12950108506168118,0,0,23.809523809523807,75.94160099244318,TNF
Disruptive, Impulse Control, and Conduct Disorders,1/21,0.041190516066627526,0.12945967121932053,0,0,23.809523809523807,75.94160099244318,TNF
Simple renal cyst,1/21,0.041190516066627526,0.12941828385639878,0,0,23.809523809523807,75.94160099244318,TNF
Sinus Node Dysfunction (disorder),1/21,0.041190516066627526,0.12937692294752806,0,0,23.809523809523807,75.94160099244318,TGFB1
Slow acetylator due to N-acetyltransferase enzyme variant,1/21,0.041190516066627526,0.12933558846735316,0,0,23.809523809523807,75.94160099244318,HLA-DRB1
Lymphoma, Follicular, Grade 2,1/21,0.041190516066627526,0.12929428039055105,0,0,23.809523809523807,75.94160099244318,MTHFR
Lymphoma, Mixed-Cell, Follicular,1/21,0.041190516066627526,0.1292529986918312,0,0,23.809523809523807,75.94160099244318,MTHFR
Lymphoma, Small Cleaved-Cell, Follicular,1/21,0.041190516066627526,0.12921174334593533,0,0,23.809523809523807,75.94160099244318,MTHFR
Neoplasms, Radiation-Induced,1/21,0.041190516066627526,0.12917051432763732,0,0,23.809523809523807,75.94160099244318,IRF1
Abnormality of the hip bone,1/21,0.041190516066627526,0.12912931161174332,0,0,23.809523809523807,75.94160099244318,VDR
Amyloid nephropathy,1/21,0.041190516066627526,0.12908813517309162,0,0,23.809523809523807,75.94160099244318,TNF
AORTIC VALVE DISEASE 2,1/21,0.041190516066627526,0.12904698498655254,0,0,23.809523809523807,75.94160099244318,TGFB1
Bile duct proliferation,1/21,0.041190516066627526,0.12900586102702846,0,0,23.809523809523807,75.94160099244318,TGFB1
Bone Marrow failure syndromes,1/21,0.041190516066627526,0.12896476326945375,0,0,23.809523809523807,75.94160099244318,IFNG
Chronic venous insufficiency,1/21,0.041190516066627526,0.1289236916887947,0,0,23.809523809523807,75.94160099244318,TGFB1
Diabetic peripheral neuropathy,1/21,0.041190516066627526,0.12888264626004944,0,0,23.809523809523807,75.94160099244318,TNF
External exotoses,1/21,0.041190516066627526,0.12884162695824805,0,0,23.809523809523807,75.94160099244318,VDR
Fibrous skin tumor of tuberous sclerosis,1/21,0.041190516066627526,0.12880063375845222,0,0,23.809523809523807,75.94160099244318,IFNG
Hemiplegia,1/21,0.041190516066627526,0.12875966663575553,0,0,23.809523809523807,75.94160099244318,TNF
Hyperkalemia,1/21,0.041190516066627526,0.1287187255652831,0,0,23.809523809523807,75.94160099244318,INS
Hypoalphalipoproteinemias,1/21,0.041190516066627526,0.1286778105221918,0,0,23.809523809523807,75.94160099244318,AHR
Indolent Non-Hodgkin Lymphoma,1/21,0.041190516066627526,0.12863692148166994,0,0,23.809523809523807,75.94160099244318,IL2
Oropharynx (excludes nasopharynx),1/21,0.041190516066627526,0.12859605841893754,0,0,23.809523809523807,75.94160099244318,TNF
Pathological accumulation of air in tissues,1/21,0.041190516066627526,0.1285552213092459,0,0,23.809523809523807,75.94160099244318,IFNG
Pseudomyxoma Peritonei,1/21,0.041190516066627526,0.1285144101278779,0,0,23.809523809523807,75.94160099244318,HIF1A
Metastatic malignant neoplasm to brain,2/163,0.04207341036083128,0.1312273808398127,0,0,6.134969325153374,19.43766454419879,TNF;CCR4
CATARACT, MARNER TYPE,1/22,0.043110145479118074,0.1344183089367933,0,0,22.727272727272727,71.45447535514064,IL6
Leukemia, T-Cell, Chronic,1/22,0.043110145479118074,0.13437567705955358,0,0,22.727272727272727,71.45447535514064,IL2RA
Lymphoma, Follicular, Grade 3,1/22,0.043110145479118074,0.13433307221584415,0,0,22.727272727272727,71.45447535514064,MTHFR
Squamous cell carcinoma of tonsil,1/22,0.043110145479118074,0.13429049437995957,0,0,22.727272727272727,71.45447535514064,HLA-DRB1
TDP-43 Proteinopathies,1/22,0.043110145479118074,0.13424794352622701,0,0,22.727272727272727,71.45447535514064,SOD1
Urethral Stricture,1/22,0.043110145479118074,0.13420541962900617,0,0,22.727272727272727,71.45447535514064,TGFB1
Adenoid cystic carcinoma of salivary gland,1/22,0.043110145479118074,0.1341629226626892,0,0,22.727272727272727,71.45447535514064,RUNX3
Adrenal Cancer,1/22,0.043110145479118074,0.1341204526017007,0,0,22.727272727272727,71.45447535514064,TLR4
AIDS with Kaposi's sarcoma,1/22,0.043110145479118074,0.1340780094204976,0,0,22.727272727272727,71.45447535514064,IL6
Anaplastic large B-cell lymphoma,1/22,0.043110145479118074,0.13403559309356927,0,0,22.727272727272727,71.45447535514064,IL10
ANOPHTHALMIA AND PULMONARY HYPOPLASIA,1/22,0.043110145479118074,0.1339932035954372,0,0,22.727272727272727,71.45447535514064,TGFB1
Basal-Like Breast Carcinoma,1/22,0.043110145479118074,0.1339508409006552,0,0,22.727272727272727,71.45447535514064,IL6
Benign Mastocytoma,1/22,0.043110145479118074,0.13390850498380924,0,0,22.727272727272727,71.45447535514064,IL2
Histiocytosis haematophagic,1/22,0.043110145479118074,0.13386619581951736,0,0,22.727272727272727,71.45447535514064,IFNG
Hypotrichosis simplex,1/22,0.043110145479118074,0.13382391338242972,0,0,22.727272727272727,71.45447535514064,TLR4
Kashin-Beck Disease,1/22,0.043110145479118074,0.13378165764722844,0,0,22.727272727272727,71.45447535514064,HLA-DRB1
Mastitis,1/22,0.043110145479118074,0.13373942858862767,0,0,22.727272727272727,71.45447535514064,TLR4
Nephrosclerosis,1/22,0.043110145479118074,0.13369722618137345,0,0,22.727272727272727,71.45447535514064,HIF1A
Protein Misfolding Disorders,1/22,0.043110145479118074,0.13365505040024367,0,0,22.727272727272727,71.45447535514064,SOD1
Sclerocystic Ovaries,2/166,0.043478991211383655,0.13475607872137452,0,0,6.024096385542169,18.888418181978363,RUNX3;INS
Anaplastic astrocytoma,2/166,0.043478991211383655,0.13471359572051658,0,0,6.024096385542169,18.888418181978363,ETS1;HIF1A
Malignant neoplasm of brain,2/166,0.043478991211383655,0.13467113949747198,0,0,6.024096385542169,18.888418181978363,IL2;TGM2
Growth retardation,2/168,0.044425783393106655,0.137560365213438,0,0,5.952380952380952,18.535328994268447,IL21;VDR
Poor growth,2/168,0.044425783393106655,0.13751703911415816,0,0,5.952380952380952,18.535328994268447,IL21;VDR
Cyst,2/169,0.0449020732929325,0.1389475995979032,0,0,5.9171597633136095,18.362552127283166,VDR;TNF
Growth delay,2/169,0.0449020732929325,0.13890386412431244,0,0,5.9171597633136095,18.362552127283166,IL21;VDR
Renal sclerosis with hypertension,1/23,0.04502602764238181,0.13924348636542744,0,0,21.73913043478261,67.40249052963264,MTHFR
Bone Cysts, Aneurysmal,1/23,0.04502602764238181,0.1391996853316541,0,0,21.73913043478261,67.40249052963264,IL2
Seborrheic dermatitis,1/23,0.04502602764238181,0.13915591184570075,0,0,21.73913043478261,67.40249052963264,TNF
Neoplasms, Second Primary,1/23,0.04502602764238181,0.13911216588158706,0,0,21.73913043478261,67.40249052963264,MTHFR
Squamous Cell Neoplasms,1/23,0.04502602764238181,0.13906844741336533,0,0,21.73913043478261,67.40249052963264,IL10
Stage III Colon Cancer AJCC v7,1/23,0.04502602764238181,0.13902475641512047,0,0,21.73913043478261,67.40249052963264,MTHFR
Opitz GBBB Syndrome, X-Linked,1/23,0.04502602764238181,0.13898109286097,0,0,21.73913043478261,67.40249052963264,MTHFR
Abnormality of the thorax,1/23,0.04502602764238181,0.13893745672506388,0,0,21.73913043478261,67.40249052963264,VDR
Acute pyelonephritis,1/23,0.04502602764238181,0.13889384798158458,0,0,21.73913043478261,67.40249052963264,TLR4
Andersen Syndrome,1/23,0.04502602764238181,0.13885026660474692,0,0,21.73913043478261,67.40249052963264,MTHFR
Anencephaly,1/23,0.04502602764238181,0.13880671256879812,0,0,21.73913043478261,67.40249052963264,MTHFR
Bloch Sulzberger syndrome,1/23,0.04502602764238181,0.1387631858480177,0,0,21.73913043478261,67.40249052963264,IFNG
Childhood Non-Hodgkin Lymphoma,1/23,0.04502602764238181,0.13871968641671736,0,0,21.73913043478261,67.40249052963264,MTHFR
Chromosome 11p11.2 Deletion Syndrome,1/23,0.04502602764238181,0.13867621424924112,0,0,21.73913043478261,67.40249052963264,HLA-DRB1
cocaine use,1/23,0.04502602764238181,0.13863276931996504,0,0,21.73913043478261,67.40249052963264,PRL
Fleck corneal dystrophy,1/23,0.04502602764238181,0.13858935160329736,0,0,21.73913043478261,67.40249052963264,IL1B
Hypobetalipoproteinemias,1/23,0.04502602764238181,0.13854596107367828,0,0,21.73913043478261,67.40249052963264,PRL
Hypofibrinogenemia,1/23,0.04502602764238181,0.1385025977055801,0,0,21.73913043478261,67.40249052963264,IL2
Hypoxic-Ischemic Encephalopathy,1/23,0.04502602764238181,0.138459261473507,0,0,21.73913043478261,67.40249052963264,HIF1A
Macule,1/23,0.04502602764238181,0.13841595235199514,0,0,21.73913043478261,67.40249052963264,HLA-DRB1
Myasthenias,1/23,0.04502602764238181,0.1383726703156124,0,0,21.73913043478261,67.40249052963264,CXCL10
Petechiae,1/23,0.04502602764238181,0.13832941533895857,0,0,21.73913043478261,67.40249052963264,HLA-DRB1
Porphyria Cutanea Tarda,1/23,0.04502602764238181,0.13828618739666512,0,0,21.73913043478261,67.40249052963264,IL6
Developmental Disabilities,2/170,0.04538028017084147,0.1393306446482443,0,0,5.88235294117647,18.192221328034226,IL10;MTHFR
Anemia, Megaloblastic,1/24,0.04693816966805759,0.14406881058640536,0,0,20.833333333333332,63.72758504855492,MTHFR
Epilepsy, Benign Psychomotor, Childhood,1/24,0.04693816966805759,0.14402383125122384,0,0,20.833333333333332,63.72758504855492,VDR
Senile lentigo,1/24,0.04693816966805759,0.14397887999303058,0,0,20.833333333333332,63.72758504855492,TNF
Microangiopathy, Diabetic,1/24,0.04693816966805759,0.14393395678554446,0,0,20.833333333333332,63.72758504855492,MTHFR
Stage III Colon Cancer,1/24,0.04693816966805759,0.14388906160251716,0,0,20.833333333333332,63.72758504855492,MTHFR
Pseudohypoparathyroidism, Type Ia,1/24,0.04693816966805759,0.14384419441773308,0,0,20.833333333333332,63.72758504855492,TNF
Uncinate Epilepsy,1/24,0.04693816966805759,0.14379935520500936,0,0,20.833333333333332,63.72758504855492,VDR
Adenoma of lung,1/24,0.04693816966805759,0.1437545439381957,0,0,20.833333333333332,63.72758504855492,RUNX3
Asphyxia Neonatorum,1/24,0.04693816966805759,0.14370976059117446,0,0,20.833333333333332,63.72758504855492,SOD1
Basophilic leukemia,1/24,0.04693816966805759,0.14366500513786049,0,0,20.833333333333332,63.72758504855492,IL6
Bronchitis,1/24,0.04693816966805759,0.1436202775522011,0,0,20.833333333333332,63.72758504855492,TGFB1
Catalepsy,1/24,0.04693816966805759,0.14357557780817615,0,0,20.833333333333332,63.72758504855492,PRL
Childhood Solid Neoplasm,1/24,0.04693816966805759,0.14353090587979775,0,0,20.833333333333332,63.72758504855492,HLA-DRB1
Chronic thromboembolic pulmonary hypertension,1/24,0.04693816966805759,0.14348626174111043,0,0,20.833333333333332,63.72758504855492,CXCL10
Infant Leukemia,1/24,0.04693816966805759,0.14344164536619092,0,0,20.833333333333332,63.72758504855492,TNF
Norrie disease,1/24,0.04693816966805759,0.14339705672914826,0,0,20.833333333333332,63.72758504855492,SOD1
Pelger-Huet Anomaly,1/24,0.04693816966805759,0.14335249580412368,0,0,20.833333333333332,63.72758504855492,PRL
Precursor T-cell lymphoblastic lymphoma,1/24,0.04693816966805759,0.14330796256529046,0,0,20.833333333333332,63.72758504855492,CCR4
Very poor growth,2/174,0.047312094972586566,0.1444047420467642,0,0,5.747126436781609,17.53442131325405,IL21;VDR
Well Differentiated Oligodendroglioma,2/176,0.04828926781183143,0.1473414852700029,0,0,5.681818181818182,17.219011031398658,HMGB1;IL2
Mammary Tumorigenesis,2/176,0.04828926781183143,0.1472957554483797,0,0,5.681818181818182,17.219011031398658,AHR;PRL
Apraxia, Developmental Verbal,1/25,0.04884657866138502,0.14894948032395036,0,0,20.0,60.381418811681364,MTHFR
Sclerosis,1/25,0.04884657866138502,0.14890328011293175,0,0,20.0,60.381418811681364,IL1B
Lymphoma, Follicular, Grade 1,1/25,0.04884657866138502,0.1488571085532068,0,0,20.0,60.381418811681364,MTHFR
Tooth Attrition,1/25,0.04884657866138502,0.14881096561813142,0,0,20.0,60.381418811681364,IL1B
Uterine Carcinosarcoma,1/25,0.04884657866138502,0.1487648512810945,0,0,20.0,60.381418811681364,TGFB1
Adolescent idiopathic scoliosis,1/25,0.04884657866138502,0.14871876551551796,0,0,20.0,60.381418811681364,VDR
Aortic Diseases,1/25,0.04884657866138502,0.1486727082948566,0,0,20.0,60.381418811681364,SOD1
Dyspepsia,1/25,0.04884657866138502,0.14862667959259812,0,0,20.0,60.381418811681364,IL17A
Familial erythrocytosis,1/25,0.04884657866138502,0.14858067938226308,0,0,20.0,60.381418811681364,HIF1A
Hyperostosis,1/25,0.04884657866138502,0.1485347076374047,0,0,20.0,60.381418811681364,TGFB1
Attention deficit hyperactivity disorder,3/412,0.04892676604331644,0.1487325260357915,0,0,3.6407766990291264,10.98579127208995,MTHFR;IL2;INS
Recurrent Childhood Acute Lymphoblastic Leukemia,1/26,0.050751261720201696,0.15423110704580775,0,0,19.23076923076923,57.32343845937452,IL10
Epilepsy, Lateral Temporal,1/26,0.050751261720201696,0.1541834312785602,0,0,19.23076923076923,57.32343845937452,VDR
Hypotension, Orthostatic,1/26,0.050751261720201696,0.15413578497717623,0,0,19.23076923076923,57.32343845937452,IL12A
Osteoarthrosis, localized, not specified whether primary or secondary,1/26,0.050751261720201696,0.1540881681143473,0,0,19.23076923076923,57.32343845937452,IL1B
Tibial bowing,1/26,0.050751261720201696,0.15404058066279872,0,0,19.23076923076923,57.32343845937452,VDR
Acute hepatitis,1/26,0.050751261720201696,0.15399302259528938,0,0,19.23076923076923,57.32343845937452,IFNG
Yellow Fever,1/26,0.050751261720201696,0.15394549388461182,0,0,19.23076923076923,57.32343845937452,IFNG
Adult T Acute Lymphoblastic Leukemia,1/26,0.050751261720201696,0.15389799450359218,0,0,19.23076923076923,57.32343845937452,IL2
Aortic root dilatation,1/26,0.050751261720201696,0.15385052442509015,0,0,19.23076923076923,57.32343845937452,HLA-DRB1
Choroideremia,1/26,0.050751261720201696,0.15380308362199885,0,0,19.23076923076923,57.32343845937452,CD14
Conjugated hyperbilirubinemia,1/26,0.050751261720201696,0.15375567206724483,0,0,19.23076923076923,57.32343845937452,IL12A
Hyperprolactinemia,1/26,0.050751261720201696,0.15370828973378806,0,0,19.23076923076923,57.32343845937452,PRL
Hypersomnia,1/26,0.050751261720201696,0.15366093659462177,0,0,19.23076923076923,57.32343845937452,HLA-DRB1
Increased drug resistance,1/26,0.050751261720201696,0.15361361262277248,0,0,19.23076923076923,57.32343845937452,IL1B
Klatskin Tumor,1/26,0.050751261720201696,0.15356631779129995,0,0,19.23076923076923,57.32343845937452,HIF1A
Mast Cell Neoplasm,1/26,0.050751261720201696,0.1535190520732971,0,0,19.23076923076923,57.32343845937452,IL2
Pituitary carcinoma,1/26,0.050751261720201696,0.15347181544188992,0,0,19.23076923076923,57.32343845937452,PRL
Plasmablastic lymphoma,1/26,0.050751261720201696,0.15342460787023754,0,0,19.23076923076923,57.32343845937452,VDR
Ciliopathies,2/181,0.05076448083951577,0.15341737936370264,0,0,5.524861878453038,16.46717328741325,TGFB1;TNF
Acidosis, Lactic,2/183,0.05176729153556806,0.15639992044622283,0,0,5.46448087431694,16.180310200517148,IL10;TNF
oligodendroglioma,2/183,0.05176729153556806,0.15635185654934325,0,0,5.46448087431694,16.180310200517148,HMGB1;IL2
Thymic Lymphoma,1/27,0.052652225928391236,0.1589757531257232,0,0,18.518518518518515,54.519384508400854,CD80
Apathy,1/27,0.052652225928391236,0.158926927648719,0,0,18.518518518518515,54.519384508400854,SOD1
Childhood Cerebral Astrocytoma,1/27,0.052652225928391236,0.15887813215358584,0,0,18.518518518518515,54.519384508400854,HIF1A
Conotruncal defect,1/27,0.052652225928391236,0.1588293666127161,0,0,18.518518518518515,54.519384508400854,MTHFR
Fluid overload,1/27,0.052652225928391236,0.15878063099853607,0,0,18.518518518518515,54.519384508400854,TNF
Gastric lymphoma,1/27,0.052652225928391236,0.15873192528350585,0,0,18.518518518518515,54.519384508400854,TLR4
Homocystinuria,1/27,0.052652225928391236,0.1586832494401193,0,0,18.518518518518515,54.519384508400854,MTHFR
Intracranial Astrocytoma,1/27,0.052652225928391236,0.15863460344090408,0,0,18.518518518518515,54.519384508400854,HIF1A
Loss of appetite (finding),1/27,0.052652225928391236,0.1585859872584214,0,0,18.518518518518515,54.519384508400854,TGFB1
Mucinous neoplasm,1/27,0.052652225928391236,0.15853740086526627,0,0,18.518518518518515,54.519384508400854,HIF1A
Personality Disorders,1/27,0.052652225928391236,0.1584888442340671,0,0,18.518518518518515,54.519384508400854,PRL
Premenopausal breast cancer,1/27,0.052652225928391236,0.15844031733748593,0,0,18.518518518518515,54.519384508400854,VDR
Protein S Deficiency,1/27,0.052652225928391236,0.15839182014821826,0,0,18.518518518518515,54.519384508400854,MTHFR
Malignant Peripheral Nerve Sheath Tumor,2/188,0.054305515587317096,0.16331536327789242,0,0,5.319148936170213,15.495369579824866,HIF1A;TNF
AMYOTROPHIC LATERAL SCLEROSIS 1, AUTOSOMAL RECESSIVE,1/28,0.05454947834145277,0.16399885993875737,0,0,17.857142857142854,51.94012731592684,SOD1
Serum gamma-glutamyl transferase measurement,1/28,0.05454947834145277,0.16394870738220116,0,0,17.857142857142854,51.94012731592684,FUT2
Hyperglycemia, Postprandial,1/28,0.05454947834145277,0.1638985854906138,0,0,17.857142857142854,51.94012731592684,INS
Lymphoma, AIDS-Related,1/28,0.05454947834145277,0.16384849423587952,0,0,17.857142857142854,51.94012731592684,IL10
Spina Bifida Occulta,1/28,0.05454947834145277,0.16379843358991683,0,0,17.857142857142854,51.94012731592684,MTHFR
Pain, Postoperative,1/28,0.05454947834145277,0.16374840352467862,0,0,17.857142857142854,51.94012731592684,TNF
Parkinsonism, Experimental,1/28,0.05454947834145277,0.163698404012152,0,0,17.857142857142854,51.94012731592684,PRL
Autosomal Dominant Juvenile Parkinson Disease,1/28,0.05454947834145277,0.1636484350243583,0,0,17.857142857142854,51.94012731592684,PRL
Benign Meningioma,1/28,0.05454947834145277,0.163598496533353,0,0,17.857142857142854,51.94012731592684,DPP4
Cerebral Astrocytoma,1/28,0.05454947834145277,0.1635485885112257,0,0,17.857142857142854,51.94012731592684,HIF1A
Childhood Burkitt Lymphoma,1/28,0.05454947834145277,0.1634987109301,0,0,17.857142857142854,51.94012731592684,IL10
Familial Juvenile Parkinsonism,1/28,0.05454947834145277,0.1634488637621335,0,0,17.857142857142854,51.94012731592684,PRL
Febrile Neutropenia,1/28,0.05454947834145277,0.16339904697951776,0,0,17.857142857142854,51.94012731592684,MTHFR
Hyperemia,1/28,0.05454947834145277,0.16334926055447832,0,0,17.857142857142854,51.94012731592684,IL1B
Plasma cell dyscrasia,1/28,0.05454947834145277,0.16329950445927438,0,0,17.857142857142854,51.94012731592684,IL6
Ramsay Hunt Paralysis Syndrome,1/28,0.05454947834145277,0.16324977866619908,0,0,17.857142857142854,51.94012731592684,PRL
Recurrent major depressive episodes,1/29,0.056443026022856134,0.16886516278618877,0,0,17.241379310344826,49.560750665033694,MTHFR
alpha-1-Antitrypsin Deficiency, Autosomal Recessive,1/29,0.056443026022856134,0.16881377350962573,0,0,17.241379310344826,49.560750665033694,TNF
Hyalinosis, Segmental Glomerular,1/29,0.056443026022856134,0.1687624155012565,0,0,17.241379310344826,49.560750665033694,TGFB1
Meningitis, Pneumococcal,1/29,0.056443026022856134,0.16871108873255175,0,0,17.241379310344826,49.560750665033694,IL1B
Staphylococcus aureus infection,1/29,0.056443026022856134,0.16865979317501675,0,0,17.241379310344826,49.560750665033694,HIF1A
T-Cell Prolymphocytic Leukemia,1/29,0.056443026022856134,0.16860852880019153,0,0,17.241379310344826,49.560750665033694,IL2RA
Angiofibroma,1/29,0.056443026022856134,0.1685572955796506,0,0,17.241379310344826,49.560750665033694,AHR
Brain Aneurysm,1/29,0.056443026022856134,0.16850609348500306,0,0,17.241379310344826,49.560750665033694,STAT1
Central Core Myopathy (disorder),1/29,0.056443026022856134,0.16845492248789254,0,0,17.241379310344826,49.560750665033694,IL6
Cholesterol gallstones,1/29,0.056443026022856134,0.168403782559997,0,0,17.241379310344826,49.560750665033694,HIF1A
Chronic Kidney Insufficiency,1/29,0.056443026022856134,0.16835267367302886,0,0,17.241379310344826,49.560750665033694,TLR4
Coronary Aneurysm,1/29,0.056443026022856134,0.16830159579873485,0,0,17.241379310344826,49.560750665033694,IL10
Discordant ventriculoarterial connection,1/29,0.056443026022856134,0.168250548908896,0,0,17.241379310344826,49.560750665033694,HIF1A
Hereditary hemorrhagic telangiectasia,1/29,0.056443026022856134,0.1681995329753275,0,0,17.241379310344826,49.560750665033694,IL6
HMN (Hereditary Motor Neuropathy) Proximal Type I,1/29,0.056443026022856134,0.1681485479698788,0,0,17.241379310344826,49.560750665033694,SOD1
Juvenile Neuronal Ceroid Lipofuscinosis,1/29,0.056443026022856134,0.16809759386443338,0,0,17.241379310344826,49.560750665033694,IL1B
Keratoconjunctivitis Sicca,1/29,0.056443026022856134,0.16804667063090886,0,0,17.241379310344826,49.560750665033694,TNF
Keratosis Follicularis,1/29,0.056443026022856134,0.16799577824125686,0,0,17.241379310344826,49.560750665033694,IL6
Metaphyseal irregularity,1/29,0.056443026022856134,0.16794491666746295,0,0,17.241379310344826,49.560750665033694,VDR
Methylmalonic aciduria,1/29,0.056443026022856134,0.16789408588154664,0,0,17.241379310344826,49.560750665033694,MTHFR
Multiple endocrine neoplasia Type 2,1/29,0.056443026022856134,0.1678432858555613,0,0,17.241379310344826,49.560750665033694,PRL
Phenylketonurias,1/29,0.056443026022856134,0.1677925165615941,0,0,17.241379310344826,49.560750665033694,SOD1
Pigmented Basal Cell Carcinoma,1/29,0.056443026022856134,0.16774177797176598,0,0,17.241379310344826,49.560750665033694,IL6
Optic Atrophy, Autosomal Dominant,1/30,0.05833287602349702,0.17330577556194945,0,0,16.666666666666668,47.35982388924428,SOD1
POLYARTERITIS NODOSA, CHILDHOOD-ONSET,1/30,0.05833287602349702,0.17325340149861854,0,0,16.666666666666668,47.35982388924428,VDR
Thymic Carcinoma,1/30,0.05833287602349702,0.17320105908124736,0,0,16.666666666666668,47.35982388924428,HMGB1
TUBEROUS SCLEROSIS 2 (disorder),1/30,0.05833287602349702,0.17314874828116242,0,0,16.666666666666668,47.35982388924428,IFNG
Adult Learning Disorders,1/30,0.05833287602349702,0.17309646906972487,0,0,16.666666666666668,47.35982388924428,IL1B
Amyotrophic Lateral Sclerosis With Dementia,1/30,0.05833287602349702,0.17304422141833045,0,0,16.666666666666668,47.35982388924428,SOD1
Carney Complex,1/30,0.05833287602349702,0.1729920052984094,0,0,16.666666666666668,47.35982388924428,PRL
Christ-Siemens-Touraine syndrome,1/30,0.05833287602349702,0.17293982068142646,0,0,16.666666666666668,47.35982388924428,TNF
Developmental Academic Disorder,1/30,0.05833287602349702,0.17288766753888082,0,0,16.666666666666668,47.35982388924428,IL1B
Femoral bowing,1/30,0.05833287602349702,0.17283554584230593,0,0,16.666666666666668,47.35982388924428,VDR
Learning Disturbance,1/30,0.05833287602349702,0.17278345556326968,0,0,16.666666666666668,47.35982388924428,IL1B
Lymphoid neoplasm,1/30,0.05833287602349702,0.17273139667337414,0,0,16.666666666666668,47.35982388924428,MTHFR
Malignant transformation,1/30,0.05833287602349702,0.17267936914425566,0,0,16.666666666666668,47.35982388924428,AHR
MERRF Syndrome,1/30,0.05833287602349702,0.1726273729475847,0,0,16.666666666666668,47.35982388924428,IL1B
Methylmalonic acidemia,1/30,0.05833287602349702,0.17257540805506585,0,0,16.666666666666668,47.35982388924428,MTHFR
Narcolepsy-Cataplexy Syndrome,1/30,0.05833287602349702,0.1725234744384378,0,0,16.666666666666668,47.35982388924428,HLA-DRB1
Pancreatic Insufficiency,1/30,0.05833287602349702,0.17247157206947317,0,0,16.666666666666668,47.35982388924428,TGFB1
Protoplasmic astrocytoma,1/30,0.05833287602349702,0.17241970091997857,0,0,16.666666666666668,47.35982388924428,HIF1A
Spinal Muscular Atrophy,2/196,0.05845711917586758,0.17273498714985766,0,0,5.1020408163265305,14.487049995229416,IL12A;SOD1
Diagnosis, Psychiatric,1/31,0.06021903535976484,0.1778877906569789,0,0,16.129032258064516,45.318818946116544,MTHFR
Hypophosphatemic Rickets, X-Linked Dominant,1/31,0.06021903535976484,0.17783433879680555,0,0,16.129032258064516,45.318818946116544,VDR
Lipomatosis, Multiple,1/31,0.06021903535976484,0.177780919049495,0,0,16.129032258064516,45.318818946116544,IRF1
Activated Protein C Resistance,1/31,0.06021903535976484,0.17772753138611677,0,0,16.129032258064516,45.318818946116544,MTHFR
Atherosclerosis of aorta,1/31,0.06021903535976484,0.1776741757777751,0,0,16.129032258064516,45.318818946116544,TLR4
Drug-Induced Stevens Johnson Syndrome,1/31,0.06021903535976484,0.1776208521956089,0,0,16.129032258064516,45.318818946116544,IFNG
Early infantile epileptic encephalopathy with suppression bursts,1/31,0.06021903535976484,0.17756756061079174,0,0,16.129032258064516,45.318818946116544,MTHFR
ESTROGEN RESISTANCE,1/31,0.06021903535976484,0.17751430099453175,0,0,16.129032258064516,45.318818946116544,PRL
Hyperdiploid B Acute Lymphoblastic Leukemia,1/31,0.06021903535976484,0.17746107331807162,0,0,16.129032258064516,45.318818946116544,TNF
Longevity,1/31,0.06021903535976484,0.1774078775526885,0,0,16.129032258064516,45.318818946116544,IL6
Mycoplasma-Induced Stevens-Johnson Syndrome,1/31,0.06021903535976484,0.177354713669694,0,0,16.129032258064516,45.318818946116544,IFNG
Myelomonocytic leukemia,1/31,0.06021903535976484,0.17730158164043405,0,0,16.129032258064516,45.318818946116544,IL6
Myxoma,1/31,0.06021903535976484,0.17724848143628896,0,0,16.129032258064516,45.318818946116544,STAT1
Neoplastic disease,1/31,0.06021903535976484,0.1771954130286733,0,0,16.129032258064516,45.318818946116544,IL6
PEELING SKIN SYNDROME,1/31,0.06021903535976484,0.17714237638903588,0,0,16.129032258064516,45.318818946116544,HLA-DRB1
Plasma Cell Neoplasm,1/31,0.06021903535976484,0.17708937148885961,0,0,16.129032258064516,45.318818946116544,IL6
Protein C Deficiency,1/31,0.06021903535976484,0.17703639829966164,0,0,16.129032258064516,45.318818946116544,MTHFR
Squamous cell carcinoma of the hypopharynx,1/32,0.06210151106078767,0.18251604387123843,0,0,15.625,43.42163996307569,TNF
Tires quickly,1/32,0.06210151106078767,0.18246148003151608,0,0,15.625,43.42163996307569,TGFB1
Aortic valve calcification,1/32,0.06210151106078767,0.18240694880616296,0,0,15.625,43.42163996307569,TNF
Bone marrow hypocellularity,1/32,0.06210151106078767,0.182352450165946,0,0,15.625,43.42163996307569,TGFB1
Bunion,1/32,0.06210151106078767,0.18229798408166706,0,0,15.625,43.42163996307569,TNF
Cataplexy,1/32,0.06210151106078767,0.18224355052416283,0,0,15.625,43.42163996307569,HLA-DRB1
Cervical high grade squamous intraepithelial lesion,1/32,0.06210151106078767,0.18218914946430487,0,0,15.625,43.42163996307569,IL10
Congenital malrotation of intestine,1/32,0.06210151106078767,0.1821347808729995,0,0,15.625,43.42163996307569,TGFB1
Decrease in appetite,1/32,0.06210151106078767,0.18208044472118773,0,0,15.625,43.42163996307569,TGFB1
Dermatofibrosarcoma Protuberans,1/32,0.06210151106078767,0.1820261409798453,0,0,15.625,43.42163996307569,TGFB1
Easy fatigability,1/32,0.06210151106078767,0.1819718696199825,0,0,15.625,43.42163996307569,TGFB1
Grade I Astrocytoma,1/32,0.06210151106078767,0.1819176306126442,0,0,15.625,43.42163996307569,HIF1A
HIV encephalitis,1/32,0.06210151106078767,0.1818634239289098,0,0,15.625,43.42163996307569,TNF
Increased hepatocellular carcinoma risk,1/32,0.06210151106078767,0.18180924953989314,0,0,15.625,43.42163996307569,IL12A
Increased incidence of hepatocellular carcinoma,1/32,0.06210151106078767,0.1817551074167425,0,0,15.625,43.42163996307569,IL12A
Intestinal Obstruction,1/32,0.06210151106078767,0.18170099753064045,0,0,15.625,43.42163996307569,IL10
Juvenile polyposis syndrome,1/32,0.06210151106078767,0.18164691985280396,0,0,15.625,43.42163996307569,TLR4
Neurotoxicity Syndromes,1/32,0.06210151106078767,0.18159287435448418,0,0,15.625,43.42163996307569,IL10
Nodular Lymphocyte Predominant Hodgkin Lymphoma,1/32,0.06210151106078767,0.18153886100696648,0,0,15.625,43.42163996307569,IL2
Periodic Fever Syndrome,1/32,0.06210151106078767,0.1814848797815704,0,0,15.625,43.42163996307569,TNF
Peritoneal Fibrosis,1/32,0.06210151106078767,0.1814309306496496,0,0,15.625,43.42163996307569,TGFB1
Prominent metopic ridge,1/32,0.06210151106078767,0.18137701358259176,0,0,15.625,43.42163996307569,INS
Pulmonary Alveolar Proteinosis,1/32,0.06210151106078767,0.18132312855181856,0,0,15.625,43.42163996307569,IL10
Cytopenia,2/206,0.06379728932244323,0.18621911477902348,0,0,4.854368932038835,13.359439692441919,IFNG;IRF1
Hyperkinesia, Generalized,1/33,0.0639803101343835,0.18669788836125922,0,0,15.151515151515152,41.65424086527227,IL2
Soluble Interleukin 6 Receptor Measurement,1/33,0.0639803101343835,0.18664247195034758,0,0,15.151515151515152,41.65424086527227,IL6R
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,1/33,0.0639803101343835,0.18658708842751365,0,0,15.151515151515152,41.65424086527227,IFNG
Superinfection,1/33,0.0639803101343835,0.1865317377634889,0,0,15.151515151515152,41.65424086527227,IL1B
Thrombotic Microangiopathies,1/33,0.0639803101343835,0.18647641992903946,0,0,15.151515151515152,41.65424086527227,HLA-DRB1
Ventricular hypertrophy,1/33,0.0639803101343835,0.1864211348949662,0,0,15.151515151515152,41.65424086527227,IRF1
Angiomyolipoma,1/33,0.0639803101343835,0.18636588263210463,0,0,15.151515151515152,41.65424086527227,IFNG
Autosomal Dominant Parkinsonism,1/33,0.0639803101343835,0.18631066311132474,0,0,15.151515151515152,41.65424086527227,PRL
Central Diabetes Insipidus,1/33,0.0639803101343835,0.18625547630353112,0,0,15.151515151515152,41.65424086527227,TNF
Craniopharyngioma,1/33,0.0639803101343835,0.18620032217966273,0,0,15.151515151515152,41.65424086527227,IL6
EPIDERMAL DIFFERENTIATION COMPLEX,1/33,0.0639803101343835,0.18614520071069302,0,0,15.151515151515152,41.65424086527227,S100A9
Fibrillary Astrocytoma,1/33,0.0639803101343835,0.18609011186762978,0,0,15.151515151515152,41.65424086527227,HIF1A
Fibrous Dysplasia,1/33,0.0639803101343835,0.1860350556215151,0,0,15.151515151515152,41.65424086527227,IL6
Gastric Cardia Adenocarcinoma,1/33,0.0639803101343835,0.18598003194342533,0,0,15.151515151515152,41.65424086527227,MTHFR
Harlequin Fetus,1/33,0.0639803101343835,0.18592504080447103,0,0,15.151515151515152,41.65424086527227,IL6
Leukocytosis,1/33,0.0639803101343835,0.18587008217579692,0,0,15.151515151515152,41.65424086527227,IL1B
Mean blood pressure,1/33,0.0639803101343835,0.18581515602858187,0,0,15.151515151515152,41.65424086527227,MTHFR
Meckel syndrome type 1,1/33,0.0639803101343835,0.1857602623340387,0,0,15.151515151515152,41.65424086527227,IL6
Meniere Disease,1/33,0.0639803101343835,0.18570540106341435,0,0,15.151515151515152,41.65424086527227,HLA-DRB1
Mixed oligoastrocytoma,1/33,0.0639803101343835,0.18565057218798967,0,0,15.151515151515152,41.65424086527227,HIF1A
Nuclear cataract,1/33,0.0639803101343835,0.1855957756790794,0,0,15.151515151515152,41.65424086527227,TGM2
Polyarteritis Nodosa,1/33,0.0639803101343835,0.18554101150803218,0,0,15.151515151515152,41.65424086527227,VDR
Primary Lesion,1/33,0.0639803101343835,0.18548627964623038,0,0,15.151515151515152,41.65424086527227,IL10
Ataxia,2/208,0.06488474384517323,0.1880528642024071,0,0,4.8076923076923075,13.14972478186944,IFNG;TGM2
Congenital anemia,2/208,0.06488474384517323,0.1879974240891399,0,0,4.8076923076923075,13.14972478186944,IFNG;IRF1
Amyotrophic Lateral Sclerosis, Guam Form,1/34,0.06585543955628825,0.19075368699062806,0,0,14.705882352941176,40.004312484496026,SOD1
Carcinoma, Ehrlich Tumor,1/34,0.06585543955628825,0.19069748378291132,0,0,14.705882352941176,40.004312484496026,HIF1A
Angle Closure Glaucoma,1/34,0.06585543955628825,0.19064131368459528,0,0,14.705882352941176,40.004312484496026,MTHFR
Autosomal Recessive Parkinsonism,1/34,0.06585543955628825,0.19058517666643138,0,0,14.705882352941176,40.004312484496026,PRL
Generalized Anxiety Disorder,1/34,0.06585543955628825,0.19052907269920547,0,0,14.705882352941176,40.004312484496026,INS
Gestational trophoblastic disease,1/34,0.06585543955628825,0.19047300175373777,0,0,14.705882352941176,40.004312484496026,TNF
Infant Acute Lymphoblastic Leukemia,1/34,0.06585543955628825,0.1904169638008829,0,0,14.705882352941176,40.004312484496026,S100A9
Metastatic Carcinoma,1/34,0.06585543955628825,0.1903609588115297,0,0,14.705882352941176,40.004312484496026,IL2
Neurofibromatosis 1,2/210,0.06597851849908759,0.1906606526930411,0,0,4.761904761904762,12.944886034388052,TGFB1;TNF
Gait, Drop Foot,1/35,0.06772690632728534,0.1956555071677132,0,0,14.285714285714285,38.461024904975446,SOD1
Cervical Dystonia,1/35,0.06772690632728534,0.19559801216119904,0,0,14.285714285714285,38.461024904975446,HLA-DRB1
Complete trisomy 18 syndrome,1/35,0.06772690632728534,0.19554055093553477,0,0,14.285714285714285,38.461024904975446,MTHFR
Hemianopsia,1/35,0.06772690632728534,0.1954831234609575,0,0,14.285714285714285,38.461024904975446,PRL
Hereditary Melanoma,1/35,0.06772690632728534,0.1954257297077394,0,0,14.285714285714285,38.461024904975446,S100A9
Intracranial Hypertension,1/35,0.06772690632728534,0.19536836964618734,0,0,14.285714285714285,38.461024904975446,HMGB1
Intrahepatic Cholestasis,1/35,0.06772690632728534,0.19531104324664328,0,0,14.285714285714285,38.461024904975446,HLA-DRB1
Juvenile Myoclonic Epilepsy,1/35,0.06772690632728534,0.19525375047948382,0,0,14.285714285714285,38.461024904975446,HLA-DRB1
Low Grade Squamous Intraepithelial Neoplasia,1/35,0.06772690632728534,0.19519649131512032,0,0,14.285714285714285,38.461024904975446,HLA-DRB1
Skeletal muscle atrophy,2/215,0.06874018071329573,0.1980587792583613,0,0,4.651162790697675,12.453122691276675,TGFB1;SOD1
Neurogenic muscle atrophy, especially in the lower limbs,2/215,0.06874018071329573,0.19800073155048956,0,0,4.651162790697675,12.453122691276675,TGFB1;SOD1
Astrocytoma, low grade,1/36,0.06959471740161192,0.2004034229777445,0,0,13.888888888888888,37.01481408228327,HIF1A
Exocrine pancreatic insufficiency,1/36,0.06959471740161192,0.2003447225023556,0,0,13.888888888888888,37.01481408228327,TGFB1
Fatigable weakness of respiratory muscles,1/36,0.06959471740161192,0.20028605640499034,0,0,13.888888888888888,37.01481408228327,SOD1
Inflammatory Myofibroblastic Tumor,1/36,0.06959471740161192,0.20022742465545726,0,0,13.888888888888888,37.01481408228327,IL6
Invasive Streptococcus pneumoniae disease,1/36,0.06959471740161192,0.20016882722360024,0,0,13.888888888888888,37.01481408228327,IL1B
Learning Disorders,1/36,0.06959471740161192,0.2001102640792984,0,0,13.888888888888888,37.01481408228327,IL1B
Ocular Hypertension,1/36,0.06959471740161192,0.20005173519246622,0,0,13.888888888888888,37.01481408228327,SOD1
Plexiform Neurofibroma,1/36,0.06959471740161192,0.19999324053305323,0,0,13.888888888888888,37.01481408228327,S100A9
Adenoma, Basal Cell,1/37,0.07145887974209389,0.20529022803428787,0,0,13.513513513513514,35.657204097603866,PRL
Adenoma, Monomorphic,1/37,0.07145887974209389,0.20523023673445318,0,0,13.513513513513514,35.657204097603866,PRL
Glomerulonephritis, Membranoproliferative,1/37,0.07145887974209389,0.2051702804865027,0,0,13.513513513513514,35.657204097603866,IL1B
Tubular Aggregate Myopathy,1/37,0.07145887974209389,0.20511035925972512,0,0,13.513513513513514,35.657204097603866,IL10
Aplasia/Hypoplasia of the radius,1/37,0.07145887974209389,0.2050504730234449,0,0,13.513513513513514,35.657204097603866,TGFB1
Fatigable weakness of swallowing muscles,1/37,0.07145887974209389,0.2049906217470224,0,0,13.513513513513514,35.657204097603866,SOD1
Flat back of the head,1/37,0.07145887974209389,0.20493080539985375,0,0,13.513513513513514,35.657204097603866,VDR
Fuchs Endothelial Dystrophy,1/37,0.07145887974209389,0.20487102395137072,0,0,13.513513513513514,35.657204097603866,ETS1
Hemorrhage,1/37,0.07145887974209389,0.20481127737104077,0,0,13.513513513513514,35.657204097603866,IL6
Immunoblastic Large-Cell Lymphoma,1/37,0.07145887974209389,0.204751565628367,0,0,13.513513513513514,35.657204097603866,VDR
Juvenile Pilocytic Astrocytoma,1/37,0.07145887974209389,0.204691888692888,0,0,13.513513513513514,35.657204097603866,HIF1A
Leukoaraiosis,1/37,0.07145887974209389,0.20463224653417797,0,0,13.513513513513514,35.657204097603866,MTHFR
Malignant neoplasm of oropharynx,1/37,0.07145887974209389,0.20457263912184642,0,0,13.513513513513514,35.657204097603866,IL10
Malignant neoplasm of pharynx,1/37,0.07145887974209389,0.20451306642553838,0,0,13.513513513513514,35.657204097603866,IL1B
Obstructive azoospermia,1/37,0.07145887974209389,0.20445352841493414,0,0,13.513513513513514,35.657204097603866,MTHFR
Pelvic Organ Prolapse,1/37,0.07145887974209389,0.20439402505974935,0,0,13.513513513513514,35.657204097603866,IL6
Adenoma, Trabecular,1/38,0.07331940027913937,0.20965465986132722,0,0,13.157894736842104,34.38065836240793,PRL
Sensorimotor neuropathy,1/38,0.07331940027913937,0.2095936782848696,0,0,13.157894736842104,34.38065836240793,SOD1
Spastic gait,1/38,0.07331940027913937,0.2095327321731264,0,0,13.157894736842104,34.38065836240793,SOD1
Nephritis, Tubulointerstitial,1/38,0.07331940027913937,0.2094718214951691,0,0,13.157894736842104,34.38065836240793,HLA-DRB1
Chronic eosinophilic leukemia,1/38,0.07331940027913937,0.20941094622010512,0,0,13.157894736842104,34.38065836240793,IFNG
DOWN SYNDROME CRITICAL REGION,1/38,0.07331940027913937,0.2093501063170778,0,0,13.157894736842104,34.38065836240793,TNF
Genu varum,1/38,0.07331940027913937,0.20928930175526625,0,0,13.157894736842104,34.38065836240793,VDR
Keratosis,1/38,0.07331940027913937,0.2092285325038855,0,0,13.157894736842104,34.38065836240793,VDR
Papillary adenoma,1/38,0.07331940027913937,0.20916779853218628,0,0,13.157894736842104,34.38065836240793,PRL
Pituitary dwarfism,1/38,0.07331940027913937,0.20910709980945494,0,0,13.157894736842104,34.38065836240793,PRL
Prostatic Diseases,1/38,0.07331940027913937,0.20904643630501354,0,0,13.157894736842104,34.38065836240793,TGFB1
Tremor,2/226,0.07494853275378349,0.21362940252441537,0,0,4.424778761061947,11.464396597163386,IL10;IL6
Streptococcal pneumonia,1/39,0.07517628596858959,0.21421645071014744,0,0,12.82051282051282,33.178454409240665,IL6
Subependymal Giant Cell Astrocytoma,1/39,0.07517628596858959,0.2141543589853039,0,0,12.82051282051282,33.178454409240665,HIF1A
Adenocarcinoma of rectum,1/39,0.07517628596858959,0.21409230324523282,0,0,12.82051282051282,33.178454409240665,HIF1A
Flat occiput,1/39,0.07517628596858959,0.2140302834586612,0,0,12.82051282051282,33.178454409240665,VDR
Growth Disorders,1/39,0.07517628596858959,0.2139682995943523,0,0,12.82051282051282,33.178454409240665,AHR
Lymphatic Diseases,1/39,0.07517628596858959,0.21390635162110552,0,0,12.82051282051282,33.178454409240665,IL10
Malignant neoplasm of adrenal cortex,1/39,0.07517628596858959,0.21384443950775645,0,0,12.82051282051282,33.178454409240665,TNF
Neonatal diabetes mellitus,1/39,0.07517628596858959,0.21378256322317665,0,0,12.82051282051282,33.178454409240665,INS
Ovarian failure,1/39,0.07517628596858959,0.2137207227362738,0,0,12.82051282051282,33.178454409240665,AHR
Seminoma,2/229,0.07667234184000585,0.2179108662821219,0,0,4.366812227074235,11.214909333915354,IL10;TNF
Drug abuse,2/229,0.07667234184000585,0.21784786805538522,0,0,4.366812227074235,11.214909333915354,IL6;TNF
No development of motor milestones,2/229,0.07667234184000585,0.2177849062438085,0,0,4.366812227074235,11.214909333915354,VDR;INS
Anxiety States, Neurotic,1/40,0.07702954369316486,0.21873630610124942,0,0,12.5,32.044578079870575,TNF
Degenerative Diseases, Spinal Cord,1/40,0.07702954369316486,0.2186731240370954,0,0,12.5,32.044578079870575,IL6
Xeroderma pigmentosum, group A,1/40,0.07702954369316486,0.2186099784627272,0,0,12.5,32.044578079870575,HIF1A
Abnormal coordination,1/40,0.07702954369316486,0.2185468693465428,0,0,12.5,32.044578079870575,MTHFR
Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,1/40,0.07702954369316486,0.2184837966569767,0,0,12.5,32.044578079870575,IRF1
Adrenal cortical hypofunction,1/40,0.07702954369316486,0.2184207603624998,0,0,12.5,32.044578079870575,MTHFR
Anthrax disease,1/40,0.07702954369316486,0.21835776043161934,0,0,12.5,32.044578079870575,HIF1A
Congenital omphalocele,1/40,0.07702954369316486,0.21829479683287897,0,0,12.5,32.044578079870575,MTHFR
Hypokalemia,1/40,0.07702954369316486,0.21823186953485854,0,0,12.5,32.044578079870575,INS
Prostate cancer recurrent,1/40,0.07702954369316486,0.21816897850617414,0,0,12.5,32.044578079870575,IL6
Motor delay,2/232,0.07840888119743594,0.22201166361521188,0,0,4.310344827586206,10.973353782163771,VDR;INS
Schwartz-Jampel Syndrome,1/41,0.07887918037823767,0.223278970264205,0,0,12.195121951219512,30.97363365224591,HLA-DRB1
Human immunodeficiency virus, type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site,1/41,0.07887918037823767,0.22321468032171604,0,0,12.195121951219512,30.97363365224591,IL6R
Pancreatitis, Alcoholic,1/41,0.07887918037823767,0.22315042739128377,0,0,12.195121951219512,30.97363365224591,CD14
Alcoholic Intoxication,1/41,0.07887918037823767,0.22308621144095533,0,0,12.195121951219512,30.97363365224591,MTHFR
Hypoplastic Left Heart Syndrome,1/41,0.07887918037823767,0.22302203243881466,0,0,12.195121951219512,30.97363365224591,ETS1
Laryngeal neoplasm,1/41,0.07887918037823767,0.2229578903529824,0,0,12.195121951219512,30.97363365224591,AHR
Malignant Meningioma,1/41,0.07887918037823767,0.22289378515161581,0,0,12.195121951219512,30.97363365224591,TGFB1
Monoclonal B-Cell Lymphocytosis,1/41,0.07887918037823767,0.22282971680290883,0,0,12.195121951219512,30.97363365224591,IL2
Degenerative Diseases, Central Nervous System,1/42,0.0807252029061721,0.22797910751777573,0,0,11.904761904761903,29.960767247533752,IL6
Vertical Talus,1/42,0.0807252029061721,0.22791361509964364,0,0,11.904761904761903,29.960767247533752,MTHFR
Bulimia Nervosa,1/42,0.0807252029061721,0.22784816029921295,0,0,11.904761904761903,29.960767247533752,DPP4
Cerebellar Diseases,1/42,0.0807252029061721,0.22778274308408253,0,0,11.904761904761903,29.960767247533752,IFNG
Cerebral Edema,1/42,0.0807252029061721,0.22771736342188847,0,0,11.904761904761903,29.960767247533752,TNF
Thin dental enamel,1/43,0.08256761817264792,0.23284779093279304,0,0,11.627906976744185,29.001601245673253,VDR
Transient Cerebral Ischemia,1/43,0.08256761817264792,0.23278099581204353,0,0,11.627906976744185,29.001601245673253,SOD1
Yolk Sac Tumor,1/43,0.08256761817264792,0.23271423900223223,0,0,11.627906976744185,29.001601245673253,RUNX3
Chloracne,1/43,0.08256761817264792,0.23264752047040818,0,0,11.627906976744185,29.001601245673253,AHR
Defective enamel matrix,1/43,0.08256761817264792,0.2325808401836583,0,0,11.627906976744185,29.001601245673253,VDR
Dysplasia of tooth enamel,1/43,0.08256761817264792,0.2325141981091071,0,0,11.627906976744185,29.001601245673253,VDR
Flushing,1/43,0.08256761817264792,0.23244759421391686,0,0,11.627906976744185,29.001601245673253,CXCL10
Gemistocytic astrocytoma,1/43,0.08256761817264792,0.23238102846528744,0,0,11.627906976744185,29.001601245673253,HIF1A
Hyperlipoproteinemias,1/43,0.08256761817264792,0.23231450083045627,0,0,11.627906976744185,29.001601245673253,TGFB1
Hyponatremia,1/43,0.08256761817264792,0.23224801127669828,0,0,11.627906976744185,29.001601245673253,IFNG
Insulin resistance syndrome,1/43,0.08256761817264792,0.23218155977132582,0,0,11.627906976744185,29.001601245673253,TNF
Non-small cell lung cancer metastatic,1/43,0.08256761817264792,0.23211514628168872,0,0,11.627906976744185,29.001601245673253,MTHFR
Radial deviation of finger,1/43,0.08256761817264792,0.23204877077517408,0,0,11.627906976744185,29.001601245673253,INS
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED,1/44,0.08440643303029116,0.23714877753622113,0,0,11.363636363636363,28.092177949395815,IL10
Sickle Cell Trait,1/44,0.08440643303029116,0.23708100137802274,0,0,11.363636363636363,28.092177949395815,IL10
Liposarcoma, Myxoid,1/44,0.08440643303029116,0.23701326394905758,0,0,11.363636363636363,28.092177949395815,IL6
Strawberry nevus of skin,1/44,0.08440643303029116,0.2369455652161387,0,0,11.363636363636363,28.092177949395815,IL6
Abnormal form of the vertebral bodies,1/44,0.08440643303029116,0.23687790514611695,0,0,11.363636363636363,28.092177949395815,VDR
Apraxias,1/44,0.08440643303029116,0.2368102837058811,0,0,11.363636363636363,28.092177949395815,IL2RA
Birth Weight,1/44,0.08440643303029116,0.23674270086235774,0,0,11.363636363636363,28.092177949395815,AHR
Congenital anomaly of brain,1/44,0.08440643303029116,0.23667515658251112,0,0,11.363636363636363,28.092177949395815,IL10
Conjunctivitis,1/44,0.08440643303029116,0.23660765083334329,0,0,11.363636363636363,28.092177949395815,TNF
Glycosuria,1/44,0.08440643303029116,0.2365401835818938,0,0,11.363636363636363,28.092177949395815,INS
Osteosclerosis,1/44,0.08440643303029116,0.23647275479523988,0,0,11.363636363636363,28.092177949395815,TGFB1
Peripheral motor neuropathy,1/44,0.08440643303029116,0.2364053644404963,0,0,11.363636363636363,28.092177949395815,SOD1
Leukemia, Plasma Cell,1/45,0.08624165433518965,0.24147663213853102,0,0,11.11111111111111,27.228910989816466,IL6
Obesity, Visceral,1/45,0.08624165433518965,0.24140785497187237,0,0,11.11111111111111,27.228910989816466,DPP4
Chondrodysplasia,1/45,0.08624165433518965,0.24133911697216512,0,0,11.11111111111111,27.228910989816466,STAT1
Congenital neutropenia,1/45,0.08624165433518965,0.24127041810596184,0,0,11.11111111111111,27.228910989816466,IL1B
Hypoparathyroidism,1/45,0.08624165433518965,0.24120175833985313,0,0,11.11111111111111,27.228910989816466,VDR
Impulsive character (finding),1/45,0.08624165433518965,0.24113313764046768,0,0,11.11111111111111,27.228910989816466,PRL
LATERAL MENINGOCELE SYNDROME,1/45,0.08624165433518965,0.2410645559744721,0,0,11.11111111111111,27.228910989816466,IFNG
Melanoderma (disorder),1/45,0.08624165433518965,0.2409960133085709,0,0,11.11111111111111,27.228910989816466,IL12A
Myxoid/Round Cell Liposarcoma,1/45,0.08624165433518965,0.2409275096095065,0,0,11.11111111111111,27.228910989816466,IL6
Panhypopituitarism,1/45,0.08624165433518965,0.24085904484405907,0,0,11.11111111111111,27.228910989816466,PRL
Telangiectasia of the skin,1/46,0.08807328892912575,0.24590462602143404,0,0,10.869565217391305,26.408543286666195,HLA-DRB1
Telangiectasis,1/46,0.08807328892912575,0.24583478659342453,0,0,10.869565217391305,26.408543286666195,TNF
Thrombus,1/46,0.08807328892912575,0.24576498682437473,0,0,10.869565217391305,26.408543286666195,TNF
Basal Cell Nevus Syndrome,1/46,0.08807328892912575,0.24569522668051313,0,0,10.869565217391305,26.408543286666195,HLA-DRB1
Drusen,1/46,0.08807328892912575,0.24562550612810663,0,0,10.869565217391305,26.408543286666195,SOD1
Exfoliative dermatitis,1/46,0.08807328892912575,0.24555582513346036,0,0,10.869565217391305,26.408543286666195,DPP4
Hereditary Diseases,1/46,0.08807328892912575,0.2454861836629177,0,0,10.869565217391305,26.408543286666195,VDR
Ketosis,1/46,0.08807328892912575,0.24541658168286015,0,0,10.869565217391305,26.408543286666195,HLA-DRB1
Malignant neoplasm of male breast,1/46,0.08807328892912575,0.2453470191597074,0,0,10.869565217391305,26.408543286666195,HIF1A
Undergrowth,3/529,0.08860366429809892,0.24675455163551038,0,0,2.835538752362949,6.8721608633080065,IL21;VDR;INS
Severe congenital neutropenia,1/47,0.08990134362975671,0.25029756521055213,0,0,10.638297872340425,25.62811055096019,IL1B
Chronic pain,1/47,0.08990134362975671,0.25022667946566096,0,0,10.638297872340425,25.62811055096019,IL17A
FRAGILE X TREMOR/ATAXIA SYNDROME,1/47,0.08990134362975671,0.25015583385992324,0,0,10.638297872340425,25.62811055096019,IL10
Hemangioblastoma,1/47,0.08990134362975671,0.2500850283592553,0,0,10.638297872340425,25.62811055096019,HIF1A
Hemoglobinopathies,1/47,0.08990134362975671,0.25001426292961204,0,0,10.638297872340425,25.62811055096019,TGFB1
LIMB-MAMMARY SYNDROME,1/47,0.08990134362975671,0.24994353753698698,0,0,10.638297872340425,25.62811055096019,IFNG
Peripheral demyelinating neuropathy,1/47,0.08990134362975671,0.24987285214741203,0,0,10.638297872340425,25.62811055096019,CXCL10
Protein measurement,1/47,0.08990134362975671,0.24980220672695758,0,0,10.638297872340425,25.62811055096019,HLA-DQA1
Hydrocephalus,2/253,0.0909041078221756,0.2525171203155291,0,0,3.952569169960474,9.478063589947741,HMGB1;PRL
Renal tubular disorder,1/48,0.09172582526946642,0.25472772273193445,0,0,10.416666666666666,24.88490949549096,IL1B
Cytochrome-c Oxidase Deficiency,1/48,0.09172582526946642,0.25465576574811183,0,0,10.416666666666666,24.88490949549096,SOD1
Failure to gain weight,3/539,0.09248544248163783,0.256692157218169,0,0,2.7829313543599254,6.625335877808775,IL21;VDR;INS
Abnormality of vision,1/49,0.09354674065934461,0.25956447408245026,0,0,10.204081632653061,24.176470076489615,HLA-DRB1
Amenorrhea,1/49,0.09354674065934461,0.25949121287045973,0,0,10.204081632653061,24.176470076489615,PRL
Cardiovascular Abnormalities,1/49,0.09354674065934461,0.2594179930022683,0,0,10.204081632653061,24.176470076489615,IL6
Central nervous system demyelination,1/49,0.09354674065934461,0.25934481444288826,0,0,10.204081632653061,24.176470076489615,IL2
Dental Enamel Hypoplasia,1/49,0.09354674065934461,0.25927167715737137,0,0,10.204081632653061,24.176470076489615,VDR
Fibrinogen assay,1/49,0.09354674065934461,0.2591985811108088,0,0,10.204081632653061,24.176470076489615,IL6R
Medullary carcinoma,1/49,0.09354674065934461,0.25912552626833113,0,0,10.204081632653061,24.176470076489615,TNF
Pediatric failure to thrive,3/543,0.0940581376248541,0.2604686888072883,0,0,2.762430939226519,6.529950835703305,IL21;VDR;INS
Carcinosarcoma,1/50,0.09536409657552716,0.26401080032233265,0,0,10.0,23.50053117532367,TGFB1
Clostridium; difficile (disorder),1/50,0.09536409657552716,0.2639364520259873,0,0,10.0,23.50053117532367,IL6
Hypercalciuria,1/50,0.09536409657552716,0.26386214559242144,0,0,10.0,23.50053117532367,VDR
Idiopathic generalized epilepsy,1/50,0.09536409657552716,0.2637878809862879,0,0,10.0,23.50053117532367,IL6
Lymphedema,1/50,0.09536409657552716,0.2637136581722794,0,0,10.0,23.50053117532367,IL6
Muscular fasciculation,1/50,0.09536409657552716,0.26363947711512825,0,0,10.0,23.50053117532367,SOD1
Opiate Addiction,1/50,0.09536409657552716,0.26356533777960656,0,0,10.0,23.50053117532367,IL1B
Tardive Dyskinesia,1/51,0.09717789979173756,0.2685027830062403,0,0,9.80392156862745,22.855019232996256,TNF
Adrenal Cushing's syndrome,1/51,0.09717789979173756,0.2684273184803813,0,0,9.80392156862745,22.855019232996256,IL6
Adult Lymphoma,1/51,0.09717789979173756,0.26835189636223566,0,0,9.80392156862745,22.855019232996256,IFNG
Bicuspid aortic valve,1/51,0.09717789979173756,0.2682765166160665,0,0,9.80392156862745,22.855019232996256,TGFB1
Breast Diseases,1/51,0.09717789979173756,0.26820117920617714,0,0,9.80392156862745,22.855019232996256,PRL
C-reactive protein measurement,1/51,0.09717789979173756,0.26812588409691096,0,0,9.80392156862745,22.855019232996256,IL6R
Cystadenoma,1/51,0.09717789979173756,0.26805063125265133,0,0,9.80392156862745,22.855019232996256,HIF1A
Drug-induced tardive dyskinesia,1/51,0.09717789979173756,0.26797542063782176,0,0,9.80392156862745,22.855019232996256,TNF
Hematuria,1/51,0.09717789979173756,0.26790025221688546,0,0,9.80392156862745,22.855019232996256,IL10
Hypsarrhythmia,1/51,0.09717789979173756,0.2678251259543457,0,0,9.80392156862745,22.855019232996256,INS
Metaplasia,1/51,0.09717789979173756,0.2677500418147454,0,0,9.80392156862745,22.855019232996256,IL10
NONAKA MYOPATHY,1/51,0.09717789979173756,0.26767499976266723,0,0,9.80392156862745,22.855019232996256,PRL
Gait, Unsteady,1/52,0.09898815707684175,0.2725849279213227,0,0,9.615384615384615,22.238029437400897,SOD1
Behavioral Symptoms,1/52,0.09898815707684175,0.2725085735997761,0,0,9.615384615384615,22.238029437400897,MTHFR
Friedreich Ataxia,1/52,0.09898815707684175,0.2724322620417812,0,0,9.615384615384615,22.238029437400897,IFNG
Hypocalcemia,1/52,0.09898815707684175,0.2723559932114224,0,0,9.615384615384615,22.238029437400897,VDR
Myopia,2/269,0.10079438999179408,0.27724804501521194,0,0,3.7174721189591073,8.530381337312154,TGFB1;VDR
Leukemia, Lymphocytic, Acute, L2,1/53,0.10079487520046404,0.2771718056715614,0,0,9.433962264150942,21.64780911228837,MTHFR
Stevens-Johnson Syndrome,1/53,0.10079487520046404,0.2770942750965484,0,0,9.433962264150942,21.64780911228837,IFNG
Anxiety neurosis (finding),1/53,0.10079487520046404,0.27701678788315454,0,0,9.433962264150942,21.64780911228837,TNF
Bradycardia,1/53,0.10079487520046404,0.27693934399501274,0,0,9.433962264150942,21.64780911228837,PRL
Childhood Lymphoma,1/53,0.10079487520046404,0.2768619433957967,0,0,9.433962264150942,21.64780911228837,IFNG
granulosa cell tumor,1/53,0.10079487520046404,0.2767845860492206,0,0,9.433962264150942,21.64780911228837,RUNX3
Hypophosphatemia,1/53,0.10079487520046404,0.27670727191903927,0,0,9.433962264150942,21.64780911228837,VDR
NEUROTICISM,1/53,0.10079487520046404,0.2766300009690479,0,0,9.433962264150942,21.64780911228837,MTHFR
Cognition,1/54,0.10259806088452916,0.2815002072510197,0,0,9.259259259259258,21.082743020231433,DPP4
Drug Withdrawal Symptoms,1/54,0.10259806088452916,0.2814216417452282,0,0,9.259259259259258,21.082743020231433,PRL
Pancreatic Diseases,1/54,0.10259806088452916,0.2813431200817948,0,0,9.259259259259258,21.082743020231433,IL6
Hallucinations, Sensory,1/55,0.10439772086926839,0.2861982707679692,0,0,9.09090909090909,20.541340313872972,HLA-DRB1
Spastic Quadriplegia,1/55,0.10439772086926839,0.2861184608765113,0,0,9.09090909090909,20.541340313872972,IL6
Primary central nervous system lymphoma,1/55,0.10439772086926839,0.2860386954845748,0,0,9.09090909090909,20.541340313872972,MTHFR
Adenoviral infections,1/56,0.10619386186177694,0.29087883901269335,0,0,8.928571428571427,20.022222944253272,TNF
Adult Cholangiocarcinoma,1/56,0.10619386186177694,0.2907977916905945,0,0,8.928571428571427,20.022222944253272,TGFB1
Glucocorticoid Receptor Deficiency,1/56,0.10619386186177694,0.2907167895202072,0,0,8.928571428571427,20.022222944253272,S100A9
Parathyroid Neoplasms,1/56,0.10619386186177694,0.2906358324638106,0,0,8.928571428571427,20.022222944253272,VDR
Pituitary-dependent Cushing's disease,1/56,0.10619386186177694,0.290554920483726,0,0,8.928571428571427,20.022222944253272,PRL
Sentinel node (disorder),1/57,0.10798649057416929,0.2953774643370264,0,0,8.771929824561402,19.52411532419468,IL10
Ectodermal Dysplasia,1/57,0.10798649057416929,0.29529527806425593,0,0,8.771929824561402,19.52411532419468,IFNG
Geographic Atrophy,1/57,0.10798649057416929,0.29521313751402944,0,0,8.771929824561402,19.52411532419468,IL6
Obsessive compulsive behavior,1/57,0.10798649057416929,0.2951310426482024,0,0,8.771929824561402,19.52411532419468,TNF
Recurrent bacterial infection,1/58,0.10977561369601414,0.2999373732011195,0,0,8.620689655172413,19.045835103967377,IL2RA
Substance Withdrawal Syndrome,1/58,0.10977561369601414,0.29985401095175845,0,0,8.620689655172413,19.045835103967377,PRL
Extrapyramidal Disorders,1/58,0.10977561369601414,0.29977069502762627,0,0,8.620689655172413,19.045835103967377,PRL
Increased susceptibility to bacterial infections,1/58,0.10977561369601414,0.2996874253901186,0,0,8.620689655172413,19.045835103967377,IL2RA
Large cell carcinoma of lung,1/58,0.10977561369601414,0.29960420200067395,0,0,8.620689655172413,19.045835103967377,IL2
Oncocytic Neoplasm,1/58,0.10977561369601414,0.2995210248207737,0,0,8.620689655172413,19.045835103967377,PRL
Prone to bacterial infection,1/58,0.10977561369601414,0.29943789381194197,0,0,8.620689655172413,19.045835103967377,IL2RA
Skin Abnormalities,1/59,0.11156123790942149,0.3042241526564357,0,0,8.474576271186441,18.58628491465166,VDR
Squamous cell carcinoma of mouth,1/59,0.11156123790942149,0.30413976315500535,0,0,8.474576271186441,18.58628491465166,HIF1A
Paraparesis, Spastic,1/59,0.11156123790942149,0.30405542045862294,0,0,8.474576271186441,18.58628491465166,MTHFR
Urinary Incontinence,1/59,0.11156123790942149,0.30397112452835995,0,0,8.474576271186441,18.58628491465166,TGFB1
Generalized myoclonic seizures,1/59,0.11156123790942149,0.30388687532533104,0,0,8.474576271186441,18.58628491465166,INS
Leukocyte adhesion deficiency type 1,1/59,0.11156123790942149,0.3038026728106939,0,0,8.474576271186441,18.58628491465166,IL17A
Angelman Syndrome,1/60,0.11334336985743067,0.3085702600993985,0,0,8.333333333333334,18.14444496996221,MTHFR
Factor V Leiden mutation,1/60,0.11334336985743067,0.3084848072442062,0,0,8.333333333333334,18.14444496996221,MTHFR
Gastrointestinal Stromal Sarcoma,1/60,0.11334336985743067,0.30839940170510205,0,0,8.333333333333334,18.14444496996221,DPP4
Aura,1/61,0.11512201623397456,0.31315227665305895,0,0,8.196721311475411,17.719366412809286,TGFB1
Awakening Epilepsy,1/61,0.11512201623397456,0.31306562688088047,0,0,8.196721311475411,17.719366412809286,TGFB1
Ganglioglioma,1/61,0.11512201623397456,0.31297902504771835,0,0,8.196721311475411,17.719366412809286,IL12A
Marijuana Abuse,1/62,0.11689718365152524,0.31771723476968755,0,0,8.064516129032258,17.310165344679206,IL1B
Nijmegen Breakage Syndrome,1/62,0.11689718365152524,0.31762939478219243,0,0,8.064516129032258,17.310165344679206,IL2
Phyllodes Tumor,1/62,0.11689718365152524,0.3175416033519044,0,0,8.064516129032258,17.310165344679206,HIF1A
Epilepsy, Cryptogenic,1/63,0.11866887875611117,0.32226519491988415,0,0,7.936507936507936,16.916017426736325,TGFB1
Brain Edema,1/63,0.11866887875611117,0.32217617138537585,0,0,7.936507936507936,16.916017426736325,TNF
Difficulty walking,1/63,0.11866887875611117,0.32208719702155775,0,0,7.936507936507936,16.916017426736325,VDR
Fibroadenoma,1/63,0.11866887875611117,0.3219982717877031,0,0,7.936507936507936,16.916017426736325,VDR
gliosarcoma,1/63,0.11866887875611117,0.3219093956431302,0,0,7.936507936507936,16.916017426736325,IL2
Idiopathic hypogonadotropic hypogonadism,1/63,0.11866887875611117,0.32182056854720215,0,0,7.936507936507936,16.916017426736325,IL2
Neuro-degenerative disease,1/63,0.11866887875611117,0.3217317904593271,0,0,7.936507936507936,16.916017426736325,SOD1
Autosomal dominant retinitis pigmentosa,1/64,0.12043710813779931,0.32643571394878423,0,0,7.8125,16.536153019288253,INS
Cytogenetically normal acute myeloid leukemia,1/64,0.12043710813779931,0.3263457123733917,0,0,7.8125,16.536153019288253,HIF1A
Extrapyramidal sign,1/64,0.12043710813779931,0.32625576041298004,0,0,7.8125,16.536153019288253,PRL
Nephronophthisis,1/64,0.12043710813779931,0.3261658580265339,0,0,7.8125,16.536153019288253,TNF
Osteopetrosis,1/64,0.12043710813779931,0.3260760051730831,0,0,7.8125,16.536153019288253,TNF
Rhabdomyolysis,1/65,0.12220187846195762,0.3307628921851059,0,0,7.6923076923076925,16.16985277179752,INS
Melanocytic nevus of skin,1/65,0.12220187846195762,0.3306718231068611,0,0,7.6923076923076925,16.16985277179752,HIF1A
Skeletal dysplasia,1/66,0.12396319624600918,0.33534552510481097,0,0,7.575757575757576,15.816443650757057,STAT1
Cleft palate with cleft lip,1/66,0.12396319624600918,0.3352532451034062,0,0,7.575757575757576,15.816443650757057,TGFB1
Dentatorubral-Pallidoluysian Atrophy,1/66,0.12396319624600918,0.33516101587504216,0,0,7.575757575757576,15.816443650757057,TNF
GRN-related frontotemporal dementia,1/66,0.12396319624600918,0.3350688373778268,0,0,7.575757575757576,15.816443650757057,SOD1
Mastocytosis, Systemic,1/67,0.12572106812860523,0.33972687862742157,0,0,7.462686567164178,15.475295305951537,IL2RA
Cerebral Hemorrhage,1/67,0.12572106812860523,0.3396334957580902,0,0,7.462686567164178,15.475295305951537,MTHFR
Cushing Syndrome,1/67,0.12572106812860523,0.33954016421212757,0,0,7.462686567164178,15.475295305951537,IL6
Multiple Chronic Conditions,1/67,0.12572106812860523,0.3394468839472341,0,0,7.462686567164178,15.475295305951537,HMGB1
Oxyphilic Adenoma,1/67,0.12572106812860523,0.3393536549211569,0,0,7.462686567164178,15.475295305951537,PRL
Recurrent infections,1/68,0.12747550064045512,0.3439948435734193,0,0,7.352941176470588,15.145816799167308,HLA-DRB1
Undifferentiated leukemia,1/68,0.12747550064045512,0.3439004173193503,0,0,7.352941176470588,15.145816799167308,IL2RA
Adenomatous polyp of colon,1/68,0.12747550064045512,0.34380604289088723,0,0,7.352941176470588,15.145816799167308,VDR
Angle class 2 malocclusion,1/68,0.12747550064045512,0.34371172024537533,0,0,7.352941176470588,15.145816799167308,IL2RA
Angle class 3 malocclusion,1/68,0.12747550064045512,0.34361744934020655,0,0,7.352941176470588,15.145816799167308,IL2RA
Primary hypogonadism,1/68,0.12747550064045512,0.3435232301328196,0,0,7.352941176470588,15.145816799167308,PRL
Simple Partial Status Epilepticus,1/69,0.12922650035538952,0.34814639404955267,0,0,7.246376811594203,14.827453605479835,TNF
Status Epilepticus, Subclinical,1/69,0.12922650035538952,0.348050985336467,0,0,7.246376811594203,14.827453605479835,TNF
Complex Partial Status Epilepticus,1/69,0.12922650035538952,0.3479556289021282,0,0,7.246376811594203,14.827453605479835,TNF
Grand Mal Status Epilepticus,1/69,0.12922650035538952,0.3478603247035793,0,0,7.246376811594203,14.827453605479835,TNF
Malignant neoplasm of salivary gland,1/69,0.12922650035538952,0.34776507269791024,0,0,7.246376811594203,14.827453605479835,RUNX3
Mucoepidermoid Carcinoma,1/69,0.12922650035538952,0.3476698728422579,0,0,7.246376811594203,14.827453605479835,RUNX3
Non-Convulsive Status Epilepticus,1/69,0.12922650035538952,0.34757472509380627,0,0,7.246376811594203,14.827453605479835,TNF
Progressive supranuclear palsy,1/69,0.12922650035538952,0.34747962940978605,0,0,7.246376811594203,14.827453605479835,TGM2
Glaucoma, Open-Angle,1/70,0.13097407381023796,0.35208238441111017,0,0,7.142857142857142,14.51968489438025,MTHFR
Hereditary pancreatitis,1/70,0.13097407381023796,0.35198610812333025,0,0,7.142857142857142,14.51968489438025,IRF1
Knee joint valgus deformity,1/70,0.13097407381023796,0.351889884474308,0,0,7.142857142857142,14.51968489438025,TGFB1
Neck Neoplasms,1/70,0.13097407381023796,0.3517937134208851,0,0,7.142857142857142,14.51968489438025,IL2
Ovarian adenocarcinoma,1/70,0.13097407381023796,0.35169759491995045,0,0,7.142857142857142,14.51968489438025,IL1B
Splenic Marginal Zone B-Cell Lymphoma,1/71,0.13271822757449078,0.3562837313854399,0,0,7.042253521126761,14.2220210409275,IL2RA
Malocclusion,1/71,0.13271822757449078,0.3561864392687317,0,0,7.042253521126761,14.2220210409275,IL2RA
Pediatric Obesity,1/71,0.13271822757449078,0.3560892002735723,0,0,7.042253521126761,14.2220210409275,INS
secondary acute myeloid leukemia,1/72,0.13445896809893665,0.36066122775009535,0,0,6.944444444444444,13.934001363749388,CD14
Varying degree of multiple fractures,1/72,0.13445896809893665,0.3605628208666711,0,0,6.944444444444444,13.934001363749388,VDR
Benign melanocytic nevus,1/72,0.13445896809893665,0.36046446766948975,0,0,6.944444444444444,13.934001363749388,TLR4
Frequent fractures,1/72,0.13445896809893665,0.36036616811463035,0,0,6.944444444444444,13.934001363749388,VDR
Hallucinations,1/72,0.13445896809893665,0.36026792215821957,0,0,6.944444444444444,13.934001363749388,HLA-DRB1
Increased fracture rate,1/72,0.13445896809893665,0.3601697297564321,0,0,6.944444444444444,13.934001363749388,VDR
Learning Disabilities,1/72,0.13445896809893665,0.3600715908654903,0,0,6.944444444444444,13.934001363749388,IL1B
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1,1/73,0.13619630195383398,0.36462469507008455,0,0,6.8493150684931505,13.655192035770261,IL6
Fractures, Multiple,1/73,0.13619630195383398,0.36452539640584974,0,0,6.8493150684931505,13.655192035770261,VDR
Attention Deficit Disorder,1/73,0.13619630195383398,0.36442615181113,0,0,6.8493150684931505,13.655192035770261,INS
Cystic Kidney Diseases,1/73,0.13619630195383398,0.3643269612417747,0,0,6.8493150684931505,13.655192035770261,INS
Dysplastic Nevus,1/73,0.13619630195383398,0.3642278246536817,0,0,6.8493150684931505,13.655192035770261,STAT1
hypopigmented skin patch,1/73,0.13619630195383398,0.3641287420027966,0,0,6.8493150684931505,13.655192035770261,HLA-DRB1
High density lipoprotein measurement,2/324,0.13683030262703566,0.36572428996967815,0,0,3.0864197530864197,6.138931444110966,IL15;IL6R
Acoustic Neuroma,1/74,0.13793023560669793,0.3685639900877181,0,0,6.756756756756757,13.38518419415403,SOD1
DiGeorge Syndrome,1/74,0.13793023560669793,0.36846380960658526,0,0,6.756756756756757,13.38518419415403,IL2
Marginal Zone B-Cell Lymphoma,1/74,0.13793023560669793,0.36836368357136606,0,0,6.756756756756757,13.38518419415403,TNF
Shy-Drager Syndrome,1/75,0.13966077554387377,0.37288402663547715,0,0,6.666666666666667,13.12359218996336,IL1B
Comatose,1/75,0.13966077554387377,0.37278275449353376,0,0,6.666666666666667,13.12359218996336,IL6
Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,1/75,0.13966077554387377,0.37268153734596565,0,0,6.666666666666667,13.12359218996336,IL6
Polycythemia,1/75,0.13966077554387377,0.372580375147989,0,0,6.666666666666667,13.12359218996336,HIF1A
Systemic arterial pressure,1/76,0.1413879282392794,0.37708563330682165,0,0,6.578947368421052,12.870051988783802,MTHFR
Varicosity,1/76,0.1413879282392794,0.3769833311816706,0,0,6.578947368421052,12.870051988783802,HIF1A
Acute Undifferentiated Leukemia,1/76,0.1413879282392794,0.37688108454994246,0,0,6.578947368421052,12.870051988783802,IL2RA
Axonal neuropathy,1/76,0.1413879282392794,0.37677889336649617,0,0,6.578947368421052,12.870051988783802,CD80
Blood Pressure,1/76,0.1413879282392794,0.3766767575862396,0,0,6.578947368421052,12.870051988783802,MTHFR
Blood pressure finding,1/76,0.1413879282392794,0.3765746771641295,0,0,6.578947368421052,12.870051988783802,MTHFR
Chest Pain,1/76,0.1413879282392794,0.37647265205517144,0,0,6.578947368421052,12.870051988783802,HLA-DRB1
Petit mal status,1/76,0.1413879282392794,0.37637068221441977,0,0,6.578947368421052,12.870051988783802,TNF
Distal amyotrophy,1/77,0.1431117001669465,0.38085615738985923,0,0,6.4935064935064934,12.624219698630808,SOD1
Non-small cell lung cancer stage I,1/77,0.1431117001669465,0.3807530561019898,0,0,6.4935064935064934,12.624219698630808,HIF1A
Parathyroid Adenoma,1/77,0.1431117001669465,0.38065001061995946,0,0,6.4935064935064934,12.624219698630808,VDR
Androgen-Insensitivity Syndrome,1/78,0.14483209774889816,0.385121714468661,0,0,6.41025641025641,12.385770218326877,MTHFR
Glioblastoma, IDH-Wildtype,1/79,0.1465491274263136,0.38958204607676766,0,0,6.329113924050633,12.15439598699508,HIF1A
Spinocerebellar Ataxia Type 1,1/79,0.1465491274263136,0.38947669668626556,0,0,6.329113924050633,12.15439598699508,HMGB1
Gliosis,1/79,0.1465491274263136,0.3893714042567748,0,0,6.329113924050633,12.15439598699508,CXCL10
Abnormality of the metaphysis,1/80,0.14826279563954406,0.3938180420393078,0,0,6.25,11.92980583500593,VDR
Dyslexia,1/80,0.14826279563954406,0.393711633489716,0,0,6.25,11.92980583500593,HMGB1
Luminal B Breast Carcinoma,1/80,0.14826279563954406,0.393605282427185,0,0,6.25,11.92980583500593,TNF
Congenital ear anomaly NOS (disorder),1/81,0.14997310878201375,0.3980382698108645,0,0,6.172839506172839,11.711723924346305,INS
Granulocyte count,1/81,0.14997310878201375,0.39793080807495446,0,0,6.172839506172839,11.711723924346305,ZMIZ1
Cholecystolithiasis,1/82,0.15168007326659602,0.40235135224402313,0,0,6.097560975609756,11.499888764887496,TLR4
Hydatidiform Mole,1/83,0.15338369548447178,0.4067606473883941,0,0,6.024096385542169,11.294052308932752,HLA-DRB1
Paraganglioma,1/83,0.15338369548447178,0.4066509196712675,0,0,6.024096385542169,11.294052308932752,HIF1A
Late tooth eruption,1/84,0.15508398180156174,0.4110478352604501,0,0,5.952380952380952,11.09397911142091,VDR
Downturned corners of mouth,1/85,0.15678093860097192,0.41543355744684607,0,0,5.88235294117647,10.89944555000165,INS
Curvature of digit,1/86,0.15847457220368777,0.41980811202637286,0,0,5.813953488372093,10.710239106230775,INS
Irritation - emotion,1/86,0.15847457220368777,0.4196949866930324,0,0,5.813953488372093,10.710239106230775,VDR
Leukoencephalopathies,1/86,0.15847457220368777,0.4195819223108414,0,0,5.813953488372093,10.710239106230775,MTHFR
Muscle Cramp,1/86,0.15847457220368777,0.419468918830553,0,0,5.813953488372093,10.710239106230775,SOD1
Muscular hypotonia of the trunk,1/86,0.15847457220368777,0.41935597620297344,0,0,5.813953488372093,10.710239106230775,INS
Generalized muscle weakness,1/87,0.16016488895102154,0.4237148125466056,0,0,5.747126436781609,10.526157692314088,SOD1
Gynecomastia,1/87,0.16016488895102154,0.423600788108353,0,0,5.747126436781609,10.526157692314088,PRL
Malignant Childhood Neoplasm,1/87,0.16016488895102154,0.42348682502304,0,0,5.747126436781609,10.526157692314088,TNF
Myoclonic Epilepsies, Progressive,1/88,0.16185189522239182,0.4278322824759728,0,0,5.681818181818182,10.34700902802518,INS
Abnormality of the skeletal system,1/88,0.16185189522239182,0.4277172428732635,0,0,5.681818181818182,10.34700902802518,IL6
Retinal Degeneration,1/89,0.16353559727600164,0.4320504973195011,0,0,5.617977528089887,10.172610067415423,SOD1
Bronchioloalveolar Adenocarcinoma,1/89,0.16353559727600164,0.43193438592543515,0,0,5.617977528089887,10.172610067415423,IRF1
Congenital clinodactyly,1/89,0.16353559727600164,0.4318183369233058,0,0,5.617977528089887,10.172610067415423,INS
Cystic kidney,1/90,0.16521600146865117,0.43613829235398976,0,0,5.555555555555555,10.002786452197885,INS
Dehydration,1/90,0.16521600146865117,0.43602117680824487,0,0,5.555555555555555,10.002786452197885,INS
Turridolichocephaly,1/91,0.16689311403362564,0.44032899992549607,0,0,5.4945054945054945,9.837372017596035,VDR
Narrow cranium shape,1/91,0.16689311403362564,0.4402108225234763,0,0,5.4945054945054945,9.837372017596035,VDR
Narrow head shape,1/91,0.16689311403362564,0.44009270853836135,0,0,5.4945054945054945,9.837372017596035,VDR
Narrow skull shape,1/91,0.16689311403362564,0.4399746579191182,0,0,5.4945054945054945,9.837372017596035,VDR
Cholestasis in newborn,1/92,0.16856694133347067,0.44426814143881727,0,0,5.434782608695652,9.676208315979686,CD14
Small for gestational age (disorder),1/93,0.17023748955633272,0.44855068293824074,0,0,5.376344086021506,9.519144190509108,INS
Low Birth Weights,1/93,0.17023748955633272,0.44843046029473005,0,0,5.376344086021506,9.519144190509108,INS
Hepatomegaly,2/373,0.1709805313479389,0.45026705843717674,0,0,2.680965147453083,4.735135605167616,IL2RA;AHR
Long narrow head,1/94,0.17190476501211555,0.45257970279642956,0,0,5.319148936170213,9.366035357992633,VDR
Renal cyst,1/95,0.17356877395262765,0.45683821917686784,0,0,5.263157894736842,9.216744034104446,TNF
MAJOR AFFECTIVE DISORDER 2,1/96,0.17522952257084182,0.461085876258697,0,0,5.208333333333333,9.071138577350286,IL10
Global developmental delay,4/1102,0.17669786424615674,0.464825109692513,0,0,1.8148820326678765,3.145760411291625,IL2RA;MTHFR;S100A9;INS
Ovarian Serous Adenocarcinoma,1/97,0.17688701714313435,0.465198181558128,0,0,5.154639175257731,8.92909315179004,IL10
Central Serous Chorioretinopathy,1/98,0.178541263849713,0.46942309821160494,0,0,5.1020408163265305,8.790487420672006,TGFB1
Malformations of Cortical Development,1/99,0.18019226886567122,0.4736372341299323,0,0,5.050505050505051,8.655206251537622,HMGB1
Erythrocyte Mean Corpuscular Hemoglobin Test,2/387,0.18099803608392664,0.4756279942868532,0,0,2.5839793281653747,4.41671601586621,HMGB1;HLA-DQA1
Finding of Mean Corpuscular Hemoglobin,2/387,0.18099803608392664,0.47550085502080486,0,0,2.5839793281653747,4.41671601586621,HMGB1;HLA-DQA1
Mood swings,1/100,0.18184003844564067,0.47758522123029307,0,0,5.0,8.523139440061096,SOD1
Neuromuscular Diseases,1/101,0.18348457872210075,0.481775698552179,0,0,4.9504950495049505,8.394181458814943,SOD1
Hypertrophy of lower jaw,1/102,0.1851258958653396,0.48595547664651645,0,0,4.901960784313725,8.268231211570072,TGFB1
mandibular excess (physical finding),1/102,0.1851258958653396,0.4858257155045547,0,0,4.901960784313725,8.268231211570072,TGFB1
Mandibular hyperplasia,1/102,0.1851258958653396,0.4856960236424339,0,0,4.901960784313725,8.268231211570072,TGFB1
Respiratory distress,1/104,0.18839888544735434,0.4941511198763273,0,0,4.8076923076923075,8.024970349720695,TGFB1
Increased size of the mandible,1/104,0.18839888544735434,0.49401927592758765,0,0,4.8076923076923075,8.024970349720695,TGFB1
Leukemia, Myelomonocytic, Chronic,1/108,0.194906457103083,0.5109470953345158,0,0,4.629629629629629,7.570534919807214,IL10
Class III malocclusion,1/108,0.194906457103083,0.5108108427757599,0,0,4.629629629629629,7.570534919807214,TGFB1
Borderline Personality Disorder,1/110,0.1981411368718355,0.5191498515532923,0,0,4.545454545454545,7.358071316971547,MTHFR
Dry skin,1/110,0.1981411368718355,0.5190114853881661,0,0,4.545454545454545,7.358071316971547,TNF
Lethargy,1/110,0.1981411368718355,0.518873192959339,0,0,4.545454545454545,7.358071316971547,IL1B
Luminal A Breast Carcinoma,1/110,0.1981411368718355,0.5187349742078847,0,0,4.545454545454545,7.358071316971547,AHR
Mental Retardation,4/1158,0.19945704311584797,0.5220409639793752,0,0,1.7271157167530224,2.784380636554516,IL6;MTHFR;IL12A;SOD1
Physical Activity Measurement,1/111,0.19975372152920057,0.5226782681546813,0,0,4.504504504504505,7.255270556642503,ZMIZ1
Muscular Dystrophy, Facioscapulohumeral,1/112,0.2013631441044547,0.526749262778435,0,0,4.4642857142857135,7.154666580054686,IRF1
Merkel cell carcinoma,1/112,0.2013631441044547,0.5266090953322461,0,0,4.4642857142857135,7.154666580054686,S100A9
Cocaine-Related Disorders,1/113,0.20296941061883486,0.5306686266458923,0,0,4.424778761061947,7.056194680979831,PRL
Obsessive-Compulsive Disorder,1/114,0.20457252711779186,0.5347177650302283,0,0,4.385964912280701,6.9597925900968045,TNF
Ataxia, Spinocerebellar,1/116,0.20776933416064633,0.5429292784181952,0,0,4.310344827586206,6.772960280280036,SOD1
Condition, Preneoplastic,1/116,0.20776933416064633,0.5427849590991047,0,0,4.310344827586206,6.772960280280036,IL6
Familial (FPAH),1/116,0.20776933416064633,0.5426407164844093,0,0,4.310344827586206,6.772960280280036,SOD1
Hypogonadism, Isolated Hypogonadotropic,1/117,0.20936303672499665,0.5466577908961922,0,0,4.273504273504273,6.682416735320993,PRL
Teratoma,1/117,0.20936303672499665,0.546512596263816,0,0,4.273504273504273,6.682416735320993,HIF1A
Diastolic blood pressure,1/117,0.20936303672499665,0.5463674787395824,0,0,4.273504273504273,6.682416735320993,MTHFR
Red Blood Cell Count measurement,1/118,0.2109536132441654,0.550372208909917,0,0,4.237288135593221,6.593716153049479,HLA-DQA1
Anemia, Hemolytic,1/118,0.2109536132441654,0.5502261440986351,0,0,4.237288135593221,6.593716153049479,MTHFR
Mental Retardation, X-Linked,1/118,0.2109536132441654,0.5500801567958762,0,0,4.237288135593221,6.593716153049479,IL1B
Systolic Pressure,1/118,0.2109536132441654,0.5499342469399622,0,0,4.237288135593221,6.593716153049479,MTHFR
Muscle Rigidity,1/119,0.2125410697572345,0.5539256519687352,0,0,4.201680672268908,6.5068068901092,SOD1
Prader-Willi Syndrome,1/119,0.2125410697572345,0.5537787999931337,0,0,4.201680672268908,6.5068068901092,IL6
Platelet distribution width measurement,1/120,0.21412541218649167,0.5577589586453328,0,0,4.166666666666667,6.421639155662539,ZMIZ1
Platelet distribution width result,1/120,0.21412541218649167,0.5576111687781771,0,0,4.166666666666667,6.421639155662539,ZMIZ1
Acute Myeloid Leukemia (AML-M2),1/121,0.21570664652092617,0.5615801117901091,0,0,4.132231404958678,6.338164927002905,RUNX3
Polycystic Kidney Diseases,1/124,0.22043176017939123,0.5737296978397926,0,0,4.032258064516129,6.097448022733102,TGFB1
Tetralogy of Fallot,1/125,0.22200062138320123,0.5776600759740804,0,0,4.0,6.020300392361384,HIF1A
Congenital hypoplasia of lung,1/125,0.22200062138320123,0.5775071749481476,0,0,4.0,6.020300392361384,TNF
Hypogonadotropic hypogonadism,1/126,0.22356640404400585,0.5814264670400872,0,0,3.968253968253968,5.94463015571553,PRL
Hyperkeratosis,1/127,0.22512911409287154,0.5853356966414659,0,0,3.9370078740157477,5.870398428930724,IL1B
Cocaine Abuse,1/128,0.2266887573639651,0.5892348869010974,0,0,3.90625,5.797567637774377,PRL
Dystonia Disorders,1/135,0.23752088236080357,0.617227718625589,0,0,3.7037037037037037,5.3240730875666005,HLA-DRB1
Flexion contractures of joints,1/135,0.23752088236080357,0.6170645603600258,0,0,3.7037037037037037,5.3240730875666005,HLA-DRB1
Hirschsprung Disease,1/135,0.23752088236080357,0.6169014883303323,0,0,3.7037037037037037,5.3240730875666005,CD14
Neurilemmoma,1/135,0.23752088236080357,0.6167385024681579,0,0,3.7037037037037037,5.3240730875666005,ETS1
Cholelithiasis,1/136,0.2390562017907975,0.6205611070258737,0,0,3.676470588235294,5.261237502788927,TLR4
Flexion contracture,1/136,0.2390562017907975,0.6203972408766723,0,0,3.676470588235294,5.261237502788927,HLA-DRB1
Follicular adenoma,1/136,0.2390562017907975,0.6202334612460291,0,0,3.676470588235294,5.261237502788927,PRL
Prominent eyes,1/137,0.24058850686050348,0.6240442980799759,0,0,3.6496350364963503,5.199515493584321,TGFB1
Protruding eyes,1/137,0.24058850686050348,0.6238796425923557,0,0,3.6496350364963503,5.199515493584321,TGFB1
Sensorineural Hearing Loss (disorder),2/471,0.242611530025512,0.6289596721421081,0,0,2.1231422505307855,3.0069931140197848,MTHFR;HLA-DRB1
Prominent globes,1/139,0.24364409692168354,0.6314699853761355,0,0,3.5971223021582737,5.079304811808925,TGFB1
Acid reflux,1/140,0.24516739343862784,0.6352504990020655,0,0,3.571428571428571,5.020764511477067,HLA-DRB1
Contracture of joint,1/140,0.24516739343862784,0.6350830634461873,0,0,3.571428571428571,5.020764511477067,HLA-DRB1
Exophthalmos,1/142,0.24820501808478276,0.6427823235144255,0,0,3.5211267605633805,4.906690804605423,TGFB1
Substance Use Disorders,1/143,0.24971935766313483,0.6465336794292121,0,0,3.4965034965034962,4.8511103532176865,TLR4
Disease Exacerbation,1/144,0.25123072303466765,0.6502753610705067,0,0,3.472222222222222,4.796470648584845,STAT1
Mammary Carcinoma, Animal,1/145,0.25273911983225783,0.6540073906559847,0,0,3.4482758620689653,4.742749893656568,PRL
Animal Mammary Neoplasms,1/145,0.25273911983225783,0.6538352381446249,0,0,3.4482758620689653,4.742749893656568,PRL
Decreased platelet count,1/152,0.26321525448837263,0.6807577687136122,0,0,3.289473684210526,4.39073395864438,HLA-DRB1
Osteochondrodysplasias,1/152,0.26321525448837263,0.6805786690638586,0,0,3.289473684210526,4.39073395864438,STAT1
Substance abuse problem,1/155,0.2676610632899671,0.6918918805927923,0,0,3.225806451612903,4.251721897039138,PRL
Monocyte count procedure,1/155,0.2676610632899671,0.6917099474135673,0,0,3.225806451612903,4.251721897039138,ETS1
Monocyte count result,1/155,0.2676610632899671,0.6915281098879591,0,0,3.225806451612903,4.251721897039138,ETS1
Anxiety disease,1/157,0.2706103934030746,0.6989642434600307,0,0,3.1847133757961785,4.162659730096573,SOD1
Cocaine Dependence,1/157,0.2706103934030746,0.6987805954717333,0,0,3.1847133757961785,4.162659730096573,PRL
Polycystic Kidney, Autosomal Dominant,1/161,0.2764743519798598,0.7137352065295671,0,0,3.105590062111801,3.992662179778549,TNF
Heartburn,1/162,0.27793314436408934,0.7173127475867306,0,0,3.0864197530864197,3.951773710223182,HLA-DRB1
Atrial Septal Defects,1/165,0.2822923362805408,0.728372034908153,0,0,3.0303030303030303,3.8327639137002607,MTHFR
Contracture,1/166,0.283739690105335,0.7319143502244705,0,0,3.0120481927710845,3.7942712207143785,HLA-DRB1
Cleft upper lip,1/169,0.28806469762723846,0.7428758457833902,0,0,2.9585798816568047,3.682160294485133,MTHFR
Movement Disorders,1/169,0.28806469762723846,0.7426809675447271,0,0,2.9585798816568047,3.682160294485133,SOD1
Azoospermia,1/174,0.29521652287167005,0.7609200070240685,0,0,2.8735632183908044,3.505879931134142,MTHFR
Prostatic Intraepithelial Neoplasias,1/174,0.29521652287167005,0.7607204999430449,0,0,2.8735632183908044,3.505879931134142,HIF1A
Small nose,1/176,0.2980575968891147,0.7678401211602148,0,0,2.840909090909091,3.438831059662376,INS
Short nose,1/179,0.30229828207251697,0.7785606698660107,0,0,2.793296089385475,3.3417348046627096,INS
Respiratory Insufficiency,1/182,0.3065139844556428,0.789211275669389,0,0,2.7472527472527473,3.2486041163847075,IL10
Delayed bone age,1/183,0.3079136916499467,0.7926075855253211,0,0,2.73224043715847,3.218403708179829,STAT1
Cerebellar Ataxia,2/565,0.31263862461827063,0.804559414178676,0,0,1.7699115044247786,2.0578890431647174,IFNG;TGM2
Vomiting,1/187,0.31348502689546265,0.8065263990389023,0,0,2.67379679144385,3.1016141207186143,IFNG
Craniofacial Abnormalities,1/187,0.31348502689546265,0.806315321729549,0,0,2.67379679144385,3.1016141207186143,ETS1
Long philtrum,1/190,0.3176348074132269,0.8167752190625835,0,0,2.631578947368421,3.018034106538042,INS
Deglutition Disorders,1/191,0.3190126249013123,0.8201036038530206,0,0,2.617801047120419,2.9909020955164376,HLA-DRB1
Platelet Count measurement,1/191,0.3190126249013123,0.8198891416135192,0,0,2.617801047120419,2.9909020955164376,IRF1
Mean Corpuscular Volume (result),1/194,0.32312982225397574,0.8302535668266858,0,0,2.5773195876288657,2.9116007990396793,HMGB1
Congenital clubfoot,1/198,0.32858168380858743,0.844040979736225,0,0,2.5252525252525255,2.810529835898808,MTHFR
Muscular Dystrophy,1/203,0.3353363294141514,0.8611668266219702,0,0,2.4630541871921183,2.6911854246202696,SOD1
Brachydactyly,1/204,0.33667928556367555,0.8643897645036058,0,0,2.4509803921568625,2.6681972466790826,HLA-DRB1
Osteogenesis Imperfecta,1/204,0.33667928556367555,0.8641640163279716,0,0,2.4509803921568625,2.6681972466790826,VDR
Hypogonadism,1/205,0.33801959598722336,0.8673776995724364,0,0,2.4390243902439024,2.6454912411856544,PRL
Intelligence,1/214,0.34996416587254775,0.8977937411107803,0,0,2.3364485981308407,2.453094656452078,DPP4
Frontal bossing,1/216,0.3525898368719749,0.9042935586580819,0,0,2.3148148148148144,2.413078316726356,VDR
Microphthalmos,1/222,0.36040495809387746,0.9240959896025639,0,0,2.2522522522522523,2.2984842255526248,TNF
Ventricular Septal Defects,1/226,0.36556385759361026,0.9370791842540432,0,0,2.2123893805309733,2.2263590753858957,ETS1
Intellectual Disability,6/2503,0.3848801816374126,0.9863370078572337,0,0,1.1985617259288852,1.14441455412521,IL6;STAT1;VDR;MTHFR;IL12A;SOD1
Dystonia,1/251,0.39689984576203136,1.0,0,0,1.9920318725099602,1.840779497609195,HLA-DRB1
Hearing Loss, Partial,1/260,0.4078071436162327,1.0,0,0,1.9230769230769231,1.7249248145094425,TGFB1
Deafness,1/273,0.42322329474576104,1.0,0,0,1.8315018315018314,1.5748266587136492,TGFB1
Infant, Small for Gestational Age,1/275,0.4255600126470455,1.0,0,0,1.8181818181818181,1.5533623647552304,INS
Intrauterine retardation,1/278,0.4290477922102243,1.0,0,0,1.7985611510791368,1.5219189973122678,INS
Anteverted nostril,1/283,0.43481492767496616,1.0,0,0,1.7667844522968197,1.471439561917475,INS
Low density lipoprotein cholesterol measurement,1/283,0.43481492767496616,1.0,0,0,1.7667844522968197,1.471439561917475,VDR
Congenital deafness,1/289,0.44166054710343694,1.0,0,0,1.7301038062283738,1.4138645068179478,TGFB1
Short stature,2/750,0.44552542049953825,1.0,0,0,1.3333333333333333,1.0780012974588578,STAT1;VDR
Charcot-Marie-Tooth Disease,1/298,0.4517776418085139,1.0,0,0,1.6778523489932886,1.3331630253272355,SOD1
Hyperreflexia,1/301,0.45511011567654686,1.0,0,0,1.6611295681063123,1.307667569494277,SOD1
Serum total cholesterol measurement,1/307,0.46171591642491533,1.0,0,0,1.6286644951140066,1.258640841273303,FUT2
Arthrogryposis,1/307,0.46171591642491533,1.0,0,0,1.6286644951140066,1.258640841273303,INS
Body Height,1/314,0.4693240310778858,1.0,0,0,1.5923566878980893,1.2045570880178837,ZMIZ1
Blepharoptosis,1/337,0.49359119355675724,1.0,0,0,1.4836795252225519,1.047548438879317,INS
Mitochondrial Diseases,1/384,0.5398632060345654,1.0,0,0,1.3020833333333333,0.8026555907207121,TNF
Curvature of spine,1/408,0.5618744229921463,1.0,0,0,1.2254901960784312,0.7064667900607302,TGFB1
Acquired scoliosis,1/418,0.5707396700035751,1.0,0,0,1.1961722488038278,0.6708398238305151,TGFB1
Cognitive delay,2/966,0.5819867037166246,1.0,0,0,1.0351966873706004,0.560359914450718,MTHFR;INS
Epileptic encephalopathy,1/468,0.6125074815615599,1.0,0,0,1.0683760683760684,0.5237116686361876,MTHFR
Mental and motor retardation,2/1021,0.6127441796786878,1.0,0,0,0.9794319294809011,0.47973335485545543,MTHFR;INS
Genetic Diseases, Inborn,1/507,0.6423095196641037,1.0,0,0,0.9861932938856016,0.4365729522848027,VDR
Small head,1/570,0.6857929735515998,1.0,0,0,0.8771929824561403,0.3308591970429981,MTHFR
Generalized hypotonia,1/633,0.7241065154833264,1.0,0,0,0.7898894154818326,0.25498955496390635,VDR
